data_2kxg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kxg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.093 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.705 HG13 ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -101.31 159.39 4.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 117.71 0.755 . . . . 0.0 111.68 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -79.31 153.32 29.93 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.054 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.06 -23.38 30.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.686 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -53.21 -32.55 48.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.341 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.43 112.83 5.18 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.658 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.58 -26.57 82.51 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.453 2.769 . . . . 0.0 113.934 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HG2' ' HH2' ' A' ' 52' ' ' TRP . 0.7 OUTLIER -78.62 -44.15 24.63 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.275 0.56 . . . . 0.0 110.384 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.705 ' CG2' HG13 ' A' ' 12' ' ' ILE . 72.9 t -65.18 -39.65 86.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.65 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -37.88 77.66 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 13.0 pt-20 -75.28 -37.24 61.01 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.214 0.531 . . . . 0.0 110.562 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.646 HG21 HG23 ' A' ' 77' ' ' VAL . 77.1 mt -74.62 -35.04 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.059 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.63 -54.89 18.48 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.242 0.544 . . . . 0.0 110.217 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 11.3 pt-20 -53.66 -44.28 69.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.078 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 26.9 t80 -60.11 -35.39 75.12 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.435 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.61 -47.11 85.46 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.903 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 37' ' ' LEU . 2.4 tp -66.92 -43.79 82.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.702 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -70.93 -18.14 62.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.741 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -87.08 -38.95 16.03 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.131 0.423 . . . . 0.0 111.205 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -102.42 125.42 49.13 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.573 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -167.5 45.43 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.195 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.536 ' HG2' ' HG2' ' A' ' 33' ' ' GLN . 0.2 OUTLIER -64.36 -37.54 87.86 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.079 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.536 ' HG2' ' HG2' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -107.34 13.3 27.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.882 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 50.93 83.07 0.05 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.407 HD21 ' CZ ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -118.68 165.11 14.38 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.403 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.86 124.25 68.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.518 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . 7.1 tp -90.26 115.75 27.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.546 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.94 -28.96 69.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.456 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 163.26 174.29 32.96 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.577 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.42 HG21 HD21 ' A' ' 60' ' ' LEU . 2.0 t -81.37 132.74 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.568 0.347 . . . . 0.0 110.694 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.1 -63.33 1.27 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.334 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.43 163.73 29.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.56 ' HA3' ' CD2' ' A' ' 58' ' ' LEU . . . -152.33 163.32 30.21 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.954 -1.117 . . . . 0.0 114.436 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.414 ' H ' ' HG ' ' A' ' 58' ' ' LEU . 68.1 mt-30 -150.27 148.69 29.17 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.127 0.571 . . . . 0.0 110.054 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -133.46 129.19 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.281 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.6 mt -107.54 114.92 47.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.195 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.83 155.49 48.94 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.7 -70.4 0.08 OUTLIER Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 0.3 OUTLIER -120.83 108.99 36.28 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.83 119.18 1.85 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.733 1.622 . . . . 0.0 115.908 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -120.88 23.21 10.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.258 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.725 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 74.44 29.47 1.2 Allowed 'General case' 0 C--N 1.344 0.335 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.711 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -122.31 27.32 7.99 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.591 177.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -50.66 149.04 3.49 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.31 132.72 43.56 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.945 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -117.63 144.18 45.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 112.081 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -143.94 116.98 8.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.666 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.56 ' CD2' ' HA3' ' A' ' 43' ' ' GLY . 4.5 mp -143.18 164.06 31.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.1 mm -119.44 131.4 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.865 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.508 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.47 169.1 18.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.931 0.396 . . . . 0.0 111.619 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.0 m -98.81 135.09 40.76 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.988 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.518 ' CB ' ' HA ' ' A' ' 37' ' ' LEU . . . -153.59 143.23 21.8 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -140.58 164.61 29.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.457 178.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -98.92 -7.17 27.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.238 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.02 148.32 18.4 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.776 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.14 -27.96 48.84 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.951 2.434 . . . . 0.0 112.342 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -89.31 14.29 11.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.741 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -128.43 167.22 17.33 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 121.453 0.644 . . . . 0.0 112.484 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 8.3 m-85 -69.5 160.95 30.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.324 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -109.6 130.99 55.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.411 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.491 ' HE2' ' HB2' ' A' ' 95' ' ' PHE . 25.5 mmmt -112.94 170.08 8.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.02 0.438 . . . . 0.0 111.74 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.73 145.66 25.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.733 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 36.1 m-85 -140.94 136.88 32.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.1 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.475 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -109.11 115.49 30.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.472 ' CG1' ' HA ' ' A' ' 91' ' ' PHE . 2.2 m -121.99 144.38 31.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.726 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.472 HG12 HG22 ' A' ' 89' ' ' VAL . 23.7 t -104.34 127.25 58.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.875 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.646 HG23 HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -126.25 146.78 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.465 HD22 ' HE2' ' A' ' 80' ' ' LYS . 11.8 tp -120.42 129.54 53.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.436 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -93.94 134.94 35.8 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HE2' HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -126.47 131.6 51.63 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.95 0.405 . . . . 0.0 111.91 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.543 ' HB3' ' HB3' ' A' ' 52' ' ' TRP . . . -89.23 -36.44 15.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.378 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 m -57.57 -41.74 81.68 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -11.23 50.75 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.05 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.53 45.51 10.56 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.1 p -165.99 -169.06 1.39 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 111.263 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.643 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -105.86 170.81 7.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.475 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.68 142.7 27.01 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.916 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.741 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 1.5 tm? -101.11 115.79 31.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.381 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.472 HG22 HG12 ' A' ' 76' ' ' VAL . 3.6 t -74.52 -52.29 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.45 156.45 16.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.95 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 4.6 t80 -120.74 124.77 45.95 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.618 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.63 137.69 30.38 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.01 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.13 138.31 12.71 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.733 2.289 . . . . 0.0 112.332 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.475 ' CD2' ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -108.85 39.99 1.9 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.638 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HB2' ' HE2' ' A' ' 71' ' ' LYS . 16.6 p90 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.641 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.224 0 N-CA-C 113.305 0.082 . . . . 0.0 113.305 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.584 HG13 ' CG2' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -97.2 167.14 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 111.267 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 m -91.92 150.34 21.08 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.092 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.97 -20.42 27.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.227 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -55.42 -35.91 65.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.547 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 13.6 t70 -57.49 115.96 12.44 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.904 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.0 Cg_endo -59.54 -28.09 86.59 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.502 2.801 . . . . 0.0 114.133 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.478 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -79.54 -43.47 22.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.034 0.445 . . . . 0.0 110.564 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.584 ' CG2' HG13 ' A' ' 12' ' ' ILE . 48.4 t -62.01 -41.46 91.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.834 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -36.12 68.48 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 12.1 pt-20 -76.87 -37.0 56.35 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.089 0.471 . . . . 0.0 110.982 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.531 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 75.4 mt -76.28 -32.24 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.723 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.27 -50.9 50.62 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.199 0.523 . . . . 0.0 110.239 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.5 pt-20 -58.57 -43.33 89.35 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.065 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 20.0 t80 -56.93 -37.45 71.5 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.415 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.91 -48.71 80.49 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.056 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 37' ' ' LEU . 1.2 tp -64.58 -47.84 77.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.23 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.554 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -67.88 -17.07 64.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.526 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 19.5 tp60 -86.65 -38.17 17.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.33 0.11 . . . . 0.0 111.24 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.494 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 1.4 t60 -104.13 127.09 51.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.781 0.325 . . . . 0.0 110.708 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -171.57 44.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.093 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -37.36 70.82 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.911 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.52 7.66 35.31 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 61.29 96.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.06 160.03 40.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.161 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 124.39 69.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.506 ' CD1' ' HB2' ' A' ' 60' ' ' LEU . 6.5 tp -87.89 116.21 25.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.182 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.27 -30.75 71.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.83 166.27 22.41 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 119.505 -1.331 . . . . 0.0 114.246 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 t -72.38 123.57 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.881 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.509 ' HB2' ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -92.4 -65.74 0.98 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.805 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.78 165.31 30.54 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.105 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.493 ' HA3' HD22 ' A' ' 58' ' ' LEU . . . -165.75 -174.06 34.89 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.665 -1.255 . . . . 0.0 114.306 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 57' ' ' ASN . 49.4 mt-30 -140.13 167.92 21.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.744 -0.728 . . . . 0.0 110.957 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 46' ' ' ILE . 77.0 mt -144.62 140.1 23.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.66 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.447 ' N ' HG23 ' A' ' 45' ' ' ILE . 28.1 mt -106.44 114.61 46.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.73 163.34 30.41 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.201 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.37 -71.8 0.02 OUTLIER Glycine 0 C--N 1.332 0.338 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.448 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 9.7 tt -120.48 109.23 36.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.1 115.22 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 N-CA-C 115.983 1.494 . . . . 0.0 115.983 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -122.24 11.42 10.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.338 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.751 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 76.51 31.97 0.57 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 124.43 1.092 . . . . 0.0 111.876 -178.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.82 26.32 8.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.069 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.06 149.88 43.97 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -101.59 124.16 46.79 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.629 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.534 ' CB ' HG23 ' A' ' 77' ' ' VAL . 13.9 m-85 -104.61 125.19 50.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.175 0.512 . . . . 0.0 112.058 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 44' ' ' GLN . 38.3 t-20 -124.32 111.47 15.85 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.496 HD22 HD11 ' A' ' 12' ' ' ILE . 4.2 mp -138.58 167.64 21.5 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.4 mm -129.05 128.29 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.756 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.509 ' HA ' ' HB2' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -133.04 169.35 16.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.779 0.324 . . . . 0.0 111.498 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -98.84 136.17 39.24 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.611 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 37' ' ' LEU . . . -148.46 144.31 27.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.144 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -145.54 165.9 27.27 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.917 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -96.98 -9.09 28.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.796 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.412 ' OG ' ' HB2' ' A' ' 68' ' ' GLU . 3.8 p -153.2 144.02 15.91 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.891 0.376 . . . . 0.0 111.582 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.87 -30.05 58.18 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.123 2.548 . . . . 0.0 112.851 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -87.8 12.72 12.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.412 ' HB2' ' OG ' ' A' ' 65' ' ' SER . 15.3 mt-10 -125.89 167.67 14.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.247 0.546 . . . . 0.0 111.741 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 8.4 m-85 -66.89 158.91 29.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.904 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -115.27 130.18 56.83 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.816 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 22.6 mmmt -107.95 169.33 8.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.767 0.318 . . . . 0.0 111.213 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -91.51 152.34 20.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.173 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 32.9 m-85 -144.16 139.67 28.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.499 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.4 ' CB ' HD21 ' A' ' 94' ' ' LEU . 50.2 t30 -109.95 127.09 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 110.139 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 91' ' ' PHE . 42.3 t -126.96 151.04 33.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.539 0.685 . . . . 0.0 112.028 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.1 t -111.01 112.4 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.59 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.534 HG23 ' CB ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -118.89 142.53 33.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.037 0.446 . . . . 0.0 111.62 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.485 HD21 ' HE3' ' A' ' 80' ' ' LYS . 12.6 tp -118.95 128.35 54.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.614 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -87.81 120.82 29.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.346 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.485 ' HE3' HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -113.01 131.22 55.86 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.136 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.14 -35.16 13.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.266 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.6 m -61.04 -42.38 98.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.553 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.34 -9.93 59.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.936 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 61.25 42.15 12.4 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.168 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 t -172.51 178.84 2.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.352 0.596 . . . . 0.0 111.321 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.639 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -86.41 167.89 14.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.102 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -146.25 141.24 27.16 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.966 0.412 . . . . 0.0 111.041 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.526 ' CB ' ' HG2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -99.91 122.53 42.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.555 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.83 -52.73 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.929 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -157.66 155.69 30.46 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.455 ' HA ' HG22 ' A' ' 75' ' ' VAL . 2.3 t80 -123.94 125.1 44.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.971 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.55 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 3.2 t -132.64 143.75 50.05 Favored Pre-proline 0 N--CA 1.469 0.493 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.55 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 68.4 Cg_endo -84.7 139.0 7.41 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.865 2.376 . . . . 0.0 112.679 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.4 HD21 ' CB ' ' A' ' 74' ' ' ASN . 0.5 OUTLIER -113.58 48.88 1.02 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.913 0.387 . . . . 0.0 110.92 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 30.3 p90 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.656 -0.688 . . . . 0.0 111.755 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.243 0 CA-C-O 120.385 -0.119 . . . . 0.0 113.145 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.649 HG13 HG12 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -100.33 163.55 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.941 0.4 . . . . 0.0 111.261 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 m -92.16 150.38 20.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.353 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.23 -22.85 31.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -53.1 -34.82 58.33 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.459 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.424 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 10.1 t70 -57.79 115.13 10.03 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.434 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.18 -29.32 86.66 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.297 2.664 . . . . 0.0 114.009 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 1.8 mpt_? -77.76 -43.29 31.26 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.185 0.517 . . . . 0.0 110.488 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.649 HG12 HG13 ' A' ' 12' ' ' ILE . 55.1 t -61.58 -43.46 97.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.831 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -36.28 73.19 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 12.3 pt-20 -76.78 -37.9 55.01 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.27 0.557 . . . . 0.0 110.848 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.506 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 58.3 mt -74.15 -33.74 36.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.523 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.429 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -69.82 -47.74 61.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.753 0.311 . . . . 0.0 110.852 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 9.8 pt-20 -57.51 -44.79 85.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.046 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.698 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 32.2 t80 -57.93 -37.38 73.98 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.64 -47.52 73.41 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.739 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.581 HD23 ' HB3' ' A' ' 37' ' ' LEU . 1.1 tp -67.26 -45.72 75.82 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.51 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.499 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -69.43 -17.92 63.69 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.534 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 6.0 tp60 -83.4 -37.94 22.61 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.469 0.176 . . . . 0.0 111.161 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.478 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 2.6 t60 -97.7 128.6 44.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.273 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -174.63 36.48 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.27 -38.38 30.99 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.97 0.414 . . . . 0.0 110.191 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 8.9 mt-30 -84.51 -19.85 32.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.146 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 27.7 t-20 74.79 91.65 0.08 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.295 0.638 . . . . 0.0 112.537 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.17 167.07 23.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.068 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.436 ' HB ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -124.83 124.76 68.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.581 ' HB3' HD23 ' A' ' 27' ' ' LEU . 9.9 tp -90.6 113.24 25.22 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.443 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.87 -27.54 68.3 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.666 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.37 177.29 35.27 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.011 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 41' ' ' ASP . 3.1 t -84.81 138.59 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.006 0.522 . . . . 0.0 110.987 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.44 ' N ' HG11 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -109.68 -66.5 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.433 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.26 169.66 17.27 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.81 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.558 ' CA ' ' HG ' ' A' ' 58' ' ' LEU . . . -159.33 174.22 36.21 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 119.761 -1.209 . . . . 0.0 114.916 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 2.1 mm100 -153.75 139.23 17.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.139 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.486 ' CD1' HD11 ' A' ' 12' ' ' ILE . 5.9 mm -124.36 133.7 68.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 111.373 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.6 mt -114.45 115.91 50.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.77 160.45 39.22 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.905 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.33 -75.77 0.07 OUTLIER Glycine 0 C--N 1.332 0.357 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.6 tt -113.39 108.99 51.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -87.34 117.57 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 116.628 1.741 . . . . 0.0 116.628 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.6 22.35 10.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.541 -1.663 . . . . 0.0 107.622 175.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.752 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 76.69 31.49 0.56 Allowed 'General case' 0 C--N 1.345 0.391 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.92 -178.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -122.03 26.97 8.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.637 177.42 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.651 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -53.14 147.5 9.69 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.527 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.91 118.15 32.68 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.919 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.651 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 44.6 m-85 -106.05 134.07 49.76 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.311 0.577 . . . . 0.0 112.397 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -130.92 126.53 36.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.51 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.558 ' HG ' ' CA ' ' A' ' 43' ' ' GLY . 1.6 mp -149.65 154.55 38.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.3 mm -112.46 127.9 69.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.97 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.512 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -130.46 169.23 15.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.954 0.407 . . . . 0.0 111.872 -178.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.9 m -100.45 133.76 44.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.328 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . . . -147.34 138.11 23.53 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 123.547 0.529 . . . . 0.0 112.101 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -135.22 164.34 27.92 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.586 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -88.78 -18.21 28.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.31 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 p -150.55 146.44 19.71 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 111.266 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.19 -26.01 49.93 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.224 2.616 . . . . 0.0 113.292 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -86.73 2.99 46.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -129.19 167.13 18.06 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.496 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.7 m-85 -54.72 159.24 2.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.546 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 11.9 m -117.61 143.44 46.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.067 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 2.8 mmmt -116.01 166.01 12.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.852 0.358 . . . . 0.0 111.094 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -91.86 146.99 23.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.32 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 22.0 m-85 -141.23 139.91 33.85 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.984 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB2' HD11 ' A' ' 59' ' ' ILE . 6.2 t-20 -110.24 125.76 53.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.845 0.355 . . . . 0.0 110.51 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.473 HG13 ' CG ' ' A' ' 91' ' ' PHE . 6.0 m -128.71 153.69 38.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.424 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.22 110.37 31.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.881 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.7 t -115.51 128.17 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.039 0.447 . . . . 0.0 111.504 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.1 tp -102.16 131.53 48.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.046 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -90.94 129.79 36.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.207 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -125.7 134.18 51.9 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.083 0.468 . . . . 0.0 111.896 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.31 -30.63 15.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.966 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.2 m -59.58 -34.88 73.28 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.542 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.46 4.85 33.65 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 46.89 57.32 5.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 111.466 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.4 p -176.0 176.12 1.83 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.313 0.578 . . . . 0.0 111.307 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.698 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -92.72 170.95 9.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.723 178.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.55 119.92 8.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.782 0.325 . . . . 0.0 111.235 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.534 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -83.15 106.01 14.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.39 -51.4 25.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.395 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.67 147.69 27.68 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.9 0.381 . . . . 0.0 111.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.473 ' CG ' HG13 ' A' ' 75' ' ' VAL . 1.2 t80 -124.73 121.7 35.39 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.903 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.48 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 11.2 t -131.85 141.85 43.05 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.404 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.48 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 84.2 Cg_endo -83.74 138.33 8.18 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.742 2.295 . . . . 0.0 111.61 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.65 40.87 1.79 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.648 0.261 . . . . 0.0 111.568 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.8 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.411 179.778 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.21 0 N-CA-C 112.319 -0.312 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.658 HG13 ' CG2' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -96.95 156.8 3.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 117.201 0.501 . . . . 0.0 111.428 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.0 m -88.5 154.62 20.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.211 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.9 -20.66 27.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.146 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -54.92 -35.62 64.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.523 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.0 114.98 10.3 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.501 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.27 -27.52 85.23 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.365 2.71 . . . . 0.0 114.216 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.567 ' HB3' HD13 ' A' ' 22' ' ' ILE . 7.9 mmp_? -78.42 -47.73 16.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.323 0.582 . . . . 0.0 110.157 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.658 ' CG2' HG13 ' A' ' 12' ' ' ILE . 55.3 t -58.31 -40.45 77.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.392 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.57 -36.07 65.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.3 pt-20 -76.21 -36.22 58.71 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.223 0.535 . . . . 0.0 110.71 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.575 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 22.5 mt -74.59 -36.94 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.056 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.28 -52.73 44.49 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.118 0.485 . . . . 0.0 110.334 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.0 pt-20 -55.16 -43.95 74.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.024 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 30.8 t80 -58.32 -35.32 71.7 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.934 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.47 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -60.37 -47.33 86.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.554 HD23 ' HB3' ' A' ' 37' ' ' LEU . 1.4 tp -65.56 -44.04 88.0 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.116 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -72.33 -18.48 61.76 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.495 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 4.3 tp60 -83.58 -37.7 22.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.454 0.169 . . . . 0.0 111.039 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.498 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -105.03 126.54 52.17 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.535 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -172.67 43.47 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.86 0.362 . . . . 0.0 111.659 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -37.52 83.09 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.817 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.67 4.82 26.22 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 65.64 97.13 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.6 153.94 51.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.7 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.14 124.47 73.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.554 ' HB3' HD23 ' A' ' 27' ' ' LEU . 9.1 tp -90.0 117.32 28.71 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.409 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.442 ' HB1' ' HE2' ' A' ' 63' ' ' LYS . . . -65.79 -31.18 72.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.314 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 160.38 171.91 26.93 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.8 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.534 HG22 HD22 ' A' ' 60' ' ' LEU . 2.5 t -75.1 128.56 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 122.798 0.439 . . . . 0.0 110.976 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -100.76 -62.78 1.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.589 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.51 167.41 27.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.54 ' HA3' HD13 ' A' ' 12' ' ' ILE . . . -156.51 169.4 33.89 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.988 -1.101 . . . . 0.0 114.279 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 57' ' ' ASN . 9.0 mt-30 -141.91 137.74 31.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.017 -0.591 . . . . 0.0 110.225 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.0 mt -122.66 124.64 71.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 111.472 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.3 mt -107.55 115.07 47.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 162.98 32.84 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.95 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.2 -68.94 0.02 OUTLIER Glycine 0 C--N 1.331 0.253 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.425 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 3.7 tt -120.53 109.11 36.75 Favored Pre-proline 0 C--O 1.233 0.201 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -88.93 116.8 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 N-CA-C 116.394 1.652 . . . . 0.0 116.394 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.3 23.76 10.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.611 175.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.762 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 75.14 33.02 0.74 Allowed 'General case' 0 C--N 1.344 0.334 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.109 -178.181 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 7.9 p-10 -122.9 27.3 7.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.904 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.489 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -56.62 144.59 31.48 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.01 121.51 40.01 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.316 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.489 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 12.9 m-85 -107.32 139.85 41.15 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.256 0.551 . . . . 0.0 112.239 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 44' ' ' GLN . 48.3 t30 -137.12 111.05 8.23 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.553 HD23 HD13 ' A' ' 12' ' ' ILE . 4.9 mp -134.76 166.23 23.44 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.4 mm -127.73 126.94 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.448 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.534 HD22 HG22 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -130.66 169.38 15.72 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 111.739 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.9 m -95.64 140.21 30.79 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.356 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 37' ' ' LEU . . . -154.8 147.11 23.89 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -149.87 166.89 28.17 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.101 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -102.15 -5.26 24.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.06 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.35 148.2 23.62 Favored Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.42 -34.25 54.84 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.082 2.522 . . . . 0.0 112.51 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -90.59 14.28 13.65 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -113.12 167.15 10.77 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.241 0.544 . . . . 0.0 112.002 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.582 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.8 m-85 -64.56 179.13 0.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.08 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.55 119.83 25.57 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 0.3 OUTLIER -107.44 165.79 11.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.03 0.443 . . . . 0.0 111.829 -178.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -90.87 146.68 23.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.848 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 16.2 m-85 -141.46 137.55 32.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.327 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.49 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 48.7 t-20 -110.38 130.19 55.6 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.799 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 91' ' ' PHE . 30.5 m -129.07 146.28 34.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 112.256 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 12.1 t -105.58 110.5 31.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.51 ' CG1' HG23 ' A' ' 22' ' ' ILE . 3.3 t -118.73 139.26 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.946 0.403 . . . . 0.0 111.491 -178.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.5 tp -114.94 127.15 55.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.973 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 1.0 OUTLIER -90.61 126.58 36.0 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.783 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.88 135.14 51.58 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.22 -31.2 17.12 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.824 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.75 -39.46 71.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.003 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.19 -7.83 34.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.251 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.17 50.5 11.71 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-O 121.061 0.458 . . . . 0.0 111.008 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.27 -175.53 1.43 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.908 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.591 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -97.27 165.87 11.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.284 179.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.86 122.91 10.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.949 0.404 . . . . 0.0 111.038 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.498 ' CD1' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -82.73 112.6 19.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.056 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 2.7 t -75.35 -49.27 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.712 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -161.79 155.53 21.56 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.521 ' HA ' HG11 ' A' ' 75' ' ' VAL . 1.3 t80 -123.21 124.07 42.21 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.392 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.56 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 4.9 t -132.25 142.61 45.65 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 83.8 Cg_endo -78.3 138.52 15.92 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.668 2.246 . . . . 0.0 111.885 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -115.64 39.49 2.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.698 0.285 . . . . 0.0 111.458 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.8 p90 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.237 179.626 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.292 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.708 HG13 ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -112.87 156.98 13.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 117.803 0.801 . . . . 0.0 112.632 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -76.55 152.16 36.08 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.097 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.56 -27.63 43.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.655 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -47.1 -38.42 11.34 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.336 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.449 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 12.6 t70 -57.13 114.03 7.31 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.352 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 12.1 Cg_endo -55.75 -31.58 80.91 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.613 2.876 . . . . 0.0 114.328 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.516 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -74.95 -44.74 46.77 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.251 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.708 ' CG2' HG13 ' A' ' 12' ' ' ILE . 54.3 t -60.94 -42.6 93.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.653 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -37.06 67.9 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.922 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.504 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 11.4 pt-20 -78.57 -39.37 37.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.803 0.335 . . . . 0.0 111.398 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 18' ' ' ARG . 43.0 mt -73.22 -32.13 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.769 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.5 -48.18 61.43 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -50.59 -49.7 55.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.764 178.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.612 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 41.7 t80 -58.32 -37.92 76.06 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.279 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.64 -39.28 70.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.028 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.584 HD23 ' HB3' ' A' ' 37' ' ' LEU . 2.0 tp -74.45 -47.86 30.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.608 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.596 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -67.14 -18.3 65.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.515 ' CD ' ' HB3' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -77.79 -31.01 51.59 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.568 0.223 . . . . 0.0 111.002 179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -75.03 -118.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.101 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 65.76 34.0 7.79 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.36 -38.49 41.83 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.864 0.364 . . . . 0.0 110.213 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 0.6 OUTLIER -117.7 10.14 13.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.116 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 14.5 t-20 69.47 95.98 0.07 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.028 0.531 . . . . 0.0 111.986 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.466 ' HA ' ' CD2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -138.46 146.85 42.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.563 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.29 124.72 72.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.584 ' HB3' HD23 ' A' ' 27' ' ' LEU . 8.5 tp -90.04 115.86 27.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.153 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.77 -28.29 68.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.408 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.8 173.92 32.08 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 119.56 -1.305 . . . . 0.0 114.12 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.461 HG22 HD22 ' A' ' 60' ' ' LEU . 2.3 t -79.32 137.79 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.228 -0.486 . . . . 0.0 110.532 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.54 -63.93 1.33 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.485 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.02 163.8 33.11 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.484 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.606 ' HA3' ' CD2' ' A' ' 58' ' ' LEU . . . -161.32 175.37 37.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.546 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 57' ' ' ASN . 50.7 mm-40 -149.43 155.53 40.57 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.384 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.427 ' CG2' ' ND2' ' A' ' 54' ' ' ASN . 4.2 mp -137.2 122.83 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.302 . . . . 0.0 110.956 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.08 118.4 55.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -137.32 163.08 31.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.897 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.56 -69.26 0.04 OUTLIER Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 7.4 tp -120.28 111.89 34.87 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -87.53 114.81 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 N-CA-C 116.357 1.637 . . . . 0.0 116.357 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -121.85 22.98 10.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.209 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.725 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.75 33.89 1.25 Allowed 'General case' 0 C--N 1.344 0.345 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.283 -177.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 15.5 m-20 -121.32 26.81 8.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.423 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -58.56 143.98 44.26 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.322 -178.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.2 125.74 40.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.316 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -109.46 129.84 55.53 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.908 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 44' ' ' GLN . 12.6 t-20 -126.5 114.19 17.8 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.606 ' CD2' ' HA3' ' A' ' 43' ' ' GLY . 4.1 mp -142.07 161.1 38.85 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 3.5 mm -119.9 131.49 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.404 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.541 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.21 165.89 24.36 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.955 0.407 . . . . 0.0 112.083 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.3 m -96.38 136.34 37.0 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.95 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.502 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . . . -148.06 142.59 26.47 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -144.05 166.07 26.02 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.708 179.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.466 ' CD2' ' HA ' ' A' ' 35' ' ' LEU . 47.6 m80 -104.84 -3.15 23.84 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.121 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.41 145.96 20.16 Favored Pre-proline 0 N--CA 1.465 0.317 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.13 -29.65 47.59 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.284 2.656 . . . . 0.0 112.598 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -98.82 14.55 28.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.843 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -120.9 167.15 12.86 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.13 0.49 . . . . 0.0 111.604 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.498 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 6.7 m-85 -69.45 160.57 31.15 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.0 m -116.6 135.76 53.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.127 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -112.04 165.35 12.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.753 0.311 . . . . 0.0 110.709 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -89.13 153.15 21.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.742 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.624 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 14.7 m-85 -139.39 142.17 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.778 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.5 ' HA ' HD12 ' A' ' 59' ' ' ILE . 53.9 t-20 -111.83 118.76 36.44 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.529 HG13 ' CG ' ' A' ' 91' ' ' PHE . 29.7 m -130.71 151.0 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.96 118.61 57.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.731 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.3 144.48 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.111 0.482 . . . . 0.0 111.819 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tp -120.33 125.65 48.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.943 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 1.9 tt0 -90.05 120.1 30.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.539 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.85 133.91 51.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.58 -37.22 15.84 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.196 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -37.83 87.27 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.464 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -15.78 58.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.761 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 72.46 31.33 1.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.56 -165.15 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.286 0.565 . . . . 0.0 111.88 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.612 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -94.3 169.12 10.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.022 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.72 138.03 21.78 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.93 0.395 . . . . 0.0 111.952 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.515 ' HB3' ' CD ' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -97.44 109.31 22.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.862 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.9 t -74.54 -54.35 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.449 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.14 145.73 31.5 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.529 ' CG ' HG13 ' A' ' 75' ' ' VAL . 1.2 t80 -125.22 117.61 24.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.877 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.522 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 2.6 t -132.7 144.44 52.95 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.969 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.522 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 89.3 Cg_endo -87.43 138.5 4.65 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.974 2.449 . . . . 0.0 112.322 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.454 ' CD2' ' HB2' ' A' ' 74' ' ' ASN . 0.4 OUTLIER -98.85 32.52 2.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.321 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.4 p90 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.593 -0.718 . . . . 0.0 111.129 -179.753 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.304 0 N-CA-C 112.219 -0.352 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.659 HG13 HG13 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -101.49 167.39 2.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 117.493 0.647 . . . . 0.0 111.237 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -101.51 157.73 16.59 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.075 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.81 -22.43 30.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -53.98 -35.88 62.3 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.479 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 16.3 t70 -59.64 113.5 7.27 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.633 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 19.1 Cg_endo -58.16 -27.83 81.66 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.304 2.669 . . . . 0.0 114.06 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -77.07 -48.67 17.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.159 0.504 . . . . 0.0 110.27 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.659 HG13 HG13 ' A' ' 12' ' ' ILE . 52.0 t -57.67 -41.56 79.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.93 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -40.66 78.51 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 12.9 pt-20 -72.93 -40.02 65.79 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.676 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.561 HG22 HG23 ' A' ' 77' ' ' VAL . 18.2 mt -65.77 -40.03 86.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.564 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.048 0.452 . . . . 0.0 110.248 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -51.94 -52.78 47.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.74 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 25.3 t80 -56.86 -35.38 68.83 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.725 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.524 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.29 -48.34 80.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.372 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.598 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.7 tp -68.63 -46.9 67.99 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.586 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.548 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -68.89 -18.2 64.09 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.423 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 5.8 tp60 -84.87 -37.3 20.8 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.401 ' HB2' HD11 ' A' ' 88' ' ' LEU . 78.3 t60 -71.56 -103.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.415 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 56.4 36.16 27.08 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -37.74 88.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.804 0.335 . . . . 0.0 110.934 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.7 13.23 9.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.482 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 68.15 86.89 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.877 0.471 . . . . 0.0 111.771 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.409 ' HB2' ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -125.91 158.19 35.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.835 178.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.505 ' HB ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -118.39 125.13 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -177.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.598 ' HB3' HD22 ' A' ' 27' ' ' LEU . 9.9 tp -90.4 113.5 25.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.966 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.06 68.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.735 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 161.38 166.77 20.77 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 119.712 -1.232 . . . . 0.0 114.09 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.1 t -77.23 137.07 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.588 0.355 . . . . 0.0 110.646 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.1 -67.9 0.91 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.154 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.09 173.53 13.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.558 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.523 ' HA3' HD21 ' A' ' 58' ' ' LEU . . . -170.14 -163.69 24.61 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 119.807 -1.187 . . . . 0.0 114.255 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -153.94 137.71 16.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.075 -0.562 . . . . 0.0 111.136 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.465 HG13 HG21 ' A' ' 12' ' ' ILE . 7.5 mt -114.97 126.16 72.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -109.64 117.62 54.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.01 162.19 33.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.935 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -135.29 -71.99 0.07 OUTLIER Glycine 0 C--N 1.334 0.431 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.455 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 12.6 tt -120.11 112.27 34.85 Favored Pre-proline 0 C--O 1.233 0.225 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.98 114.54 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 N-CA-C 115.891 1.458 . . . . 0.0 115.891 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.97 20.37 10.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.227 -1.806 . . . . 0.0 107.3 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.735 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 71.87 32.93 1.79 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.215 -178.054 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 5.0 p-10 -122.16 26.98 8.23 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.542 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.435 ' ND2' ' CG2' ' A' ' 45' ' ' ILE . 0.3 OUTLIER -57.34 148.03 24.15 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.95 132.79 44.01 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.981 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.482 ' CE1' HD13 ' A' ' 22' ' ' ILE . 32.3 m-85 -119.22 135.46 54.67 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.23 0.538 . . . . 0.0 112.022 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -130.73 111.85 12.54 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.845 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.523 HD21 ' HA3' ' A' ' 43' ' ' GLY . 3.9 mp -141.7 163.81 31.91 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.3 mm -122.72 138.18 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.345 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -141.61 168.93 18.6 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.779 0.323 . . . . 0.0 111.84 -179.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.8 m -92.1 138.5 31.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.224 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . . . -156.38 146.61 21.4 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -149.67 164.49 35.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.675 178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.409 ' CE1' ' HB2' ' A' ' 35' ' ' LEU . 60.5 m80 -102.17 -2.76 28.62 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.93 144.54 19.18 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-O 121.031 0.443 . . . . 0.0 112.132 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.23 -33.01 50.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.121 2.547 . . . . 0.0 112.108 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -90.45 14.63 12.48 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.671 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -117.87 167.09 11.73 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.2 0.524 . . . . 0.0 111.725 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.546 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 6.7 m-85 -64.77 -176.4 0.25 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.402 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.416 ' C ' ' HD3' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -130.61 122.62 27.8 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.416 ' HD3' ' C ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -111.06 169.71 8.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.936 0.398 . . . . 0.0 111.643 -178.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.426 ' C ' ' HB2' ' A' ' 94' ' ' LEU . 10.6 m-85 -92.75 149.57 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.578 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 24.8 m-85 -144.0 137.87 28.0 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.767 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HB2' HD12 ' A' ' 94' ' ' LEU . 51.4 t30 -109.4 126.48 53.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 110.412 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -127.73 146.17 33.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.483 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.24 117.61 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.738 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.561 HG23 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -119.1 135.24 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.066 0.46 . . . . 0.0 112.146 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.486 HD22 ' HD2' ' A' ' 80' ' ' LYS . 5.4 tp -117.35 124.45 48.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.333 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -89.45 124.36 34.41 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.831 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HD2' HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -126.55 149.72 49.24 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.2 -27.39 13.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.968 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -54.53 -43.39 71.88 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.61 0.243 . . . . 0.0 110.932 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.14 -6.93 43.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.061 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 61.03 50.33 5.12 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 120.769 0.318 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -174.47 -163.19 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.112 0.482 . . . . 0.0 111.266 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.568 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -104.11 170.31 7.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.076 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.45 ' HE3' HD23 ' A' ' 78' ' ' LEU . 2.2 tmmm? -148.27 117.98 7.08 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.817 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -79.04 106.74 11.29 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.61 -54.38 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.713 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.47 151.32 40.18 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.09 0.471 . . . . 0.0 112.232 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.432 ' HA ' HG11 ' A' ' 75' ' ' VAL . 3.2 t80 -127.04 120.33 28.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.692 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.433 HG12 ' HD2' ' A' ' 93' ' ' PRO . 12.2 t -132.32 138.99 33.47 Favored Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.45 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 94.6 Cg_endo -82.88 135.61 7.77 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.847 2.365 . . . . 0.0 111.838 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 74' ' ' ASN . 1.4 mt -109.68 44.78 1.15 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.765 0.317 . . . . 0.0 111.297 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 93' ' ' PRO . 43.8 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.092 -0.956 . . . . 0.0 111.132 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.612 HG13 HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -96.64 161.0 2.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 121.05 0.452 . . . . 0.0 111.596 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.75 153.83 20.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.981 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.39 -21.66 29.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 109.974 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.55 -36.34 61.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.646 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 10.7 t70 -59.72 114.82 10.51 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.489 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.2 Cg_endo -59.4 -30.08 91.77 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.542 2.828 . . . . 0.0 114.193 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 4.6 mpt_? -76.5 -43.67 38.51 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.257 0.551 . . . . 0.0 110.535 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.612 HG12 HG13 ' A' ' 12' ' ' ILE . 47.2 t -62.19 -42.32 94.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.329 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -36.03 71.51 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.509 ' HG3' HD13 ' A' ' 86' ' ' LEU . 12.2 pt-20 -76.29 -38.25 56.4 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.228 0.537 . . . . 0.0 110.679 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.582 HG23 HG22 ' A' ' 77' ' ' VAL . 85.6 mt -75.46 -32.64 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.325 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.77 -51.1 36.92 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.382 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -56.16 -43.39 78.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.703 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.633 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 23.7 t80 -57.31 -38.27 73.76 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.731 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.456 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -57.05 -46.18 82.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.107 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 37' ' ' LEU . 3.1 tp -69.18 -45.03 70.98 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.635 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -71.12 -17.78 62.55 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.433 ' HB3' HD12 ' A' ' 88' ' ' LEU . 3.9 tp-100 -84.41 -38.59 20.05 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.455 ' HB2' HD13 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -97.66 124.98 42.18 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -162.71 40.81 0.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.756 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -37.87 34.53 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 16.0 mt-30 -95.34 -16.7 22.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.955 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 16.6 t30 72.62 91.58 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.045 0.45 . . . . 0.0 111.903 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.75 162.64 34.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.11 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.77 124.74 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.499 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 12.0 tp -83.58 118.91 24.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.206 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.31 -30.69 71.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.831 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.9 166.29 15.09 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 119.983 -1.103 . . . . 0.0 113.843 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.507 HG21 HD23 ' A' ' 60' ' ' LEU . 18.2 t -68.5 130.14 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.516 -0.342 . . . . 0.0 110.325 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.95 -56.91 2.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.505 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.81 154.59 39.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.411 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 58' ' ' LEU . . . -152.73 173.3 31.75 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.325 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' ASN . 18.1 mt-30 -146.97 159.54 43.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.98 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.417 HD12 HG21 ' A' ' 45' ' ' ILE . 14.7 mt -144.0 131.14 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.714 0.293 . . . . 0.0 111.473 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.5 mt -107.63 115.56 49.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.323 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 162.66 32.52 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.65 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.43 -87.46 0.08 OUTLIER Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.3 108.52 60.57 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.96 115.91 3.35 Favored 'Trans proline' 0 C--N 1.347 0.453 0 N-CA-C 116.491 1.689 . . . . 0.0 116.491 -175.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 19.91 11.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.325 175.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.737 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.08 38.28 0.91 Allowed 'General case' 0 C--N 1.345 0.408 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.631 -178.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.36 26.33 8.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.603 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -49.1 136.55 14.66 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.394 0.678 . . . . 0.0 112.609 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -99.86 126.34 45.96 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.73 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.519 ' HB2' HG23 ' A' ' 77' ' ' VAL . 6.0 m-85 -109.38 144.83 37.05 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 44' ' ' GLN . 9.0 t-20 -144.14 112.26 6.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.808 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.547 HD23 HD12 ' A' ' 12' ' ' ILE . 5.0 mp -138.16 168.78 19.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 2.7 mm -126.85 120.61 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.565 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.507 HD23 HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -127.03 164.1 22.27 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.94 0.4 . . . . 0.0 111.279 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.8 m -94.39 141.65 28.33 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.738 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 37' ' ' LEU . . . -152.05 148.09 27.27 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.511 0.507 . . . . 0.0 112.23 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -150.54 164.57 35.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.726 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -93.96 -11.64 30.47 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.844 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 p -149.7 143.1 16.41 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 111.935 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.88 -22.81 48.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.507 2.805 . . . . 0.0 113.539 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -89.6 3.32 52.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -128.04 166.95 17.43 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 121.377 0.608 . . . . 0.0 112.526 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 5.6 m-85 -53.46 167.46 0.21 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.834 -1.076 . . . . 0.0 113.749 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -125.69 134.1 51.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.825 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 23.9 mmmt -107.76 167.98 9.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.067 0.461 . . . . 0.0 111.819 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' C ' ' HB2' ' A' ' 94' ' ' LEU . 95.7 m-85 -88.37 151.31 22.68 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.621 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 14.0 m-85 -142.42 138.19 30.91 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.865 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.525 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . 8.1 t-20 -110.82 119.68 39.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.498 HG21 ' CD2' ' A' ' 91' ' ' PHE . 41.4 t -130.94 149.59 33.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.049 0.452 . . . . 0.0 111.671 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.424 HG11 HG21 ' A' ' 89' ' ' VAL . 33.6 t -109.24 129.79 63.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.273 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -128.85 146.89 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.016 0.436 . . . . 0.0 111.97 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.409 HD23 ' HE3' ' A' ' 80' ' ' LYS . 12.0 tp -118.58 126.25 51.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.442 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.497 ' HB2' HD13 ' A' ' 22' ' ' ILE . 1.6 tt0 -88.77 128.04 35.62 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.901 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.409 ' HE3' HD23 ' A' ' 78' ' ' LEU . 1.1 ttmt -125.03 130.14 51.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' A' ' 52' ' ' TRP . . . -89.45 -35.79 15.79 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.324 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.2 m -61.88 -35.48 78.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.55 -7.3 53.23 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.973 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 m120 55.71 47.43 20.52 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 122.646 0.379 . . . . 0.0 111.411 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.4 t -174.04 -169.0 0.44 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.268 0.556 . . . . 0.0 111.167 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.596 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -105.14 168.15 9.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.925 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -147.05 132.67 18.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.973 0.416 . . . . 0.0 111.449 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' HA ' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -85.96 121.57 28.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.822 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.424 HG21 HG11 ' A' ' 76' ' ' VAL . 2.4 t -85.02 -54.95 7.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.847 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.82 134.14 6.62 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.251 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.498 ' CD2' HG21 ' A' ' 75' ' ' VAL . 1.4 t80 -106.49 126.82 52.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.787 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.413 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 2.1 t -132.47 147.41 65.54 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.45 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.413 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 61.5 Cg_endo -92.44 138.37 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.17 2.58 . . . . 0.0 112.826 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.406 ' HB2' ' C ' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -99.61 27.47 5.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.275 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.42 ' CB ' ' HE3' ' A' ' 71' ' ' LYS . 6.5 p90 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.534 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.234 0 CA-C-O 120.084 -0.287 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.692 HG13 ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -96.45 167.3 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 117.185 0.492 . . . . 0.0 111.482 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 m -91.27 149.76 21.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.15 -19.04 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.506 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -57.43 -37.94 73.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.008 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 18.4 t70 -57.99 113.63 6.87 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.031 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 13.9 Cg_endo -56.17 -27.45 65.76 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.57 2.846 . . . . 0.0 114.321 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.5 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.73 -38.99 32.13 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.903 0.383 . . . . 0.0 110.873 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.692 ' CG2' HG13 ' A' ' 12' ' ' ILE . 45.1 t -67.31 -41.17 86.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.906 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.466 ' HE3' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -73.86 -34.16 64.38 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 10.8 pt-20 -77.52 -37.77 50.27 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.935 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 77' ' ' VAL . 93.8 mt -75.92 -31.15 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.734 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.09 -51.82 34.76 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.041 0.448 . . . . 0.0 110.271 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 8.3 pt-20 -55.71 -47.34 77.01 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.203 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.625 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 27.0 t80 -55.57 -37.96 68.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.818 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.521 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.15 -51.16 68.98 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.234 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.542 HD21 ' HB3' ' A' ' 37' ' ' LEU . 2.7 tp -62.21 -44.98 95.36 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.499 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -72.59 -17.41 61.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.438 ' HB3' HD12 ' A' ' 88' ' ' LEU . 3.5 tp-100 -82.12 -38.55 24.6 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.597 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 2.9 t60 -108.23 129.18 55.21 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.814 0.34 . . . . 0.0 110.353 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -170.28 41.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.543 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.13 86.55 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.85 9.18 42.66 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.524 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 42.2 t30 52.78 88.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.99 157.63 40.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.515 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.59 124.15 72.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.542 ' HB3' HD21 ' A' ' 27' ' ' LEU . 1.5 tt -90.99 113.99 26.39 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.866 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.17 -28.01 69.11 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.825 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.93 168.73 25.3 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 119.313 -1.422 . . . . 0.0 114.345 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.6 t -76.14 136.42 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.106 -0.547 . . . . 0.0 110.956 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.61 -65.32 1.02 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.714 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.58 171.3 20.56 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.155 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.517 ' HA3' HD21 ' A' ' 58' ' ' LEU . . . -166.39 -174.39 35.7 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.558 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 57' ' ' ASN . 25.7 mt-30 -151.24 143.17 23.89 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.128 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.583 ' CD1' HG23 ' A' ' 12' ' ' ILE . 2.9 mp -122.17 125.52 73.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.234 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.0 mt -107.41 118.89 56.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.77 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.403 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -136.47 163.16 31.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.975 -178.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -148.19 -66.72 0.01 OUTLIER Glycine 0 C--N 1.33 0.224 0 N-CA-C 108.534 -1.827 . . . . 0.0 108.534 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 0.6 OUTLIER -120.46 108.27 37.88 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 175.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -90.53 117.51 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 116.212 1.582 . . . . 0.0 116.212 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 23.36 10.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.463 175.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.726 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.97 31.85 1.44 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.314 -178.122 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 20.9 m-20 -121.91 27.18 8.23 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.556 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.445 ' ND2' HG23 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -56.02 153.61 8.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.116 -178.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.15 122.44 45.34 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.437 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.437 ' CD1' HD13 ' A' ' 22' ' ' ILE . 17.7 m-85 -102.13 133.35 47.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.037 0.446 . . . . 0.0 111.953 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 44' ' ' GLN . 39.8 t30 -132.91 111.68 11.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.067 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.533 HD23 HG13 ' A' ' 19' ' ' VAL . 4.0 mp -140.34 166.27 25.14 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.8 mm -124.12 129.44 74.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.439 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.479 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -131.63 168.84 17.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.722 0.296 . . . . 0.0 111.504 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.3 m -100.65 133.95 44.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.362 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.56 ' HB1' ' CE1' ' A' ' 73' ' ' TYR . . . -145.1 141.03 28.46 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.486 0.491 . . . . 0.0 112.186 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -139.74 166.55 24.31 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.751 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -93.2 -16.48 24.79 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.652 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.75 153.05 35.82 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.688 0.28 . . . . 0.0 111.659 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.21 -31.62 74.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.76 2.307 . . . . 0.0 112.111 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -96.16 14.38 24.18 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.463 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -115.37 167.32 10.97 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-O 121.105 0.478 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 9.3 m-85 -71.72 152.16 43.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.852 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 m -115.08 133.79 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.377 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 22.7 mmmt -113.99 165.08 12.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -87.69 148.45 24.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.532 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 46.6 m-85 -138.62 140.75 39.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.881 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.431 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 31.4 t-20 -108.79 116.49 32.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 0.0 109.956 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.509 HG13 HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -119.33 142.67 33.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.941 -178.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 t -107.52 120.16 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.959 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.53 HG23 HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -123.37 146.37 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.3 tp -119.81 125.39 48.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.341 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 1.7 tt0 -87.73 124.2 33.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.686 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -122.7 137.82 54.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.404 0.621 . . . . 0.0 112.545 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.43 -27.16 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.688 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -59.58 -41.35 90.02 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.323 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.34 9.1 43.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.509 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.81 57.51 5.93 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.498 0.319 . . . . 0.0 111.557 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 177.96 -177.99 0.23 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.455 0.645 . . . . 0.0 111.613 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.625 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -93.31 166.83 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.905 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.96 126.93 13.62 Favored 'General case' 0 CA--C 1.526 0.052 0 CA-C-O 120.797 0.332 . . . . 0.0 111.258 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.597 ' CD1' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -86.7 114.77 23.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.197 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.73 -54.11 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.319 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.408 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -159.33 144.28 15.62 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.86 0.362 . . . . 0.0 111.856 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -112.77 127.32 56.12 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.82 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.446 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 5.2 t -132.46 139.78 35.84 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.2 Cg_endo -81.99 138.59 10.37 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.903 2.402 . . . . 0.0 112.217 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.431 ' CD2' ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -107.6 25.44 11.49 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.64 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.565 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 30.4 p90 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.586 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.279 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.736 HG13 ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -98.0 166.84 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 117.706 0.753 . . . . 0.0 112.144 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 t -89.9 154.26 20.0 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.58 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 p -64.75 -23.3 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.725 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -51.62 -36.76 47.22 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.972 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 14.1 t70 -58.79 113.24 6.32 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.702 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 19.7 Cg_endo -58.31 -28.14 83.56 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.435 2.757 . . . . 0.0 113.994 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.552 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 5.9 mmt-85 -76.85 -46.24 25.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.095 0.474 . . . . 0.0 110.124 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.736 ' CG2' HG13 ' A' ' 12' ' ' ILE . 69.8 t -59.51 -42.44 87.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.493 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -37.78 71.03 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.497 ' HG3' HG13 ' A' ' 22' ' ' ILE . 8.0 pt-20 -77.18 -37.25 54.05 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.021 0.439 . . . . 0.0 111.191 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.614 HD12 ' CE2' ' A' ' 56' ' ' TYR . 27.2 mt -75.11 -31.52 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.016 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -70.6 -52.68 19.85 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.042 0.448 . . . . 0.0 109.962 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.4 pt-20 -55.27 -41.78 72.69 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.718 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 28.4 t80 -59.65 -38.01 80.27 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.905 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.524 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.28 -43.53 88.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.113 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.432 HD22 ' CB ' ' A' ' 37' ' ' LEU . 3.6 tp -69.31 -48.06 62.65 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.376 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 25' ' ' PHE . 1.5 pttm -67.73 -25.4 65.63 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.609 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 5.0 tp60 -74.99 -27.91 60.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -65.03 -95.53 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.94 32.1 12.05 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.52 -38.02 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.937 0.399 . . . . 0.0 109.957 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -113.79 -5.16 13.29 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.152 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.8 t30 67.51 91.94 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.953 0.501 . . . . 0.0 111.374 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.58 160.14 38.36 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.436 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.33 124.6 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.559 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 6.2 tp -92.17 113.94 26.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.385 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.18 72.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.324 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.88 163.28 23.65 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.204 -1.474 . . . . 0.0 114.808 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.43 HG22 HD23 ' A' ' 60' ' ' LEU . 2.2 t -75.47 125.6 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.196 -0.502 . . . . 0.0 109.918 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.02 -62.63 1.41 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.57 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.75 171.68 16.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.025 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.575 ' HA3' ' CG ' ' A' ' 58' ' ' LEU . . . -171.1 -174.41 38.88 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.427 -1.368 . . . . 0.0 114.883 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 57' ' ' ASN . 28.3 mt-30 -146.82 168.79 20.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.451 -0.875 . . . . 0.0 111.172 -178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.604 ' CD1' HG23 ' A' ' 12' ' ' ILE . 4.7 mp -142.86 132.49 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.419 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.6 mm -107.44 116.87 51.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.134 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.07 162.75 32.04 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.816 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -149.42 -70.78 0.01 OUTLIER Glycine 0 C--N 1.33 0.23 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -120.61 108.8 36.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -87.65 117.47 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 N-CA-C 116.395 1.652 . . . . 0.0 116.395 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.423 ' NE2' ' HB2' ' A' ' 53' ' ' ASP . 32.1 p-80 -121.7 23.47 10.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.605 -1.634 . . . . 0.0 107.446 175.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.719 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 73.7 33.4 1.04 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.028 -178.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -122.24 28.1 7.64 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.832 177.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.461 ' ND2' ' CG2' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -57.83 143.72 41.29 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -95.06 138.62 32.54 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.591 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.614 ' CE2' HD12 ' A' ' 22' ' ' ILE . 10.2 m-85 -119.56 135.61 54.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 112.036 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 44' ' ' GLN . 64.1 t-20 -133.52 114.24 13.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.15 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.575 ' CG ' ' HA3' ' A' ' 43' ' ' GLY . 4.6 mp -144.35 168.68 19.5 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.1 mm -125.85 131.88 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.272 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.436 HD23 ' HB3' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -134.37 168.89 18.08 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.61 129.7 45.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.046 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.559 ' HB1' ' HA ' ' A' ' 37' ' ' LEU . . . -144.62 141.76 29.63 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.066 0.46 . . . . 0.0 112.194 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -142.06 165.4 27.54 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.507 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -94.74 -13.8 25.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.94 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.82 150.98 24.0 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-O 121.213 0.53 . . . . 0.0 112.109 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -63.65 -37.7 45.28 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.554 2.836 . . . . 0.0 113.026 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -80.85 9.05 6.91 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -124.1 167.45 14.2 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.228 0.537 . . . . 0.0 111.728 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.498 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.7 m-85 -68.79 166.18 18.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.368 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 m -119.84 131.86 55.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.951 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 1.5 mmmp? -110.51 155.0 22.89 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.47 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.546 ' O ' ' HB2' ' A' ' 94' ' ' LEU . 20.8 m-85 -85.23 138.04 32.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.19 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 5.9 m-30 -125.71 140.37 52.76 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.949 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -111.95 119.2 37.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 110.424 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.631 HG13 ' CG ' ' A' ' 91' ' ' PHE . 34.3 m -128.78 158.91 41.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.496 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.08 127.36 73.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.724 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.435 ' HB ' ' CG2' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -124.53 145.41 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.047 0.451 . . . . 0.0 111.751 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 9.4 tp -114.32 127.0 55.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.784 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -91.91 127.97 37.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.558 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.01 139.99 52.97 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' A' ' 52' ' ' TRP . . . -93.72 -30.34 14.94 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.791 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 m -54.23 -39.3 66.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.241 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.98 -3.86 27.04 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.457 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 54.56 53.77 10.23 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 120.996 0.427 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 t -171.49 -173.95 1.32 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.551 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -101.45 165.97 10.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.798 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -147.91 128.69 14.3 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.026 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.609 ' CB ' ' HG2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -82.63 121.9 27.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.454 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -83.57 -55.02 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.45 156.18 34.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.353 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.631 ' CG ' HG13 ' A' ' 75' ' ' VAL . 1.4 t80 -124.72 123.05 39.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.505 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 7.1 t -131.78 142.97 47.16 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.911 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.505 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.4 Cg_endo -86.99 138.6 5.03 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.008 2.472 . . . . 0.0 112.176 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -105.63 20.5 18.8 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 47.8 p90 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.068 -0.968 . . . . 0.0 111.469 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.204 0 N-CA-C 112.283 -0.327 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.693 HG13 HG13 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -96.78 147.97 5.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 117.212 0.506 . . . . 0.0 111.218 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 t -79.24 151.38 31.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.694 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -63.53 -21.83 29.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -53.01 -35.77 59.76 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.601 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 15.1 t0 -57.25 111.12 3.0 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.258 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.414 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 18.2 Cg_endo -59.89 -27.67 85.45 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.429 2.753 . . . . 0.0 113.801 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -77.64 -44.38 28.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.149 0.5 . . . . 0.0 110.068 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.693 HG13 HG13 ' A' ' 12' ' ' ILE . 54.0 t -61.53 -47.56 92.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.191 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -40.24 96.73 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 14.0 pt-20 -75.0 -42.95 56.46 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.901 0.381 . . . . 0.0 110.99 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.2 mt -65.0 -34.65 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.339 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.68 -48.17 80.48 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -49.75 -51.28 40.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.364 178.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.652 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 32.0 t80 -56.55 -37.36 70.43 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.316 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.22 -48.1 79.65 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.97 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.6 tp -67.52 -43.08 81.69 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.6 ' HE2' ' CD2' ' A' ' 25' ' ' PHE . 3.7 pttm -75.03 -18.15 60.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.56 -39.0 32.82 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.967 0.349 . . . . 0.0 110.922 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -103.97 122.27 44.86 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.358 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -168.63 43.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.552 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -37.66 71.89 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.3 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.83 1.21 36.84 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.861 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 63.73 99.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.31 158.41 43.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -116.36 125.22 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.659 ' HB3' HD22 ' A' ' 27' ' ' LEU . 3.4 tp -87.0 120.77 28.62 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.865 0.364 . . . . 0.0 110.749 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 61' ' ' SER . . . -65.96 -34.51 78.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.895 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.85 162.57 11.32 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.186 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.8 136.03 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.86 0.464 . . . . 0.0 110.753 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.02 -65.76 1.14 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.619 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.13 146.66 25.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.389 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.56 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -146.95 -170.93 15.68 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 119.793 -1.194 . . . . 0.0 114.812 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' ASN . 17.3 mm-40 -142.16 150.74 41.46 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.558 -0.821 . . . . 0.0 111.295 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' A' ' 47' ' ' LYS . 63.0 mt -128.33 129.4 69.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.79 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.87 115.27 48.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.452 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.472 ' HD2' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -136.01 162.75 32.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.662 0.744 . . . . 0.0 112.829 -178.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.89 -66.92 0.01 OUTLIER Glycine 0 C--N 1.329 0.193 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.435 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -120.26 109.27 37.13 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 175.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -87.02 117.04 1.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 N-CA-C 116.226 1.587 . . . . 0.0 116.226 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.99 24.02 10.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.426 -1.716 . . . . 0.0 107.03 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TRP . . . . . 0.727 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 62.88 35.51 13.48 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.44 -177.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.84 28.29 7.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.389 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.635 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 1.1 t-20 -47.64 146.03 2.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.05 116.52 30.44 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.73 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 38.8 m-85 -104.87 143.0 33.74 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.206 0.527 . . . . 0.0 111.844 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 44' ' ' GLN . 15.9 t-20 -144.39 110.63 5.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.56 ' HG ' ' HA3' ' A' ' 43' ' ' GLY . 4.0 mp -136.74 167.35 21.6 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 2.7 mm -122.04 121.62 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.042 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.561 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -125.08 168.21 13.69 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.771 0.319 . . . . 0.0 111.26 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 50.2 m -98.97 146.04 26.43 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . . . -155.28 147.02 23.24 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -149.16 165.36 32.05 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.338 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -103.86 -5.82 21.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.042 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 68' ' ' GLU . 2.2 p -146.39 143.41 18.96 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-O 121.136 0.493 . . . . 0.0 112.046 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.42 -27.63 54.64 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.476 2.784 . . . . 0.0 113.365 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -95.23 14.19 23.05 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HB2' ' OG ' ' A' ' 65' ' ' SER . 7.8 mt-10 -126.78 167.23 16.05 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.46 0.648 . . . . 0.0 112.48 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 5.3 m-85 -64.69 167.65 7.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.273 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 m -124.29 135.74 53.6 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.889 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HG3' ' CD2' ' A' ' 95' ' ' PHE . 27.9 mmmt -110.37 169.98 8.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.677 0.275 . . . . 0.0 111.067 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.465 ' C ' ' HB2' ' A' ' 94' ' ' LEU . 20.4 m-85 -89.85 151.17 21.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.52 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.59 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 9.2 m-85 -141.65 141.07 33.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.34 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.443 ' HB2' HD22 ' A' ' 94' ' ' LEU . 65.2 t30 -113.72 126.39 55.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.495 0.188 . . . . 0.0 110.89 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 91' ' ' PHE . 6.4 m -132.37 140.21 48.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.161 0.505 . . . . 0.0 112.238 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.99 110.42 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -113.25 136.86 48.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.568 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 79' ' ' GLU . 7.3 tp -112.51 131.74 55.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.018 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.424 ' O ' HD13 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -91.39 129.43 37.38 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.0 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.405 ' HD3' ' HB3' ' A' ' 82' ' ' SER . 1.7 ttmp? -125.4 143.79 50.82 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.37 -29.91 11.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.572 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.405 ' HB3' ' HD3' ' A' ' 80' ' ' LYS . 6.8 t -53.81 -43.49 69.4 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.12 9.12 36.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.325 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.57 58.88 3.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.068 0.461 . . . . 0.0 111.375 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.6 p -173.8 -174.3 0.94 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.806 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.652 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -101.15 166.9 10.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.01 179.2 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HE2' HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -147.39 121.65 9.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.016 0.436 . . . . 0.0 111.717 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -81.01 110.17 16.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.902 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.98 -50.04 21.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.596 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.8 146.82 26.62 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.443 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 1.9 t80 -125.88 119.24 27.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.421 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.542 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 5.8 t -132.34 142.78 46.2 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.542 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.6 Cg_endo -80.34 139.04 12.83 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.925 2.417 . . . . 0.0 111.701 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.465 ' HB2' ' C ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -112.66 47.47 1.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.478 ' CD2' ' HG3' ' A' ' 71' ' ' LYS . 3.2 p90 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.855 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 CA-C-O 120.186 -0.23 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.55 165.47 30.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.163 2.576 . . . . 0.0 112.755 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.81 70.04 0.05 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.651 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.22 160.37 15.28 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.891 2.394 . . . . 0.0 112.94 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.14 26.09 2.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.091 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.54 -49.33 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.302 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.68 151.24 23.16 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.788 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -146.02 133.89 21.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.8 t -109.61 143.65 19.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.356 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.3 pt -117.78 162.08 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 43' ' ' GLY . . . -91.61 -158.09 34.28 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.093 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.705 HG13 ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -101.31 159.39 4.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 117.71 0.755 . . . . 0.0 111.68 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -79.31 153.32 29.93 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.054 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.06 -23.38 30.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.686 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -53.21 -32.55 48.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.341 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -57.43 112.83 5.18 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.658 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.58 -26.57 82.51 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.453 2.769 . . . . 0.0 113.934 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HG2' ' HH2' ' A' ' 52' ' ' TRP . 0.7 OUTLIER -78.62 -44.15 24.63 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.275 0.56 . . . . 0.0 110.384 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.705 ' CG2' HG13 ' A' ' 12' ' ' ILE . 72.9 t -65.18 -39.65 86.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.65 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -37.88 77.66 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 13.0 pt-20 -75.28 -37.24 61.01 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.214 0.531 . . . . 0.0 110.562 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.646 HG21 HG23 ' A' ' 77' ' ' VAL . 77.1 mt -74.62 -35.04 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.059 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.63 -54.89 18.48 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.242 0.544 . . . . 0.0 110.217 178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 11.3 pt-20 -53.66 -44.28 69.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.078 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 26.9 t80 -60.11 -35.39 75.12 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.435 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.61 -47.11 85.46 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.903 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 37' ' ' LEU . 2.4 tp -66.92 -43.79 82.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.702 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -70.93 -18.14 62.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.741 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -87.08 -38.95 16.03 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.131 0.423 . . . . 0.0 111.205 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -102.42 125.42 49.13 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.573 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -167.5 45.43 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.195 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.536 ' HG2' ' HG2' ' A' ' 33' ' ' GLN . 0.2 OUTLIER -64.36 -37.54 87.86 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.079 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.536 ' HG2' ' HG2' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -107.34 13.3 27.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.882 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 50.93 83.07 0.05 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.407 HD21 ' CZ ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -118.68 165.11 14.38 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.403 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.86 124.25 68.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.518 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . 7.1 tp -90.26 115.75 27.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.546 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.94 -28.96 69.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.456 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 163.26 174.29 32.96 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.577 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.42 HG21 HD21 ' A' ' 60' ' ' LEU . 2.0 t -81.37 132.74 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.568 0.347 . . . . 0.0 110.694 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.1 -63.33 1.27 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.334 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.43 163.73 29.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.56 ' HA3' ' CD2' ' A' ' 58' ' ' LEU . . . -152.33 163.32 30.21 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.954 -1.117 . . . . 0.0 114.436 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.414 ' H ' ' HG ' ' A' ' 58' ' ' LEU . 68.1 mt-30 -150.27 148.69 29.17 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.127 0.571 . . . . 0.0 110.054 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mp -133.46 129.19 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.281 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.6 mt -107.54 114.92 47.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.195 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.83 155.49 48.94 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.7 -70.4 0.08 OUTLIER Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 0.3 OUTLIER -120.83 108.99 36.28 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.708 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.83 119.18 1.85 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.733 1.622 . . . . 0.0 115.908 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -120.88 23.21 10.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.258 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.725 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 74.44 29.47 1.2 Allowed 'General case' 0 C--N 1.344 0.335 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.711 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -122.31 27.32 7.99 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.591 177.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -50.66 149.04 3.49 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.31 132.72 43.56 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.945 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -117.63 144.18 45.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 112.081 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -143.94 116.98 8.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.666 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.56 ' CD2' ' HA3' ' A' ' 43' ' ' GLY . 4.5 mp -143.18 164.06 31.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.1 mm -119.44 131.4 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.865 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.508 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.47 169.1 18.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.931 0.396 . . . . 0.0 111.619 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.0 m -98.81 135.09 40.76 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.988 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.518 ' CB ' ' HA ' ' A' ' 37' ' ' LEU . . . -153.59 143.23 21.8 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -140.58 164.61 29.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.457 178.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -98.92 -7.17 27.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.238 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.02 148.32 18.4 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.776 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.14 -27.96 48.84 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.951 2.434 . . . . 0.0 112.342 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -89.31 14.29 11.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.741 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -128.43 167.22 17.33 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 121.453 0.644 . . . . 0.0 112.484 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 8.3 m-85 -69.5 160.95 30.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.324 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -109.6 130.99 55.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.411 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.491 ' HE2' ' HB2' ' A' ' 95' ' ' PHE . 25.5 mmmt -112.94 170.08 8.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.02 0.438 . . . . 0.0 111.74 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.73 145.66 25.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.733 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 36.1 m-85 -140.94 136.88 32.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.1 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.475 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -109.11 115.49 30.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.472 ' CG1' ' HA ' ' A' ' 91' ' ' PHE . 2.2 m -121.99 144.38 31.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.726 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.472 HG12 HG22 ' A' ' 89' ' ' VAL . 23.7 t -104.34 127.25 58.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.875 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.646 HG23 HG21 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -126.25 146.78 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.465 HD22 ' HE2' ' A' ' 80' ' ' LYS . 11.8 tp -120.42 129.54 53.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.436 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.521 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -93.94 134.94 35.8 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' HE2' HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -126.47 131.6 51.63 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.95 0.405 . . . . 0.0 111.91 -179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.543 ' HB3' ' HB3' ' A' ' 52' ' ' TRP . . . -89.23 -36.44 15.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.378 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 m -57.57 -41.74 81.68 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -11.23 50.75 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.05 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.53 45.51 10.56 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.1 p -165.99 -169.06 1.39 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 111.263 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.643 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -105.86 170.81 7.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.475 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.68 142.7 27.01 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.916 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.741 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 1.5 tm? -101.11 115.79 31.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.381 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.472 HG22 HG12 ' A' ' 76' ' ' VAL . 3.6 t -74.52 -52.29 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.45 156.45 16.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.95 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 4.6 t80 -120.74 124.77 45.95 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.618 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.63 137.69 30.38 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.01 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.13 138.31 12.71 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.733 2.289 . . . . 0.0 112.332 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.475 ' CD2' ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -108.85 39.99 1.9 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.638 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HB2' ' HE2' ' A' ' 71' ' ' LYS . 16.6 p90 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.641 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.097 0 CA-C-O 120.166 -0.241 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.97 154.96 71.83 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.964 2.443 . . . . 0.0 112.582 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.413 ' HA2' ' HD3' ' A' ' 4' ' ' PRO . . . -104.58 112.51 4.11 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.54 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.413 ' HD3' ' HA2' ' A' ' 3' ' ' GLY . 7.3 Cg_endo -86.49 153.14 9.09 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.266 2.644 . . . . 0.0 112.556 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.23 19.45 9.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.769 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.21 -49.43 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.844 -0.162 . . . . 0.0 111.073 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.83 119.89 1.26 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.953 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.42 167.11 15.43 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.549 0.214 . . . . 0.0 110.659 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 t -120.0 112.14 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.858 0.361 . . . . 0.0 111.485 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -143.56 159.03 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.007 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.42 -178.95 16.93 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.305 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.584 HG13 ' CG2' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -97.2 167.14 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 111.267 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 m -91.92 150.34 21.08 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.092 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.97 -20.42 27.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.227 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -55.42 -35.91 65.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.547 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 13.6 t70 -57.49 115.96 12.44 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.904 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.0 Cg_endo -59.54 -28.09 86.59 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.502 2.801 . . . . 0.0 114.133 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.478 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -79.54 -43.47 22.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.034 0.445 . . . . 0.0 110.564 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.584 ' CG2' HG13 ' A' ' 12' ' ' ILE . 48.4 t -62.01 -41.46 91.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.834 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -36.12 68.48 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 12.1 pt-20 -76.87 -37.0 56.35 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.089 0.471 . . . . 0.0 110.982 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.531 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 75.4 mt -76.28 -32.24 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.723 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.27 -50.9 50.62 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.199 0.523 . . . . 0.0 110.239 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.5 pt-20 -58.57 -43.33 89.35 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.065 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 20.0 t80 -56.93 -37.45 71.5 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.415 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.91 -48.71 80.49 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.056 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.475 HD21 ' HB3' ' A' ' 37' ' ' LEU . 1.2 tp -64.58 -47.84 77.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.23 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.554 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -67.88 -17.07 64.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.526 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 19.5 tp60 -86.65 -38.17 17.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.33 0.11 . . . . 0.0 111.24 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.494 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 1.4 t60 -104.13 127.09 51.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.781 0.325 . . . . 0.0 110.708 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -171.57 44.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.093 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -37.36 70.82 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.911 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.52 7.66 35.31 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 61.29 96.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.06 160.03 40.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.161 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 124.39 69.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.506 ' CD1' ' HB2' ' A' ' 60' ' ' LEU . 6.5 tp -87.89 116.21 25.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.182 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.27 -30.75 71.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.83 166.27 22.41 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 119.505 -1.331 . . . . 0.0 114.246 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.0 t -72.38 123.57 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.881 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.509 ' HB2' ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -92.4 -65.74 0.98 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.805 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.78 165.31 30.54 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.105 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.493 ' HA3' HD22 ' A' ' 58' ' ' LEU . . . -165.75 -174.06 34.89 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.665 -1.255 . . . . 0.0 114.306 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 57' ' ' ASN . 49.4 mt-30 -140.13 167.92 21.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.744 -0.728 . . . . 0.0 110.957 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.447 HG23 ' N ' ' A' ' 46' ' ' ILE . 77.0 mt -144.62 140.1 23.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.66 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.447 ' N ' HG23 ' A' ' 45' ' ' ILE . 28.1 mt -106.44 114.61 46.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.73 163.34 30.41 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.201 -177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.37 -71.8 0.02 OUTLIER Glycine 0 C--N 1.332 0.338 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.448 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 9.7 tt -120.48 109.23 36.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.1 115.22 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 N-CA-C 115.983 1.494 . . . . 0.0 115.983 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -122.24 11.42 10.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.338 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.751 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 76.51 31.97 0.57 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 124.43 1.092 . . . . 0.0 111.876 -178.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.82 26.32 8.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.069 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.06 149.88 43.97 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -101.59 124.16 46.79 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.629 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.534 ' CB ' HG23 ' A' ' 77' ' ' VAL . 13.9 m-85 -104.61 125.19 50.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.175 0.512 . . . . 0.0 112.058 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 44' ' ' GLN . 38.3 t-20 -124.32 111.47 15.85 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.496 HD22 HD11 ' A' ' 12' ' ' ILE . 4.2 mp -138.58 167.64 21.5 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.4 mm -129.05 128.29 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.756 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.509 ' HA ' ' HB2' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -133.04 169.35 16.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.779 0.324 . . . . 0.0 111.498 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m -98.84 136.17 39.24 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.611 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 37' ' ' LEU . . . -148.46 144.31 27.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.144 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -145.54 165.9 27.27 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.917 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -96.98 -9.09 28.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.796 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.412 ' OG ' ' HB2' ' A' ' 68' ' ' GLU . 3.8 p -153.2 144.02 15.91 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.891 0.376 . . . . 0.0 111.582 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.87 -30.05 58.18 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.123 2.548 . . . . 0.0 112.851 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -87.8 12.72 12.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.412 ' HB2' ' OG ' ' A' ' 65' ' ' SER . 15.3 mt-10 -125.89 167.67 14.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.247 0.546 . . . . 0.0 111.741 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.435 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 8.4 m-85 -66.89 158.91 29.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.904 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -115.27 130.18 56.83 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.816 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 22.6 mmmt -107.95 169.33 8.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.767 0.318 . . . . 0.0 111.213 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -91.51 152.34 20.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.173 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 32.9 m-85 -144.16 139.67 28.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.499 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.4 ' CB ' HD21 ' A' ' 94' ' ' LEU . 50.2 t30 -109.95 127.09 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 110.139 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 91' ' ' PHE . 42.3 t -126.96 151.04 33.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.539 0.685 . . . . 0.0 112.028 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.1 t -111.01 112.4 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.59 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.534 HG23 ' CB ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -118.89 142.53 33.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.037 0.446 . . . . 0.0 111.62 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.485 HD21 ' HE3' ' A' ' 80' ' ' LYS . 12.6 tp -118.95 128.35 54.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.614 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -87.81 120.82 29.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.346 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.485 ' HE3' HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -113.01 131.22 55.86 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.136 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.14 -35.16 13.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.266 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.6 m -61.04 -42.38 98.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.553 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.34 -9.93 59.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.936 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 61.25 42.15 12.4 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.168 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 t -172.51 178.84 2.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.352 0.596 . . . . 0.0 111.321 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.639 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -86.41 167.89 14.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.102 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -146.25 141.24 27.16 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.966 0.412 . . . . 0.0 111.041 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.526 ' CB ' ' HG2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -99.91 122.53 42.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.555 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.83 -52.73 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.929 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' O ' HG12 ' A' ' 75' ' ' VAL . . . -157.66 155.69 30.46 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.455 ' HA ' HG22 ' A' ' 75' ' ' VAL . 2.3 t80 -123.94 125.1 44.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.971 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.55 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 3.2 t -132.64 143.75 50.05 Favored Pre-proline 0 N--CA 1.469 0.493 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.55 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 68.4 Cg_endo -84.7 139.0 7.41 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.865 2.376 . . . . 0.0 112.679 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.4 HD21 ' CB ' ' A' ' 74' ' ' ASN . 0.5 OUTLIER -113.58 48.88 1.02 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.913 0.387 . . . . 0.0 110.92 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 30.3 p90 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.656 -0.688 . . . . 0.0 111.755 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.09 0 N-CA-C 112.364 -0.295 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.65 146.78 74.47 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.803 2.335 . . . . 0.0 112.728 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.476 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 179.1 -105.91 0.2 Allowed Glycine 0 C--N 1.332 0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.273 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.476 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 4.0 Cg_exo -79.82 163.94 23.22 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.035 2.49 . . . . 0.0 112.454 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.99 29.88 4.35 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.232 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.4 mt -127.22 -55.18 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.444 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.04 -178.25 30.93 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.616 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -90.34 137.37 32.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.599 0.238 . . . . 0.0 110.874 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.1 142.67 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.449 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.5 pt -141.13 165.89 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.838 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.02 -166.66 22.2 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.145 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.649 HG13 HG12 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -100.33 163.55 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.941 0.4 . . . . 0.0 111.261 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 m -92.16 150.38 20.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.353 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.23 -22.85 31.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -53.1 -34.82 58.33 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.459 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.424 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 10.1 t70 -57.79 115.13 10.03 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.434 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.18 -29.32 86.66 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.297 2.664 . . . . 0.0 114.009 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 1.8 mpt_? -77.76 -43.29 31.26 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.185 0.517 . . . . 0.0 110.488 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.649 HG12 HG13 ' A' ' 12' ' ' ILE . 55.1 t -61.58 -43.46 97.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.831 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 -36.28 73.19 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 12.3 pt-20 -76.78 -37.9 55.01 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.27 0.557 . . . . 0.0 110.848 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.506 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 58.3 mt -74.15 -33.74 36.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.523 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.429 ' HB3' HD22 ' A' ' 60' ' ' LEU . . . -69.82 -47.74 61.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.753 0.311 . . . . 0.0 110.852 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 9.8 pt-20 -57.51 -44.79 85.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.046 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.698 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 32.2 t80 -57.93 -37.38 73.98 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.64 -47.52 73.41 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.739 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.581 HD23 ' HB3' ' A' ' 37' ' ' LEU . 1.1 tp -67.26 -45.72 75.82 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.51 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.499 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -69.43 -17.92 63.69 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.534 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 6.0 tp60 -83.4 -37.94 22.61 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.469 0.176 . . . . 0.0 111.161 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.478 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 2.6 t60 -97.7 128.6 44.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.273 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -174.63 36.48 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.27 -38.38 30.99 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.97 0.414 . . . . 0.0 110.191 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 8.9 mt-30 -84.51 -19.85 32.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.146 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.449 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 27.7 t-20 74.79 91.65 0.08 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.295 0.638 . . . . 0.0 112.537 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.17 167.07 23.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.068 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.436 ' HB ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -124.83 124.76 68.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.581 ' HB3' HD23 ' A' ' 27' ' ' LEU . 9.9 tp -90.6 113.24 25.22 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.443 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.87 -27.54 68.3 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.666 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.37 177.29 35.27 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.011 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 41' ' ' ASP . 3.1 t -84.81 138.59 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.006 0.522 . . . . 0.0 110.987 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.44 ' N ' HG11 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -109.68 -66.5 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.433 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.26 169.66 17.27 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.81 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.558 ' CA ' ' HG ' ' A' ' 58' ' ' LEU . . . -159.33 174.22 36.21 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 119.761 -1.209 . . . . 0.0 114.916 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 43' ' ' GLY . 2.1 mm100 -153.75 139.23 17.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.139 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.486 ' CD1' HD11 ' A' ' 12' ' ' ILE . 5.9 mm -124.36 133.7 68.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 111.373 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.6 mt -114.45 115.91 50.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.77 160.45 39.22 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.905 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.33 -75.77 0.07 OUTLIER Glycine 0 C--N 1.332 0.357 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.6 tt -113.39 108.99 51.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -87.34 117.57 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 116.628 1.741 . . . . 0.0 116.628 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.6 22.35 10.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.541 -1.663 . . . . 0.0 107.622 175.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.752 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 76.69 31.49 0.56 Allowed 'General case' 0 C--N 1.345 0.391 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.92 -178.856 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.511 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -122.03 26.97 8.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.637 177.42 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.651 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -53.14 147.5 9.69 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.527 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.91 118.15 32.68 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.919 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.651 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 44.6 m-85 -106.05 134.07 49.76 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.311 0.577 . . . . 0.0 112.397 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -130.92 126.53 36.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.51 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.558 ' HG ' ' CA ' ' A' ' 43' ' ' GLY . 1.6 mp -149.65 154.55 38.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.3 mm -112.46 127.9 69.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.97 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.512 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 0.0 OUTLIER -130.46 169.23 15.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.954 0.407 . . . . 0.0 111.872 -178.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.9 m -100.45 133.76 44.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.328 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . . . -147.34 138.11 23.53 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 123.547 0.529 . . . . 0.0 112.101 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -135.22 164.34 27.92 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.586 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -88.78 -18.21 28.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.31 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 p -150.55 146.44 19.71 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 111.266 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.19 -26.01 49.93 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.224 2.616 . . . . 0.0 113.292 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -86.73 2.99 46.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -129.19 167.13 18.06 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.496 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.7 m-85 -54.72 159.24 2.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.546 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 11.9 m -117.61 143.44 46.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.067 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 2.8 mmmt -116.01 166.01 12.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.852 0.358 . . . . 0.0 111.094 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -91.86 146.99 23.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.32 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 22.0 m-85 -141.23 139.91 33.85 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.984 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB2' HD11 ' A' ' 59' ' ' ILE . 6.2 t-20 -110.24 125.76 53.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.845 0.355 . . . . 0.0 110.51 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.473 HG13 ' CG ' ' A' ' 91' ' ' PHE . 6.0 m -128.71 153.69 38.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.424 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.22 110.37 31.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.881 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.7 t -115.51 128.17 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.039 0.447 . . . . 0.0 111.504 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.1 tp -102.16 131.53 48.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.046 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -90.94 129.79 36.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.207 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -125.7 134.18 51.9 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.083 0.468 . . . . 0.0 111.896 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.31 -30.63 15.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.966 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.2 m -59.58 -34.88 73.28 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.542 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.46 4.85 33.65 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 46.89 57.32 5.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 111.466 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.4 p -176.0 176.12 1.83 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.313 0.578 . . . . 0.0 111.307 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.698 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -92.72 170.95 9.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.723 178.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.55 119.92 8.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.782 0.325 . . . . 0.0 111.235 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.534 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -83.15 106.01 14.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.39 -51.4 25.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.395 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.67 147.69 27.68 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.9 0.381 . . . . 0.0 111.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.473 ' CG ' HG13 ' A' ' 75' ' ' VAL . 1.2 t80 -124.73 121.7 35.39 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.903 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.48 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 11.2 t -131.85 141.85 43.05 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.404 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.48 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 84.2 Cg_endo -83.74 138.33 8.18 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.742 2.295 . . . . 0.0 111.61 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.65 40.87 1.79 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.648 0.261 . . . . 0.0 111.568 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.8 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.411 179.778 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 CA-C-O 120.13 -0.261 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.24 132.9 31.0 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.834 2.356 . . . . 0.0 112.34 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.93 121.8 1.01 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.726 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -84.77 -176.52 2.5 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.959 2.439 . . . . 0.0 112.622 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.53 -60.31 0.99 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.771 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.6 mt -121.72 2.06 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.821 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.33 149.07 16.57 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.627 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -136.09 124.62 23.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.772 0.32 . . . . 0.0 111.035 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.13 143.29 39.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.223 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.61 153.73 31.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.467 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.47 -173.48 14.97 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.319 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.658 HG13 ' CG2' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -96.95 156.8 3.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 117.201 0.501 . . . . 0.0 111.428 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.0 m -88.5 154.62 20.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.211 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.9 -20.66 27.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.146 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -54.92 -35.62 64.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.523 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.0 114.98 10.3 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.501 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.27 -27.52 85.23 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.365 2.71 . . . . 0.0 114.216 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.567 ' HB3' HD13 ' A' ' 22' ' ' ILE . 7.9 mmp_? -78.42 -47.73 16.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.323 0.582 . . . . 0.0 110.157 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.658 ' CG2' HG13 ' A' ' 12' ' ' ILE . 55.3 t -58.31 -40.45 77.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.392 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.57 -36.07 65.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.3 pt-20 -76.21 -36.22 58.71 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.223 0.535 . . . . 0.0 110.71 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.575 ' HA ' ' HG ' ' A' ' 86' ' ' LEU . 22.5 mt -74.59 -36.94 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.056 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.28 -52.73 44.49 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.118 0.485 . . . . 0.0 110.334 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.0 pt-20 -55.16 -43.95 74.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.024 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 30.8 t80 -58.32 -35.32 71.7 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.934 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.47 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -60.37 -47.33 86.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.554 HD23 ' HB3' ' A' ' 37' ' ' LEU . 1.4 tp -65.56 -44.04 88.0 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.116 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -72.33 -18.48 61.76 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.495 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 4.3 tp60 -83.58 -37.7 22.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.454 0.169 . . . . 0.0 111.039 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.498 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -105.03 126.54 52.17 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.535 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -172.67 43.47 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.86 0.362 . . . . 0.0 111.659 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -37.52 83.09 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.817 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.67 4.82 26.22 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 65.64 97.13 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.6 153.94 51.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.7 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.14 124.47 73.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.554 ' HB3' HD23 ' A' ' 27' ' ' LEU . 9.1 tp -90.0 117.32 28.71 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.409 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.442 ' HB1' ' HE2' ' A' ' 63' ' ' LYS . . . -65.79 -31.18 72.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.314 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 160.38 171.91 26.93 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.8 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.534 HG22 HD22 ' A' ' 60' ' ' LEU . 2.5 t -75.1 128.56 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 122.798 0.439 . . . . 0.0 110.976 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -100.76 -62.78 1.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.589 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.51 167.41 27.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.54 ' HA3' HD13 ' A' ' 12' ' ' ILE . . . -156.51 169.4 33.89 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.988 -1.101 . . . . 0.0 114.279 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 57' ' ' ASN . 9.0 mt-30 -141.91 137.74 31.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.017 -0.591 . . . . 0.0 110.225 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.0 mt -122.66 124.64 71.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 111.472 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.3 mt -107.55 115.07 47.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 162.98 32.84 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.95 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.2 -68.94 0.02 OUTLIER Glycine 0 C--N 1.331 0.253 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.425 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 3.7 tt -120.53 109.11 36.75 Favored Pre-proline 0 C--O 1.233 0.201 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -88.93 116.8 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 N-CA-C 116.394 1.652 . . . . 0.0 116.394 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.3 23.76 10.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.611 175.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.762 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 75.14 33.02 0.74 Allowed 'General case' 0 C--N 1.344 0.334 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.109 -178.181 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 7.9 p-10 -122.9 27.3 7.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.904 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.489 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -56.62 144.59 31.48 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.01 121.51 40.01 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.316 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.489 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 12.9 m-85 -107.32 139.85 41.15 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.256 0.551 . . . . 0.0 112.239 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 44' ' ' GLN . 48.3 t30 -137.12 111.05 8.23 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.553 HD23 HD13 ' A' ' 12' ' ' ILE . 4.9 mp -134.76 166.23 23.44 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.4 mm -127.73 126.94 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.448 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.534 HD22 HG22 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -130.66 169.38 15.72 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 111.739 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.9 m -95.64 140.21 30.79 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.356 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 37' ' ' LEU . . . -154.8 147.11 23.89 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -149.87 166.89 28.17 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.101 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -102.15 -5.26 24.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.06 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.35 148.2 23.62 Favored Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.42 -34.25 54.84 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.082 2.522 . . . . 0.0 112.51 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -90.59 14.28 13.65 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -113.12 167.15 10.77 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.241 0.544 . . . . 0.0 112.002 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.582 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.8 m-85 -64.56 179.13 0.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.08 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.55 119.83 25.57 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 0.3 OUTLIER -107.44 165.79 11.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.03 0.443 . . . . 0.0 111.829 -178.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -90.87 146.68 23.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.848 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.559 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 16.2 m-85 -141.46 137.55 32.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.327 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.49 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 48.7 t-20 -110.38 130.19 55.6 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.799 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' A' ' 91' ' ' PHE . 30.5 m -129.07 146.28 34.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 112.256 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 12.1 t -105.58 110.5 31.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.51 ' CG1' HG23 ' A' ' 22' ' ' ILE . 3.3 t -118.73 139.26 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.946 0.403 . . . . 0.0 111.491 -178.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.5 tp -114.94 127.15 55.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.973 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 1.0 OUTLIER -90.61 126.58 36.0 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.783 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.88 135.14 51.58 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -90.22 -31.2 17.12 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.824 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.75 -39.46 71.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.003 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.19 -7.83 34.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.251 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.17 50.5 11.71 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-O 121.061 0.458 . . . . 0.0 111.008 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.27 -175.53 1.43 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.908 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.591 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -97.27 165.87 11.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.284 179.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.86 122.91 10.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.949 0.404 . . . . 0.0 111.038 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.498 ' CD1' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -82.73 112.6 19.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.056 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 2.7 t -75.35 -49.27 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.712 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -161.79 155.53 21.56 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.521 ' HA ' HG11 ' A' ' 75' ' ' VAL . 1.3 t80 -123.21 124.07 42.21 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.392 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.56 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 4.9 t -132.25 142.61 45.65 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 83.8 Cg_endo -78.3 138.52 15.92 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.668 2.246 . . . . 0.0 111.885 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -115.64 39.49 2.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.698 0.285 . . . . 0.0 111.458 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.8 p90 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.237 179.626 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 CA-C-O 120.147 -0.252 . . . . 0.0 112.693 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.32 148.85 34.6 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.928 2.419 . . . . 0.0 112.575 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.21 -159.71 9.42 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.818 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.14 -175.0 2.32 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.341 2.694 . . . . 0.0 112.272 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.82 -66.02 0.96 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.779 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -147.08 57.39 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.531 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.69 -47.05 0.5 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.359 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -117.82 140.23 49.98 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.953 0.406 . . . . 0.0 112.018 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.8 t -124.38 136.21 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.409 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.7 pt -138.76 165.9 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.03 -176.48 22.06 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.679 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.708 HG13 ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -112.87 156.98 13.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 117.803 0.801 . . . . 0.0 112.632 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -76.55 152.16 36.08 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.097 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.56 -27.63 43.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.655 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -47.1 -38.42 11.34 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.336 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.449 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 12.6 t70 -57.13 114.03 7.31 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.352 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 12.1 Cg_endo -55.75 -31.58 80.91 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.613 2.876 . . . . 0.0 114.328 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.516 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -74.95 -44.74 46.77 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.251 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.708 ' CG2' HG13 ' A' ' 12' ' ' ILE . 54.3 t -60.94 -42.6 93.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.653 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -37.06 67.9 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.922 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.504 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 11.4 pt-20 -78.57 -39.37 37.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.803 0.335 . . . . 0.0 111.398 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 18' ' ' ARG . 43.0 mt -73.22 -32.13 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.769 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.5 -48.18 61.43 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -50.59 -49.7 55.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.764 178.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.612 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 41.7 t80 -58.32 -37.92 76.06 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.279 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.64 -39.28 70.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.028 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.584 HD23 ' HB3' ' A' ' 37' ' ' LEU . 2.0 tp -74.45 -47.86 30.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.608 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.596 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -67.14 -18.3 65.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.515 ' CD ' ' HB3' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -77.79 -31.01 51.59 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.568 0.223 . . . . 0.0 111.002 179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -75.03 -118.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.101 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 65.76 34.0 7.79 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.36 -38.49 41.83 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.864 0.364 . . . . 0.0 110.213 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 0.6 OUTLIER -117.7 10.14 13.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.116 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 14.5 t-20 69.47 95.98 0.07 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.028 0.531 . . . . 0.0 111.986 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.466 ' HA ' ' CD2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -138.46 146.85 42.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.563 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.29 124.72 72.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.584 ' HB3' HD23 ' A' ' 27' ' ' LEU . 8.5 tp -90.04 115.86 27.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.153 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.77 -28.29 68.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.408 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.8 173.92 32.08 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 119.56 -1.305 . . . . 0.0 114.12 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.461 HG22 HD22 ' A' ' 60' ' ' LEU . 2.3 t -79.32 137.79 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.228 -0.486 . . . . 0.0 110.532 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.54 -63.93 1.33 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.485 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.02 163.8 33.11 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.484 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.606 ' HA3' ' CD2' ' A' ' 58' ' ' LEU . . . -161.32 175.37 37.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.546 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 57' ' ' ASN . 50.7 mm-40 -149.43 155.53 40.57 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.384 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.427 ' CG2' ' ND2' ' A' ' 54' ' ' ASN . 4.2 mp -137.2 122.83 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.302 . . . . 0.0 110.956 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.08 118.4 55.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -137.32 163.08 31.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.897 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.56 -69.26 0.04 OUTLIER Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 7.4 tp -120.28 111.89 34.87 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -87.53 114.81 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 N-CA-C 116.357 1.637 . . . . 0.0 116.357 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -121.85 22.98 10.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.209 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.725 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.75 33.89 1.25 Allowed 'General case' 0 C--N 1.344 0.345 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.283 -177.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 15.5 m-20 -121.32 26.81 8.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.423 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.446 ' OD1' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -58.56 143.98 44.26 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.322 -178.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.2 125.74 40.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.316 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -109.46 129.84 55.53 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.908 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 44' ' ' GLN . 12.6 t-20 -126.5 114.19 17.8 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.606 ' CD2' ' HA3' ' A' ' 43' ' ' GLY . 4.1 mp -142.07 161.1 38.85 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.624 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 3.5 mm -119.9 131.49 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.404 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.541 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.21 165.89 24.36 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.955 0.407 . . . . 0.0 112.083 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.3 m -96.38 136.34 37.0 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.95 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.502 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . . . -148.06 142.59 26.47 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -144.05 166.07 26.02 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.708 179.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.466 ' CD2' ' HA ' ' A' ' 35' ' ' LEU . 47.6 m80 -104.84 -3.15 23.84 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.121 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.41 145.96 20.16 Favored Pre-proline 0 N--CA 1.465 0.317 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.13 -29.65 47.59 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.284 2.656 . . . . 0.0 112.598 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -98.82 14.55 28.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.843 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -120.9 167.15 12.86 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.13 0.49 . . . . 0.0 111.604 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.498 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 6.7 m-85 -69.45 160.57 31.15 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.0 m -116.6 135.76 53.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.127 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -112.04 165.35 12.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.753 0.311 . . . . 0.0 110.709 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -89.13 153.15 21.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.742 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.624 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 14.7 m-85 -139.39 142.17 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.778 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.5 ' HA ' HD12 ' A' ' 59' ' ' ILE . 53.9 t-20 -111.83 118.76 36.44 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.529 HG13 ' CG ' ' A' ' 91' ' ' PHE . 29.7 m -130.71 151.0 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.96 118.61 57.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.731 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.3 144.48 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.111 0.482 . . . . 0.0 111.819 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.9 tp -120.33 125.65 48.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.943 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 1.9 tt0 -90.05 120.1 30.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.539 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.85 133.91 51.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.58 -37.22 15.84 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.196 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -37.83 87.27 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.464 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -15.78 58.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.761 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 72.46 31.33 1.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.56 -165.15 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.286 0.565 . . . . 0.0 111.88 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.612 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -94.3 169.12 10.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.022 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.72 138.03 21.78 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.93 0.395 . . . . 0.0 111.952 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.515 ' HB3' ' CD ' ' A' ' 29' ' ' GLN . 0.2 OUTLIER -97.44 109.31 22.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.862 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 1.9 t -74.54 -54.35 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.449 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.14 145.73 31.5 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.529 ' CG ' HG13 ' A' ' 75' ' ' VAL . 1.2 t80 -125.22 117.61 24.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.877 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.522 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 2.6 t -132.7 144.44 52.95 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.969 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.522 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 89.3 Cg_endo -87.43 138.5 4.65 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.974 2.449 . . . . 0.0 112.322 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.454 ' CD2' ' HB2' ' A' ' 74' ' ' ASN . 0.4 OUTLIER -98.85 32.52 2.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.321 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 10.4 p90 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.593 -0.718 . . . . 0.0 111.129 -179.753 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 CA-C-O 120.219 -0.212 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.21 164.5 35.17 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.801 2.334 . . . . 0.0 112.641 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.85 90.53 0.19 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.754 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.65 -174.06 2.12 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.161 2.574 . . . . 0.0 112.198 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.95 -68.24 0.94 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -143.85 56.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.996 0.427 . . . . 0.0 111.19 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -146.62 132.8 4.57 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.633 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -142.19 124.38 15.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.837 0.351 . . . . 0.0 111.251 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.15 144.07 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.958 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.4 pt -111.03 158.14 11.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.964 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.52 -163.88 14.56 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.219 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.659 HG13 HG13 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -101.49 167.39 2.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 117.493 0.647 . . . . 0.0 111.237 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -101.51 157.73 16.59 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.075 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.81 -22.43 30.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -53.98 -35.88 62.3 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.479 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.424 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 16.3 t70 -59.64 113.5 7.27 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.633 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 19.1 Cg_endo -58.16 -27.83 81.66 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.304 2.669 . . . . 0.0 114.06 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.416 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -77.07 -48.67 17.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.159 0.504 . . . . 0.0 110.27 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.659 HG13 HG13 ' A' ' 12' ' ' ILE . 52.0 t -57.67 -41.56 79.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.93 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -40.66 78.51 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 12.9 pt-20 -72.93 -40.02 65.79 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.676 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.561 HG22 HG23 ' A' ' 77' ' ' VAL . 18.2 mt -65.77 -40.03 86.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.564 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.048 0.452 . . . . 0.0 110.248 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.48 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -51.94 -52.78 47.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.74 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 25.3 t80 -56.86 -35.38 68.83 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.725 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.524 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.29 -48.34 80.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.372 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.598 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.7 tp -68.63 -46.9 67.99 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.586 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.548 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -68.89 -18.2 64.09 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.423 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 5.8 tp60 -84.87 -37.3 20.8 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.401 ' HB2' HD11 ' A' ' 88' ' ' LEU . 78.3 t60 -71.56 -103.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.415 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 56.4 36.16 27.08 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -37.74 88.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.804 0.335 . . . . 0.0 110.934 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.7 13.23 9.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.482 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 68.15 86.89 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.877 0.471 . . . . 0.0 111.771 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.409 ' HB2' ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -125.91 158.19 35.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.835 178.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.505 ' HB ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -118.39 125.13 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -177.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.598 ' HB3' HD22 ' A' ' 27' ' ' LEU . 9.9 tp -90.4 113.5 25.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.966 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.06 68.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.735 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 161.38 166.77 20.77 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 119.712 -1.232 . . . . 0.0 114.09 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.1 t -77.23 137.07 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.588 0.355 . . . . 0.0 110.646 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.1 -67.9 0.91 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.154 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.09 173.53 13.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.558 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.523 ' HA3' HD21 ' A' ' 58' ' ' LEU . . . -170.14 -163.69 24.61 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 119.807 -1.187 . . . . 0.0 114.255 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -153.94 137.71 16.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.075 -0.562 . . . . 0.0 111.136 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.465 HG13 HG21 ' A' ' 12' ' ' ILE . 7.5 mt -114.97 126.16 72.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -109.64 117.62 54.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.01 162.19 33.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.935 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -135.29 -71.99 0.07 OUTLIER Glycine 0 C--N 1.334 0.431 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.455 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 12.6 tt -120.11 112.27 34.85 Favored Pre-proline 0 C--O 1.233 0.225 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.98 114.54 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 N-CA-C 115.891 1.458 . . . . 0.0 115.891 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.97 20.37 10.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.227 -1.806 . . . . 0.0 107.3 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.735 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 71.87 32.93 1.79 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.215 -178.054 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 5.0 p-10 -122.16 26.98 8.23 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.542 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.435 ' ND2' ' CG2' ' A' ' 45' ' ' ILE . 0.3 OUTLIER -57.34 148.03 24.15 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.95 132.79 44.01 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.981 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.482 ' CE1' HD13 ' A' ' 22' ' ' ILE . 32.3 m-85 -119.22 135.46 54.67 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.23 0.538 . . . . 0.0 112.022 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -130.73 111.85 12.54 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.845 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.523 HD21 ' HA3' ' A' ' 43' ' ' GLY . 3.9 mp -141.7 163.81 31.91 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.3 mm -122.72 138.18 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.345 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -141.61 168.93 18.6 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.779 0.323 . . . . 0.0 111.84 -179.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.8 m -92.1 138.5 31.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.224 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . . . -156.38 146.61 21.4 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -149.67 164.49 35.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.675 178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.409 ' CE1' ' HB2' ' A' ' 35' ' ' LEU . 60.5 m80 -102.17 -2.76 28.62 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.93 144.54 19.18 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-O 121.031 0.443 . . . . 0.0 112.132 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.23 -33.01 50.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.121 2.547 . . . . 0.0 112.108 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -90.45 14.63 12.48 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.671 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -117.87 167.09 11.73 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.2 0.524 . . . . 0.0 111.725 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.546 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 6.7 m-85 -64.77 -176.4 0.25 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.402 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.416 ' C ' ' HD3' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -130.61 122.62 27.8 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.231 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.416 ' HD3' ' C ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -111.06 169.71 8.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.936 0.398 . . . . 0.0 111.643 -178.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.426 ' C ' ' HB2' ' A' ' 94' ' ' LEU . 10.6 m-85 -92.75 149.57 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.578 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 24.8 m-85 -144.0 137.87 28.0 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.767 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.433 ' HB2' HD12 ' A' ' 94' ' ' LEU . 51.4 t30 -109.4 126.48 53.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 110.412 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.432 HG11 ' HA ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -127.73 146.17 33.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.483 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.24 117.61 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.738 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.561 HG23 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -119.1 135.24 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.066 0.46 . . . . 0.0 112.146 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.486 HD22 ' HD2' ' A' ' 80' ' ' LYS . 5.4 tp -117.35 124.45 48.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.333 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.516 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -89.45 124.36 34.41 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.831 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.486 ' HD2' HD22 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -126.55 149.72 49.24 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.2 -27.39 13.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.968 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -54.53 -43.39 71.88 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.61 0.243 . . . . 0.0 110.932 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.14 -6.93 43.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.061 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 61.03 50.33 5.12 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 120.769 0.318 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -174.47 -163.19 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.112 0.482 . . . . 0.0 111.266 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.568 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -104.11 170.31 7.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.076 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.45 ' HE3' HD23 ' A' ' 78' ' ' LEU . 2.2 tmmm? -148.27 117.98 7.08 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.817 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -79.04 106.74 11.29 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.563 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.61 -54.38 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.713 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.47 151.32 40.18 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.09 0.471 . . . . 0.0 112.232 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.432 ' HA ' HG11 ' A' ' 75' ' ' VAL . 3.2 t80 -127.04 120.33 28.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.692 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.433 HG12 ' HD2' ' A' ' 93' ' ' PRO . 12.2 t -132.32 138.99 33.47 Favored Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.45 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 94.6 Cg_endo -82.88 135.61 7.77 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.847 2.365 . . . . 0.0 111.838 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 74' ' ' ASN . 1.4 mt -109.68 44.78 1.15 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.765 0.317 . . . . 0.0 111.297 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 93' ' ' PRO . 43.8 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.092 -0.956 . . . . 0.0 111.132 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 CA-C-O 120.165 -0.241 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.94 165.34 30.32 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.95 2.434 . . . . 0.0 112.733 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 124.12 -102.53 0.72 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.661 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.615 ' HG3' ' HB3' ' A' ' 8' ' ' GLU . 85.7 Cg_endo -84.74 174.26 7.71 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.007 2.471 . . . . 0.0 112.627 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.73 -28.73 6.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.655 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.9 mm -111.42 -55.48 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 116.726 -0.216 . . . . 0.0 111.012 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.62 169.13 35.61 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.172 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.615 ' HB3' ' HG3' ' A' ' 4' ' ' PRO . 2.7 pt-20 -146.96 167.89 22.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.834 0.35 . . . . 0.0 111.127 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.41 110.75 29.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -144.21 147.84 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.242 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 43' ' ' GLY . . . 108.91 -171.47 15.49 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.466 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.612 HG13 HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -96.64 161.0 2.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 121.05 0.452 . . . . 0.0 111.596 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.75 153.83 20.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.981 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.39 -21.66 29.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 109.974 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.55 -36.34 61.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.646 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 10.7 t70 -59.72 114.82 10.51 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.489 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.2 Cg_endo -59.4 -30.08 91.77 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.542 2.828 . . . . 0.0 114.193 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 4.6 mpt_? -76.5 -43.67 38.51 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.257 0.551 . . . . 0.0 110.535 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.612 HG12 HG13 ' A' ' 12' ' ' ILE . 47.2 t -62.19 -42.32 94.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.329 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.3 -36.03 71.51 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.509 ' HG3' HD13 ' A' ' 86' ' ' LEU . 12.2 pt-20 -76.29 -38.25 56.4 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.228 0.537 . . . . 0.0 110.679 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.582 HG23 HG22 ' A' ' 77' ' ' VAL . 85.6 mt -75.46 -32.64 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.325 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.77 -51.1 36.92 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.382 178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -56.16 -43.39 78.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.703 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.633 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 23.7 t80 -57.31 -38.27 73.76 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.731 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.456 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -57.05 -46.18 82.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.107 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 37' ' ' LEU . 3.1 tp -69.18 -45.03 70.98 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.635 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.633 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -71.12 -17.78 62.55 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.433 ' HB3' HD12 ' A' ' 88' ' ' LEU . 3.9 tp-100 -84.41 -38.59 20.05 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.455 ' HB2' HD13 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -97.66 124.98 42.18 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -162.71 40.81 0.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.756 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -37.87 34.53 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 16.0 mt-30 -95.34 -16.7 22.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.955 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 16.6 t30 72.62 91.58 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.045 0.45 . . . . 0.0 111.903 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.75 162.64 34.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.11 178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.77 124.74 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.499 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 12.0 tp -83.58 118.91 24.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.206 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.31 -30.69 71.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.831 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.9 166.29 15.09 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 119.983 -1.103 . . . . 0.0 113.843 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.507 HG21 HD23 ' A' ' 60' ' ' LEU . 18.2 t -68.5 130.14 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.516 -0.342 . . . . 0.0 110.325 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.95 -56.91 2.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.505 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.81 154.59 39.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.411 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 58' ' ' LEU . . . -152.73 173.3 31.75 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.325 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' ASN . 18.1 mt-30 -146.97 159.54 43.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.98 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.417 HD12 HG21 ' A' ' 45' ' ' ILE . 14.7 mt -144.0 131.14 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.714 0.293 . . . . 0.0 111.473 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.5 mt -107.63 115.56 49.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.323 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 162.66 32.52 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.65 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.43 -87.46 0.08 OUTLIER Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.3 108.52 60.57 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.96 115.91 3.35 Favored 'Trans proline' 0 C--N 1.347 0.453 0 N-CA-C 116.491 1.689 . . . . 0.0 116.491 -175.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 19.91 11.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.325 175.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.737 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.08 38.28 0.91 Allowed 'General case' 0 C--N 1.345 0.408 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.631 -178.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.36 26.33 8.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.603 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -49.1 136.55 14.66 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.394 0.678 . . . . 0.0 112.609 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -99.86 126.34 45.96 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.73 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.519 ' HB2' HG23 ' A' ' 77' ' ' VAL . 6.0 m-85 -109.38 144.83 37.05 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 44' ' ' GLN . 9.0 t-20 -144.14 112.26 6.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.808 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.547 HD23 HD12 ' A' ' 12' ' ' ILE . 5.0 mp -138.16 168.78 19.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 2.7 mm -126.85 120.61 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.565 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.507 HD23 HG21 ' A' ' 40' ' ' VAL . 0.1 OUTLIER -127.03 164.1 22.27 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.94 0.4 . . . . 0.0 111.279 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.8 m -94.39 141.65 28.33 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.738 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 37' ' ' LEU . . . -152.05 148.09 27.27 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.511 0.507 . . . . 0.0 112.23 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -150.54 164.57 35.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.726 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -93.96 -11.64 30.47 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.844 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 p -149.7 143.1 16.41 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 111.935 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.88 -22.81 48.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.507 2.805 . . . . 0.0 113.539 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -89.6 3.32 52.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -128.04 166.95 17.43 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 121.377 0.608 . . . . 0.0 112.526 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 5.6 m-85 -53.46 167.46 0.21 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.834 -1.076 . . . . 0.0 113.749 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -125.69 134.1 51.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.825 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 23.9 mmmt -107.76 167.98 9.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.067 0.461 . . . . 0.0 111.819 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' C ' ' HB2' ' A' ' 94' ' ' LEU . 95.7 m-85 -88.37 151.31 22.68 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.621 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 14.0 m-85 -142.42 138.19 30.91 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.865 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.525 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . 8.1 t-20 -110.82 119.68 39.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.498 HG21 ' CD2' ' A' ' 91' ' ' PHE . 41.4 t -130.94 149.59 33.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.049 0.452 . . . . 0.0 111.671 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.424 HG11 HG21 ' A' ' 89' ' ' VAL . 33.6 t -109.24 129.79 63.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.273 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -128.85 146.89 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.016 0.436 . . . . 0.0 111.97 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.409 HD23 ' HE3' ' A' ' 80' ' ' LYS . 12.0 tp -118.58 126.25 51.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.442 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.497 ' HB2' HD13 ' A' ' 22' ' ' ILE . 1.6 tt0 -88.77 128.04 35.62 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.901 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.409 ' HE3' HD23 ' A' ' 78' ' ' LEU . 1.1 ttmt -125.03 130.14 51.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.513 ' HB1' ' HB3' ' A' ' 52' ' ' TRP . . . -89.45 -35.79 15.79 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.324 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.2 m -61.88 -35.48 78.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.55 -7.3 53.23 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.973 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 m120 55.71 47.43 20.52 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 122.646 0.379 . . . . 0.0 111.411 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.4 t -174.04 -169.0 0.44 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.268 0.556 . . . . 0.0 111.167 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.596 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -105.14 168.15 9.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.925 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -147.05 132.67 18.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.973 0.416 . . . . 0.0 111.449 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.456 ' HG ' ' HA ' ' A' ' 26' ' ' ALA . 0.1 OUTLIER -85.96 121.57 28.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.822 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.424 HG21 HG11 ' A' ' 76' ' ' VAL . 2.4 t -85.02 -54.95 7.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.847 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.82 134.14 6.62 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.251 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.498 ' CD2' HG21 ' A' ' 75' ' ' VAL . 1.4 t80 -106.49 126.82 52.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.787 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.413 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 2.1 t -132.47 147.41 65.54 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.45 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.413 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 61.5 Cg_endo -92.44 138.37 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.17 2.58 . . . . 0.0 112.826 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.406 ' HB2' ' C ' ' A' ' 72' ' ' PHE . 0.4 OUTLIER -99.61 27.47 5.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.275 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.42 ' CB ' ' HE3' ' A' ' 71' ' ' LYS . 6.5 p90 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.534 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 CA-C-O 120.1 -0.278 . . . . 0.0 112.652 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.15 132.84 28.96 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.836 2.357 . . . . 0.0 112.668 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.54 130.74 1.18 Allowed Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.794 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -84.45 176.26 6.55 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.877 2.385 . . . . 0.0 112.791 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.93 -45.34 0.86 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.461 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.76 -38.58 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.287 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.52 -133.37 3.32 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.778 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -128.7 136.94 51.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.729 0.3 . . . . 0.0 111.198 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.69 143.58 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.45 160.59 13.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.76 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -110.45 -157.29 15.67 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.51 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.692 HG13 ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -96.45 167.3 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 117.185 0.492 . . . . 0.0 111.482 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 m -91.27 149.76 21.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.15 -19.04 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.506 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -57.43 -37.94 73.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.008 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 18.4 t70 -57.99 113.63 6.87 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.031 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HA ' ' HE3' ' A' ' 20' ' ' LYS . 13.9 Cg_endo -56.17 -27.45 65.76 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.57 2.846 . . . . 0.0 114.321 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.5 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.73 -38.99 32.13 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.903 0.383 . . . . 0.0 110.873 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.692 ' CG2' HG13 ' A' ' 12' ' ' ILE . 45.1 t -67.31 -41.17 86.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.906 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.466 ' HE3' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -73.86 -34.16 64.38 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 10.8 pt-20 -77.52 -37.77 50.27 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.935 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.53 HG23 HG23 ' A' ' 77' ' ' VAL . 93.8 mt -75.92 -31.15 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.734 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.09 -51.82 34.76 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.041 0.448 . . . . 0.0 110.271 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 8.3 pt-20 -55.71 -47.34 77.01 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.203 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.625 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 27.0 t80 -55.57 -37.96 68.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.818 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.521 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.15 -51.16 68.98 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.234 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.542 HD21 ' HB3' ' A' ' 37' ' ' LEU . 2.7 tp -62.21 -44.98 95.36 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.499 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -72.59 -17.41 61.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.438 ' HB3' HD12 ' A' ' 88' ' ' LEU . 3.5 tp-100 -82.12 -38.55 24.6 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.597 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 2.9 t60 -108.23 129.18 55.21 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.814 0.34 . . . . 0.0 110.353 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -170.28 41.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.543 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.13 86.55 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.85 9.18 42.66 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.524 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 42.2 t30 52.78 88.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.99 157.63 40.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.515 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.59 124.15 72.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.542 ' HB3' HD21 ' A' ' 27' ' ' LEU . 1.5 tt -90.99 113.99 26.39 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.866 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.17 -28.01 69.11 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.825 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.93 168.73 25.3 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 119.313 -1.422 . . . . 0.0 114.345 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.6 t -76.14 136.42 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.106 -0.547 . . . . 0.0 110.956 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.61 -65.32 1.02 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.714 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.58 171.3 20.56 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.155 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.517 ' HA3' HD21 ' A' ' 58' ' ' LEU . . . -166.39 -174.39 35.7 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.558 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 57' ' ' ASN . 25.7 mt-30 -151.24 143.17 23.89 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.128 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.583 ' CD1' HG23 ' A' ' 12' ' ' ILE . 2.9 mp -122.17 125.52 73.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.234 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.0 mt -107.41 118.89 56.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.77 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.403 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -136.47 163.16 31.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.975 -178.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -148.19 -66.72 0.01 OUTLIER Glycine 0 C--N 1.33 0.224 0 N-CA-C 108.534 -1.827 . . . . 0.0 108.534 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.436 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 0.6 OUTLIER -120.46 108.27 37.88 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 175.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -90.53 117.51 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 116.212 1.582 . . . . 0.0 116.212 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 23.36 10.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.463 175.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.726 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.97 31.85 1.44 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.314 -178.122 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 20.9 m-20 -121.91 27.18 8.23 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.556 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.445 ' ND2' HG23 ' A' ' 45' ' ' ILE . 0.2 OUTLIER -56.02 153.61 8.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.116 -178.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.15 122.44 45.34 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.437 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.437 ' CD1' HD13 ' A' ' 22' ' ' ILE . 17.7 m-85 -102.13 133.35 47.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.037 0.446 . . . . 0.0 111.953 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 44' ' ' GLN . 39.8 t30 -132.91 111.68 11.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.067 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.533 HD23 HG13 ' A' ' 19' ' ' VAL . 4.0 mp -140.34 166.27 25.14 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.605 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.8 mm -124.12 129.44 74.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.439 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.479 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -131.63 168.84 17.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.722 0.296 . . . . 0.0 111.504 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.3 m -100.65 133.95 44.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.362 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.56 ' HB1' ' CE1' ' A' ' 73' ' ' TYR . . . -145.1 141.03 28.46 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.486 0.491 . . . . 0.0 112.186 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -139.74 166.55 24.31 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.751 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -93.2 -16.48 24.79 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.652 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.75 153.05 35.82 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.688 0.28 . . . . 0.0 111.659 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.21 -31.62 74.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.76 2.307 . . . . 0.0 112.111 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -96.16 14.38 24.18 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.463 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -115.37 167.32 10.97 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-O 121.105 0.478 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.49 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 9.3 m-85 -71.72 152.16 43.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.852 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 m -115.08 133.79 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.377 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 22.7 mmmt -113.99 165.08 12.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -87.69 148.45 24.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.532 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 46.6 m-85 -138.62 140.75 39.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.881 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.431 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . 31.4 t-20 -108.79 116.49 32.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 0.0 109.956 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.509 HG13 HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -119.33 142.67 33.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.941 -178.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 t -107.52 120.16 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.959 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.53 HG23 HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -123.37 146.37 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.3 tp -119.81 125.39 48.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.341 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 1.7 tt0 -87.73 124.2 33.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.686 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -122.7 137.82 54.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.404 0.621 . . . . 0.0 112.545 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.43 -27.16 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.688 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -59.58 -41.35 90.02 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.323 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.34 9.1 43.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.509 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.81 57.51 5.93 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.498 0.319 . . . . 0.0 111.557 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 177.96 -177.99 0.23 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.455 0.645 . . . . 0.0 111.613 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.625 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -93.31 166.83 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.905 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.96 126.93 13.62 Favored 'General case' 0 CA--C 1.526 0.052 0 CA-C-O 120.797 0.332 . . . . 0.0 111.258 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.597 ' CD1' ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -86.7 114.77 23.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.197 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.73 -54.11 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.319 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.408 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -159.33 144.28 15.62 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.86 0.362 . . . . 0.0 111.856 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -112.77 127.32 56.12 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.82 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.446 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 5.2 t -132.46 139.78 35.84 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.2 Cg_endo -81.99 138.59 10.37 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.903 2.402 . . . . 0.0 112.217 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.431 ' CD2' ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -107.6 25.44 11.49 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.64 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.565 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 30.4 p90 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.586 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 CA-C-O 120.074 -0.292 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.18 135.11 11.95 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.903 2.402 . . . . 0.0 112.629 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.49 150.3 17.14 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.629 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -90.38 164.75 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.178 2.585 . . . . 0.0 112.636 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.24 -46.84 3.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.911 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pt -125.73 32.53 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.098 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.15 -124.66 3.72 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.762 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -134.2 143.97 48.17 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.861 0.363 . . . . 0.0 111.604 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.1 t -100.92 143.33 14.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.87 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.3 150.86 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.091 0.472 . . . . 0.0 112.108 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.25 -160.95 9.13 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.486 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.736 HG13 ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -98.0 166.84 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 117.706 0.753 . . . . 0.0 112.144 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 t -89.9 154.26 20.0 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.58 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 p -64.75 -23.3 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.725 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -51.62 -36.76 47.22 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.972 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 14.1 t70 -58.79 113.24 6.32 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.702 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 19.7 Cg_endo -58.31 -28.14 83.56 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.435 2.757 . . . . 0.0 113.994 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.552 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 5.9 mmt-85 -76.85 -46.24 25.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.095 0.474 . . . . 0.0 110.124 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.736 ' CG2' HG13 ' A' ' 12' ' ' ILE . 69.8 t -59.51 -42.44 87.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.493 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -37.78 71.03 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.497 ' HG3' HG13 ' A' ' 22' ' ' ILE . 8.0 pt-20 -77.18 -37.25 54.05 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.021 0.439 . . . . 0.0 111.191 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.614 HD12 ' CE2' ' A' ' 56' ' ' TYR . 27.2 mt -75.11 -31.52 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.016 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -70.6 -52.68 19.85 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.042 0.448 . . . . 0.0 109.962 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.4 pt-20 -55.27 -41.78 72.69 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.718 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 28.4 t80 -59.65 -38.01 80.27 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.905 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.524 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.28 -43.53 88.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.113 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.432 HD22 ' CB ' ' A' ' 37' ' ' LEU . 3.6 tp -69.31 -48.06 62.65 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.376 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 25' ' ' PHE . 1.5 pttm -67.73 -25.4 65.63 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.609 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 5.0 tp60 -74.99 -27.91 60.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -65.03 -95.53 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.94 32.1 12.05 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.52 -38.02 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.937 0.399 . . . . 0.0 109.957 178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -113.79 -5.16 13.29 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.152 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.8 t30 67.51 91.94 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.953 0.501 . . . . 0.0 111.374 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.58 160.14 38.36 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.436 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.33 124.6 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.559 ' HA ' ' HB1' ' A' ' 62' ' ' ALA . 6.2 tp -92.17 113.94 26.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.385 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.18 72.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.324 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.88 163.28 23.65 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.204 -1.474 . . . . 0.0 114.808 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.43 HG22 HD23 ' A' ' 60' ' ' LEU . 2.2 t -75.47 125.6 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.196 -0.502 . . . . 0.0 109.918 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.02 -62.63 1.41 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.57 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.75 171.68 16.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.025 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.575 ' HA3' ' CG ' ' A' ' 58' ' ' LEU . . . -171.1 -174.41 38.88 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.427 -1.368 . . . . 0.0 114.883 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 57' ' ' ASN . 28.3 mt-30 -146.82 168.79 20.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.451 -0.875 . . . . 0.0 111.172 -178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.604 ' CD1' HG23 ' A' ' 12' ' ' ILE . 4.7 mp -142.86 132.49 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.419 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.6 mm -107.44 116.87 51.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.134 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.07 162.75 32.04 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.816 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -149.42 -70.78 0.01 OUTLIER Glycine 0 C--N 1.33 0.23 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -120.61 108.8 36.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -87.65 117.47 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 N-CA-C 116.395 1.652 . . . . 0.0 116.395 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.423 ' NE2' ' HB2' ' A' ' 53' ' ' ASP . 32.1 p-80 -121.7 23.47 10.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.605 -1.634 . . . . 0.0 107.446 175.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.719 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 73.7 33.4 1.04 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.028 -178.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.534 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.5 OUTLIER -122.24 28.1 7.64 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.832 177.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.461 ' ND2' ' CG2' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -57.83 143.72 41.29 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 -95.06 138.62 32.54 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.591 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.614 ' CE2' HD12 ' A' ' 22' ' ' ILE . 10.2 m-85 -119.56 135.61 54.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 112.036 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 44' ' ' GLN . 64.1 t-20 -133.52 114.24 13.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.15 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.575 ' CG ' ' HA3' ' A' ' 43' ' ' GLY . 4.6 mp -144.35 168.68 19.5 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.1 mm -125.85 131.88 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.272 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.436 HD23 ' HB3' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -134.37 168.89 18.08 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.61 129.7 45.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.046 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.559 ' HB1' ' HA ' ' A' ' 37' ' ' LEU . . . -144.62 141.76 29.63 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.066 0.46 . . . . 0.0 112.194 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -142.06 165.4 27.54 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.507 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -94.74 -13.8 25.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.94 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.82 150.98 24.0 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-O 121.213 0.53 . . . . 0.0 112.109 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -63.65 -37.7 45.28 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.554 2.836 . . . . 0.0 113.026 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -80.85 9.05 6.91 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -124.1 167.45 14.2 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.228 0.537 . . . . 0.0 111.728 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.498 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.7 m-85 -68.79 166.18 18.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.368 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 m -119.84 131.86 55.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.951 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 1.5 mmmp? -110.51 155.0 22.89 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.47 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.546 ' O ' ' HB2' ' A' ' 94' ' ' LEU . 20.8 m-85 -85.23 138.04 32.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.19 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 5.9 m-30 -125.71 140.37 52.76 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.949 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -111.95 119.2 37.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 110.424 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.631 HG13 ' CG ' ' A' ' 91' ' ' PHE . 34.3 m -128.78 158.91 41.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.496 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.08 127.36 73.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.724 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.435 ' HB ' ' CG2' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -124.53 145.41 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.047 0.451 . . . . 0.0 111.751 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 87' ' ' LYS . 9.4 tp -114.32 127.0 55.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.784 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -91.91 127.97 37.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.558 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.01 139.99 52.97 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' A' ' 52' ' ' TRP . . . -93.72 -30.34 14.94 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.791 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 m -54.23 -39.3 66.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.241 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.98 -3.86 27.04 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.457 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 54.56 53.77 10.23 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 120.996 0.427 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 t -171.49 -173.95 1.32 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.551 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -101.45 165.97 10.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.798 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -147.91 128.69 14.3 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.026 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.609 ' CB ' ' HG2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -82.63 121.9 27.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.454 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -83.57 -55.02 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.45 156.18 34.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.353 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.631 ' CG ' HG13 ' A' ' 75' ' ' VAL . 1.4 t80 -124.72 123.05 39.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.505 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 7.1 t -131.78 142.97 47.16 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.911 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.505 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.4 Cg_endo -86.99 138.6 5.03 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.008 2.472 . . . . 0.0 112.176 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -105.63 20.5 18.8 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 47.8 p90 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.068 -0.968 . . . . 0.0 111.469 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 CA-C-O 120.081 -0.288 . . . . 0.0 112.592 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 148.6 52.95 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.651 2.234 . . . . 0.0 112.556 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.56 -72.06 0.95 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.635 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.561 ' HD2' ' HA2' ' A' ' 7' ' ' GLY . 1.1 Cg_endo -82.99 -172.7 1.46 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.279 2.653 . . . . 0.0 112.398 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -38.49 69.2 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.027 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.7 -46.87 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.561 ' HA2' ' HD2' ' A' ' 4' ' ' PRO . . . 105.53 -138.05 14.06 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.829 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.7 162.13 32.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.681 0.276 . . . . 0.0 110.824 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.16 112.68 31.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.878 0.37 . . . . 0.0 111.384 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 pt -140.16 138.91 37.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.277 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.39 -170.97 24.48 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.283 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.693 HG13 HG13 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -96.78 147.97 5.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 117.212 0.506 . . . . 0.0 111.218 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 t -79.24 151.38 31.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.694 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -63.53 -21.83 29.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -53.01 -35.77 59.76 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.601 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 15.1 t0 -57.25 111.12 3.0 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.258 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.414 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 18.2 Cg_endo -59.89 -27.67 85.45 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.429 2.753 . . . . 0.0 113.801 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.472 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -77.64 -44.38 28.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.149 0.5 . . . . 0.0 110.068 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.693 HG13 HG13 ' A' ' 12' ' ' ILE . 54.0 t -61.53 -47.56 92.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.191 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -40.24 96.73 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 14.0 pt-20 -75.0 -42.95 56.46 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.901 0.381 . . . . 0.0 110.99 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 50.2 mt -65.0 -34.65 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.339 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.68 -48.17 80.48 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER -49.75 -51.28 40.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.364 178.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.652 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 32.0 t80 -56.55 -37.36 70.43 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.316 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.22 -48.1 79.65 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.97 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.6 tp -67.52 -43.08 81.69 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.6 ' HE2' ' CD2' ' A' ' 25' ' ' PHE . 3.7 pttm -75.03 -18.15 60.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.56 -39.0 32.82 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.967 0.349 . . . . 0.0 110.922 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -103.97 122.27 44.86 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.358 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -168.63 43.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.552 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -37.66 71.89 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.3 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.83 1.21 36.84 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.861 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 63.73 99.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.31 158.41 43.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -116.36 125.22 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.659 ' HB3' HD22 ' A' ' 27' ' ' LEU . 3.4 tp -87.0 120.77 28.62 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.865 0.364 . . . . 0.0 110.749 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 61' ' ' SER . . . -65.96 -34.51 78.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.895 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.85 162.57 11.32 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.186 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.8 136.03 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.86 0.464 . . . . 0.0 110.753 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.02 -65.76 1.14 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.619 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.13 146.66 25.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.389 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.56 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -146.95 -170.93 15.68 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 119.793 -1.194 . . . . 0.0 114.812 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' ASN . 17.3 mm-40 -142.16 150.74 41.46 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.558 -0.821 . . . . 0.0 111.295 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' A' ' 47' ' ' LYS . 63.0 mt -128.33 129.4 69.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.79 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.87 115.27 48.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.452 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.472 ' HD2' HG23 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -136.01 162.75 32.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.662 0.744 . . . . 0.0 112.829 -178.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.89 -66.92 0.01 OUTLIER Glycine 0 C--N 1.329 0.193 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.435 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -120.26 109.27 37.13 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 175.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -87.02 117.04 1.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 N-CA-C 116.226 1.587 . . . . 0.0 116.226 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.99 24.02 10.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.426 -1.716 . . . . 0.0 107.03 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.727 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 62.88 35.51 13.48 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.44 -177.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.84 28.29 7.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.389 177.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.635 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 1.1 t-20 -47.64 146.03 2.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.05 116.52 30.44 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.73 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 38.8 m-85 -104.87 143.0 33.74 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.206 0.527 . . . . 0.0 111.844 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 44' ' ' GLN . 15.9 t-20 -144.39 110.63 5.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.56 ' HG ' ' HA3' ' A' ' 43' ' ' GLY . 4.0 mp -136.74 167.35 21.6 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 2.7 mm -122.04 121.62 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.042 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.561 ' HB2' ' CD1' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -125.08 168.21 13.69 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.771 0.319 . . . . 0.0 111.26 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 50.2 m -98.97 146.04 26.43 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 37' ' ' LEU . . . -155.28 147.02 23.24 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -149.16 165.36 32.05 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.338 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -103.86 -5.82 21.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.042 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 68' ' ' GLU . 2.2 p -146.39 143.41 18.96 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-O 121.136 0.493 . . . . 0.0 112.046 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.42 -27.63 54.64 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.476 2.784 . . . . 0.0 113.365 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -95.23 14.19 23.05 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.41 ' HB2' ' OG ' ' A' ' 65' ' ' SER . 7.8 mt-10 -126.78 167.23 16.05 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.46 0.648 . . . . 0.0 112.48 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 5.3 m-85 -64.69 167.65 7.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.273 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 m -124.29 135.74 53.6 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.889 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HG3' ' CD2' ' A' ' 95' ' ' PHE . 27.9 mmmt -110.37 169.98 8.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.677 0.275 . . . . 0.0 111.067 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.465 ' C ' ' HB2' ' A' ' 94' ' ' LEU . 20.4 m-85 -89.85 151.17 21.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.52 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.59 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 9.2 m-85 -141.65 141.07 33.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.34 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.443 ' HB2' HD22 ' A' ' 94' ' ' LEU . 65.2 t30 -113.72 126.39 55.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.495 0.188 . . . . 0.0 110.89 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.443 ' CG1' ' HA ' ' A' ' 91' ' ' PHE . 6.4 m -132.37 140.21 48.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.161 0.505 . . . . 0.0 112.238 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -102.99 110.42 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -113.25 136.86 48.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.568 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.424 HD13 ' O ' ' A' ' 79' ' ' GLU . 7.3 tp -112.51 131.74 55.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.018 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' O ' HD13 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -91.39 129.43 37.38 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.0 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.405 ' HD3' ' HB3' ' A' ' 82' ' ' SER . 1.7 ttmp? -125.4 143.79 50.82 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.37 -29.91 11.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.572 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.405 ' HB3' ' HD3' ' A' ' 80' ' ' LYS . 6.8 t -53.81 -43.49 69.4 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.12 9.12 36.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.325 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.57 58.88 3.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.068 0.461 . . . . 0.0 111.375 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.6 p -173.8 -174.3 0.94 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.806 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.652 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -101.15 166.9 10.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.01 179.2 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HE2' HD21 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -147.39 121.65 9.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.016 0.436 . . . . 0.0 111.717 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -81.01 110.17 16.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.902 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.98 -50.04 21.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.596 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.8 146.82 26.62 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.443 ' HA ' ' CG1' ' A' ' 75' ' ' VAL . 1.9 t80 -125.88 119.24 27.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.421 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.542 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 5.8 t -132.34 142.78 46.2 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.542 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.6 Cg_endo -80.34 139.04 12.83 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.925 2.417 . . . . 0.0 111.701 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.465 ' HB2' ' C ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -112.66 47.47 1.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.242 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' CD2' ' HG3' ' A' ' 71' ' ' LYS . 3.2 p90 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.855 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.093 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.074 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -101.31 159.39 4.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 117.71 0.755 . . . . 0.0 111.68 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -79.31 153.32 29.93 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.054 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.06 -23.38 30.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.686 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -53.21 -32.55 48.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.341 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 12.4 t70 -57.43 112.83 5.18 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.658 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.417 ' HA ' ' CG ' ' A' ' 20' ' ' LYS . 18.6 Cg_endo -59.58 -26.57 82.51 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.453 2.769 . . . . 0.0 113.934 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.498 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -78.62 -44.15 24.63 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.275 0.56 . . . . 0.0 110.384 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.074 HG21 HG13 ' A' ' 12' ' ' ILE . 72.9 t -65.18 -39.65 86.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.65 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -69.41 -37.88 77.66 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 13.0 pt-20 -75.28 -37.24 61.01 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.214 0.531 . . . . 0.0 110.562 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.738 HG12 HD12 ' A' ' 86' ' ' LEU . 77.1 mt -74.62 -35.04 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.059 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -66.63 -54.89 18.48 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.242 0.544 . . . . 0.0 110.217 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 11.3 pt-20 -53.66 -44.28 69.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.078 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.657 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 26.9 t80 -60.11 -35.39 75.12 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.435 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 23' ' ' ALA . . . -58.61 -47.11 85.46 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.903 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 37' ' ' LEU . 2.4 tp -66.92 -43.79 82.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.702 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.585 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -70.93 -18.14 62.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.763 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -87.08 -38.95 16.03 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.131 0.423 . . . . 0.0 111.205 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -102.42 125.42 49.13 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.573 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -167.5 45.43 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.195 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.544 ' HG2' ' HG2' ' A' ' 33' ' ' GLN . 0.2 OUTLIER -64.36 -37.54 87.86 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.079 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.544 ' HG2' ' HG2' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -107.34 13.3 27.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.882 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 50.93 83.07 0.05 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -118.68 165.11 14.38 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.403 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.86 124.25 68.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.036 HD12 ' HB2' ' A' ' 62' ' ' ALA . 7.1 tp -90.26 115.75 27.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.546 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.94 -28.96 69.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.456 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 163.26 174.29 32.96 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.577 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.664 HG22 HD23 ' A' ' 60' ' ' LEU . 2.0 t -81.37 132.74 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.568 0.347 . . . . 0.0 110.694 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.1 -63.33 1.27 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.334 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.43 163.73 29.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.788 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -152.33 163.32 30.21 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.954 -1.117 . . . . 0.0 114.436 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.41 ' H ' ' HG ' ' A' ' 58' ' ' LEU . 68.1 mt-30 -150.27 148.69 29.17 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.127 0.571 . . . . 0.0 110.054 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.59 ' CD1' HG21 ' A' ' 12' ' ' ILE . 4.6 mp -133.46 129.19 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.281 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.6 mt -107.54 114.92 47.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.195 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.83 155.49 48.94 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.7 -70.4 0.08 OUTLIER Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -120.83 108.99 36.28 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.708 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.83 119.18 1.85 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.733 1.622 . . . . 0.0 115.908 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -120.88 23.21 10.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.258 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.753 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 74.44 29.47 1.2 Allowed 'General case' 0 C--N 1.344 0.335 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.711 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -122.31 27.32 7.99 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.591 177.582 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.402 ' HB3' ' HE1' ' A' ' 56' ' ' TYR . 2.3 t-20 -50.66 149.04 3.49 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.48 ' CE1' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -98.31 132.72 43.56 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.945 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.675 ' CB ' HG23 ' A' ' 77' ' ' VAL . 21.1 m-85 -117.63 144.18 45.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 112.081 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -143.94 116.98 8.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.666 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.788 HD23 ' HA3' ' A' ' 43' ' ' GLY . 4.5 mp -143.18 164.06 31.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.1 mm -119.44 131.4 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.865 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.001 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.47 169.1 18.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.931 0.396 . . . . 0.0 111.619 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.0 m -98.81 135.09 40.76 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.988 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 1.036 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -153.59 143.23 21.8 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -140.58 164.61 29.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.457 178.594 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -98.92 -7.17 27.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.238 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.02 148.32 18.4 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.776 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.14 -27.96 48.84 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.951 2.434 . . . . 0.0 112.342 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -89.31 14.29 11.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.741 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -128.43 167.22 17.33 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 121.453 0.644 . . . . 0.0 112.484 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.513 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 8.3 m-85 -69.5 160.95 30.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.324 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -109.6 130.99 55.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.411 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.526 ' HE2' ' HB2' ' A' ' 95' ' ' PHE . 25.5 mmmt -112.94 170.08 8.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.02 0.438 . . . . 0.0 111.74 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.73 145.66 25.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.733 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 36.1 m-85 -140.94 136.88 32.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.1 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.79 ' HB2' HD23 ' A' ' 94' ' ' LEU . 10.0 t-20 -109.11 115.49 30.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.993 HG12 ' HA ' ' A' ' 91' ' ' PHE . 2.2 m -121.99 144.38 31.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.726 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 23.7 t -104.34 127.25 58.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.875 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.675 HG23 ' CB ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -126.25 146.78 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.477 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 79' ' ' GLU . 11.8 tp -120.42 129.54 53.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.436 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -93.94 134.94 35.8 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.47 131.6 51.63 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.95 0.405 . . . . 0.0 111.91 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' A' ' 52' ' ' TRP . . . -89.23 -36.44 15.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.378 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 m -57.57 -41.74 81.68 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -11.23 50.75 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.05 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.53 45.51 10.56 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.1 p -165.99 -169.06 1.39 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 111.263 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.738 HD12 HG12 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -105.86 170.81 7.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.475 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.68 142.7 27.01 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.916 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.763 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 1.5 tm? -101.11 115.79 31.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.381 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 3.6 t -74.52 -52.29 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.45 156.45 16.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.95 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.993 ' HA ' HG12 ' A' ' 75' ' ' VAL . 4.6 t80 -120.74 124.77 45.95 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.618 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.41 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 2.9 t -132.63 137.69 30.38 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.01 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 96.6 Cg_endo -80.13 138.31 12.71 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.733 2.289 . . . . 0.0 112.332 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -108.85 39.99 1.9 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.638 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.526 ' HB2' ' HE2' ' A' ' 71' ' ' LYS . 16.6 p90 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.641 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . . . . . . 0 CA--C 1.518 0.224 0 N-CA-C 113.305 0.082 . . . . 0.0 113.305 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.908 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -97.2 167.14 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 111.267 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 m -91.92 150.34 21.08 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.092 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.97 -20.42 27.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.227 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -55.42 -35.91 65.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.547 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.435 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 13.6 t70 -57.49 115.96 12.44 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.904 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.0 Cg_endo -59.54 -28.09 86.59 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.502 2.801 . . . . 0.0 114.133 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.488 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -79.54 -43.47 22.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.034 0.445 . . . . 0.0 110.564 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.908 HG21 HG13 ' A' ' 12' ' ' ILE . 48.4 t -62.01 -41.46 91.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.834 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -72.44 -36.12 68.48 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 12.1 pt-20 -76.87 -37.0 56.35 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.089 0.471 . . . . 0.0 110.982 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.827 HG12 HD12 ' A' ' 86' ' ' LEU . 75.4 mt -76.28 -32.24 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.723 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.482 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -68.27 -50.9 50.62 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.199 0.523 . . . . 0.0 110.239 177.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.5 pt-20 -58.57 -43.33 89.35 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.065 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.653 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 20.0 t80 -56.93 -37.45 71.5 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.713 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -58.91 -48.71 80.49 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.056 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.899 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.2 tp -64.58 -47.84 77.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.23 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.548 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -67.88 -17.07 64.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.569 ' HB3' HD12 ' A' ' 88' ' ' LEU . 6.5 tp-100 -86.65 -38.17 17.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.33 0.11 . . . . 0.0 111.24 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.606 ' HB2' HD11 ' A' ' 88' ' ' LEU . 1.4 t60 -104.13 127.09 51.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.781 0.325 . . . . 0.0 110.708 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -171.57 44.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.093 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -37.36 70.82 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.911 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.52 7.66 35.31 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 61.29 96.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.58 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -141.06 160.03 40.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.161 178.791 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 124.39 69.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.991 HD11 ' HB2' ' A' ' 60' ' ' LEU . 6.5 tp -87.89 116.21 25.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.182 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.27 -30.75 71.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.83 166.27 22.41 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 119.505 -1.331 . . . . 0.0 114.246 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.812 HG22 HD23 ' A' ' 60' ' ' LEU . 35.0 t -72.38 123.57 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.881 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.535 ' HB2' ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -92.4 -65.74 0.98 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.805 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.78 165.31 30.54 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.105 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.508 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -165.75 -174.06 34.89 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.665 -1.255 . . . . 0.0 114.306 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 57' ' ' ASN . 49.4 mt-30 -140.13 167.92 21.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.744 -0.728 . . . . 0.0 110.957 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.509 HG22 ' HD3' ' A' ' 47' ' ' LYS . 77.0 mt -144.62 140.1 23.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.66 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 28.1 mt -106.44 114.61 46.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.509 ' HD3' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -135.73 163.34 30.41 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.201 -177.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.37 -71.8 0.02 OUTLIER Glycine 0 C--N 1.332 0.338 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.585 ' O ' HG23 ' A' ' 49' ' ' ILE . 9.7 tt -120.48 109.23 36.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.1 115.22 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 N-CA-C 115.983 1.494 . . . . 0.0 115.983 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -122.24 11.42 10.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.338 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.777 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 76.51 31.97 0.57 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 124.43 1.092 . . . . 0.0 111.876 -178.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.82 26.32 8.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.069 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.06 149.88 43.97 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.434 ' CE1' HD13 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -101.59 124.16 46.79 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.629 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.672 ' HB2' HG23 ' A' ' 77' ' ' VAL . 13.9 m-85 -104.61 125.19 50.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.175 0.512 . . . . 0.0 112.058 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 44' ' ' GLN . 38.3 t-20 -124.32 111.47 15.85 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.654 HD21 HG13 ' A' ' 19' ' ' VAL . 4.2 mp -138.58 167.64 21.5 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.4 mm -129.05 128.29 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.756 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.991 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -133.04 169.35 16.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.779 0.324 . . . . 0.0 111.498 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 1.1 m -98.84 136.17 39.24 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.611 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.93 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -148.46 144.31 27.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.144 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -145.54 165.9 27.27 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.917 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -96.98 -9.09 28.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.796 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 68' ' ' GLU . 3.8 p -153.2 144.02 15.91 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.891 0.376 . . . . 0.0 111.582 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.87 -30.05 58.18 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.123 2.548 . . . . 0.0 112.851 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -87.8 12.72 12.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 65' ' ' SER . 15.3 mt-10 -125.89 167.67 14.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.247 0.546 . . . . 0.0 111.741 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 8.4 m-85 -66.89 158.91 29.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.904 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -115.27 130.18 56.83 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.816 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 22.6 mmmt -107.95 169.33 8.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.767 0.318 . . . . 0.0 111.213 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -91.51 152.34 20.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.173 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.681 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 32.9 m-85 -144.16 139.67 28.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.499 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -109.95 127.09 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 110.139 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.713 HG11 ' HB1' ' A' ' 26' ' ' ALA . 42.3 t -126.96 151.04 33.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.539 0.685 . . . . 0.0 112.028 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.1 t -111.01 112.4 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.59 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.672 HG23 ' HB2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -118.89 142.53 33.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.037 0.446 . . . . 0.0 111.62 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 79' ' ' GLU . 12.6 tp -118.95 128.35 54.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.614 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.528 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.8 tt0 -87.81 120.82 29.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.346 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HE3' ' CD2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -113.01 131.22 55.86 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.136 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.14 -35.16 13.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.266 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.6 m -61.04 -42.38 98.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.553 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.34 -9.93 59.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.936 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 61.25 42.15 12.4 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.168 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 t -172.51 178.84 2.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.352 0.596 . . . . 0.0 111.321 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.827 HD12 HG12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -86.41 167.89 14.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.102 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -146.25 141.24 27.16 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.966 0.412 . . . . 0.0 111.041 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.606 HD11 ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -99.91 122.53 42.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.555 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.83 -52.73 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.929 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -157.66 155.69 30.46 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.492 ' HA ' HG22 ' A' ' 75' ' ' VAL . 2.3 t80 -123.94 125.1 44.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.971 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.569 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 3.2 t -132.64 143.75 50.05 Favored Pre-proline 0 N--CA 1.469 0.493 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.569 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 68.4 Cg_endo -84.7 139.0 7.41 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.865 2.376 . . . . 0.0 112.679 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.414 ' HA ' HD22 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -113.58 48.88 1.02 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.913 0.387 . . . . 0.0 110.92 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 30.3 p90 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.656 -0.688 . . . . 0.0 111.755 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.243 0 CA-C-O 120.385 -0.119 . . . . 0.0 113.145 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.798 HD12 HD11 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -100.33 163.55 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.941 0.4 . . . . 0.0 111.261 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 m -92.16 150.38 20.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.353 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.23 -22.85 31.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -53.1 -34.82 58.33 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.459 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.424 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 10.1 t70 -57.79 115.13 10.03 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.434 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 20' ' ' LYS . 20.6 Cg_endo -61.18 -29.32 86.66 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.297 2.664 . . . . 0.0 114.009 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 1.8 mpt_? -77.76 -43.29 31.26 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.185 0.517 . . . . 0.0 110.488 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.722 HG11 HG13 ' A' ' 12' ' ' ILE . 55.1 t -61.58 -43.46 97.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.831 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -70.7 -36.28 73.19 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 12.3 pt-20 -76.78 -37.9 55.01 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.27 0.557 . . . . 0.0 110.848 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.703 HG12 HD12 ' A' ' 86' ' ' LEU . 58.3 mt -74.15 -33.74 36.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.523 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -69.82 -47.74 61.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.753 0.311 . . . . 0.0 110.852 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 9.8 pt-20 -57.51 -44.79 85.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.046 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.714 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 32.2 t80 -57.93 -37.38 73.98 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.826 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -54.64 -47.52 73.41 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.739 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.074 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.1 tp -67.26 -45.72 75.82 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.51 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.529 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -69.43 -17.92 63.69 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.561 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 6.0 tp60 -83.4 -37.94 22.61 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.469 0.176 . . . . 0.0 111.161 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.485 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 2.6 t60 -97.7 128.6 44.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.273 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -174.63 36.48 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.27 -38.38 30.99 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.97 0.414 . . . . 0.0 110.191 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 8.9 mt-30 -84.51 -19.85 32.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.146 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 27.7 t-20 74.79 91.65 0.08 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.295 0.638 . . . . 0.0 112.537 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.525 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -141.17 167.07 23.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.068 178.454 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.451 ' HB ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -124.83 124.76 68.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.688 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.074 ' HB3' HD22 ' A' ' 27' ' ' LEU . 9.9 tp -90.6 113.24 25.22 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.443 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.87 -27.54 68.3 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.666 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.37 177.29 35.27 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.011 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.672 HG22 HD23 ' A' ' 60' ' ' LEU . 3.1 t -84.81 138.59 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.006 0.522 . . . . 0.0 110.987 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.68 -66.5 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.433 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.26 169.66 17.27 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.81 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.58 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -159.33 174.22 36.21 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 119.761 -1.209 . . . . 0.0 114.916 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.581 ' O ' HD13 ' A' ' 45' ' ' ILE . 2.1 mm100 -153.75 139.23 17.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.139 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 56' ' ' TYR . 5.9 mm -124.36 133.7 68.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 111.373 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.6 mt -114.45 115.91 50.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.77 160.45 39.22 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.905 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.33 -75.77 0.07 OUTLIER Glycine 0 C--N 1.332 0.357 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.565 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.6 tt -113.39 108.99 51.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -87.34 117.57 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 116.628 1.741 . . . . 0.0 116.628 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.6 22.35 10.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.541 -1.663 . . . . 0.0 107.622 175.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.779 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 76.69 31.49 0.56 Allowed 'General case' 0 C--N 1.345 0.391 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.92 -178.856 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -122.03 26.97 8.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.637 177.42 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.669 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -53.14 147.5 9.69 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.527 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.91 118.15 32.68 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.919 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.864 ' CD2' HD12 ' A' ' 45' ' ' ILE . 44.6 m-85 -106.05 134.07 49.76 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.311 0.577 . . . . 0.0 112.397 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -130.92 126.53 36.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.51 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.589 HD21 HG13 ' A' ' 19' ' ' VAL . 1.6 mp -149.65 154.55 38.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.619 HD13 ' HB2' ' A' ' 74' ' ' ASN . 1.3 mm -112.46 127.9 69.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.97 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.986 HD22 HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -130.46 169.23 15.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.954 0.407 . . . . 0.0 111.872 -178.411 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.9 m -100.45 133.76 44.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.328 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.996 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -147.34 138.11 23.53 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 123.547 0.529 . . . . 0.0 112.101 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -135.22 164.34 27.92 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.586 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -88.78 -18.21 28.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.31 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 p -150.55 146.44 19.71 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 111.266 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.19 -26.01 49.93 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.224 2.616 . . . . 0.0 113.292 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.73 2.99 46.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -129.19 167.13 18.06 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.519 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.7 m-85 -54.72 159.24 2.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.569 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 11.9 m -117.61 143.44 46.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.067 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.485 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 2.8 mmmt -116.01 166.01 12.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.852 0.358 . . . . 0.0 111.094 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -91.86 146.99 23.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.32 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.691 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 22.0 m-85 -141.23 139.91 33.85 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.984 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.619 ' HB2' HD13 ' A' ' 59' ' ' ILE . 6.2 t-20 -110.24 125.76 53.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.845 0.355 . . . . 0.0 110.51 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.918 HG12 ' HA ' ' A' ' 91' ' ' PHE . 6.0 m -128.71 153.69 38.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.424 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.22 110.37 31.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.881 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 26' ' ' ALA . 1.7 t -115.51 128.17 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.039 0.447 . . . . 0.0 111.504 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 79' ' ' GLU . 12.1 tp -102.16 131.53 48.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.046 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -90.94 129.79 36.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.207 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -125.7 134.18 51.9 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.083 0.468 . . . . 0.0 111.896 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.31 -30.63 15.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.966 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.2 m -59.58 -34.88 73.28 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.542 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.46 4.85 33.65 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 46.89 57.32 5.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 111.466 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.4 p -176.0 176.12 1.83 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.313 0.578 . . . . 0.0 111.307 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.714 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -92.72 170.95 9.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.723 178.841 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.55 119.92 8.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.782 0.325 . . . . 0.0 111.235 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.561 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -83.15 106.01 14.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.39 -51.4 25.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.395 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.67 147.69 27.68 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.9 0.381 . . . . 0.0 111.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.918 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.2 t80 -124.73 121.7 35.39 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.903 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.487 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 11.2 t -131.85 141.85 43.05 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.404 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.487 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 84.2 Cg_endo -83.74 138.33 8.18 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.742 2.295 . . . . 0.0 111.61 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -109.65 40.87 1.79 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.648 0.261 . . . . 0.0 111.568 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.8 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.411 179.778 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.21 0 N-CA-C 112.319 -0.312 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.918 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -96.95 156.8 3.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 117.201 0.501 . . . . 0.0 111.428 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.0 m -88.5 154.62 20.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.211 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.9 -20.66 27.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.146 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -54.92 -35.62 64.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.523 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 12.8 t70 -59.0 114.98 10.3 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.501 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.3 Cg_endo -59.27 -27.52 85.23 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.365 2.71 . . . . 0.0 114.216 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.563 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 7.9 mmp_? -78.42 -47.73 16.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.323 0.582 . . . . 0.0 110.157 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.918 HG21 HG13 ' A' ' 12' ' ' ILE . 55.3 t -58.31 -40.45 77.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.392 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.401 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -73.57 -36.07 65.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.3 pt-20 -76.21 -36.22 58.71 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.223 0.535 . . . . 0.0 110.71 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.698 HG12 HD12 ' A' ' 86' ' ' LEU . 22.5 mt -74.59 -36.94 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.056 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -66.28 -52.73 44.49 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.118 0.485 . . . . 0.0 110.334 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.0 pt-20 -55.16 -43.95 74.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.024 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 30.8 t80 -58.32 -35.32 71.7 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.934 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -60.37 -47.33 86.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.839 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.4 tp -65.56 -44.04 88.0 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.116 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -72.33 -18.48 61.76 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.594 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.3 tp60 -83.58 -37.7 22.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.454 0.169 . . . . 0.0 111.039 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.501 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -105.03 126.54 52.17 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.535 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -172.67 43.47 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.86 0.362 . . . . 0.0 111.659 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -37.52 83.09 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.817 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.67 4.82 26.22 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 65.64 97.13 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.415 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -134.6 153.94 51.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.7 178.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.14 124.47 73.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.946 HD11 ' HB2' ' A' ' 60' ' ' LEU . 9.1 tp -90.0 117.32 28.71 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.409 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.45 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . . . -65.79 -31.18 72.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.314 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 160.38 171.91 26.93 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.8 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.705 HG22 HD23 ' A' ' 60' ' ' LEU . 2.5 t -75.1 128.56 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 122.798 0.439 . . . . 0.0 110.976 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -100.76 -62.78 1.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.589 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.51 167.41 27.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.538 ' HA3' ' CD2' ' A' ' 58' ' ' LEU . . . -156.51 169.4 33.89 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.988 -1.101 . . . . 0.0 114.279 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 57' ' ' ASN . 9.0 mt-30 -141.91 137.74 31.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.017 -0.591 . . . . 0.0 110.225 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.634 HG13 HD12 ' A' ' 12' ' ' ILE . 40.0 mt -122.66 124.64 71.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 111.472 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.3 mt -107.55 115.07 47.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.565 ' HG3' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -138.16 162.98 32.84 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.95 -178.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.2 -68.94 0.02 OUTLIER Glycine 0 C--N 1.331 0.253 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.567 ' O ' HG23 ' A' ' 49' ' ' ILE . 3.7 tt -120.53 109.11 36.75 Favored Pre-proline 0 C--O 1.233 0.201 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -88.93 116.8 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 N-CA-C 116.394 1.652 . . . . 0.0 116.394 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.3 23.76 10.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.611 175.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.803 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 75.14 33.02 0.74 Allowed 'General case' 0 C--N 1.344 0.334 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.109 -178.181 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 7.9 p-10 -122.9 27.3 7.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.904 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.505 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -56.62 144.59 31.48 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.01 121.51 40.01 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.316 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 12.9 m-85 -107.32 139.85 41.15 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.256 0.551 . . . . 0.0 112.239 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 44' ' ' GLN . 48.3 t30 -137.12 111.05 8.23 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.705 HD21 HG13 ' A' ' 19' ' ' VAL . 4.9 mp -134.76 166.23 23.44 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.4 mm -127.73 126.94 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.448 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.946 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -130.66 169.38 15.72 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 111.739 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.9 m -95.64 140.21 30.79 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.356 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.913 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -154.8 147.11 23.89 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -149.87 166.89 28.17 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.101 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -102.15 -5.26 24.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.06 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.35 148.2 23.62 Favored Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.42 -34.25 54.84 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.082 2.522 . . . . 0.0 112.51 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -90.59 14.28 13.65 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -113.12 167.15 10.77 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.241 0.544 . . . . 0.0 112.002 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.594 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.8 m-85 -64.56 179.13 0.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.08 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.55 119.83 25.57 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 0.3 OUTLIER -107.44 165.79 11.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.03 0.443 . . . . 0.0 111.829 -178.149 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -90.87 146.68 23.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.848 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.839 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 16.2 m-85 -141.46 137.55 32.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.327 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.506 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 48.7 t-20 -110.38 130.19 55.6 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.799 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 91' ' ' PHE . 30.5 m -129.07 146.28 34.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 112.256 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 12.1 t -105.58 110.5 31.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.73 139.26 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.946 0.403 . . . . 0.0 111.491 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 79' ' ' GLU . 9.5 tp -114.94 127.15 55.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.973 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.51 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -90.61 126.58 36.0 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.783 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.88 135.14 51.58 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 52' ' ' TRP . . . -90.22 -31.2 17.12 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.824 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.75 -39.46 71.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.003 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.19 -7.83 34.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.251 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.17 50.5 11.71 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-O 121.061 0.458 . . . . 0.0 111.008 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.27 -175.53 1.43 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.908 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.698 HD12 HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -97.27 165.87 11.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.284 179.668 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.86 122.91 10.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.949 0.404 . . . . 0.0 111.038 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -82.73 112.6 19.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.056 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 2.7 t -75.35 -49.27 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.712 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -161.79 155.53 21.56 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.587 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.3 t80 -123.21 124.07 42.21 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.392 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.566 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 4.9 t -132.25 142.61 45.65 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 83.8 Cg_endo -78.3 138.52 15.92 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.668 2.246 . . . . 0.0 111.885 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -115.64 39.49 2.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.698 0.285 . . . . 0.0 111.458 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.8 p90 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.237 179.626 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.292 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.097 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -112.87 156.98 13.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 117.803 0.801 . . . . 0.0 112.632 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -76.55 152.16 36.08 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.097 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.56 -27.63 43.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.655 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -47.1 -38.42 11.34 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.336 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.48 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 12.6 t70 -57.13 114.03 7.31 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.352 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.48 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 12.1 Cg_endo -55.75 -31.58 80.91 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.613 2.876 . . . . 0.0 114.328 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.535 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -74.95 -44.74 46.77 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.251 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.097 HG21 HG13 ' A' ' 12' ' ' ILE . 54.3 t -60.94 -42.6 93.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.653 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -72.72 -37.06 67.9 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.922 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 11.4 pt-20 -78.57 -39.37 37.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.803 0.335 . . . . 0.0 111.398 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.423 HD12 ' CE2' ' A' ' 56' ' ' TYR . 43.0 mt -73.22 -32.13 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.769 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.616 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -69.5 -48.18 61.43 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -50.59 -49.7 55.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.764 178.305 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.626 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 41.7 t80 -58.32 -37.92 76.06 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.279 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 23' ' ' ALA . . . -55.64 -39.28 70.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.028 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.894 HD22 ' HB3' ' A' ' 37' ' ' LEU . 2.0 tp -74.45 -47.86 30.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.608 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.626 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -67.14 -18.3 65.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.53 ' CD ' ' HB3' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -77.79 -31.01 51.59 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.568 0.223 . . . . 0.0 111.002 179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -75.03 -118.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.101 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 65.76 34.0 7.79 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.36 -38.49 41.83 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.864 0.364 . . . . 0.0 110.213 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 0.6 OUTLIER -117.7 10.14 13.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.116 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 14.5 t-20 69.47 95.98 0.07 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.028 0.531 . . . . 0.0 111.986 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.416 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -138.46 146.85 42.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.563 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.29 124.72 72.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.978 HD11 ' HB2' ' A' ' 60' ' ' LEU . 8.5 tp -90.04 115.86 27.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.153 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.77 -28.29 68.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.408 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.8 173.92 32.08 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 119.56 -1.305 . . . . 0.0 114.12 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.629 HG22 HD23 ' A' ' 60' ' ' LEU . 2.3 t -79.32 137.79 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.228 -0.486 . . . . 0.0 110.532 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.54 -63.93 1.33 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.485 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.02 163.8 33.11 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.484 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.757 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -161.32 175.37 37.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.546 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' ASN . 50.7 mm-40 -149.43 155.53 40.57 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.384 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.651 ' CD1' HG21 ' A' ' 12' ' ' ILE . 4.2 mp -137.2 122.83 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.302 . . . . 0.0 110.956 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.08 118.4 55.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.607 ' HB3' ' ND2' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -137.32 163.08 31.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.897 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.56 -69.26 0.04 OUTLIER Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 49' ' ' ILE . 7.4 tp -120.28 111.89 34.87 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -87.53 114.81 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 N-CA-C 116.357 1.637 . . . . 0.0 116.357 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -121.85 22.98 10.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.209 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.752 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.75 33.89 1.25 Allowed 'General case' 0 C--N 1.344 0.345 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.283 -177.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 15.5 m-20 -121.32 26.81 8.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.423 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.607 ' ND2' ' HB3' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -58.56 143.98 44.26 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.322 -178.117 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.434 ' HE1' HD22 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -96.2 125.74 40.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.316 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 22' ' ' ILE . 15.8 m-85 -109.46 129.84 55.53 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.908 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 44' ' ' GLN . 12.6 t-20 -126.5 114.19 17.8 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.763 HD21 HG13 ' A' ' 19' ' ' VAL . 4.1 mp -142.07 161.1 38.85 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.734 HD13 ' HA ' ' A' ' 74' ' ' ASN . 3.5 mm -119.9 131.49 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.404 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.978 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.21 165.89 24.36 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.955 0.407 . . . . 0.0 112.083 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.3 m -96.38 136.34 37.0 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.95 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.936 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -148.06 142.59 26.47 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -144.05 166.07 26.02 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.708 179.235 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -104.84 -3.15 23.84 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.121 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.41 145.96 20.16 Favored Pre-proline 0 N--CA 1.465 0.317 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.13 -29.65 47.59 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.284 2.656 . . . . 0.0 112.598 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -98.82 14.55 28.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.843 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -120.9 167.15 12.86 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.13 0.49 . . . . 0.0 111.604 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 6.7 m-85 -69.45 160.57 31.15 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.0 m -116.6 135.76 53.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.127 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 95' ' ' PHE . 3.5 mmmm -112.04 165.35 12.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.753 0.311 . . . . 0.0 110.709 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -89.13 153.15 21.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.742 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.85 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 14.7 m-85 -139.39 142.17 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.778 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.734 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.9 t-20 -111.83 118.76 36.44 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.909 HG12 ' HA ' ' A' ' 91' ' ' PHE . 29.7 m -130.71 151.0 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.96 118.61 57.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.731 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.419 HG21 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -117.3 144.48 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.111 0.482 . . . . 0.0 111.819 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 79' ' ' GLU . 5.9 tp -120.33 125.65 48.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.943 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.9 tt0 -90.05 120.1 30.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.539 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.85 133.91 51.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.58 -37.22 15.84 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.196 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -37.83 87.27 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.464 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -15.78 58.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.761 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 72.46 31.33 1.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.56 -165.15 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.286 0.565 . . . . 0.0 111.88 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.733 HD22 ' H ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -94.3 169.12 10.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.022 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.501 ' NZ ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -148.72 138.03 21.78 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.93 0.395 . . . . 0.0 111.952 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 89' ' ' VAL . 0.2 OUTLIER -97.44 109.31 22.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.862 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.542 ' N ' HD22 ' A' ' 88' ' ' LEU . 1.9 t -74.54 -54.35 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.449 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.14 145.73 31.5 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.909 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.2 t80 -125.22 117.61 24.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.877 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.622 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.6 t -132.7 144.44 52.95 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.969 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.622 ' HD2' HG12 ' A' ' 92' ' ' VAL . 89.3 Cg_endo -87.43 138.5 4.65 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.974 2.449 . . . . 0.0 112.322 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.479 ' CD2' ' HB2' ' A' ' 74' ' ' ASN . 0.4 OUTLIER -98.85 32.52 2.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.321 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.423 ' HB3' ' HE2' ' A' ' 71' ' ' LYS . 10.4 p90 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.593 -0.718 . . . . 0.0 111.129 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.304 0 N-CA-C 112.219 -0.352 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.901 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -101.49 167.39 2.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 117.493 0.647 . . . . 0.0 111.237 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -101.51 157.73 16.59 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.075 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.81 -22.43 30.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -53.98 -35.88 62.3 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.479 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.455 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 16.3 t70 -59.64 113.5 7.27 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.633 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 19.1 Cg_endo -58.16 -27.83 81.66 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.304 2.669 . . . . 0.0 114.06 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.517 ' O ' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -77.07 -48.67 17.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.159 0.504 . . . . 0.0 110.27 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.901 HG21 HG13 ' A' ' 12' ' ' ILE . 52.0 t -57.67 -41.56 79.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.93 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -40.66 78.51 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.9 pt-20 -72.93 -40.02 65.79 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.676 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 18' ' ' ARG . 18.2 mt -65.77 -40.03 86.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.564 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.048 0.452 . . . . 0.0 110.248 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -51.94 -52.78 47.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.74 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 25.3 t80 -56.86 -35.38 68.83 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.725 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.29 -48.34 80.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.372 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.833 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.7 tp -68.63 -46.9 67.99 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.586 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -68.89 -18.2 64.09 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.314 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.44 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 5.8 tp60 -84.87 -37.3 20.8 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -71.56 -103.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.415 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 56.4 36.16 27.08 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -37.74 88.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.804 0.335 . . . . 0.0 110.934 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.436 ' H ' ' HG3' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -123.7 13.23 9.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.482 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 68.15 86.89 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.877 0.471 . . . . 0.0 111.771 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.505 HD21 ' CZ ' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -125.91 158.19 35.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.835 178.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.542 ' HB ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -118.39 125.13 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -177.46 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.977 HD12 ' HB2' ' A' ' 62' ' ' ALA . 9.9 tp -90.4 113.5 25.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.966 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.06 68.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.735 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 161.38 166.77 20.77 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 119.712 -1.232 . . . . 0.0 114.09 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.806 HG22 HD23 ' A' ' 60' ' ' LEU . 10.1 t -77.23 137.07 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.588 0.355 . . . . 0.0 110.646 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.1 -67.9 0.91 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.154 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.09 173.53 13.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.558 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.52 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -170.14 -163.69 24.61 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 119.807 -1.187 . . . . 0.0 114.255 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 57' ' ' ASN . 41.0 mt-30 -153.94 137.71 16.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.075 -0.562 . . . . 0.0 111.136 -178.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.695 HG22 ' ND2' ' A' ' 54' ' ' ASN . 7.5 mt -114.97 126.16 72.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -109.64 117.62 54.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.01 162.19 33.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.935 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -135.29 -71.99 0.07 OUTLIER Glycine 0 C--N 1.334 0.431 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 49' ' ' ILE . 12.6 tt -120.11 112.27 34.85 Favored Pre-proline 0 C--O 1.233 0.225 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.98 114.54 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 N-CA-C 115.891 1.458 . . . . 0.0 115.891 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.97 20.37 10.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.227 -1.806 . . . . 0.0 107.3 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.765 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 71.87 32.93 1.79 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.215 -178.054 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 5.0 p-10 -122.16 26.98 8.23 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.542 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.695 ' ND2' HG22 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -57.34 148.03 24.15 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.44 ' CE1' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -98.95 132.79 44.01 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.981 179.049 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.815 ' HB2' HG23 ' A' ' 77' ' ' VAL . 32.3 m-85 -119.22 135.46 54.67 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.23 0.538 . . . . 0.0 112.022 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' GLN . 49.0 t30 -130.73 111.85 12.54 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.845 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.624 HD21 HD11 ' A' ' 12' ' ' ILE . 3.9 mp -141.7 163.81 31.91 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.3 mm -122.72 138.18 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.345 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.962 HD22 HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -141.61 168.93 18.6 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.779 0.323 . . . . 0.0 111.84 -179.367 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.8 m -92.1 138.5 31.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.224 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.977 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -156.38 146.61 21.4 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -149.67 164.49 35.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.675 178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -102.17 -2.76 28.62 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.93 144.54 19.18 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-O 121.031 0.443 . . . . 0.0 112.132 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.23 -33.01 50.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.121 2.547 . . . . 0.0 112.108 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -90.45 14.63 12.48 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.671 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -117.87 167.09 11.73 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.2 0.524 . . . . 0.0 111.725 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.562 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 6.7 m-85 -64.77 -176.4 0.25 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.402 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.421 ' C ' ' HD3' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -130.61 122.62 27.8 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.231 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -111.06 169.71 8.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.936 0.398 . . . . 0.0 111.643 -178.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.436 ' C ' ' HB2' ' A' ' 94' ' ' LEU . 10.6 m-85 -92.75 149.57 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.578 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.791 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 24.8 m-85 -144.0 137.87 28.0 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.767 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.51 ' HB2' HD11 ' A' ' 94' ' ' LEU . 51.4 t30 -109.4 126.48 53.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 110.412 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.769 HG12 ' HA ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -127.73 146.17 33.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.483 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.24 117.61 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.738 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -119.1 135.24 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.066 0.46 . . . . 0.0 112.146 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 79' ' ' GLU . 5.4 tp -117.35 124.45 48.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.333 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.45 124.36 34.41 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.831 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.55 149.72 49.24 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.2 -27.39 13.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.968 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -54.53 -43.39 71.88 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.61 0.243 . . . . 0.0 110.932 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.14 -6.93 43.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.061 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 61.03 50.33 5.12 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 120.769 0.318 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -174.47 -163.19 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.112 0.482 . . . . 0.0 111.266 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.72 HD22 ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -104.11 170.31 7.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.076 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.564 ' HE3' HD23 ' A' ' 78' ' ' LEU . 2.2 tmmm? -148.27 117.98 7.08 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.817 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -79.04 106.74 11.29 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.563 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.61 -54.38 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.713 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.47 151.32 40.18 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.09 0.471 . . . . 0.0 112.232 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.769 ' HA ' HG12 ' A' ' 75' ' ' VAL . 3.2 t80 -127.04 120.33 28.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.692 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.41 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 12.2 t -132.32 138.99 33.47 Favored Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.471 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 94.6 Cg_endo -82.88 135.61 7.77 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.847 2.365 . . . . 0.0 111.838 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 74' ' ' ASN . 1.4 mt -109.68 44.78 1.15 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.765 0.317 . . . . 0.0 111.297 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.471 ' CE1' ' HB2' ' A' ' 93' ' ' PRO . 43.8 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.092 -0.956 . . . . 0.0 111.132 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.857 HG13 HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -96.64 161.0 2.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 121.05 0.452 . . . . 0.0 111.596 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.75 153.83 20.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.981 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.39 -21.66 29.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 109.974 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.55 -36.34 61.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.646 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.442 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 10.7 t70 -59.72 114.82 10.51 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.489 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.2 Cg_endo -59.4 -30.08 91.77 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.542 2.828 . . . . 0.0 114.193 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 4.6 mpt_? -76.5 -43.67 38.51 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.257 0.551 . . . . 0.0 110.535 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.857 HG21 HG13 ' A' ' 12' ' ' ILE . 47.2 t -62.19 -42.32 94.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.329 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -71.3 -36.03 71.51 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HG3' HG13 ' A' ' 22' ' ' ILE . 12.2 pt-20 -76.29 -38.25 56.4 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.228 0.537 . . . . 0.0 110.679 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.804 HG12 HD12 ' A' ' 86' ' ' LEU . 85.6 mt -75.46 -32.64 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.325 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.526 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -69.77 -51.1 36.92 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.382 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 11.3 pt-20 -56.16 -43.39 78.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.703 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.659 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 23.7 t80 -57.31 -38.27 73.76 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.731 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -57.05 -46.18 82.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.107 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.924 HD22 ' HB3' ' A' ' 37' ' ' LEU . 3.1 tp -69.18 -45.03 70.98 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.635 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -71.12 -17.78 62.55 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.68 ' HB3' HD12 ' A' ' 88' ' ' LEU . 3.9 tp-100 -84.41 -38.59 20.05 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.401 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -97.66 124.98 42.18 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -162.71 40.81 0.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.756 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -37.87 34.53 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 16.0 mt-30 -95.34 -16.7 22.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.955 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 16.6 t30 72.62 91.58 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.045 0.45 . . . . 0.0 111.903 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.445 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -140.75 162.64 34.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.11 178.712 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.77 124.74 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.975 HD11 ' HB2' ' A' ' 60' ' ' LEU . 12.0 tp -83.58 118.91 24.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.206 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.415 ' H ' ' HA ' ' A' ' 62' ' ' ALA . . . -65.31 -30.69 71.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.831 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.9 166.29 15.09 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 119.983 -1.103 . . . . 0.0 113.843 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.765 HG22 HD23 ' A' ' 60' ' ' LEU . 18.2 t -68.5 130.14 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.516 -0.342 . . . . 0.0 110.325 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.95 -56.91 2.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.505 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.81 154.59 39.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.411 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.59 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -152.73 173.3 31.75 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.325 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' ASN . 18.1 mt-30 -146.97 159.54 43.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.98 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 19' ' ' VAL . 14.7 mt -144.0 131.14 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.714 0.293 . . . . 0.0 111.473 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.5 mt -107.63 115.56 49.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.323 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 162.66 32.52 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.65 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.43 -87.46 0.08 OUTLIER Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 49' ' ' ILE . 1.5 mt -104.3 108.52 60.57 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.96 115.91 3.35 Favored 'Trans proline' 0 C--N 1.347 0.453 0 N-CA-C 116.491 1.689 . . . . 0.0 116.491 -175.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 19.91 11.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.325 175.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.763 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.08 38.28 0.91 Allowed 'General case' 0 C--N 1.345 0.408 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.631 -178.294 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.36 26.33 8.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.603 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -49.1 136.55 14.66 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.394 0.678 . . . . 0.0 112.609 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.635 ' CE1' HD13 ' A' ' 78' ' ' LEU . 3.8 m-85 -99.86 126.34 45.96 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.73 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.659 ' HB2' HG23 ' A' ' 77' ' ' VAL . 6.0 m-85 -109.38 144.83 37.05 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 44' ' ' GLN . 46.5 t30 -144.14 112.26 6.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.808 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.708 HD21 HG13 ' A' ' 19' ' ' VAL . 5.0 mp -138.16 168.78 19.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 2.7 mm -126.85 120.61 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.565 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.975 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -127.03 164.1 22.27 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.94 0.4 . . . . 0.0 111.279 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.8 m -94.39 141.65 28.33 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.738 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.895 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -152.05 148.09 27.27 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.511 0.507 . . . . 0.0 112.23 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -150.54 164.57 35.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.726 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -93.96 -11.64 30.47 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.844 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 p -149.7 143.1 16.41 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 111.935 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.88 -22.81 48.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.507 2.805 . . . . 0.0 113.539 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -89.6 3.32 52.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -128.04 166.95 17.43 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 121.377 0.608 . . . . 0.0 112.526 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 5.6 m-85 -53.46 167.46 0.21 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.834 -1.076 . . . . 0.0 113.749 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -125.69 134.1 51.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.825 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 23.9 mmmt -107.76 167.98 9.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.067 0.461 . . . . 0.0 111.819 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . 95.7 m-85 -88.37 151.31 22.68 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.621 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.873 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 14.0 m-85 -142.42 138.19 30.91 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.865 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.524 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . 4.3 t30 -110.82 119.68 39.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.623 ' CG1' HD21 ' A' ' 88' ' ' LEU . 41.4 t -130.94 149.59 33.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.049 0.452 . . . . 0.0 111.671 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.6 t -109.24 129.79 63.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.273 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -128.85 146.89 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.016 0.436 . . . . 0.0 111.97 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.635 HD13 ' CE1' ' A' ' 55' ' ' TYR . 12.0 tp -118.58 126.25 51.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.442 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -88.77 128.04 35.62 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.901 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -125.03 130.14 51.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 52' ' ' TRP . . . -89.45 -35.79 15.79 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.324 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.2 m -61.88 -35.48 78.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.55 -7.3 53.23 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.973 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 m120 55.71 47.43 20.52 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 122.646 0.379 . . . . 0.0 111.411 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.4 t -174.04 -169.0 0.44 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.268 0.556 . . . . 0.0 111.167 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.804 HD12 HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -105.14 168.15 9.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.925 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -147.05 132.67 18.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.973 0.416 . . . . 0.0 111.449 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.68 HD12 ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -85.96 121.57 28.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.822 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.566 HG23 ' HA ' ' A' ' 77' ' ' VAL . 2.4 t -85.02 -54.95 7.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.847 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.485 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -160.82 134.14 6.62 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.251 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 75' ' ' VAL . 1.4 t80 -106.49 126.82 52.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.787 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.703 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.1 t -132.47 147.41 65.54 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.45 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.703 ' HD2' HG12 ' A' ' 92' ' ' VAL . 61.5 Cg_endo -92.44 138.37 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.17 2.58 . . . . 0.0 112.826 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.451 HD23 ' CB ' ' A' ' 74' ' ' ASN . 0.4 OUTLIER -99.61 27.47 5.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.275 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.44 ' CB ' ' HE3' ' A' ' 71' ' ' LYS . 6.5 p90 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.534 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.234 0 CA-C-O 120.084 -0.287 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.102 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -96.45 167.3 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 117.185 0.492 . . . . 0.0 111.482 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 m -91.27 149.76 21.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.15 -19.04 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.506 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -57.43 -37.94 73.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.008 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 18.4 t70 -57.99 113.63 6.87 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.031 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HA ' ' CD ' ' A' ' 20' ' ' LYS . 13.9 Cg_endo -56.17 -27.45 65.76 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.57 2.846 . . . . 0.0 114.321 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.73 -38.99 32.13 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.903 0.383 . . . . 0.0 110.873 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.102 HG21 HG13 ' A' ' 12' ' ' ILE . 45.1 t -67.31 -41.17 86.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.906 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.473 ' CD ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -73.86 -34.16 64.38 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.519 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 10.8 pt-20 -77.52 -37.77 50.27 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.935 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.854 HG12 HD12 ' A' ' 86' ' ' LEU . 93.8 mt -75.92 -31.15 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.734 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -69.09 -51.82 34.76 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.041 0.448 . . . . 0.0 110.271 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 8.3 pt-20 -55.71 -47.34 77.01 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.203 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.64 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 27.0 t80 -55.57 -37.96 68.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.818 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.535 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.15 -51.16 68.98 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.234 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.915 HD22 ' HB3' ' A' ' 37' ' ' LEU . 2.7 tp -62.21 -44.98 95.36 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -72.59 -17.41 61.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.615 ' HB3' HD12 ' A' ' 88' ' ' LEU . 3.5 tp-100 -82.12 -38.55 24.6 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.617 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 2.9 t60 -108.23 129.18 55.21 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.814 0.34 . . . . 0.0 110.353 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -170.28 41.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.543 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.13 86.55 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.85 9.18 42.66 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.524 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 42.2 t30 52.78 88.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.592 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -127.99 157.63 40.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.515 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.59 124.15 72.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.915 ' HB3' HD22 ' A' ' 27' ' ' LEU . 1.5 tt -90.99 113.99 26.39 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.866 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.17 -28.01 69.11 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.825 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.93 168.73 25.3 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 119.313 -1.422 . . . . 0.0 114.345 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.519 ' CG2' HD23 ' A' ' 60' ' ' LEU . 1.6 t -76.14 136.42 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.106 -0.547 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.61 -65.32 1.02 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.714 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.58 171.3 20.56 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.155 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -166.39 -174.39 35.7 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.558 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 57' ' ' ASN . 25.7 mt-30 -151.24 143.17 23.89 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.128 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.703 HD12 HD12 ' A' ' 12' ' ' ILE . 2.9 mp -122.17 125.52 73.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.234 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.0 mt -107.41 118.89 56.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.77 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.684 ' HB3' HD22 ' A' ' 54' ' ' ASN . 0.0 OUTLIER -136.47 163.16 31.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.975 -178.752 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -148.19 -66.72 0.01 OUTLIER Glycine 0 C--N 1.33 0.224 0 N-CA-C 108.534 -1.827 . . . . 0.0 108.534 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -120.46 108.27 37.88 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 175.511 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -90.53 117.51 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 116.212 1.582 . . . . 0.0 116.212 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 23.36 10.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.463 175.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.757 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.97 31.85 1.44 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.314 -178.122 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 20.9 m-20 -121.91 27.18 8.23 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.556 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.684 HD22 ' HB3' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -56.02 153.61 8.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.116 -178.32 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.15 122.44 45.34 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.437 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.584 ' CB ' HG23 ' A' ' 77' ' ' VAL . 17.7 m-85 -102.13 133.35 47.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.037 0.446 . . . . 0.0 111.953 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 44' ' ' GLN . 39.8 t30 -132.91 111.68 11.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.067 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.642 HD21 HD11 ' A' ' 12' ' ' ILE . 4.0 mp -140.34 166.27 25.14 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.8 mm -124.12 129.44 74.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.439 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.897 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -131.63 168.84 17.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.722 0.296 . . . . 0.0 111.504 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.3 m -100.65 133.95 44.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.362 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.592 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -145.1 141.03 28.46 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.486 0.491 . . . . 0.0 112.186 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -139.74 166.55 24.31 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.751 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -93.2 -16.48 24.79 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.652 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.75 153.05 35.82 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.688 0.28 . . . . 0.0 111.659 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.21 -31.62 74.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.76 2.307 . . . . 0.0 112.111 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -96.16 14.38 24.18 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.463 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -115.37 167.32 10.97 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-O 121.105 0.478 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.514 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 9.3 m-85 -71.72 152.16 43.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.852 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 m -115.08 133.79 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.377 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 22.7 mmmt -113.99 165.08 12.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . 1.1 m-85 -87.69 148.45 24.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.532 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 46.6 m-85 -138.62 140.75 39.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.881 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.683 ' HB2' HD23 ' A' ' 94' ' ' LEU . 31.4 t-20 -108.79 116.49 32.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 0.0 109.956 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.747 HG12 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -119.33 142.67 33.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.941 -178.524 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 t -107.52 120.16 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.959 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.592 HG21 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -123.37 146.37 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 79' ' ' GLU . 9.3 tp -119.81 125.39 48.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.341 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.501 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.7 tt0 -87.73 124.2 33.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.686 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -122.7 137.82 54.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.404 0.621 . . . . 0.0 112.545 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.43 -27.16 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.688 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -59.58 -41.35 90.02 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.323 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.34 9.1 43.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.509 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.81 57.51 5.93 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.498 0.319 . . . . 0.0 111.557 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 177.96 -177.99 0.23 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.455 0.645 . . . . 0.0 111.613 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.854 HD12 HG12 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -93.31 166.83 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.905 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.96 126.93 13.62 Favored 'General case' 0 CA--C 1.526 0.052 0 CA-C-O 120.797 0.332 . . . . 0.0 111.258 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.747 HD21 HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -86.7 114.77 23.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.197 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.73 -54.11 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.319 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.33 144.28 15.62 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.86 0.362 . . . . 0.0 111.856 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.638 ' HA ' HG13 ' A' ' 75' ' ' VAL . 6.0 t80 -112.77 127.32 56.12 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.82 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.456 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 5.2 t -132.46 139.78 35.84 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.456 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.2 Cg_endo -81.99 138.59 10.37 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.903 2.402 . . . . 0.0 112.217 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -107.6 25.44 11.49 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.64 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.586 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 30.4 p90 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.586 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.279 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 1.069 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -98.0 166.84 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 117.706 0.753 . . . . 0.0 112.144 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 t -89.9 154.26 20.0 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.58 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 p -64.75 -23.3 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.725 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -51.62 -36.76 47.22 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.972 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.463 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 14.1 t70 -58.79 113.24 6.32 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.702 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 19.7 Cg_endo -58.31 -28.14 83.56 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.435 2.757 . . . . 0.0 113.994 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.551 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 5.9 mmt-85 -76.85 -46.24 25.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.095 0.474 . . . . 0.0 110.124 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.069 HG21 HG13 ' A' ' 12' ' ' ILE . 69.8 t -59.51 -42.44 87.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.493 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -71.57 -37.78 71.03 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.597 ' CD ' HD11 ' A' ' 86' ' ' LEU . 8.0 pt-20 -77.18 -37.25 54.05 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.021 0.439 . . . . 0.0 111.191 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.755 HG12 HD12 ' A' ' 86' ' ' LEU . 27.2 mt -75.11 -31.52 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.016 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -70.6 -52.68 19.85 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.042 0.448 . . . . 0.0 109.962 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.4 pt-20 -55.27 -41.78 72.69 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.718 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 28.4 t80 -59.65 -38.01 80.27 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.905 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.28 -43.53 88.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.113 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 37' ' ' LEU . 3.6 tp -69.31 -48.06 62.65 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.376 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 25' ' ' PHE . 1.5 pttm -67.73 -25.4 65.63 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.611 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 5.0 tp60 -74.99 -27.91 60.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.513 ' ND1' HD21 ' A' ' 35' ' ' LEU . 10.0 t-160 -65.03 -95.53 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.94 32.1 12.05 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -93.52 -38.02 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.937 0.399 . . . . 0.0 109.957 178.628 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.79 -5.16 13.29 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.152 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.8 t30 67.51 91.94 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.953 0.501 . . . . 0.0 111.374 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.513 HD21 ' ND1' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -133.58 160.14 38.36 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.436 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.33 124.6 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.116 HD12 ' HB2' ' A' ' 62' ' ' ALA . 6.2 tp -92.17 113.94 26.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.385 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.18 72.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.324 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.88 163.28 23.65 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.204 -1.474 . . . . 0.0 114.808 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.725 HG22 HD23 ' A' ' 60' ' ' LEU . 2.2 t -75.47 125.6 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.196 -0.502 . . . . 0.0 109.918 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.02 -62.63 1.41 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.57 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.75 171.68 16.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.025 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.596 ' HA3' ' CG ' ' A' ' 58' ' ' LEU . . . -171.1 -174.41 38.88 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.427 -1.368 . . . . 0.0 114.883 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 57' ' ' ASN . 28.3 mt-30 -146.82 168.79 20.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.451 -0.875 . . . . 0.0 111.172 -178.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.651 HD13 HG21 ' A' ' 12' ' ' ILE . 4.7 mp -142.86 132.49 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.419 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.6 mm -107.44 116.87 51.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.134 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.666 ' HB3' HD22 ' A' ' 54' ' ' ASN . 0.1 OUTLIER -136.07 162.75 32.04 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.816 -179.251 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -149.42 -70.78 0.01 OUTLIER Glycine 0 C--N 1.33 0.23 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -120.61 108.8 36.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -87.65 117.47 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 N-CA-C 116.395 1.652 . . . . 0.0 116.395 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.438 ' NE2' ' HB2' ' A' ' 53' ' ' ASP . 32.1 p-80 -121.7 23.47 10.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.605 -1.634 . . . . 0.0 107.446 175.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.744 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 73.7 33.4 1.04 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.028 -178.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.594 ' OD1' HD11 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -122.24 28.1 7.64 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.832 177.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.666 HD22 ' HB3' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -57.83 143.72 41.29 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.6 ' CE1' HD13 ' A' ' 78' ' ' LEU . 1.3 m-30 -95.06 138.62 32.54 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.591 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -119.56 135.61 54.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 112.036 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 44' ' ' GLN . 64.1 t-20 -133.52 114.24 13.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.15 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 19' ' ' VAL . 4.6 mp -144.35 168.68 19.5 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.1 mm -125.85 131.88 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.272 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.841 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -134.37 168.89 18.08 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.402 ' O ' ' HG ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -99.61 129.7 45.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.046 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 1.116 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -144.62 141.76 29.63 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.066 0.46 . . . . 0.0 112.194 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -142.06 165.4 27.54 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.507 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -94.74 -13.8 25.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.94 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -153.82 150.98 24.0 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-O 121.213 0.53 . . . . 0.0 112.109 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 65' ' ' SER . 19.3 Cg_exo -63.65 -37.7 45.28 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.554 2.836 . . . . 0.0 113.026 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -80.85 9.05 6.91 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -124.1 167.45 14.2 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.228 0.537 . . . . 0.0 111.728 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.521 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.7 m-85 -68.79 166.18 18.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.368 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 m -119.84 131.86 55.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.951 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 1.5 mmmp? -110.51 155.0 22.89 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.47 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.559 ' O ' ' HB2' ' A' ' 94' ' ' LEU . 20.8 m-85 -85.23 138.04 32.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.19 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 1.009 ' CE2' ' HB3' ' A' ' 62' ' ' ALA . 5.9 m-30 -125.71 140.37 52.76 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.949 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.482 ' HB2' HD12 ' A' ' 59' ' ' ILE . 3.6 t-20 -111.95 119.2 37.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 110.424 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 91' ' ' PHE . 34.3 m -128.78 158.91 41.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.496 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.08 127.36 73.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.724 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.674 HG21 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -124.53 145.41 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.047 0.451 . . . . 0.0 111.751 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.6 HD13 ' CE1' ' A' ' 55' ' ' TYR . 9.4 tp -114.32 127.0 55.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.784 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -91.91 127.97 37.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.558 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.01 139.99 52.97 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 52' ' ' TRP . . . -93.72 -30.34 14.94 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.791 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 m -54.23 -39.3 66.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.241 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.98 -3.86 27.04 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.457 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 54.56 53.77 10.23 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 120.996 0.427 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 t -171.49 -173.95 1.32 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.755 HD12 HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -101.45 165.97 10.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.798 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -147.91 128.69 14.3 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.026 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.611 ' CB ' ' HG2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -82.63 121.9 27.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.454 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 77' ' ' VAL . 2.5 t -83.57 -55.02 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.45 156.18 34.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.353 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.937 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.4 t80 -124.72 123.05 39.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.517 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 7.1 t -131.78 142.97 47.16 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.911 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.517 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.4 Cg_endo -86.99 138.6 5.03 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.008 2.472 . . . . 0.0 112.176 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -105.63 20.5 18.8 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 47.8 p90 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.068 -0.968 . . . . 0.0 111.469 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.204 0 N-CA-C 112.283 -0.327 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.728 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -96.78 147.97 5.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 117.212 0.506 . . . . 0.0 111.218 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 t -79.24 151.38 31.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.694 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -63.53 -21.83 29.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -53.01 -35.77 59.76 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.601 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 15.1 t0 -57.25 111.12 3.0 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.258 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.2 Cg_endo -59.89 -27.67 85.45 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.429 2.753 . . . . 0.0 113.801 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.485 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -77.64 -44.38 28.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.149 0.5 . . . . 0.0 110.068 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.728 HG21 HG13 ' A' ' 12' ' ' ILE . 54.0 t -61.53 -47.56 92.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.191 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -40.24 96.73 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 14.0 pt-20 -75.0 -42.95 56.46 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.901 0.381 . . . . 0.0 110.99 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 56' ' ' TYR . 50.2 mt -65.0 -34.65 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.339 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -62.68 -48.17 80.48 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -49.75 -51.28 40.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.364 178.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.667 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 32.0 t80 -56.55 -37.36 70.43 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.316 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.554 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -57.22 -48.1 79.65 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.97 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.6 tp -67.52 -43.08 81.69 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.624 ' HE2' ' CD2' ' A' ' 25' ' ' PHE . 3.7 pttm -75.03 -18.15 60.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -79.56 -39.0 32.82 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.967 0.349 . . . . 0.0 110.922 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -103.97 122.27 44.86 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.358 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -168.63 43.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.552 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -37.66 71.89 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.3 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.83 1.21 36.84 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.861 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 63.73 99.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.499 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -141.31 158.41 43.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 178.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.433 HD12 ' HE3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -116.36 125.22 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -177.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.037 HD11 ' HB2' ' A' ' 60' ' ' LEU . 3.4 tp -87.0 120.77 28.62 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.865 0.364 . . . . 0.0 110.749 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.417 ' H ' ' HA ' ' A' ' 62' ' ' ALA . . . -65.96 -34.51 78.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.895 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.85 162.57 11.32 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.186 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.62 HG22 ' CD2' ' A' ' 60' ' ' LEU . 54.2 t -67.8 136.03 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.86 0.464 . . . . 0.0 110.753 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.02 -65.76 1.14 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.619 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.13 146.66 25.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.389 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.584 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -146.95 -170.93 15.68 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 119.793 -1.194 . . . . 0.0 114.812 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' ASN . 3.1 mm100 -142.16 150.74 41.46 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.558 -0.821 . . . . 0.0 111.295 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.517 HG22 ' CD ' ' A' ' 47' ' ' LYS . 63.0 mt -128.33 129.4 69.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.79 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 55' ' ' TYR . 4.7 mt -106.87 115.27 48.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.452 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.517 ' CD ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -136.01 162.75 32.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.662 0.744 . . . . 0.0 112.829 -178.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.89 -66.92 0.01 OUTLIER Glycine 0 C--N 1.329 0.193 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -120.26 109.27 37.13 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 175.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -87.02 117.04 1.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 N-CA-C 116.226 1.587 . . . . 0.0 116.226 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.99 24.02 10.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.426 -1.716 . . . . 0.0 107.03 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TRP . . . . . 0.764 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 62.88 35.51 13.48 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.44 -177.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.504 ' OD2' HD11 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -122.84 28.29 7.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.389 177.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.649 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 1.1 t-20 -47.64 146.03 2.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.447 ' HB3' HD12 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -98.05 116.52 30.44 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.73 178.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.649 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 38.8 m-85 -104.87 143.0 33.74 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.206 0.527 . . . . 0.0 111.844 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 44' ' ' GLN . 15.9 t-20 -144.39 110.63 5.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.715 HD21 HG13 ' A' ' 19' ' ' VAL . 4.0 mp -136.74 167.35 21.6 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 2.7 mm -122.04 121.62 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.042 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.037 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -125.08 168.21 13.69 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.771 0.319 . . . . 0.0 111.26 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 50.2 m -98.97 146.04 26.43 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.881 ' HB3' ' CE1' ' A' ' 73' ' ' TYR . . . -155.28 147.02 23.24 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -149.16 165.36 32.05 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.338 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -103.86 -5.82 21.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.042 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 68' ' ' GLU . 2.2 p -146.39 143.41 18.96 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-O 121.136 0.493 . . . . 0.0 112.046 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.42 -27.63 54.64 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.476 2.784 . . . . 0.0 113.365 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -95.23 14.19 23.05 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.423 ' HB2' ' OG ' ' A' ' 65' ' ' SER . 7.8 mt-10 -126.78 167.23 16.05 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.46 0.648 . . . . 0.0 112.48 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.496 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 5.3 m-85 -64.69 167.65 7.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.273 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 m -124.29 135.74 53.6 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.889 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HG3' ' CD2' ' A' ' 95' ' ' PHE . 27.9 mmmt -110.37 169.98 8.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.677 0.275 . . . . 0.0 111.067 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.477 ' C ' ' HB2' ' A' ' 94' ' ' LEU . 20.4 m-85 -89.85 151.17 21.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.52 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.881 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 9.2 m-85 -141.65 141.07 33.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.34 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.436 ' CB ' HD13 ' A' ' 59' ' ' ILE . 3.2 t-20 -113.72 126.39 55.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.495 0.188 . . . . 0.0 110.89 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.961 HG12 ' HA ' ' A' ' 91' ' ' PHE . 6.4 m -132.37 140.21 48.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.161 0.505 . . . . 0.0 112.238 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.432 HG13 HD22 ' A' ' 57' ' ' ASN . 0.6 OUTLIER -102.99 110.42 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.655 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 26' ' ' ALA . 6.2 t -113.25 136.86 48.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.568 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 79' ' ' GLU . 7.3 tp -112.51 131.74 55.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.018 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.649 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -91.39 129.43 37.38 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.0 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HD3' ' HB3' ' A' ' 82' ' ' SER . 1.7 ttmp? -125.4 143.79 50.82 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.37 -29.91 11.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.572 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.449 ' HB3' ' HD3' ' A' ' 80' ' ' LYS . 6.8 t -53.81 -43.49 69.4 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.12 9.12 36.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.325 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.57 58.88 3.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.068 0.461 . . . . 0.0 111.375 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.6 p -173.8 -174.3 0.94 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.806 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.667 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -101.15 166.9 10.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.01 179.2 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.402 ' NZ ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -147.39 121.65 9.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.016 0.436 . . . . 0.0 111.717 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -81.01 110.17 16.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.902 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.98 -50.04 21.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.596 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.8 146.82 26.62 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.961 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.9 t80 -125.88 119.24 27.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.421 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.553 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 5.8 t -132.34 142.78 46.2 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.553 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.6 Cg_endo -80.34 139.04 12.83 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.925 2.417 . . . . 0.0 111.701 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.477 ' HB2' ' C ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -112.66 47.47 1.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.242 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CD2' ' HG3' ' A' ' 71' ' ' LYS . 3.2 p90 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.855 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 CA-C-O 120.186 -0.23 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.55 165.47 30.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.163 2.576 . . . . 0.0 112.755 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.81 70.04 0.05 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.651 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.22 160.37 15.28 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.891 2.394 . . . . 0.0 112.94 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.14 26.09 2.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.091 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.54 -49.33 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.302 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.68 151.24 23.16 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.788 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -146.02 133.89 21.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.8 t -109.61 143.65 19.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.356 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.3 pt -117.78 162.08 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 43' ' ' GLY . . . -91.61 -158.09 34.28 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.093 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.074 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -101.31 159.39 4.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 117.71 0.755 . . . . 0.0 111.68 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -79.31 153.32 29.93 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.054 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.06 -23.38 30.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.686 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -53.21 -32.55 48.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.341 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 12.4 t70 -57.43 112.83 5.18 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.658 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.417 ' HA ' ' CG ' ' A' ' 20' ' ' LYS . 18.6 Cg_endo -59.58 -26.57 82.51 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.453 2.769 . . . . 0.0 113.934 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.498 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -78.62 -44.15 24.63 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.275 0.56 . . . . 0.0 110.384 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.074 HG21 HG13 ' A' ' 12' ' ' ILE . 72.9 t -65.18 -39.65 86.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.65 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -69.41 -37.88 77.66 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 13.0 pt-20 -75.28 -37.24 61.01 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.214 0.531 . . . . 0.0 110.562 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.738 HG12 HD12 ' A' ' 86' ' ' LEU . 77.1 mt -74.62 -35.04 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.059 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -66.63 -54.89 18.48 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.242 0.544 . . . . 0.0 110.217 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 11.3 pt-20 -53.66 -44.28 69.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.078 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.657 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 26.9 t80 -60.11 -35.39 75.12 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.435 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 23' ' ' ALA . . . -58.61 -47.11 85.46 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.903 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 37' ' ' LEU . 2.4 tp -66.92 -43.79 82.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.702 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.585 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -70.93 -18.14 62.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.763 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -87.08 -38.95 16.03 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.131 0.423 . . . . 0.0 111.205 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -102.42 125.42 49.13 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.573 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -167.5 45.43 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.195 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.544 ' HG2' ' HG2' ' A' ' 33' ' ' GLN . 0.2 OUTLIER -64.36 -37.54 87.86 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.079 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.544 ' HG2' ' HG2' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -107.34 13.3 27.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.882 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 50.93 83.07 0.05 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -118.68 165.11 14.38 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.403 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.86 124.25 68.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.036 HD12 ' HB2' ' A' ' 62' ' ' ALA . 7.1 tp -90.26 115.75 27.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.546 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.94 -28.96 69.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.456 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 163.26 174.29 32.96 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.577 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.664 HG22 HD23 ' A' ' 60' ' ' LEU . 2.0 t -81.37 132.74 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.568 0.347 . . . . 0.0 110.694 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.1 -63.33 1.27 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.334 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.43 163.73 29.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.788 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -152.33 163.32 30.21 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.954 -1.117 . . . . 0.0 114.436 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.41 ' H ' ' HG ' ' A' ' 58' ' ' LEU . 68.1 mt-30 -150.27 148.69 29.17 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.127 0.571 . . . . 0.0 110.054 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.59 ' CD1' HG21 ' A' ' 12' ' ' ILE . 4.6 mp -133.46 129.19 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.281 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.6 mt -107.54 114.92 47.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.195 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.83 155.49 48.94 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.7 -70.4 0.08 OUTLIER Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -120.83 108.99 36.28 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.83 119.18 1.85 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.733 1.622 . . . . 0.0 115.908 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -120.88 23.21 10.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.258 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.753 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 74.44 29.47 1.2 Allowed 'General case' 0 C--N 1.344 0.335 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.711 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -122.31 27.32 7.99 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.591 177.582 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.402 ' HB3' ' HE1' ' A' ' 56' ' ' TYR . 2.3 t-20 -50.66 149.04 3.49 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.48 ' CE1' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -98.31 132.72 43.56 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.945 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.675 ' CB ' HG23 ' A' ' 77' ' ' VAL . 21.1 m-85 -117.63 144.18 45.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 112.081 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -143.94 116.98 8.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.666 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.788 HD23 ' HA3' ' A' ' 43' ' ' GLY . 4.5 mp -143.18 164.06 31.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.1 mm -119.44 131.4 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.865 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.001 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.47 169.1 18.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.931 0.396 . . . . 0.0 111.619 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.0 m -98.81 135.09 40.76 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.988 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 1.036 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -153.59 143.23 21.8 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -140.58 164.61 29.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.457 178.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -98.92 -7.17 27.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.238 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.02 148.32 18.4 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.776 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.14 -27.96 48.84 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.951 2.434 . . . . 0.0 112.342 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -89.31 14.29 11.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.741 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -128.43 167.22 17.33 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 121.453 0.644 . . . . 0.0 112.484 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.513 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 8.3 m-85 -69.5 160.95 30.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.324 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -109.6 130.99 55.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.411 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.526 ' HE2' ' HB2' ' A' ' 95' ' ' PHE . 25.5 mmmt -112.94 170.08 8.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.02 0.438 . . . . 0.0 111.74 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.73 145.66 25.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.733 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 36.1 m-85 -140.94 136.88 32.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.1 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.79 ' HB2' HD23 ' A' ' 94' ' ' LEU . 10.0 t-20 -109.11 115.49 30.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.993 HG12 ' HA ' ' A' ' 91' ' ' PHE . 2.2 m -121.99 144.38 31.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.726 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 23.7 t -104.34 127.25 58.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.875 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.675 HG23 ' CB ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -126.25 146.78 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 79' ' ' GLU . 11.8 tp -120.42 129.54 53.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.436 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -93.94 134.94 35.8 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.47 131.6 51.63 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.95 0.405 . . . . 0.0 111.91 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' A' ' 52' ' ' TRP . . . -89.23 -36.44 15.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.378 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 m -57.57 -41.74 81.68 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -11.23 50.75 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.05 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.53 45.51 10.56 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.1 p -165.99 -169.06 1.39 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 111.263 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.738 HD12 HG12 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -105.86 170.81 7.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.475 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.68 142.7 27.01 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.916 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.763 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 1.5 tm? -101.11 115.79 31.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.381 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 3.6 t -74.52 -52.29 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.45 156.45 16.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.95 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.993 ' HA ' HG12 ' A' ' 75' ' ' VAL . 4.6 t80 -120.74 124.77 45.95 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.618 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.41 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 2.9 t -132.63 137.69 30.38 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.01 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 96.6 Cg_endo -80.13 138.31 12.71 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.733 2.289 . . . . 0.0 112.332 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -108.85 39.99 1.9 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.638 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.526 ' HB2' ' HE2' ' A' ' 71' ' ' LYS . 16.6 p90 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.641 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.097 0 CA-C-O 120.166 -0.241 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.97 154.96 71.83 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.964 2.443 . . . . 0.0 112.582 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' A' ' 4' ' ' PRO . . . -104.58 112.51 4.11 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.54 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' A' ' 3' ' ' GLY . 7.3 Cg_endo -86.49 153.14 9.09 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.266 2.644 . . . . 0.0 112.556 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.23 19.45 9.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.769 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.21 -49.43 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.844 -0.162 . . . . 0.0 111.073 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.83 119.89 1.26 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.953 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.418 ' CG ' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -125.42 167.11 15.43 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.549 0.214 . . . . 0.0 110.659 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 t -120.0 112.14 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.858 0.361 . . . . 0.0 111.485 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -143.56 159.03 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.007 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . 118.42 -178.95 16.93 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.305 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.908 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -97.2 167.14 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 111.267 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 m -91.92 150.34 21.08 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.092 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.97 -20.42 27.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.227 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -55.42 -35.91 65.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.547 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.435 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 13.6 t70 -57.49 115.96 12.44 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.904 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.0 Cg_endo -59.54 -28.09 86.59 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.502 2.801 . . . . 0.0 114.133 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.488 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -79.54 -43.47 22.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.034 0.445 . . . . 0.0 110.564 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.908 HG21 HG13 ' A' ' 12' ' ' ILE . 48.4 t -62.01 -41.46 91.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.834 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -72.44 -36.12 68.48 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 12.1 pt-20 -76.87 -37.0 56.35 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.089 0.471 . . . . 0.0 110.982 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.827 HG12 HD12 ' A' ' 86' ' ' LEU . 75.4 mt -76.28 -32.24 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.723 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.482 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -68.27 -50.9 50.62 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.199 0.523 . . . . 0.0 110.239 177.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.5 pt-20 -58.57 -43.33 89.35 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.065 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.653 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 20.0 t80 -56.93 -37.45 71.5 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.713 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -58.91 -48.71 80.49 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.056 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.899 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.2 tp -64.58 -47.84 77.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.23 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.548 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -67.88 -17.07 64.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.569 ' HB3' HD12 ' A' ' 88' ' ' LEU . 6.5 tp-100 -86.65 -38.17 17.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.33 0.11 . . . . 0.0 111.24 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.606 ' HB2' HD11 ' A' ' 88' ' ' LEU . 1.4 t60 -104.13 127.09 51.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.781 0.325 . . . . 0.0 110.708 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -171.57 44.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.093 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -37.36 70.82 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.911 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.52 7.66 35.31 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 61.29 96.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.58 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -141.06 160.03 40.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.161 178.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 124.39 69.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.991 HD11 ' HB2' ' A' ' 60' ' ' LEU . 6.5 tp -87.89 116.21 25.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.182 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.27 -30.75 71.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.83 166.27 22.41 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 119.505 -1.331 . . . . 0.0 114.246 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.812 HG22 HD23 ' A' ' 60' ' ' LEU . 35.0 t -72.38 123.57 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.881 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.535 ' HB2' ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -92.4 -65.74 0.98 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.805 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.78 165.31 30.54 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.105 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.508 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -165.75 -174.06 34.89 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.665 -1.255 . . . . 0.0 114.306 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 57' ' ' ASN . 49.4 mt-30 -140.13 167.92 21.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.744 -0.728 . . . . 0.0 110.957 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.509 HG22 ' HD3' ' A' ' 47' ' ' LYS . 77.0 mt -144.62 140.1 23.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.66 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 28.1 mt -106.44 114.61 46.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.509 ' HD3' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -135.73 163.34 30.41 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.201 -177.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.37 -71.8 0.02 OUTLIER Glycine 0 C--N 1.332 0.338 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.585 ' O ' HG23 ' A' ' 49' ' ' ILE . 9.7 tt -120.48 109.23 36.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.1 115.22 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 N-CA-C 115.983 1.494 . . . . 0.0 115.983 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -122.24 11.42 10.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.338 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.777 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 76.51 31.97 0.57 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 124.43 1.092 . . . . 0.0 111.876 -178.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.82 26.32 8.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.069 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.06 149.88 43.97 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.434 ' CE1' HD13 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -101.59 124.16 46.79 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.629 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.672 ' HB2' HG23 ' A' ' 77' ' ' VAL . 13.9 m-85 -104.61 125.19 50.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.175 0.512 . . . . 0.0 112.058 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 44' ' ' GLN . 38.3 t-20 -124.32 111.47 15.85 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.654 HD21 HG13 ' A' ' 19' ' ' VAL . 4.2 mp -138.58 167.64 21.5 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.4 mm -129.05 128.29 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.756 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.991 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -133.04 169.35 16.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.779 0.324 . . . . 0.0 111.498 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 1.1 m -98.84 136.17 39.24 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.611 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.93 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -148.46 144.31 27.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.144 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -145.54 165.9 27.27 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.917 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -96.98 -9.09 28.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.796 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 68' ' ' GLU . 3.8 p -153.2 144.02 15.91 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.891 0.376 . . . . 0.0 111.582 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.87 -30.05 58.18 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.123 2.548 . . . . 0.0 112.851 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -87.8 12.72 12.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 65' ' ' SER . 15.3 mt-10 -125.89 167.67 14.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.247 0.546 . . . . 0.0 111.741 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 8.4 m-85 -66.89 158.91 29.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.904 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -115.27 130.18 56.83 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.816 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 22.6 mmmt -107.95 169.33 8.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.767 0.318 . . . . 0.0 111.213 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -91.51 152.34 20.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.173 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.681 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 32.9 m-85 -144.16 139.67 28.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.499 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -109.95 127.09 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 110.139 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.713 HG11 ' HB1' ' A' ' 26' ' ' ALA . 42.3 t -126.96 151.04 33.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.539 0.685 . . . . 0.0 112.028 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.1 t -111.01 112.4 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.59 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.672 HG23 ' HB2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -118.89 142.53 33.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.037 0.446 . . . . 0.0 111.62 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 79' ' ' GLU . 12.6 tp -118.95 128.35 54.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.614 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.528 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.8 tt0 -87.81 120.82 29.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.346 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HE3' ' CD2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -113.01 131.22 55.86 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.136 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.14 -35.16 13.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.266 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.6 m -61.04 -42.38 98.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.553 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.34 -9.93 59.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.936 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 61.25 42.15 12.4 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.168 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 t -172.51 178.84 2.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.352 0.596 . . . . 0.0 111.321 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.827 HD12 HG12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -86.41 167.89 14.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.102 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -146.25 141.24 27.16 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.966 0.412 . . . . 0.0 111.041 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.606 HD11 ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -99.91 122.53 42.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.555 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.83 -52.73 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.929 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -157.66 155.69 30.46 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.492 ' HA ' HG22 ' A' ' 75' ' ' VAL . 2.3 t80 -123.94 125.1 44.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.971 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.569 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 3.2 t -132.64 143.75 50.05 Favored Pre-proline 0 N--CA 1.469 0.493 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.569 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 68.4 Cg_endo -84.7 139.0 7.41 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.865 2.376 . . . . 0.0 112.679 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.414 ' HA ' HD22 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -113.58 48.88 1.02 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.913 0.387 . . . . 0.0 110.92 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 30.3 p90 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.656 -0.688 . . . . 0.0 111.755 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.09 0 N-CA-C 112.364 -0.295 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.65 146.78 74.47 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.803 2.335 . . . . 0.0 112.728 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.486 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 179.1 -105.91 0.2 Allowed Glycine 0 C--N 1.332 0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.273 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.486 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 4.0 Cg_exo -79.82 163.94 23.22 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.035 2.49 . . . . 0.0 112.454 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.99 29.88 4.35 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.232 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.4 mt -127.22 -55.18 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.444 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.04 -178.25 30.93 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.616 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -90.34 137.37 32.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.599 0.238 . . . . 0.0 110.874 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.1 142.67 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.449 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.5 pt -141.13 165.89 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.838 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.02 -166.66 22.2 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.145 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.798 HD12 HD11 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -100.33 163.55 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.941 0.4 . . . . 0.0 111.261 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 m -92.16 150.38 20.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.353 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.23 -22.85 31.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -53.1 -34.82 58.33 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.459 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.424 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 10.1 t70 -57.79 115.13 10.03 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.434 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 20' ' ' LYS . 20.6 Cg_endo -61.18 -29.32 86.66 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.297 2.664 . . . . 0.0 114.009 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 1.8 mpt_? -77.76 -43.29 31.26 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.185 0.517 . . . . 0.0 110.488 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.722 HG11 HG13 ' A' ' 12' ' ' ILE . 55.1 t -61.58 -43.46 97.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.831 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -70.7 -36.28 73.19 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 12.3 pt-20 -76.78 -37.9 55.01 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.27 0.557 . . . . 0.0 110.848 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.703 HG12 HD12 ' A' ' 86' ' ' LEU . 58.3 mt -74.15 -33.74 36.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.523 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -69.82 -47.74 61.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.753 0.311 . . . . 0.0 110.852 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 9.8 pt-20 -57.51 -44.79 85.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.046 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.714 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 32.2 t80 -57.93 -37.38 73.98 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.826 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -54.64 -47.52 73.41 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.739 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.074 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.1 tp -67.26 -45.72 75.82 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.51 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.529 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -69.43 -17.92 63.69 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.561 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 6.0 tp60 -83.4 -37.94 22.61 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.469 0.176 . . . . 0.0 111.161 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.485 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 2.6 t60 -97.7 128.6 44.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.273 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -174.63 36.48 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.27 -38.38 30.99 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.97 0.414 . . . . 0.0 110.191 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 8.9 mt-30 -84.51 -19.85 32.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.146 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 27.7 t-20 74.79 91.65 0.08 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.295 0.638 . . . . 0.0 112.537 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.525 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -141.17 167.07 23.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.068 178.454 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.451 ' HB ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -124.83 124.76 68.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.688 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.074 ' HB3' HD22 ' A' ' 27' ' ' LEU . 9.9 tp -90.6 113.24 25.22 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.443 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.87 -27.54 68.3 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.666 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.37 177.29 35.27 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.011 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.672 HG22 HD23 ' A' ' 60' ' ' LEU . 3.1 t -84.81 138.59 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.006 0.522 . . . . 0.0 110.987 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.68 -66.5 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.433 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.26 169.66 17.27 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.81 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.58 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -159.33 174.22 36.21 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 119.761 -1.209 . . . . 0.0 114.916 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.581 ' O ' HD13 ' A' ' 45' ' ' ILE . 2.1 mm100 -153.75 139.23 17.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.139 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 56' ' ' TYR . 5.9 mm -124.36 133.7 68.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 111.373 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.6 mt -114.45 115.91 50.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.77 160.45 39.22 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.905 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.33 -75.77 0.07 OUTLIER Glycine 0 C--N 1.332 0.357 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.565 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.6 tt -113.39 108.99 51.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -87.34 117.57 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 116.628 1.741 . . . . 0.0 116.628 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.6 22.35 10.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.541 -1.663 . . . . 0.0 107.622 175.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.779 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 76.69 31.49 0.56 Allowed 'General case' 0 C--N 1.345 0.391 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.92 -178.856 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -122.03 26.97 8.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.637 177.42 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.669 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -53.14 147.5 9.69 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.527 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.91 118.15 32.68 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.919 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.864 ' CD2' HD12 ' A' ' 45' ' ' ILE . 44.6 m-85 -106.05 134.07 49.76 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.311 0.577 . . . . 0.0 112.397 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -130.92 126.53 36.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.51 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.589 HD21 HG13 ' A' ' 19' ' ' VAL . 1.6 mp -149.65 154.55 38.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.619 HD13 ' HB2' ' A' ' 74' ' ' ASN . 1.3 mm -112.46 127.9 69.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.97 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.986 HD22 HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -130.46 169.23 15.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.954 0.407 . . . . 0.0 111.872 -178.411 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.9 m -100.45 133.76 44.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.328 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.996 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -147.34 138.11 23.53 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 123.547 0.529 . . . . 0.0 112.101 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -135.22 164.34 27.92 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.586 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -88.78 -18.21 28.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.31 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 p -150.55 146.44 19.71 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 111.266 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.19 -26.01 49.93 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.224 2.616 . . . . 0.0 113.292 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -86.73 2.99 46.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -129.19 167.13 18.06 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.519 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.7 m-85 -54.72 159.24 2.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.569 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 11.9 m -117.61 143.44 46.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.067 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.485 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 2.8 mmmt -116.01 166.01 12.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.852 0.358 . . . . 0.0 111.094 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -91.86 146.99 23.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.32 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.691 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 22.0 m-85 -141.23 139.91 33.85 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.984 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.619 ' HB2' HD13 ' A' ' 59' ' ' ILE . 6.2 t-20 -110.24 125.76 53.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.845 0.355 . . . . 0.0 110.51 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.918 HG12 ' HA ' ' A' ' 91' ' ' PHE . 6.0 m -128.71 153.69 38.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.424 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.22 110.37 31.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.881 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 26' ' ' ALA . 1.7 t -115.51 128.17 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.039 0.447 . . . . 0.0 111.504 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 79' ' ' GLU . 12.1 tp -102.16 131.53 48.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.046 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -90.94 129.79 36.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.207 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -125.7 134.18 51.9 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.083 0.468 . . . . 0.0 111.896 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.31 -30.63 15.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.966 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.2 m -59.58 -34.88 73.28 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.542 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.46 4.85 33.65 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 46.89 57.32 5.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 111.466 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.4 p -176.0 176.12 1.83 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.313 0.578 . . . . 0.0 111.307 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.714 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -92.72 170.95 9.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.723 178.841 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.55 119.92 8.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.782 0.325 . . . . 0.0 111.235 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.561 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -83.15 106.01 14.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.39 -51.4 25.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.395 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.67 147.69 27.68 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.9 0.381 . . . . 0.0 111.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.918 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.2 t80 -124.73 121.7 35.39 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.903 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.487 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 11.2 t -131.85 141.85 43.05 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.404 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.487 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 84.2 Cg_endo -83.74 138.33 8.18 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.742 2.295 . . . . 0.0 111.61 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -109.65 40.87 1.79 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.648 0.261 . . . . 0.0 111.568 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.8 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.411 179.778 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 CA-C-O 120.13 -0.261 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.24 132.9 31.0 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.834 2.356 . . . . 0.0 112.34 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.93 121.8 1.01 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.726 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -84.77 -176.52 2.5 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.959 2.439 . . . . 0.0 112.622 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.53 -60.31 0.99 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.771 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.6 mt -121.72 2.06 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.821 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.33 149.07 16.57 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.627 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -136.09 124.62 23.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.772 0.32 . . . . 0.0 111.035 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.13 143.29 39.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.223 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.61 153.73 31.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.467 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.47 -173.48 14.97 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.319 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.918 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -96.95 156.8 3.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 117.201 0.501 . . . . 0.0 111.428 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.0 m -88.5 154.62 20.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.211 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.9 -20.66 27.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.146 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -54.92 -35.62 64.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.523 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 12.8 t70 -59.0 114.98 10.3 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.501 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.3 Cg_endo -59.27 -27.52 85.23 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.365 2.71 . . . . 0.0 114.216 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.563 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 7.9 mmp_? -78.42 -47.73 16.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.323 0.582 . . . . 0.0 110.157 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.918 HG21 HG13 ' A' ' 12' ' ' ILE . 55.3 t -58.31 -40.45 77.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.392 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.401 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -73.57 -36.07 65.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.3 pt-20 -76.21 -36.22 58.71 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.223 0.535 . . . . 0.0 110.71 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.698 HG12 HD12 ' A' ' 86' ' ' LEU . 22.5 mt -74.59 -36.94 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.056 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -66.28 -52.73 44.49 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.118 0.485 . . . . 0.0 110.334 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.0 pt-20 -55.16 -43.95 74.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.024 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 30.8 t80 -58.32 -35.32 71.7 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.934 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -60.37 -47.33 86.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.839 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.4 tp -65.56 -44.04 88.0 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.116 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -72.33 -18.48 61.76 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.594 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.3 tp60 -83.58 -37.7 22.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.454 0.169 . . . . 0.0 111.039 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.501 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -105.03 126.54 52.17 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.535 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -172.67 43.47 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.86 0.362 . . . . 0.0 111.659 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -37.52 83.09 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.817 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.67 4.82 26.22 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 65.64 97.13 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.415 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -134.6 153.94 51.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.7 178.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.14 124.47 73.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.946 HD11 ' HB2' ' A' ' 60' ' ' LEU . 9.1 tp -90.0 117.32 28.71 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.409 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.45 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . . . -65.79 -31.18 72.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.314 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 160.38 171.91 26.93 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.8 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.705 HG22 HD23 ' A' ' 60' ' ' LEU . 2.5 t -75.1 128.56 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 122.798 0.439 . . . . 0.0 110.976 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -100.76 -62.78 1.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.589 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.51 167.41 27.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.538 ' HA3' ' CD2' ' A' ' 58' ' ' LEU . . . -156.51 169.4 33.89 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.988 -1.101 . . . . 0.0 114.279 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 57' ' ' ASN . 9.0 mt-30 -141.91 137.74 31.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.017 -0.591 . . . . 0.0 110.225 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.634 HG13 HD12 ' A' ' 12' ' ' ILE . 40.0 mt -122.66 124.64 71.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 111.472 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.3 mt -107.55 115.07 47.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.565 ' HG3' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -138.16 162.98 32.84 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.95 -178.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.2 -68.94 0.02 OUTLIER Glycine 0 C--N 1.331 0.253 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.567 ' O ' HG23 ' A' ' 49' ' ' ILE . 3.7 tt -120.53 109.11 36.75 Favored Pre-proline 0 C--O 1.233 0.201 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -88.93 116.8 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 N-CA-C 116.394 1.652 . . . . 0.0 116.394 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.3 23.76 10.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.611 175.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.803 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 75.14 33.02 0.74 Allowed 'General case' 0 C--N 1.344 0.334 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.109 -178.181 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 7.9 p-10 -122.9 27.3 7.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.904 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.505 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -56.62 144.59 31.48 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.01 121.51 40.01 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.316 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 12.9 m-85 -107.32 139.85 41.15 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.256 0.551 . . . . 0.0 112.239 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 44' ' ' GLN . 48.3 t30 -137.12 111.05 8.23 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.705 HD21 HG13 ' A' ' 19' ' ' VAL . 4.9 mp -134.76 166.23 23.44 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.4 mm -127.73 126.94 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.448 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.946 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -130.66 169.38 15.72 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 111.739 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.9 m -95.64 140.21 30.79 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.356 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.913 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -154.8 147.11 23.89 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -149.87 166.89 28.17 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.101 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -102.15 -5.26 24.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.06 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.35 148.2 23.62 Favored Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.42 -34.25 54.84 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.082 2.522 . . . . 0.0 112.51 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -90.59 14.28 13.65 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -113.12 167.15 10.77 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.241 0.544 . . . . 0.0 112.002 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.594 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.8 m-85 -64.56 179.13 0.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.08 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.55 119.83 25.57 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 0.3 OUTLIER -107.44 165.79 11.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.03 0.443 . . . . 0.0 111.829 -178.149 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -90.87 146.68 23.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.848 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.839 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 16.2 m-85 -141.46 137.55 32.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.327 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.506 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 48.7 t-20 -110.38 130.19 55.6 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.799 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 91' ' ' PHE . 30.5 m -129.07 146.28 34.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 112.256 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 12.1 t -105.58 110.5 31.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.73 139.26 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.946 0.403 . . . . 0.0 111.491 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 79' ' ' GLU . 9.5 tp -114.94 127.15 55.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.973 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.51 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -90.61 126.58 36.0 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.783 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.88 135.14 51.58 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 52' ' ' TRP . . . -90.22 -31.2 17.12 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.824 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.75 -39.46 71.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.003 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.19 -7.83 34.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.251 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.17 50.5 11.71 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-O 121.061 0.458 . . . . 0.0 111.008 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.27 -175.53 1.43 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.908 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.698 HD12 HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -97.27 165.87 11.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.284 179.668 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.86 122.91 10.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.949 0.404 . . . . 0.0 111.038 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -82.73 112.6 19.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.056 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 2.7 t -75.35 -49.27 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.712 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -161.79 155.53 21.56 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.587 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.3 t80 -123.21 124.07 42.21 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.392 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.566 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 4.9 t -132.25 142.61 45.65 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 83.8 Cg_endo -78.3 138.52 15.92 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.668 2.246 . . . . 0.0 111.885 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -115.64 39.49 2.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.698 0.285 . . . . 0.0 111.458 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.8 p90 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.237 179.626 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 CA-C-O 120.147 -0.252 . . . . 0.0 112.693 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.32 148.85 34.6 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.928 2.419 . . . . 0.0 112.575 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.21 -159.71 9.42 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.818 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.14 -175.0 2.32 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.341 2.694 . . . . 0.0 112.272 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.82 -66.02 0.96 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.779 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -147.08 57.39 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.531 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.69 -47.05 0.5 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.359 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -117.82 140.23 49.98 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.953 0.406 . . . . 0.0 112.018 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.8 t -124.38 136.21 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.409 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.7 pt -138.76 165.9 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.03 -176.48 22.06 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.679 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.097 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -112.87 156.98 13.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 117.803 0.801 . . . . 0.0 112.632 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -76.55 152.16 36.08 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.097 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.56 -27.63 43.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.655 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -47.1 -38.42 11.34 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.336 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 12.6 t70 -57.13 114.03 7.31 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.352 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.48 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 12.1 Cg_endo -55.75 -31.58 80.91 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.613 2.876 . . . . 0.0 114.328 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.535 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -74.95 -44.74 46.77 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.251 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.097 HG21 HG13 ' A' ' 12' ' ' ILE . 54.3 t -60.94 -42.6 93.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.653 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -72.72 -37.06 67.9 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.922 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 11.4 pt-20 -78.57 -39.37 37.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.803 0.335 . . . . 0.0 111.398 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.423 HD12 ' CE2' ' A' ' 56' ' ' TYR . 43.0 mt -73.22 -32.13 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.769 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.616 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -69.5 -48.18 61.43 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -50.59 -49.7 55.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.764 178.305 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.626 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 41.7 t80 -58.32 -37.92 76.06 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.279 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 23' ' ' ALA . . . -55.64 -39.28 70.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.028 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.894 HD22 ' HB3' ' A' ' 37' ' ' LEU . 2.0 tp -74.45 -47.86 30.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.608 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.626 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -67.14 -18.3 65.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.53 ' CD ' ' HB3' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -77.79 -31.01 51.59 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.568 0.223 . . . . 0.0 111.002 179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -75.03 -118.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.101 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 65.76 34.0 7.79 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.36 -38.49 41.83 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.864 0.364 . . . . 0.0 110.213 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 0.6 OUTLIER -117.7 10.14 13.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.116 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 14.5 t-20 69.47 95.98 0.07 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.028 0.531 . . . . 0.0 111.986 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.416 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -138.46 146.85 42.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.563 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.29 124.72 72.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.978 HD11 ' HB2' ' A' ' 60' ' ' LEU . 8.5 tp -90.04 115.86 27.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.153 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.77 -28.29 68.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.408 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.8 173.92 32.08 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 119.56 -1.305 . . . . 0.0 114.12 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.629 HG22 HD23 ' A' ' 60' ' ' LEU . 2.3 t -79.32 137.79 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.228 -0.486 . . . . 0.0 110.532 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.54 -63.93 1.33 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.485 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.02 163.8 33.11 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.484 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.757 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -161.32 175.37 37.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.546 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' ASN . 50.7 mm-40 -149.43 155.53 40.57 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.384 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.651 ' CD1' HG21 ' A' ' 12' ' ' ILE . 4.2 mp -137.2 122.83 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.302 . . . . 0.0 110.956 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.08 118.4 55.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.607 ' HB3' ' ND2' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -137.32 163.08 31.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.897 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.56 -69.26 0.04 OUTLIER Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 49' ' ' ILE . 7.4 tp -120.28 111.89 34.87 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -87.53 114.81 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 N-CA-C 116.357 1.637 . . . . 0.0 116.357 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -121.85 22.98 10.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.209 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.752 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.75 33.89 1.25 Allowed 'General case' 0 C--N 1.344 0.345 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.283 -177.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 15.5 m-20 -121.32 26.81 8.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.423 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.607 ' ND2' ' HB3' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -58.56 143.98 44.26 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.322 -178.117 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.434 ' HE1' HD22 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -96.2 125.74 40.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.316 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 22' ' ' ILE . 15.8 m-85 -109.46 129.84 55.53 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.908 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 44' ' ' GLN . 12.6 t-20 -126.5 114.19 17.8 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.763 HD21 HG13 ' A' ' 19' ' ' VAL . 4.1 mp -142.07 161.1 38.85 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.734 HD13 ' HA ' ' A' ' 74' ' ' ASN . 3.5 mm -119.9 131.49 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.404 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.978 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.21 165.89 24.36 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.955 0.407 . . . . 0.0 112.083 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.3 m -96.38 136.34 37.0 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.95 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.936 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -148.06 142.59 26.47 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -144.05 166.07 26.02 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.708 179.235 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -104.84 -3.15 23.84 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.121 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.41 145.96 20.16 Favored Pre-proline 0 N--CA 1.465 0.317 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.13 -29.65 47.59 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.284 2.656 . . . . 0.0 112.598 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -98.82 14.55 28.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.843 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -120.9 167.15 12.86 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.13 0.49 . . . . 0.0 111.604 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 6.7 m-85 -69.45 160.57 31.15 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.0 m -116.6 135.76 53.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.127 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 95' ' ' PHE . 3.5 mmmm -112.04 165.35 12.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.753 0.311 . . . . 0.0 110.709 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -89.13 153.15 21.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.742 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.85 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 14.7 m-85 -139.39 142.17 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.778 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.734 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.9 t-20 -111.83 118.76 36.44 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.909 HG12 ' HA ' ' A' ' 91' ' ' PHE . 29.7 m -130.71 151.0 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.96 118.61 57.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.731 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.419 HG21 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -117.3 144.48 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.111 0.482 . . . . 0.0 111.819 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 79' ' ' GLU . 5.9 tp -120.33 125.65 48.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.943 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.9 tt0 -90.05 120.1 30.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.539 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.85 133.91 51.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.58 -37.22 15.84 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.196 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -37.83 87.27 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.464 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -15.78 58.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.761 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 72.46 31.33 1.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.56 -165.15 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.286 0.565 . . . . 0.0 111.88 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.733 HD22 ' H ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -94.3 169.12 10.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.022 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.501 ' NZ ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -148.72 138.03 21.78 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.93 0.395 . . . . 0.0 111.952 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 89' ' ' VAL . 0.2 OUTLIER -97.44 109.31 22.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.862 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.542 ' N ' HD22 ' A' ' 88' ' ' LEU . 1.9 t -74.54 -54.35 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.449 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.14 145.73 31.5 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.909 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.2 t80 -125.22 117.61 24.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.877 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.622 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.6 t -132.7 144.44 52.95 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.969 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.622 ' HD2' HG12 ' A' ' 92' ' ' VAL . 89.3 Cg_endo -87.43 138.5 4.65 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.974 2.449 . . . . 0.0 112.322 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.479 ' CD2' ' HB2' ' A' ' 74' ' ' ASN . 0.4 OUTLIER -98.85 32.52 2.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.321 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.423 ' HB3' ' HE2' ' A' ' 71' ' ' LYS . 10.4 p90 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.593 -0.718 . . . . 0.0 111.129 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 CA-C-O 120.219 -0.212 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.21 164.5 35.17 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.801 2.334 . . . . 0.0 112.641 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.85 90.53 0.19 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.754 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.65 -174.06 2.12 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.161 2.574 . . . . 0.0 112.198 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.95 -68.24 0.94 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -143.85 56.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.996 0.427 . . . . 0.0 111.19 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -146.62 132.8 4.57 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.633 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -142.19 124.38 15.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.837 0.351 . . . . 0.0 111.251 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.15 144.07 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.958 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.4 pt -111.03 158.14 11.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.964 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.52 -163.88 14.56 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.219 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.901 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -101.49 167.39 2.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 117.493 0.647 . . . . 0.0 111.237 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -101.51 157.73 16.59 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.075 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.81 -22.43 30.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -53.98 -35.88 62.3 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.479 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.455 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 16.3 t70 -59.64 113.5 7.27 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.633 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 19.1 Cg_endo -58.16 -27.83 81.66 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.304 2.669 . . . . 0.0 114.06 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.517 ' O ' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -77.07 -48.67 17.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.159 0.504 . . . . 0.0 110.27 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.901 HG21 HG13 ' A' ' 12' ' ' ILE . 52.0 t -57.67 -41.56 79.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.93 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -40.66 78.51 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.9 pt-20 -72.93 -40.02 65.79 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.676 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 18' ' ' ARG . 18.2 mt -65.77 -40.03 86.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.564 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.048 0.452 . . . . 0.0 110.248 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.48 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -51.94 -52.78 47.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.74 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 25.3 t80 -56.86 -35.38 68.83 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.725 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.29 -48.34 80.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.372 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.833 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.7 tp -68.63 -46.9 67.99 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.586 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -68.89 -18.2 64.09 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.314 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.44 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 5.8 tp60 -84.87 -37.3 20.8 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -71.56 -103.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.415 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 56.4 36.16 27.08 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -37.74 88.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.804 0.335 . . . . 0.0 110.934 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.436 ' H ' ' HG3' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -123.7 13.23 9.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.482 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 68.15 86.89 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.877 0.471 . . . . 0.0 111.771 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.505 HD21 ' CZ ' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -125.91 158.19 35.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.835 178.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.542 ' HB ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -118.39 125.13 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -177.46 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.977 HD12 ' HB2' ' A' ' 62' ' ' ALA . 9.9 tp -90.4 113.5 25.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.966 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.06 68.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.735 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 161.38 166.77 20.77 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 119.712 -1.232 . . . . 0.0 114.09 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.806 HG22 HD23 ' A' ' 60' ' ' LEU . 10.1 t -77.23 137.07 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.588 0.355 . . . . 0.0 110.646 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.1 -67.9 0.91 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.154 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.09 173.53 13.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.558 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.52 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -170.14 -163.69 24.61 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 119.807 -1.187 . . . . 0.0 114.255 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 57' ' ' ASN . 41.0 mt-30 -153.94 137.71 16.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.075 -0.562 . . . . 0.0 111.136 -178.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.695 HG22 ' ND2' ' A' ' 54' ' ' ASN . 7.5 mt -114.97 126.16 72.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -109.64 117.62 54.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.01 162.19 33.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.935 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -135.29 -71.99 0.07 OUTLIER Glycine 0 C--N 1.334 0.431 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 49' ' ' ILE . 12.6 tt -120.11 112.27 34.85 Favored Pre-proline 0 C--O 1.233 0.225 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.98 114.54 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 N-CA-C 115.891 1.458 . . . . 0.0 115.891 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.97 20.37 10.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.227 -1.806 . . . . 0.0 107.3 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.765 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 71.87 32.93 1.79 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.215 -178.054 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 5.0 p-10 -122.16 26.98 8.23 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.542 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.695 ' ND2' HG22 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -57.34 148.03 24.15 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.44 ' CE1' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -98.95 132.79 44.01 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.981 179.049 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.815 ' HB2' HG23 ' A' ' 77' ' ' VAL . 32.3 m-85 -119.22 135.46 54.67 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.23 0.538 . . . . 0.0 112.022 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' GLN . 49.0 t30 -130.73 111.85 12.54 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.845 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.624 HD21 HD11 ' A' ' 12' ' ' ILE . 3.9 mp -141.7 163.81 31.91 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.3 mm -122.72 138.18 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.345 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.962 HD22 HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -141.61 168.93 18.6 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.779 0.323 . . . . 0.0 111.84 -179.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.8 m -92.1 138.5 31.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.224 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.977 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -156.38 146.61 21.4 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -149.67 164.49 35.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.675 178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -102.17 -2.76 28.62 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.93 144.54 19.18 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-O 121.031 0.443 . . . . 0.0 112.132 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.23 -33.01 50.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.121 2.547 . . . . 0.0 112.108 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -90.45 14.63 12.48 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.671 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -117.87 167.09 11.73 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.2 0.524 . . . . 0.0 111.725 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.562 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 6.7 m-85 -64.77 -176.4 0.25 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.402 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.421 ' C ' ' HD3' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -130.61 122.62 27.8 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.231 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -111.06 169.71 8.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.936 0.398 . . . . 0.0 111.643 -178.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.436 ' C ' ' HB2' ' A' ' 94' ' ' LEU . 10.6 m-85 -92.75 149.57 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.578 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.791 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 24.8 m-85 -144.0 137.87 28.0 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.767 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.51 ' HB2' HD11 ' A' ' 94' ' ' LEU . 51.4 t30 -109.4 126.48 53.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 110.412 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.769 HG12 ' HA ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -127.73 146.17 33.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.483 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.24 117.61 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.738 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -119.1 135.24 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.066 0.46 . . . . 0.0 112.146 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 79' ' ' GLU . 5.4 tp -117.35 124.45 48.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.333 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.45 124.36 34.41 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.831 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.55 149.72 49.24 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.2 -27.39 13.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.968 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -54.53 -43.39 71.88 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.61 0.243 . . . . 0.0 110.932 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.14 -6.93 43.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.061 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 61.03 50.33 5.12 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 120.769 0.318 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -174.47 -163.19 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.112 0.482 . . . . 0.0 111.266 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.72 HD22 ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -104.11 170.31 7.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.076 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.564 ' HE3' HD23 ' A' ' 78' ' ' LEU . 2.2 tmmm? -148.27 117.98 7.08 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.817 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -79.04 106.74 11.29 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.563 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.61 -54.38 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.713 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.47 151.32 40.18 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.09 0.471 . . . . 0.0 112.232 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.769 ' HA ' HG12 ' A' ' 75' ' ' VAL . 3.2 t80 -127.04 120.33 28.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.692 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.41 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 12.2 t -132.32 138.99 33.47 Favored Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.471 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 94.6 Cg_endo -82.88 135.61 7.77 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.847 2.365 . . . . 0.0 111.838 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 74' ' ' ASN . 1.4 mt -109.68 44.78 1.15 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.765 0.317 . . . . 0.0 111.297 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.471 ' CE1' ' HB2' ' A' ' 93' ' ' PRO . 43.8 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.092 -0.956 . . . . 0.0 111.132 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 CA-C-O 120.165 -0.241 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.94 165.34 30.32 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.95 2.434 . . . . 0.0 112.733 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 124.12 -102.53 0.72 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.661 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.617 ' HG3' ' HB3' ' A' ' 8' ' ' GLU . 85.7 Cg_endo -84.74 174.26 7.71 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.007 2.471 . . . . 0.0 112.627 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.73 -28.73 6.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.655 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.9 mm -111.42 -55.48 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 116.726 -0.216 . . . . 0.0 111.012 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.62 169.13 35.61 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.172 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.617 ' HB3' ' HG3' ' A' ' 4' ' ' PRO . 2.7 pt-20 -146.96 167.89 22.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.834 0.35 . . . . 0.0 111.127 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.41 110.75 29.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -144.21 147.84 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.242 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 43' ' ' GLY . . . 108.91 -171.47 15.49 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.466 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.857 HG13 HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -96.64 161.0 2.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 121.05 0.452 . . . . 0.0 111.596 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.75 153.83 20.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.981 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.39 -21.66 29.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 109.974 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.55 -36.34 61.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.646 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.442 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 10.7 t70 -59.72 114.82 10.51 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.489 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.2 Cg_endo -59.4 -30.08 91.77 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.542 2.828 . . . . 0.0 114.193 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 4.6 mpt_? -76.5 -43.67 38.51 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.257 0.551 . . . . 0.0 110.535 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.857 HG21 HG13 ' A' ' 12' ' ' ILE . 47.2 t -62.19 -42.32 94.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.329 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -71.3 -36.03 71.51 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HG3' HG13 ' A' ' 22' ' ' ILE . 12.2 pt-20 -76.29 -38.25 56.4 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.228 0.537 . . . . 0.0 110.679 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.804 HG12 HD12 ' A' ' 86' ' ' LEU . 85.6 mt -75.46 -32.64 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.325 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.526 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -69.77 -51.1 36.92 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.382 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 11.3 pt-20 -56.16 -43.39 78.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.703 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.659 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 23.7 t80 -57.31 -38.27 73.76 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.731 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -57.05 -46.18 82.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.107 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.924 HD22 ' HB3' ' A' ' 37' ' ' LEU . 3.1 tp -69.18 -45.03 70.98 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.635 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -71.12 -17.78 62.55 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.68 ' HB3' HD12 ' A' ' 88' ' ' LEU . 3.9 tp-100 -84.41 -38.59 20.05 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.401 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -97.66 124.98 42.18 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -162.71 40.81 0.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.756 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -37.87 34.53 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 16.0 mt-30 -95.34 -16.7 22.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.955 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 16.6 t30 72.62 91.58 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.045 0.45 . . . . 0.0 111.903 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.445 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -140.75 162.64 34.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.11 178.712 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.77 124.74 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.975 HD11 ' HB2' ' A' ' 60' ' ' LEU . 12.0 tp -83.58 118.91 24.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.206 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.415 ' H ' ' HA ' ' A' ' 62' ' ' ALA . . . -65.31 -30.69 71.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.831 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.9 166.29 15.09 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 119.983 -1.103 . . . . 0.0 113.843 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.765 HG22 HD23 ' A' ' 60' ' ' LEU . 18.2 t -68.5 130.14 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.516 -0.342 . . . . 0.0 110.325 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.95 -56.91 2.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.505 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.81 154.59 39.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.411 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.59 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -152.73 173.3 31.75 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.325 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' ASN . 18.1 mt-30 -146.97 159.54 43.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.98 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 19' ' ' VAL . 14.7 mt -144.0 131.14 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.714 0.293 . . . . 0.0 111.473 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.5 mt -107.63 115.56 49.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.323 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 162.66 32.52 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.65 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.43 -87.46 0.08 OUTLIER Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 49' ' ' ILE . 1.5 mt -104.3 108.52 60.57 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.96 115.91 3.35 Favored 'Trans proline' 0 C--N 1.347 0.453 0 N-CA-C 116.491 1.689 . . . . 0.0 116.491 -175.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 19.91 11.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.325 175.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.763 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.08 38.28 0.91 Allowed 'General case' 0 C--N 1.345 0.408 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.631 -178.294 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.36 26.33 8.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.603 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -49.1 136.55 14.66 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.394 0.678 . . . . 0.0 112.609 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.635 ' CE1' HD13 ' A' ' 78' ' ' LEU . 3.8 m-85 -99.86 126.34 45.96 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.73 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.659 ' HB2' HG23 ' A' ' 77' ' ' VAL . 6.0 m-85 -109.38 144.83 37.05 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 44' ' ' GLN . 46.5 t30 -144.14 112.26 6.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.808 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.708 HD21 HG13 ' A' ' 19' ' ' VAL . 5.0 mp -138.16 168.78 19.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 2.7 mm -126.85 120.61 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.565 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.975 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -127.03 164.1 22.27 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.94 0.4 . . . . 0.0 111.279 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.8 m -94.39 141.65 28.33 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.738 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.895 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -152.05 148.09 27.27 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.511 0.507 . . . . 0.0 112.23 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -150.54 164.57 35.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.726 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -93.96 -11.64 30.47 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.844 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 p -149.7 143.1 16.41 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 111.935 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.88 -22.81 48.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.507 2.805 . . . . 0.0 113.539 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -89.6 3.32 52.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -128.04 166.95 17.43 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 121.377 0.608 . . . . 0.0 112.526 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 5.6 m-85 -53.46 167.46 0.21 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.834 -1.076 . . . . 0.0 113.749 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -125.69 134.1 51.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.825 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 23.9 mmmt -107.76 167.98 9.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.067 0.461 . . . . 0.0 111.819 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . 95.7 m-85 -88.37 151.31 22.68 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.621 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.873 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 14.0 m-85 -142.42 138.19 30.91 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.865 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.524 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . 4.3 t30 -110.82 119.68 39.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.623 ' CG1' HD21 ' A' ' 88' ' ' LEU . 41.4 t -130.94 149.59 33.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.049 0.452 . . . . 0.0 111.671 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.6 t -109.24 129.79 63.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.273 178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -128.85 146.89 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.016 0.436 . . . . 0.0 111.97 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.635 HD13 ' CE1' ' A' ' 55' ' ' TYR . 12.0 tp -118.58 126.25 51.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.442 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -88.77 128.04 35.62 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.901 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -125.03 130.14 51.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 52' ' ' TRP . . . -89.45 -35.79 15.79 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.324 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.2 m -61.88 -35.48 78.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.55 -7.3 53.23 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.973 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 m120 55.71 47.43 20.52 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 122.646 0.379 . . . . 0.0 111.411 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.4 t -174.04 -169.0 0.44 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.268 0.556 . . . . 0.0 111.167 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.804 HD12 HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -105.14 168.15 9.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.925 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -147.05 132.67 18.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.973 0.416 . . . . 0.0 111.449 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.68 HD12 ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -85.96 121.57 28.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.822 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.566 HG23 ' HA ' ' A' ' 77' ' ' VAL . 2.4 t -85.02 -54.95 7.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.847 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.485 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -160.82 134.14 6.62 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.251 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 75' ' ' VAL . 1.4 t80 -106.49 126.82 52.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.787 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.703 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.1 t -132.47 147.41 65.54 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.45 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.703 ' HD2' HG12 ' A' ' 92' ' ' VAL . 61.5 Cg_endo -92.44 138.37 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.17 2.58 . . . . 0.0 112.826 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.451 HD23 ' CB ' ' A' ' 74' ' ' ASN . 0.4 OUTLIER -99.61 27.47 5.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.275 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.44 ' CB ' ' HE3' ' A' ' 71' ' ' LYS . 6.5 p90 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.534 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 CA-C-O 120.1 -0.278 . . . . 0.0 112.652 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.15 132.84 28.96 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.836 2.357 . . . . 0.0 112.668 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.54 130.74 1.18 Allowed Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.794 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -84.45 176.26 6.55 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.877 2.385 . . . . 0.0 112.791 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.93 -45.34 0.86 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.461 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.76 -38.58 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.287 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.52 -133.37 3.32 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.778 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -128.7 136.94 51.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.729 0.3 . . . . 0.0 111.198 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.69 143.58 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.415 HD13 ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -114.45 160.59 13.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.76 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -110.45 -157.29 15.67 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.51 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.102 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -96.45 167.3 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 117.185 0.492 . . . . 0.0 111.482 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 m -91.27 149.76 21.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.15 -19.04 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.506 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -57.43 -37.94 73.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.008 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 18.4 t70 -57.99 113.63 6.87 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.031 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HA ' ' CD ' ' A' ' 20' ' ' LYS . 13.9 Cg_endo -56.17 -27.45 65.76 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.57 2.846 . . . . 0.0 114.321 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.73 -38.99 32.13 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.903 0.383 . . . . 0.0 110.873 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.102 HG21 HG13 ' A' ' 12' ' ' ILE . 45.1 t -67.31 -41.17 86.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.906 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.473 ' CD ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -73.86 -34.16 64.38 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.519 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 10.8 pt-20 -77.52 -37.77 50.27 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.935 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.854 HG12 HD12 ' A' ' 86' ' ' LEU . 93.8 mt -75.92 -31.15 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.734 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -69.09 -51.82 34.76 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.041 0.448 . . . . 0.0 110.271 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 8.3 pt-20 -55.71 -47.34 77.01 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.203 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.64 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 27.0 t80 -55.57 -37.96 68.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.818 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.535 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.15 -51.16 68.98 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.234 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.915 HD22 ' HB3' ' A' ' 37' ' ' LEU . 2.7 tp -62.21 -44.98 95.36 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -72.59 -17.41 61.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.615 ' HB3' HD12 ' A' ' 88' ' ' LEU . 3.5 tp-100 -82.12 -38.55 24.6 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.617 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 2.9 t60 -108.23 129.18 55.21 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.814 0.34 . . . . 0.0 110.353 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -170.28 41.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.543 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.13 86.55 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.85 9.18 42.66 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.524 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 42.2 t30 52.78 88.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.592 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -127.99 157.63 40.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.515 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.59 124.15 72.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.915 ' HB3' HD22 ' A' ' 27' ' ' LEU . 1.5 tt -90.99 113.99 26.39 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.866 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.17 -28.01 69.11 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.825 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.93 168.73 25.3 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 119.313 -1.422 . . . . 0.0 114.345 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.519 ' CG2' HD23 ' A' ' 60' ' ' LEU . 1.6 t -76.14 136.42 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.106 -0.547 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.61 -65.32 1.02 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.714 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.58 171.3 20.56 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.155 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -166.39 -174.39 35.7 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.558 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 57' ' ' ASN . 25.7 mt-30 -151.24 143.17 23.89 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.128 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.703 HD12 HD12 ' A' ' 12' ' ' ILE . 2.9 mp -122.17 125.52 73.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.234 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.0 mt -107.41 118.89 56.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.77 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.684 ' HB3' HD22 ' A' ' 54' ' ' ASN . 0.0 OUTLIER -136.47 163.16 31.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.975 -178.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -148.19 -66.72 0.01 OUTLIER Glycine 0 C--N 1.33 0.224 0 N-CA-C 108.534 -1.827 . . . . 0.0 108.534 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -120.46 108.27 37.88 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 175.511 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -90.53 117.51 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 116.212 1.582 . . . . 0.0 116.212 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 23.36 10.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.463 175.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.757 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.97 31.85 1.44 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.314 -178.122 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 20.9 m-20 -121.91 27.18 8.23 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.556 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.684 HD22 ' HB3' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -56.02 153.61 8.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.116 -178.32 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.15 122.44 45.34 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.437 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.584 ' CB ' HG23 ' A' ' 77' ' ' VAL . 17.7 m-85 -102.13 133.35 47.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.037 0.446 . . . . 0.0 111.953 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 44' ' ' GLN . 39.8 t30 -132.91 111.68 11.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.067 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.642 HD21 HD11 ' A' ' 12' ' ' ILE . 4.0 mp -140.34 166.27 25.14 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.8 mm -124.12 129.44 74.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.439 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.897 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -131.63 168.84 17.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.722 0.296 . . . . 0.0 111.504 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.3 m -100.65 133.95 44.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.362 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.592 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -145.1 141.03 28.46 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.486 0.491 . . . . 0.0 112.186 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -139.74 166.55 24.31 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.751 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -93.2 -16.48 24.79 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.652 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.75 153.05 35.82 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.688 0.28 . . . . 0.0 111.659 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.21 -31.62 74.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.76 2.307 . . . . 0.0 112.111 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -96.16 14.38 24.18 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.463 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -115.37 167.32 10.97 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-O 121.105 0.478 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.514 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 9.3 m-85 -71.72 152.16 43.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.852 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 m -115.08 133.79 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.377 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 22.7 mmmt -113.99 165.08 12.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . 1.1 m-85 -87.69 148.45 24.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.532 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 46.6 m-85 -138.62 140.75 39.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.881 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.683 ' HB2' HD23 ' A' ' 94' ' ' LEU . 31.4 t-20 -108.79 116.49 32.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 0.0 109.956 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.747 HG12 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -119.33 142.67 33.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.941 -178.524 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 t -107.52 120.16 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.959 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.592 HG21 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -123.37 146.37 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 79' ' ' GLU . 9.3 tp -119.81 125.39 48.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.341 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.501 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.7 tt0 -87.73 124.2 33.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.686 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -122.7 137.82 54.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.404 0.621 . . . . 0.0 112.545 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.43 -27.16 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.688 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -59.58 -41.35 90.02 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.323 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.34 9.1 43.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.509 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.81 57.51 5.93 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.498 0.319 . . . . 0.0 111.557 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 177.96 -177.99 0.23 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.455 0.645 . . . . 0.0 111.613 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.854 HD12 HG12 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -93.31 166.83 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.905 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.96 126.93 13.62 Favored 'General case' 0 CA--C 1.526 0.052 0 CA-C-O 120.797 0.332 . . . . 0.0 111.258 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.747 HD21 HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -86.7 114.77 23.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.197 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.73 -54.11 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.319 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.33 144.28 15.62 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.86 0.362 . . . . 0.0 111.856 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.638 ' HA ' HG13 ' A' ' 75' ' ' VAL . 6.0 t80 -112.77 127.32 56.12 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.82 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.456 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 5.2 t -132.46 139.78 35.84 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.456 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.2 Cg_endo -81.99 138.59 10.37 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.903 2.402 . . . . 0.0 112.217 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -107.6 25.44 11.49 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.64 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.586 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 30.4 p90 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.586 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 CA-C-O 120.074 -0.292 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.18 135.11 11.95 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.903 2.402 . . . . 0.0 112.629 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.49 150.3 17.14 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.629 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -90.38 164.75 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.178 2.585 . . . . 0.0 112.636 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.24 -46.84 3.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.911 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pt -125.73 32.53 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.098 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.15 -124.66 3.72 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.762 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -134.2 143.97 48.17 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.861 0.363 . . . . 0.0 111.604 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.1 t -100.92 143.33 14.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.87 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.3 150.86 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.091 0.472 . . . . 0.0 112.108 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.25 -160.95 9.13 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.486 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 1.069 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -98.0 166.84 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 117.706 0.753 . . . . 0.0 112.144 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 t -89.9 154.26 20.0 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.58 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 p -64.75 -23.3 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.725 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -51.62 -36.76 47.22 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.972 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.463 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 14.1 t70 -58.79 113.24 6.32 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.702 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 19.7 Cg_endo -58.31 -28.14 83.56 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.435 2.757 . . . . 0.0 113.994 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.551 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 5.9 mmt-85 -76.85 -46.24 25.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.095 0.474 . . . . 0.0 110.124 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.069 HG21 HG13 ' A' ' 12' ' ' ILE . 69.8 t -59.51 -42.44 87.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.493 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -71.57 -37.78 71.03 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.597 ' CD ' HD11 ' A' ' 86' ' ' LEU . 8.0 pt-20 -77.18 -37.25 54.05 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.021 0.439 . . . . 0.0 111.191 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.755 HG12 HD12 ' A' ' 86' ' ' LEU . 27.2 mt -75.11 -31.52 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.016 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -70.6 -52.68 19.85 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.042 0.448 . . . . 0.0 109.962 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.4 pt-20 -55.27 -41.78 72.69 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.718 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 28.4 t80 -59.65 -38.01 80.27 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.905 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.28 -43.53 88.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.113 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 37' ' ' LEU . 3.6 tp -69.31 -48.06 62.65 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.376 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 25' ' ' PHE . 1.5 pttm -67.73 -25.4 65.63 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.611 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 5.0 tp60 -74.99 -27.91 60.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.513 ' ND1' HD21 ' A' ' 35' ' ' LEU . 10.0 t-160 -65.03 -95.53 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.94 32.1 12.05 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -93.52 -38.02 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.937 0.399 . . . . 0.0 109.957 178.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.79 -5.16 13.29 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.152 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.8 t30 67.51 91.94 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.953 0.501 . . . . 0.0 111.374 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.513 HD21 ' ND1' ' A' ' 30' ' ' HIS . 0.4 OUTLIER -133.58 160.14 38.36 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.436 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.33 124.6 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.116 HD12 ' HB2' ' A' ' 62' ' ' ALA . 6.2 tp -92.17 113.94 26.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.385 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.18 72.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.324 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.88 163.28 23.65 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.204 -1.474 . . . . 0.0 114.808 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.725 HG22 HD23 ' A' ' 60' ' ' LEU . 2.2 t -75.47 125.6 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.196 -0.502 . . . . 0.0 109.918 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.02 -62.63 1.41 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.57 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.75 171.68 16.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.025 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.596 ' HA3' ' CG ' ' A' ' 58' ' ' LEU . . . -171.1 -174.41 38.88 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.427 -1.368 . . . . 0.0 114.883 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 57' ' ' ASN . 28.3 mt-30 -146.82 168.79 20.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.451 -0.875 . . . . 0.0 111.172 -178.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.651 HD13 HG21 ' A' ' 12' ' ' ILE . 4.7 mp -142.86 132.49 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.419 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.6 mm -107.44 116.87 51.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.134 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.666 ' HB3' HD22 ' A' ' 54' ' ' ASN . 0.1 OUTLIER -136.07 162.75 32.04 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.816 -179.251 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -149.42 -70.78 0.01 OUTLIER Glycine 0 C--N 1.33 0.23 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -120.61 108.8 36.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -87.65 117.47 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 N-CA-C 116.395 1.652 . . . . 0.0 116.395 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.438 ' NE2' ' HB2' ' A' ' 53' ' ' ASP . 32.1 p-80 -121.7 23.47 10.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.605 -1.634 . . . . 0.0 107.446 175.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.744 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 73.7 33.4 1.04 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.028 -178.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.594 ' OD1' HD11 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -122.24 28.1 7.64 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.832 177.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.666 HD22 ' HB3' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -57.83 143.72 41.29 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.6 ' CE1' HD13 ' A' ' 78' ' ' LEU . 1.3 m-30 -95.06 138.62 32.54 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.591 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -119.56 135.61 54.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 112.036 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 44' ' ' GLN . 64.1 t-20 -133.52 114.24 13.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.15 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 19' ' ' VAL . 4.6 mp -144.35 168.68 19.5 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.1 mm -125.85 131.88 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.272 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.841 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -134.37 168.89 18.08 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.402 ' O ' ' HG ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -99.61 129.7 45.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.046 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 1.116 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -144.62 141.76 29.63 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.066 0.46 . . . . 0.0 112.194 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -142.06 165.4 27.54 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.507 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -94.74 -13.8 25.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.94 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -153.82 150.98 24.0 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-O 121.213 0.53 . . . . 0.0 112.109 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 65' ' ' SER . 19.3 Cg_exo -63.65 -37.7 45.28 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.554 2.836 . . . . 0.0 113.026 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -80.85 9.05 6.91 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -124.1 167.45 14.2 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.228 0.537 . . . . 0.0 111.728 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.521 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.7 m-85 -68.79 166.18 18.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.368 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 m -119.84 131.86 55.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.951 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 1.5 mmmp? -110.51 155.0 22.89 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.47 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.559 ' O ' ' HB2' ' A' ' 94' ' ' LEU . 20.8 m-85 -85.23 138.04 32.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.19 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 1.009 ' CE2' ' HB3' ' A' ' 62' ' ' ALA . 5.9 m-30 -125.71 140.37 52.76 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.949 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.482 ' HB2' HD12 ' A' ' 59' ' ' ILE . 3.6 t-20 -111.95 119.2 37.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 110.424 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 91' ' ' PHE . 34.3 m -128.78 158.91 41.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.496 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.08 127.36 73.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.724 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.674 HG21 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -124.53 145.41 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.047 0.451 . . . . 0.0 111.751 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.6 HD13 ' CE1' ' A' ' 55' ' ' TYR . 9.4 tp -114.32 127.0 55.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.784 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -91.91 127.97 37.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.558 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.01 139.99 52.97 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 52' ' ' TRP . . . -93.72 -30.34 14.94 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.791 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 m -54.23 -39.3 66.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.241 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.98 -3.86 27.04 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.457 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 54.56 53.77 10.23 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 120.996 0.427 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 t -171.49 -173.95 1.32 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.755 HD12 HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -101.45 165.97 10.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.798 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -147.91 128.69 14.3 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.026 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.611 ' CB ' ' HG2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -82.63 121.9 27.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.454 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 77' ' ' VAL . 2.5 t -83.57 -55.02 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.45 156.18 34.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.353 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.937 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.4 t80 -124.72 123.05 39.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.517 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 7.1 t -131.78 142.97 47.16 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.911 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.517 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.4 Cg_endo -86.99 138.6 5.03 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.008 2.472 . . . . 0.0 112.176 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -105.63 20.5 18.8 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 47.8 p90 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.068 -0.968 . . . . 0.0 111.469 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 CA-C-O 120.081 -0.288 . . . . 0.0 112.592 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 148.6 52.95 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.651 2.234 . . . . 0.0 112.556 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.56 -72.06 0.95 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.635 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.572 ' HD2' ' HA2' ' A' ' 7' ' ' GLY . 1.1 Cg_endo -82.99 -172.7 1.46 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.279 2.653 . . . . 0.0 112.398 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -38.49 69.2 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.027 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.7 -46.87 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.572 ' HA2' ' HD2' ' A' ' 4' ' ' PRO . . . 105.53 -138.05 14.06 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.829 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.7 162.13 32.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.681 0.276 . . . . 0.0 110.824 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.16 112.68 31.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.878 0.37 . . . . 0.0 111.384 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 pt -140.16 138.91 37.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.277 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.39 -170.97 24.48 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.283 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.728 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -96.78 147.97 5.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 117.212 0.506 . . . . 0.0 111.218 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 t -79.24 151.38 31.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.694 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -63.53 -21.83 29.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -53.01 -35.77 59.76 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.601 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 15.1 t0 -57.25 111.12 3.0 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.258 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.2 Cg_endo -59.89 -27.67 85.45 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.429 2.753 . . . . 0.0 113.801 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.485 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -77.64 -44.38 28.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.149 0.5 . . . . 0.0 110.068 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.728 HG21 HG13 ' A' ' 12' ' ' ILE . 54.0 t -61.53 -47.56 92.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.191 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -40.24 96.73 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 14.0 pt-20 -75.0 -42.95 56.46 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.901 0.381 . . . . 0.0 110.99 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 56' ' ' TYR . 50.2 mt -65.0 -34.65 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.339 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -62.68 -48.17 80.48 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -49.75 -51.28 40.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.364 178.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.667 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 32.0 t80 -56.55 -37.36 70.43 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.316 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.554 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -57.22 -48.1 79.65 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.97 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.6 tp -67.52 -43.08 81.69 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.624 ' HE2' ' CD2' ' A' ' 25' ' ' PHE . 3.7 pttm -75.03 -18.15 60.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -79.56 -39.0 32.82 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.967 0.349 . . . . 0.0 110.922 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -103.97 122.27 44.86 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.358 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -168.63 43.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.552 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -37.66 71.89 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.3 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.83 1.21 36.84 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.861 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 63.73 99.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.499 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -141.31 158.41 43.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 178.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.433 HD12 ' HE3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -116.36 125.22 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -177.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.037 HD11 ' HB2' ' A' ' 60' ' ' LEU . 3.4 tp -87.0 120.77 28.62 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.865 0.364 . . . . 0.0 110.749 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.417 ' H ' ' HA ' ' A' ' 62' ' ' ALA . . . -65.96 -34.51 78.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.895 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.85 162.57 11.32 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.186 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.62 HG22 ' CD2' ' A' ' 60' ' ' LEU . 54.2 t -67.8 136.03 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.86 0.464 . . . . 0.0 110.753 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.02 -65.76 1.14 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.619 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.13 146.66 25.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.389 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.584 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -146.95 -170.93 15.68 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 119.793 -1.194 . . . . 0.0 114.812 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' ASN . 3.1 mm100 -142.16 150.74 41.46 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.558 -0.821 . . . . 0.0 111.295 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.517 HG22 ' CD ' ' A' ' 47' ' ' LYS . 63.0 mt -128.33 129.4 69.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.79 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 55' ' ' TYR . 4.7 mt -106.87 115.27 48.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.452 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.517 ' CD ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -136.01 162.75 32.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.662 0.744 . . . . 0.0 112.829 -178.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.89 -66.92 0.01 OUTLIER Glycine 0 C--N 1.329 0.193 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -120.26 109.27 37.13 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 175.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -87.02 117.04 1.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 N-CA-C 116.226 1.587 . . . . 0.0 116.226 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.99 24.02 10.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.426 -1.716 . . . . 0.0 107.03 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.764 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 62.88 35.51 13.48 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.44 -177.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.504 ' OD2' HD11 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -122.84 28.29 7.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.389 177.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.649 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 1.1 t-20 -47.64 146.03 2.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.447 ' HB3' HD12 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -98.05 116.52 30.44 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.73 178.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.649 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 38.8 m-85 -104.87 143.0 33.74 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.206 0.527 . . . . 0.0 111.844 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 44' ' ' GLN . 15.9 t-20 -144.39 110.63 5.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.715 HD21 HG13 ' A' ' 19' ' ' VAL . 4.0 mp -136.74 167.35 21.6 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 2.7 mm -122.04 121.62 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.042 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.037 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -125.08 168.21 13.69 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.771 0.319 . . . . 0.0 111.26 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 50.2 m -98.97 146.04 26.43 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.881 ' HB3' ' CE1' ' A' ' 73' ' ' TYR . . . -155.28 147.02 23.24 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -149.16 165.36 32.05 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.338 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -103.86 -5.82 21.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.042 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 68' ' ' GLU . 2.2 p -146.39 143.41 18.96 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-O 121.136 0.493 . . . . 0.0 112.046 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.42 -27.63 54.64 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.476 2.784 . . . . 0.0 113.365 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -95.23 14.19 23.05 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.423 ' HB2' ' OG ' ' A' ' 65' ' ' SER . 7.8 mt-10 -126.78 167.23 16.05 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.46 0.648 . . . . 0.0 112.48 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.496 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 5.3 m-85 -64.69 167.65 7.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.273 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 m -124.29 135.74 53.6 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.889 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HG3' ' CD2' ' A' ' 95' ' ' PHE . 27.9 mmmt -110.37 169.98 8.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.677 0.275 . . . . 0.0 111.067 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.477 ' C ' ' HB2' ' A' ' 94' ' ' LEU . 20.4 m-85 -89.85 151.17 21.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.52 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.881 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 9.2 m-85 -141.65 141.07 33.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.34 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.436 ' CB ' HD13 ' A' ' 59' ' ' ILE . 3.2 t-20 -113.72 126.39 55.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.495 0.188 . . . . 0.0 110.89 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.961 HG12 ' HA ' ' A' ' 91' ' ' PHE . 6.4 m -132.37 140.21 48.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.161 0.505 . . . . 0.0 112.238 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.432 HG13 HD22 ' A' ' 57' ' ' ASN . 0.6 OUTLIER -102.99 110.42 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 26' ' ' ALA . 6.2 t -113.25 136.86 48.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.568 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 79' ' ' GLU . 7.3 tp -112.51 131.74 55.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.018 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.649 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -91.39 129.43 37.38 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.0 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HD3' ' HB3' ' A' ' 82' ' ' SER . 1.7 ttmp? -125.4 143.79 50.82 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.37 -29.91 11.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.572 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.449 ' HB3' ' HD3' ' A' ' 80' ' ' LYS . 6.8 t -53.81 -43.49 69.4 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.12 9.12 36.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.325 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.57 58.88 3.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.068 0.461 . . . . 0.0 111.375 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.6 p -173.8 -174.3 0.94 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.806 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.667 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -101.15 166.9 10.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.01 179.2 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.402 ' NZ ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -147.39 121.65 9.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.016 0.436 . . . . 0.0 111.717 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -81.01 110.17 16.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.902 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.98 -50.04 21.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.596 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.8 146.82 26.62 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.961 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.9 t80 -125.88 119.24 27.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.421 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.553 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 5.8 t -132.34 142.78 46.2 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.553 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.6 Cg_endo -80.34 139.04 12.83 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.925 2.417 . . . . 0.0 111.701 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.477 ' HB2' ' C ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -112.66 47.47 1.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.242 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CD2' ' HG3' ' A' ' 71' ' ' LYS . 3.2 p90 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.855 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.363 0 CA-C-O 119.818 -0.434 . . . . 0.0 112.093 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.074 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -101.31 159.39 4.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 117.71 0.755 . . . . 0.0 111.68 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -79.31 153.32 29.93 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.054 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.06 -23.38 30.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.686 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -53.21 -32.55 48.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.341 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 12.4 t70 -57.43 112.83 5.18 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.658 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.417 ' HA ' ' CG ' ' A' ' 20' ' ' LYS . 18.6 Cg_endo -59.58 -26.57 82.51 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.453 2.769 . . . . 0.0 113.934 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.498 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -78.62 -44.15 24.63 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.275 0.56 . . . . 0.0 110.384 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.074 HG21 HG13 ' A' ' 12' ' ' ILE . 72.9 t -65.18 -39.65 86.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.65 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.417 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -69.41 -37.88 77.66 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 13.0 pt-20 -75.28 -37.24 61.01 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.214 0.531 . . . . 0.0 110.562 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.738 HG12 HD12 ' A' ' 86' ' ' LEU . 77.1 mt -74.62 -35.04 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.059 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -66.63 -54.89 18.48 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.242 0.544 . . . . 0.0 110.217 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 11.3 pt-20 -53.66 -44.28 69.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.078 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.657 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 26.9 t80 -60.11 -35.39 75.12 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.435 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 23' ' ' ALA . . . -58.61 -47.11 85.46 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.903 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 37' ' ' LEU . 2.4 tp -66.92 -43.79 82.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.702 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.585 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -70.93 -18.14 62.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.763 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -87.08 -38.95 16.03 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.131 0.423 . . . . 0.0 111.205 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -102.42 125.42 49.13 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.573 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -167.5 45.43 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.195 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.544 ' HG2' ' HG2' ' A' ' 33' ' ' GLN . 0.2 OUTLIER -64.36 -37.54 87.86 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.079 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.544 ' HG2' ' HG2' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -107.34 13.3 27.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.882 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 50.93 83.07 0.05 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -118.68 165.11 14.38 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.403 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.86 124.25 68.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.036 HD12 ' HB2' ' A' ' 62' ' ' ALA . 7.1 tp -90.26 115.75 27.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.546 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.94 -28.96 69.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.456 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 163.26 174.29 32.96 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.577 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.664 HG22 HD23 ' A' ' 60' ' ' LEU . 2.0 t -81.37 132.74 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.568 0.347 . . . . 0.0 110.694 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.1 -63.33 1.27 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.334 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.43 163.73 29.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.788 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -152.33 163.32 30.21 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.954 -1.117 . . . . 0.0 114.436 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.41 ' H ' ' HG ' ' A' ' 58' ' ' LEU . 68.1 mt-30 -150.27 148.69 29.17 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.127 0.571 . . . . 0.0 110.054 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.59 ' CD1' HG21 ' A' ' 12' ' ' ILE . 4.6 mp -133.46 129.19 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.281 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.6 mt -107.54 114.92 47.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.195 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.83 155.49 48.94 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.7 -70.4 0.08 OUTLIER Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -120.83 108.99 36.28 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.83 119.18 1.85 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.733 1.622 . . . . 0.0 115.908 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -120.88 23.21 10.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.258 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.753 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 74.44 29.47 1.2 Allowed 'General case' 0 C--N 1.344 0.335 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.711 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -122.31 27.32 7.99 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.591 177.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.402 ' HB3' ' HE1' ' A' ' 56' ' ' TYR . 2.3 t-20 -50.66 149.04 3.49 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.48 ' CE1' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -98.31 132.72 43.56 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.945 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.675 ' CB ' HG23 ' A' ' 77' ' ' VAL . 21.1 m-85 -117.63 144.18 45.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 112.081 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -143.94 116.98 8.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.666 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.788 HD23 ' HA3' ' A' ' 43' ' ' GLY . 4.5 mp -143.18 164.06 31.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.1 mm -119.44 131.4 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.865 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.001 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.47 169.1 18.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.931 0.396 . . . . 0.0 111.619 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.0 m -98.81 135.09 40.76 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.988 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 1.036 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -153.59 143.23 21.8 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -140.58 164.61 29.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.457 178.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -98.92 -7.17 27.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.238 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.02 148.32 18.4 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.776 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.14 -27.96 48.84 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.951 2.434 . . . . 0.0 112.342 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -89.31 14.29 11.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.741 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -128.43 167.22 17.33 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 121.453 0.644 . . . . 0.0 112.484 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.513 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 8.3 m-85 -69.5 160.95 30.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.324 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -109.6 130.99 55.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.411 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.526 ' HE2' ' HB2' ' A' ' 95' ' ' PHE . 25.5 mmmt -112.94 170.08 8.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.02 0.438 . . . . 0.0 111.74 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.73 145.66 25.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.733 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 36.1 m-85 -140.94 136.88 32.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.1 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.79 ' HB2' HD23 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -109.11 115.49 30.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.993 HG12 ' HA ' ' A' ' 91' ' ' PHE . 2.2 m -121.99 144.38 31.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.726 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 23.7 t -104.34 127.25 58.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.875 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.675 HG23 ' CB ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -126.25 146.78 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 79' ' ' GLU . 11.8 tp -120.42 129.54 53.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.436 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -93.94 134.94 35.8 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.47 131.6 51.63 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.95 0.405 . . . . 0.0 111.91 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' A' ' 52' ' ' TRP . . . -89.23 -36.44 15.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.378 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 m -57.57 -41.74 81.68 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -11.23 50.75 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.05 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.53 45.51 10.56 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.1 p -165.99 -169.06 1.39 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 111.263 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.738 HD12 HG12 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -105.86 170.81 7.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.475 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.68 142.7 27.01 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.916 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.763 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 1.5 tm? -101.11 115.79 31.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.381 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 3.6 t -74.52 -52.29 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.45 156.45 16.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.95 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.993 ' HA ' HG12 ' A' ' 75' ' ' VAL . 4.6 t80 -120.74 124.77 45.95 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.618 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.41 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 2.9 t -132.63 137.69 30.38 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.01 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 96.6 Cg_endo -80.13 138.31 12.71 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.733 2.289 . . . . 0.0 112.332 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -108.85 39.99 1.9 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.638 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.526 ' HB2' ' HE2' ' A' ' 71' ' ' LYS . 16.6 p90 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.641 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . . . . . . 0 CA--C 1.518 0.224 0 N-CA-C 113.305 0.082 . . . . 0.0 113.305 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.908 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -97.2 167.14 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 111.267 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 m -91.92 150.34 21.08 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.092 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.97 -20.42 27.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.227 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -55.42 -35.91 65.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.547 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.435 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 13.6 t70 -57.49 115.96 12.44 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.904 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.0 Cg_endo -59.54 -28.09 86.59 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.502 2.801 . . . . 0.0 114.133 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.488 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -79.54 -43.47 22.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.034 0.445 . . . . 0.0 110.564 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.908 HG21 HG13 ' A' ' 12' ' ' ILE . 48.4 t -62.01 -41.46 91.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.834 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -72.44 -36.12 68.48 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 12.1 pt-20 -76.87 -37.0 56.35 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.089 0.471 . . . . 0.0 110.982 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.827 HG12 HD12 ' A' ' 86' ' ' LEU . 75.4 mt -76.28 -32.24 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.723 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.482 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -68.27 -50.9 50.62 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.199 0.523 . . . . 0.0 110.239 177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.5 pt-20 -58.57 -43.33 89.35 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.065 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.653 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 20.0 t80 -56.93 -37.45 71.5 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.713 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -58.91 -48.71 80.49 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.056 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.899 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.2 tp -64.58 -47.84 77.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.23 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.548 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -67.88 -17.07 64.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.569 ' HB3' HD12 ' A' ' 88' ' ' LEU . 19.5 tp60 -86.65 -38.17 17.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.33 0.11 . . . . 0.0 111.24 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.606 ' HB2' HD11 ' A' ' 88' ' ' LEU . 1.4 t60 -104.13 127.09 51.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.781 0.325 . . . . 0.0 110.708 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -171.57 44.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.093 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -37.36 70.82 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.911 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.52 7.66 35.31 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 61.29 96.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.58 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -141.06 160.03 40.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.161 178.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 124.39 69.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.991 HD11 ' HB2' ' A' ' 60' ' ' LEU . 6.5 tp -87.89 116.21 25.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.182 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.27 -30.75 71.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.83 166.27 22.41 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 119.505 -1.331 . . . . 0.0 114.246 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.812 HG22 HD23 ' A' ' 60' ' ' LEU . 35.0 t -72.38 123.57 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.881 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.535 ' HB2' ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -92.4 -65.74 0.98 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.805 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.78 165.31 30.54 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.105 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.508 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -165.75 -174.06 34.89 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.665 -1.255 . . . . 0.0 114.306 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 57' ' ' ASN . 49.4 mt-30 -140.13 167.92 21.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.744 -0.728 . . . . 0.0 110.957 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.509 HG22 ' HD3' ' A' ' 47' ' ' LYS . 77.0 mt -144.62 140.1 23.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.66 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 28.1 mt -106.44 114.61 46.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.509 ' HD3' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -135.73 163.34 30.41 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.201 -177.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.37 -71.8 0.02 OUTLIER Glycine 0 C--N 1.332 0.338 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.585 ' O ' HG23 ' A' ' 49' ' ' ILE . 9.7 tt -120.48 109.23 36.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.1 115.22 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 N-CA-C 115.983 1.494 . . . . 0.0 115.983 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -122.24 11.42 10.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.338 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.777 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 76.51 31.97 0.57 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 124.43 1.092 . . . . 0.0 111.876 -178.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.82 26.32 8.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.069 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.06 149.88 43.97 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.434 ' CE1' HD13 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -101.59 124.16 46.79 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.629 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.672 ' HB2' HG23 ' A' ' 77' ' ' VAL . 13.9 m-85 -104.61 125.19 50.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.175 0.512 . . . . 0.0 112.058 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 44' ' ' GLN . 38.3 t-20 -124.32 111.47 15.85 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.654 HD21 HG13 ' A' ' 19' ' ' VAL . 4.2 mp -138.58 167.64 21.5 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.4 mm -129.05 128.29 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.756 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.991 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -133.04 169.35 16.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.779 0.324 . . . . 0.0 111.498 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 1.1 m -98.84 136.17 39.24 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.611 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.93 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -148.46 144.31 27.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.144 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -145.54 165.9 27.27 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.917 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -96.98 -9.09 28.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.796 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 68' ' ' GLU . 3.8 p -153.2 144.02 15.91 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.891 0.376 . . . . 0.0 111.582 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.87 -30.05 58.18 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.123 2.548 . . . . 0.0 112.851 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -87.8 12.72 12.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 65' ' ' SER . 15.3 mt-10 -125.89 167.67 14.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.247 0.546 . . . . 0.0 111.741 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 8.4 m-85 -66.89 158.91 29.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.904 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -115.27 130.18 56.83 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.816 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 22.6 mmmt -107.95 169.33 8.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.767 0.318 . . . . 0.0 111.213 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -91.51 152.34 20.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.173 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.681 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 32.9 m-85 -144.16 139.67 28.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.499 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -109.95 127.09 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 110.139 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.713 HG11 ' HB1' ' A' ' 26' ' ' ALA . 42.3 t -126.96 151.04 33.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.539 0.685 . . . . 0.0 112.028 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.1 t -111.01 112.4 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.59 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.672 HG23 ' HB2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -118.89 142.53 33.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.037 0.446 . . . . 0.0 111.62 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 79' ' ' GLU . 12.6 tp -118.95 128.35 54.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.614 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.528 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.8 tt0 -87.81 120.82 29.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.346 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HE3' ' CD2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -113.01 131.22 55.86 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.136 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.14 -35.16 13.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.266 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.6 m -61.04 -42.38 98.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.553 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.34 -9.93 59.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.936 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 61.25 42.15 12.4 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.168 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 t -172.51 178.84 2.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.352 0.596 . . . . 0.0 111.321 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.827 HD12 HG12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -86.41 167.89 14.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.102 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -146.25 141.24 27.16 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.966 0.412 . . . . 0.0 111.041 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.606 HD11 ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -99.91 122.53 42.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.555 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.83 -52.73 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.929 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -157.66 155.69 30.46 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.492 ' HA ' HG22 ' A' ' 75' ' ' VAL . 2.3 t80 -123.94 125.1 44.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.971 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.569 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 3.2 t -132.64 143.75 50.05 Favored Pre-proline 0 N--CA 1.469 0.493 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.569 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 68.4 Cg_endo -84.7 139.0 7.41 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.865 2.376 . . . . 0.0 112.679 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.414 ' HA ' HD22 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -113.58 48.88 1.02 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.913 0.387 . . . . 0.0 110.92 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 30.3 p90 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.656 -0.688 . . . . 0.0 111.755 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.243 0 CA-C-O 120.385 -0.119 . . . . 0.0 113.145 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.798 HD12 HD11 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -100.33 163.55 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.941 0.4 . . . . 0.0 111.261 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 m -92.16 150.38 20.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.353 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.23 -22.85 31.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -53.1 -34.82 58.33 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.459 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.424 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 10.1 t70 -57.79 115.13 10.03 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.434 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 20' ' ' LYS . 20.6 Cg_endo -61.18 -29.32 86.66 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.297 2.664 . . . . 0.0 114.009 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 1.8 mpt_? -77.76 -43.29 31.26 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.185 0.517 . . . . 0.0 110.488 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.722 HG11 HG13 ' A' ' 12' ' ' ILE . 55.1 t -61.58 -43.46 97.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.831 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -70.7 -36.28 73.19 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 12.3 pt-20 -76.78 -37.9 55.01 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.27 0.557 . . . . 0.0 110.848 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.703 HG12 HD12 ' A' ' 86' ' ' LEU . 58.3 mt -74.15 -33.74 36.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.523 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -69.82 -47.74 61.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.753 0.311 . . . . 0.0 110.852 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 9.8 pt-20 -57.51 -44.79 85.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.046 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.714 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 32.2 t80 -57.93 -37.38 73.98 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.826 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -54.64 -47.52 73.41 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.739 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.074 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.1 tp -67.26 -45.72 75.82 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.51 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.529 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -69.43 -17.92 63.69 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.561 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 6.0 tp60 -83.4 -37.94 22.61 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.469 0.176 . . . . 0.0 111.161 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.485 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 2.6 t60 -97.7 128.6 44.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.273 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -174.63 36.48 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.27 -38.38 30.99 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.97 0.414 . . . . 0.0 110.191 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 8.9 mt-30 -84.51 -19.85 32.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.146 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 27.7 t-20 74.79 91.65 0.08 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.295 0.638 . . . . 0.0 112.537 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.525 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -141.17 167.07 23.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.068 178.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.451 ' HB ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -124.83 124.76 68.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.074 ' HB3' HD22 ' A' ' 27' ' ' LEU . 9.9 tp -90.6 113.24 25.22 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.443 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.87 -27.54 68.3 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.666 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.37 177.29 35.27 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.011 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.672 HG22 HD23 ' A' ' 60' ' ' LEU . 3.1 t -84.81 138.59 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.006 0.522 . . . . 0.0 110.987 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.68 -66.5 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.433 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.26 169.66 17.27 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.81 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.58 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -159.33 174.22 36.21 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 119.761 -1.209 . . . . 0.0 114.916 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.581 ' O ' HD13 ' A' ' 45' ' ' ILE . 2.1 mm100 -153.75 139.23 17.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.139 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 56' ' ' TYR . 5.9 mm -124.36 133.7 68.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 111.373 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.6 mt -114.45 115.91 50.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.77 160.45 39.22 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.905 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.33 -75.77 0.07 OUTLIER Glycine 0 C--N 1.332 0.357 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.565 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.6 tt -113.39 108.99 51.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -87.34 117.57 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 116.628 1.741 . . . . 0.0 116.628 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.6 22.35 10.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.541 -1.663 . . . . 0.0 107.622 175.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.779 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 76.69 31.49 0.56 Allowed 'General case' 0 C--N 1.345 0.391 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.92 -178.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -122.03 26.97 8.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.637 177.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.669 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -53.14 147.5 9.69 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.527 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.91 118.15 32.68 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.919 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.864 ' CD2' HD12 ' A' ' 45' ' ' ILE . 44.6 m-85 -106.05 134.07 49.76 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.311 0.577 . . . . 0.0 112.397 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -130.92 126.53 36.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.51 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.589 HD21 HG13 ' A' ' 19' ' ' VAL . 1.6 mp -149.65 154.55 38.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.619 HD13 ' HB2' ' A' ' 74' ' ' ASN . 1.3 mm -112.46 127.9 69.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.97 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.986 HD22 HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -130.46 169.23 15.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.954 0.407 . . . . 0.0 111.872 -178.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.9 m -100.45 133.76 44.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.328 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.996 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -147.34 138.11 23.53 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 123.547 0.529 . . . . 0.0 112.101 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -135.22 164.34 27.92 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.586 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -88.78 -18.21 28.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.31 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 p -150.55 146.44 19.71 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 111.266 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.19 -26.01 49.93 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.224 2.616 . . . . 0.0 113.292 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -86.73 2.99 46.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -129.19 167.13 18.06 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.519 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.7 m-85 -54.72 159.24 2.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.569 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 11.9 m -117.61 143.44 46.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.067 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.485 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 2.8 mmmt -116.01 166.01 12.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.852 0.358 . . . . 0.0 111.094 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -91.86 146.99 23.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.32 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.691 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 22.0 m-85 -141.23 139.91 33.85 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.984 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.619 ' HB2' HD13 ' A' ' 59' ' ' ILE . 6.2 t-20 -110.24 125.76 53.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.845 0.355 . . . . 0.0 110.51 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.918 HG12 ' HA ' ' A' ' 91' ' ' PHE . 6.0 m -128.71 153.69 38.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.424 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.22 110.37 31.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.881 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 26' ' ' ALA . 1.7 t -115.51 128.17 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.039 0.447 . . . . 0.0 111.504 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 79' ' ' GLU . 12.1 tp -102.16 131.53 48.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.046 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -90.94 129.79 36.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.207 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -125.7 134.18 51.9 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.083 0.468 . . . . 0.0 111.896 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.31 -30.63 15.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.966 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.2 m -59.58 -34.88 73.28 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.542 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.46 4.85 33.65 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 46.89 57.32 5.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 111.466 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.4 p -176.0 176.12 1.83 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.313 0.578 . . . . 0.0 111.307 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.714 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -92.72 170.95 9.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.723 178.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.55 119.92 8.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.782 0.325 . . . . 0.0 111.235 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.561 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -83.15 106.01 14.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.39 -51.4 25.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.395 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.67 147.69 27.68 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.9 0.381 . . . . 0.0 111.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.918 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.2 t80 -124.73 121.7 35.39 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.903 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.487 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 11.2 t -131.85 141.85 43.05 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.404 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.487 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 84.2 Cg_endo -83.74 138.33 8.18 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.742 2.295 . . . . 0.0 111.61 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -109.65 40.87 1.79 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.648 0.261 . . . . 0.0 111.568 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.8 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.411 179.778 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.21 0 N-CA-C 112.319 -0.312 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.918 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -96.95 156.8 3.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 117.201 0.501 . . . . 0.0 111.428 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.0 m -88.5 154.62 20.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.211 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.9 -20.66 27.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.146 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -54.92 -35.62 64.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.523 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 12.8 t70 -59.0 114.98 10.3 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.501 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.3 Cg_endo -59.27 -27.52 85.23 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.365 2.71 . . . . 0.0 114.216 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.563 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 7.9 mmp_? -78.42 -47.73 16.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.323 0.582 . . . . 0.0 110.157 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.918 HG21 HG13 ' A' ' 12' ' ' ILE . 55.3 t -58.31 -40.45 77.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.392 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.401 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -73.57 -36.07 65.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.3 pt-20 -76.21 -36.22 58.71 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.223 0.535 . . . . 0.0 110.71 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.698 HG12 HD12 ' A' ' 86' ' ' LEU . 22.5 mt -74.59 -36.94 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.056 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -66.28 -52.73 44.49 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.118 0.485 . . . . 0.0 110.334 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.0 pt-20 -55.16 -43.95 74.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.024 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 30.8 t80 -58.32 -35.32 71.7 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.934 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -60.37 -47.33 86.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.839 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.4 tp -65.56 -44.04 88.0 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.116 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -72.33 -18.48 61.76 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.594 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.3 tp60 -83.58 -37.7 22.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.454 0.169 . . . . 0.0 111.039 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.501 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -105.03 126.54 52.17 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.535 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -172.67 43.47 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.86 0.362 . . . . 0.0 111.659 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -37.52 83.09 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.817 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.67 4.82 26.22 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 65.64 97.13 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.415 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -134.6 153.94 51.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.7 178.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.14 124.47 73.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.946 HD11 ' HB2' ' A' ' 60' ' ' LEU . 9.1 tp -90.0 117.32 28.71 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.409 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.45 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . . . -65.79 -31.18 72.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.314 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 160.38 171.91 26.93 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.8 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.705 HG22 HD23 ' A' ' 60' ' ' LEU . 2.5 t -75.1 128.56 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 122.798 0.439 . . . . 0.0 110.976 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -100.76 -62.78 1.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.589 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.51 167.41 27.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.538 ' HA3' ' CD2' ' A' ' 58' ' ' LEU . . . -156.51 169.4 33.89 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.988 -1.101 . . . . 0.0 114.279 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 57' ' ' ASN . 9.0 mt-30 -141.91 137.74 31.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.017 -0.591 . . . . 0.0 110.225 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.634 HG13 HD12 ' A' ' 12' ' ' ILE . 40.0 mt -122.66 124.64 71.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 111.472 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.3 mt -107.55 115.07 47.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.565 ' HG3' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -138.16 162.98 32.84 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.95 -178.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.2 -68.94 0.02 OUTLIER Glycine 0 C--N 1.331 0.253 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.567 ' O ' HG23 ' A' ' 49' ' ' ILE . 3.7 tt -120.53 109.11 36.75 Favored Pre-proline 0 C--O 1.233 0.201 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -88.93 116.8 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 N-CA-C 116.394 1.652 . . . . 0.0 116.394 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.3 23.76 10.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.611 175.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.803 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 75.14 33.02 0.74 Allowed 'General case' 0 C--N 1.344 0.334 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.109 -178.181 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 7.9 p-10 -122.9 27.3 7.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.904 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.505 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -56.62 144.59 31.48 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.01 121.51 40.01 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.316 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 12.9 m-85 -107.32 139.85 41.15 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.256 0.551 . . . . 0.0 112.239 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 44' ' ' GLN . 48.3 t30 -137.12 111.05 8.23 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.705 HD21 HG13 ' A' ' 19' ' ' VAL . 4.9 mp -134.76 166.23 23.44 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.4 mm -127.73 126.94 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.448 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.946 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -130.66 169.38 15.72 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 111.739 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.9 m -95.64 140.21 30.79 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.356 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.913 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -154.8 147.11 23.89 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -149.87 166.89 28.17 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.101 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -102.15 -5.26 24.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.06 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.35 148.2 23.62 Favored Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.42 -34.25 54.84 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.082 2.522 . . . . 0.0 112.51 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -90.59 14.28 13.65 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -113.12 167.15 10.77 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.241 0.544 . . . . 0.0 112.002 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.594 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.8 m-85 -64.56 179.13 0.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.08 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.55 119.83 25.57 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 0.3 OUTLIER -107.44 165.79 11.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.03 0.443 . . . . 0.0 111.829 -178.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -90.87 146.68 23.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.848 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.839 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 16.2 m-85 -141.46 137.55 32.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.327 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.506 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 48.7 t-20 -110.38 130.19 55.6 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.799 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 91' ' ' PHE . 30.5 m -129.07 146.28 34.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 112.256 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 12.1 t -105.58 110.5 31.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.73 139.26 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.946 0.403 . . . . 0.0 111.491 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 79' ' ' GLU . 9.5 tp -114.94 127.15 55.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.973 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.51 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -90.61 126.58 36.0 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.783 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.88 135.14 51.58 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 52' ' ' TRP . . . -90.22 -31.2 17.12 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.824 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.75 -39.46 71.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.003 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.19 -7.83 34.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.251 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.17 50.5 11.71 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-O 121.061 0.458 . . . . 0.0 111.008 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.27 -175.53 1.43 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.908 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.698 HD12 HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -97.27 165.87 11.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.284 179.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.86 122.91 10.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.949 0.404 . . . . 0.0 111.038 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -82.73 112.6 19.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.056 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 2.7 t -75.35 -49.27 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.712 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -161.79 155.53 21.56 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.587 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.3 t80 -123.21 124.07 42.21 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.392 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.566 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 4.9 t -132.25 142.61 45.65 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 83.8 Cg_endo -78.3 138.52 15.92 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.668 2.246 . . . . 0.0 111.885 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -115.64 39.49 2.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.698 0.285 . . . . 0.0 111.458 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.8 p90 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.237 179.626 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.292 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.097 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -112.87 156.98 13.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 117.803 0.801 . . . . 0.0 112.632 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -76.55 152.16 36.08 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.097 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.56 -27.63 43.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.655 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -47.1 -38.42 11.34 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.336 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.48 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 12.6 t70 -57.13 114.03 7.31 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.352 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.48 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 12.1 Cg_endo -55.75 -31.58 80.91 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.613 2.876 . . . . 0.0 114.328 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.535 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -74.95 -44.74 46.77 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.251 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.097 HG21 HG13 ' A' ' 12' ' ' ILE . 54.3 t -60.94 -42.6 93.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.653 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -72.72 -37.06 67.9 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.922 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 11.4 pt-20 -78.57 -39.37 37.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.803 0.335 . . . . 0.0 111.398 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.423 HD12 ' CE2' ' A' ' 56' ' ' TYR . 43.0 mt -73.22 -32.13 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.769 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.616 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -69.5 -48.18 61.43 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -50.59 -49.7 55.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.764 178.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.626 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 41.7 t80 -58.32 -37.92 76.06 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.279 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 23' ' ' ALA . . . -55.64 -39.28 70.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.028 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.894 HD22 ' HB3' ' A' ' 37' ' ' LEU . 2.0 tp -74.45 -47.86 30.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.608 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.626 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -67.14 -18.3 65.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.53 ' CD ' ' HB3' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -77.79 -31.01 51.59 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.568 0.223 . . . . 0.0 111.002 179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -75.03 -118.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.101 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 65.76 34.0 7.79 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.36 -38.49 41.83 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.864 0.364 . . . . 0.0 110.213 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 0.6 OUTLIER -117.7 10.14 13.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.116 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 14.5 t-20 69.47 95.98 0.07 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.028 0.531 . . . . 0.0 111.986 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.49 ' HA ' ' CD2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -138.46 146.85 42.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.563 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.29 124.72 72.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.978 HD11 ' HB2' ' A' ' 60' ' ' LEU . 8.5 tp -90.04 115.86 27.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.153 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.77 -28.29 68.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.408 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.8 173.92 32.08 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 119.56 -1.305 . . . . 0.0 114.12 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.629 HG22 HD23 ' A' ' 60' ' ' LEU . 2.3 t -79.32 137.79 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.228 -0.486 . . . . 0.0 110.532 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.54 -63.93 1.33 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.485 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.02 163.8 33.11 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.484 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.757 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -161.32 175.37 37.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.546 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' ASN . 50.7 mm-40 -149.43 155.53 40.57 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.384 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.651 ' CD1' HG21 ' A' ' 12' ' ' ILE . 4.2 mp -137.2 122.83 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.302 . . . . 0.0 110.956 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.08 118.4 55.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.457 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -137.32 163.08 31.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.897 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.56 -69.26 0.04 OUTLIER Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 49' ' ' ILE . 7.4 tp -120.28 111.89 34.87 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -87.53 114.81 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 N-CA-C 116.357 1.637 . . . . 0.0 116.357 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -121.85 22.98 10.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.209 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.752 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.75 33.89 1.25 Allowed 'General case' 0 C--N 1.344 0.345 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.283 -177.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 15.5 m-20 -121.32 26.81 8.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.423 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.457 ' OD1' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -58.56 143.98 44.26 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.322 -178.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.434 ' HE1' HD22 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -96.2 125.74 40.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.316 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 22' ' ' ILE . 15.8 m-85 -109.46 129.84 55.53 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.908 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 44' ' ' GLN . 12.6 t-20 -126.5 114.19 17.8 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.763 HD21 HG13 ' A' ' 19' ' ' VAL . 4.1 mp -142.07 161.1 38.85 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.734 HD13 ' HA ' ' A' ' 74' ' ' ASN . 3.5 mm -119.9 131.49 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.404 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.978 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.21 165.89 24.36 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.955 0.407 . . . . 0.0 112.083 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.3 m -96.38 136.34 37.0 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.95 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.936 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -148.06 142.59 26.47 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -144.05 166.07 26.02 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.708 179.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.49 ' CD2' ' HA ' ' A' ' 35' ' ' LEU . 47.6 m80 -104.84 -3.15 23.84 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.121 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.41 145.96 20.16 Favored Pre-proline 0 N--CA 1.465 0.317 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.13 -29.65 47.59 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.284 2.656 . . . . 0.0 112.598 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -98.82 14.55 28.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.843 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -120.9 167.15 12.86 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.13 0.49 . . . . 0.0 111.604 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 6.7 m-85 -69.45 160.57 31.15 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.0 m -116.6 135.76 53.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.127 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 95' ' ' PHE . 3.5 mmmm -112.04 165.35 12.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.753 0.311 . . . . 0.0 110.709 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -89.13 153.15 21.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.742 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.85 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 14.7 m-85 -139.39 142.17 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.778 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.734 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.9 t-20 -111.83 118.76 36.44 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.909 HG12 ' HA ' ' A' ' 91' ' ' PHE . 29.7 m -130.71 151.0 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.96 118.61 57.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.731 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.419 HG21 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -117.3 144.48 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.111 0.482 . . . . 0.0 111.819 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 79' ' ' GLU . 5.9 tp -120.33 125.65 48.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.943 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.9 tt0 -90.05 120.1 30.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.539 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.85 133.91 51.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.58 -37.22 15.84 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.196 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -37.83 87.27 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.464 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -15.78 58.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.761 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 72.46 31.33 1.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.56 -165.15 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.286 0.565 . . . . 0.0 111.88 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.733 HD22 ' H ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -94.3 169.12 10.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.022 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.501 ' NZ ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -148.72 138.03 21.78 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.93 0.395 . . . . 0.0 111.952 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 89' ' ' VAL . 0.2 OUTLIER -97.44 109.31 22.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.862 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.542 ' N ' HD22 ' A' ' 88' ' ' LEU . 1.9 t -74.54 -54.35 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.449 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.14 145.73 31.5 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.909 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.2 t80 -125.22 117.61 24.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.877 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.622 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.6 t -132.7 144.44 52.95 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.969 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.622 ' HD2' HG12 ' A' ' 92' ' ' VAL . 89.3 Cg_endo -87.43 138.5 4.65 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.974 2.449 . . . . 0.0 112.322 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.479 ' CD2' ' HB2' ' A' ' 74' ' ' ASN . 0.4 OUTLIER -98.85 32.52 2.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.321 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.423 ' HB3' ' HE2' ' A' ' 71' ' ' LYS . 10.4 p90 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.593 -0.718 . . . . 0.0 111.129 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.304 0 N-CA-C 112.219 -0.352 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.901 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -101.49 167.39 2.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 117.493 0.647 . . . . 0.0 111.237 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -101.51 157.73 16.59 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.075 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.81 -22.43 30.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -53.98 -35.88 62.3 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.479 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.455 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 16.3 t70 -59.64 113.5 7.27 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.633 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 19.1 Cg_endo -58.16 -27.83 81.66 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.304 2.669 . . . . 0.0 114.06 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.517 ' O ' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -77.07 -48.67 17.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.159 0.504 . . . . 0.0 110.27 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.901 HG21 HG13 ' A' ' 12' ' ' ILE . 52.0 t -57.67 -41.56 79.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.93 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -40.66 78.51 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.9 pt-20 -72.93 -40.02 65.79 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.676 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 18' ' ' ARG . 18.2 mt -65.77 -40.03 86.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.564 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.048 0.452 . . . . 0.0 110.248 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -51.94 -52.78 47.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.74 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 25.3 t80 -56.86 -35.38 68.83 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.725 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.29 -48.34 80.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.372 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.833 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.7 tp -68.63 -46.9 67.99 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.586 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.555 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -68.89 -18.2 64.09 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.44 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 5.8 tp60 -84.87 -37.3 20.8 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -71.56 -103.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.415 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 56.4 36.16 27.08 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -37.74 88.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.804 0.335 . . . . 0.0 110.934 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.436 ' H ' ' HG3' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -123.7 13.23 9.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.482 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 68.15 86.89 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.877 0.471 . . . . 0.0 111.771 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.505 HD21 ' CZ ' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -125.91 158.19 35.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.835 178.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.542 ' HB ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -118.39 125.13 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -177.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.977 HD12 ' HB2' ' A' ' 62' ' ' ALA . 9.9 tp -90.4 113.5 25.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.966 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.06 68.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.735 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 161.38 166.77 20.77 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 119.712 -1.232 . . . . 0.0 114.09 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.806 HG22 HD23 ' A' ' 60' ' ' LEU . 10.1 t -77.23 137.07 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.588 0.355 . . . . 0.0 110.646 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.1 -67.9 0.91 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.154 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.09 173.53 13.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.558 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.52 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -170.14 -163.69 24.61 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 119.807 -1.187 . . . . 0.0 114.255 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 57' ' ' ASN . 41.0 mt-30 -153.94 137.71 16.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.075 -0.562 . . . . 0.0 111.136 -178.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.695 HG22 ' ND2' ' A' ' 54' ' ' ASN . 7.5 mt -114.97 126.16 72.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -109.64 117.62 54.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.01 162.19 33.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.935 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -135.29 -71.99 0.07 OUTLIER Glycine 0 C--N 1.334 0.431 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 49' ' ' ILE . 12.6 tt -120.11 112.27 34.85 Favored Pre-proline 0 C--O 1.233 0.225 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.98 114.54 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 N-CA-C 115.891 1.458 . . . . 0.0 115.891 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.97 20.37 10.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.227 -1.806 . . . . 0.0 107.3 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.765 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 71.87 32.93 1.79 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.215 -178.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 5.0 p-10 -122.16 26.98 8.23 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.542 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.695 ' ND2' HG22 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -57.34 148.03 24.15 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.44 ' CE1' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -98.95 132.79 44.01 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.981 179.049 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.815 ' HB2' HG23 ' A' ' 77' ' ' VAL . 32.3 m-85 -119.22 135.46 54.67 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.23 0.538 . . . . 0.0 112.022 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' GLN . 49.0 t30 -130.73 111.85 12.54 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.845 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.624 HD21 HD11 ' A' ' 12' ' ' ILE . 3.9 mp -141.7 163.81 31.91 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.3 mm -122.72 138.18 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.345 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.962 HD22 HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -141.61 168.93 18.6 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.779 0.323 . . . . 0.0 111.84 -179.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.8 m -92.1 138.5 31.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.224 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.977 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -156.38 146.61 21.4 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -149.67 164.49 35.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.675 178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.424 ' CE1' ' HB2' ' A' ' 35' ' ' LEU . 60.5 m80 -102.17 -2.76 28.62 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.93 144.54 19.18 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-O 121.031 0.443 . . . . 0.0 112.132 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.23 -33.01 50.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.121 2.547 . . . . 0.0 112.108 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -90.45 14.63 12.48 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.671 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -117.87 167.09 11.73 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.2 0.524 . . . . 0.0 111.725 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.562 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 6.7 m-85 -64.77 -176.4 0.25 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.402 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.421 ' C ' ' HD3' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -130.61 122.62 27.8 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -111.06 169.71 8.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.936 0.398 . . . . 0.0 111.643 -178.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.436 ' C ' ' HB2' ' A' ' 94' ' ' LEU . 10.6 m-85 -92.75 149.57 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.578 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.791 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 24.8 m-85 -144.0 137.87 28.0 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.767 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.51 ' HB2' HD11 ' A' ' 94' ' ' LEU . 51.4 t30 -109.4 126.48 53.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 110.412 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.769 HG12 ' HA ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -127.73 146.17 33.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.483 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.24 117.61 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.738 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -119.1 135.24 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.066 0.46 . . . . 0.0 112.146 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 79' ' ' GLU . 5.4 tp -117.35 124.45 48.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.333 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.45 124.36 34.41 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.831 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.55 149.72 49.24 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.2 -27.39 13.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.968 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -54.53 -43.39 71.88 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.61 0.243 . . . . 0.0 110.932 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.14 -6.93 43.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.061 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 61.03 50.33 5.12 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 120.769 0.318 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -174.47 -163.19 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.112 0.482 . . . . 0.0 111.266 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.72 HD22 ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -104.11 170.31 7.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.076 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.564 ' HE3' HD23 ' A' ' 78' ' ' LEU . 2.2 tmmm? -148.27 117.98 7.08 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.817 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -79.04 106.74 11.29 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.61 -54.38 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.713 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.47 151.32 40.18 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.09 0.471 . . . . 0.0 112.232 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.769 ' HA ' HG12 ' A' ' 75' ' ' VAL . 3.2 t80 -127.04 120.33 28.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.692 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.41 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 12.2 t -132.32 138.99 33.47 Favored Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.471 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 94.6 Cg_endo -82.88 135.61 7.77 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.847 2.365 . . . . 0.0 111.838 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 74' ' ' ASN . 1.4 mt -109.68 44.78 1.15 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.765 0.317 . . . . 0.0 111.297 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.471 ' CE1' ' HB2' ' A' ' 93' ' ' PRO . 43.8 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.092 -0.956 . . . . 0.0 111.132 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 43' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.857 HG13 HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -96.64 161.0 2.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 121.05 0.452 . . . . 0.0 111.596 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.75 153.83 20.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.981 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.39 -21.66 29.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 109.974 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.55 -36.34 61.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.646 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.442 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 10.7 t70 -59.72 114.82 10.51 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.489 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.2 Cg_endo -59.4 -30.08 91.77 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.542 2.828 . . . . 0.0 114.193 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 4.6 mpt_? -76.5 -43.67 38.51 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.257 0.551 . . . . 0.0 110.535 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.857 HG21 HG13 ' A' ' 12' ' ' ILE . 47.2 t -62.19 -42.32 94.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.329 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -71.3 -36.03 71.51 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HG3' HG13 ' A' ' 22' ' ' ILE . 12.2 pt-20 -76.29 -38.25 56.4 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.228 0.537 . . . . 0.0 110.679 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.804 HG12 HD12 ' A' ' 86' ' ' LEU . 85.6 mt -75.46 -32.64 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.325 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.526 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -69.77 -51.1 36.92 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.382 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 11.3 pt-20 -56.16 -43.39 78.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.703 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.659 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 23.7 t80 -57.31 -38.27 73.76 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.731 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -57.05 -46.18 82.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.107 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.924 HD22 ' HB3' ' A' ' 37' ' ' LEU . 3.1 tp -69.18 -45.03 70.98 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.635 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -71.12 -17.78 62.55 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.68 ' HB3' HD12 ' A' ' 88' ' ' LEU . 3.9 tp-100 -84.41 -38.59 20.05 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.401 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -97.66 124.98 42.18 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -162.71 40.81 0.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.756 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -37.87 34.53 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 16.0 mt-30 -95.34 -16.7 22.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.955 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 16.6 t30 72.62 91.58 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.045 0.45 . . . . 0.0 111.903 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.445 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -140.75 162.64 34.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.11 178.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.77 124.74 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.975 HD11 ' HB2' ' A' ' 60' ' ' LEU . 12.0 tp -83.58 118.91 24.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.206 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.415 ' H ' ' HA ' ' A' ' 62' ' ' ALA . . . -65.31 -30.69 71.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.831 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.9 166.29 15.09 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 119.983 -1.103 . . . . 0.0 113.843 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.765 HG22 HD23 ' A' ' 60' ' ' LEU . 18.2 t -68.5 130.14 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.516 -0.342 . . . . 0.0 110.325 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.95 -56.91 2.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.505 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.81 154.59 39.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.411 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.59 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -152.73 173.3 31.75 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.325 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' ASN . 18.1 mt-30 -146.97 159.54 43.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.98 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 19' ' ' VAL . 14.7 mt -144.0 131.14 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.714 0.293 . . . . 0.0 111.473 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.5 mt -107.63 115.56 49.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.323 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 162.66 32.52 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.65 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.43 -87.46 0.08 OUTLIER Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 49' ' ' ILE . 1.5 mt -104.3 108.52 60.57 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.96 115.91 3.35 Favored 'Trans proline' 0 C--N 1.347 0.453 0 N-CA-C 116.491 1.689 . . . . 0.0 116.491 -175.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 19.91 11.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.325 175.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.763 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.08 38.28 0.91 Allowed 'General case' 0 C--N 1.345 0.408 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.631 -178.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.36 26.33 8.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.603 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -49.1 136.55 14.66 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.394 0.678 . . . . 0.0 112.609 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.635 ' CE1' HD13 ' A' ' 78' ' ' LEU . 3.8 m-85 -99.86 126.34 45.96 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.73 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.659 ' HB2' HG23 ' A' ' 77' ' ' VAL . 6.0 m-85 -109.38 144.83 37.05 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 44' ' ' GLN . 9.0 t-20 -144.14 112.26 6.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.808 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.708 HD21 HG13 ' A' ' 19' ' ' VAL . 5.0 mp -138.16 168.78 19.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 2.7 mm -126.85 120.61 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.565 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.975 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -127.03 164.1 22.27 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.94 0.4 . . . . 0.0 111.279 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.8 m -94.39 141.65 28.33 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.738 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.895 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -152.05 148.09 27.27 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.511 0.507 . . . . 0.0 112.23 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -150.54 164.57 35.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.726 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -93.96 -11.64 30.47 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.844 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 p -149.7 143.1 16.41 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 111.935 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.88 -22.81 48.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.507 2.805 . . . . 0.0 113.539 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -89.6 3.32 52.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -128.04 166.95 17.43 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 121.377 0.608 . . . . 0.0 112.526 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 5.6 m-85 -53.46 167.46 0.21 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.834 -1.076 . . . . 0.0 113.749 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -125.69 134.1 51.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.825 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 23.9 mmmt -107.76 167.98 9.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.067 0.461 . . . . 0.0 111.819 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . 95.7 m-85 -88.37 151.31 22.68 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.621 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.873 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 14.0 m-85 -142.42 138.19 30.91 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.865 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.524 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . 8.1 t-20 -110.82 119.68 39.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.623 ' CG1' HD21 ' A' ' 88' ' ' LEU . 41.4 t -130.94 149.59 33.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.049 0.452 . . . . 0.0 111.671 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.413 HG22 ' ND2' ' A' ' 57' ' ' ASN . 33.6 t -109.24 129.79 63.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.273 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -128.85 146.89 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.016 0.436 . . . . 0.0 111.97 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.635 HD13 ' CE1' ' A' ' 55' ' ' TYR . 12.0 tp -118.58 126.25 51.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.442 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -88.77 128.04 35.62 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.901 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -125.03 130.14 51.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 52' ' ' TRP . . . -89.45 -35.79 15.79 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.324 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.2 m -61.88 -35.48 78.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.55 -7.3 53.23 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.973 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 m120 55.71 47.43 20.52 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 122.646 0.379 . . . . 0.0 111.411 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.4 t -174.04 -169.0 0.44 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.268 0.556 . . . . 0.0 111.167 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.804 HD12 HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -105.14 168.15 9.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.925 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -147.05 132.67 18.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.973 0.416 . . . . 0.0 111.449 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.68 HD12 ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -85.96 121.57 28.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.822 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.566 HG23 ' HA ' ' A' ' 77' ' ' VAL . 2.4 t -85.02 -54.95 7.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.847 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.485 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -160.82 134.14 6.62 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.251 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 75' ' ' VAL . 1.4 t80 -106.49 126.82 52.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.787 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.703 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.1 t -132.47 147.41 65.54 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.45 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.703 ' HD2' HG12 ' A' ' 92' ' ' VAL . 61.5 Cg_endo -92.44 138.37 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.17 2.58 . . . . 0.0 112.826 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.451 HD23 ' CB ' ' A' ' 74' ' ' ASN . 0.4 OUTLIER -99.61 27.47 5.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.275 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.44 ' CB ' ' HE3' ' A' ' 71' ' ' LYS . 6.5 p90 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.534 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.234 0 CA-C-O 120.084 -0.287 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.102 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -96.45 167.3 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 117.185 0.492 . . . . 0.0 111.482 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 m -91.27 149.76 21.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.15 -19.04 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.506 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -57.43 -37.94 73.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.008 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 18.4 t70 -57.99 113.63 6.87 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.031 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HA ' ' CD ' ' A' ' 20' ' ' LYS . 13.9 Cg_endo -56.17 -27.45 65.76 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.57 2.846 . . . . 0.0 114.321 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.73 -38.99 32.13 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.903 0.383 . . . . 0.0 110.873 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.102 HG21 HG13 ' A' ' 12' ' ' ILE . 45.1 t -67.31 -41.17 86.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.906 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.473 ' CD ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -73.86 -34.16 64.38 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.519 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 10.8 pt-20 -77.52 -37.77 50.27 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.935 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.854 HG12 HD12 ' A' ' 86' ' ' LEU . 93.8 mt -75.92 -31.15 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.734 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -69.09 -51.82 34.76 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.041 0.448 . . . . 0.0 110.271 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 8.3 pt-20 -55.71 -47.34 77.01 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.203 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.64 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 27.0 t80 -55.57 -37.96 68.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.818 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.535 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.15 -51.16 68.98 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.234 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.915 HD22 ' HB3' ' A' ' 37' ' ' LEU . 2.7 tp -62.21 -44.98 95.36 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -72.59 -17.41 61.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.615 ' HB3' HD12 ' A' ' 88' ' ' LEU . 3.5 tp-100 -82.12 -38.55 24.6 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.617 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 2.9 t60 -108.23 129.18 55.21 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.814 0.34 . . . . 0.0 110.353 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -170.28 41.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.543 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.13 86.55 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.85 9.18 42.66 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.524 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 42.2 t30 52.78 88.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.592 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -127.99 157.63 40.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.515 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.59 124.15 72.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.915 ' HB3' HD22 ' A' ' 27' ' ' LEU . 1.5 tt -90.99 113.99 26.39 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.866 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.17 -28.01 69.11 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.825 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.93 168.73 25.3 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 119.313 -1.422 . . . . 0.0 114.345 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.519 ' CG2' HD23 ' A' ' 60' ' ' LEU . 1.6 t -76.14 136.42 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.106 -0.547 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.61 -65.32 1.02 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.714 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.58 171.3 20.56 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.155 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -166.39 -174.39 35.7 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.558 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 57' ' ' ASN . 25.7 mt-30 -151.24 143.17 23.89 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.128 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.703 HD12 HD12 ' A' ' 12' ' ' ILE . 2.9 mp -122.17 125.52 73.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.234 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.0 mt -107.41 118.89 56.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.77 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -136.47 163.16 31.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.975 -178.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -148.19 -66.72 0.01 OUTLIER Glycine 0 C--N 1.33 0.224 0 N-CA-C 108.534 -1.827 . . . . 0.0 108.534 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -120.46 108.27 37.88 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 175.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -90.53 117.51 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 116.212 1.582 . . . . 0.0 116.212 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 23.36 10.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.463 175.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.757 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.97 31.85 1.44 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.314 -178.122 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 20.9 m-20 -121.91 27.18 8.23 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.556 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.412 ' OD1' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -56.02 153.61 8.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.116 -178.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.15 122.44 45.34 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.437 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.584 ' CB ' HG23 ' A' ' 77' ' ' VAL . 17.7 m-85 -102.13 133.35 47.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.037 0.446 . . . . 0.0 111.953 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 44' ' ' GLN . 39.8 t30 -132.91 111.68 11.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.067 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.642 HD21 HD11 ' A' ' 12' ' ' ILE . 4.0 mp -140.34 166.27 25.14 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.8 mm -124.12 129.44 74.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.439 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.897 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -131.63 168.84 17.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.722 0.296 . . . . 0.0 111.504 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.3 m -100.65 133.95 44.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.362 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.592 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -145.1 141.03 28.46 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.486 0.491 . . . . 0.0 112.186 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -139.74 166.55 24.31 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.751 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -93.2 -16.48 24.79 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.652 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.75 153.05 35.82 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.688 0.28 . . . . 0.0 111.659 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.21 -31.62 74.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.76 2.307 . . . . 0.0 112.111 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -96.16 14.38 24.18 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.463 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -115.37 167.32 10.97 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-O 121.105 0.478 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.514 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 9.3 m-85 -71.72 152.16 43.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.852 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 m -115.08 133.79 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.377 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 22.7 mmmt -113.99 165.08 12.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . 1.1 m-85 -87.69 148.45 24.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.532 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 46.6 m-85 -138.62 140.75 39.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.881 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.683 ' HB2' HD23 ' A' ' 94' ' ' LEU . 31.4 t-20 -108.79 116.49 32.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 0.0 109.956 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.747 HG12 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -119.33 142.67 33.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.941 -178.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 t -107.52 120.16 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.959 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.592 HG21 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -123.37 146.37 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 79' ' ' GLU . 9.3 tp -119.81 125.39 48.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.341 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.501 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.7 tt0 -87.73 124.2 33.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.686 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -122.7 137.82 54.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.404 0.621 . . . . 0.0 112.545 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.43 -27.16 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.688 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -59.58 -41.35 90.02 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.323 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.34 9.1 43.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.509 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.81 57.51 5.93 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.498 0.319 . . . . 0.0 111.557 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 177.96 -177.99 0.23 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.455 0.645 . . . . 0.0 111.613 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.854 HD12 HG12 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -93.31 166.83 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.905 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.96 126.93 13.62 Favored 'General case' 0 CA--C 1.526 0.052 0 CA-C-O 120.797 0.332 . . . . 0.0 111.258 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.747 HD21 HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -86.7 114.77 23.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.197 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.73 -54.11 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.319 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.33 144.28 15.62 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.86 0.362 . . . . 0.0 111.856 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.638 ' HA ' HG13 ' A' ' 75' ' ' VAL . 6.0 t80 -112.77 127.32 56.12 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.82 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.456 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 5.2 t -132.46 139.78 35.84 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.456 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.2 Cg_endo -81.99 138.59 10.37 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.903 2.402 . . . . 0.0 112.217 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -107.6 25.44 11.49 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.64 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.586 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 30.4 p90 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.586 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.279 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 1.069 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -98.0 166.84 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 117.706 0.753 . . . . 0.0 112.144 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 t -89.9 154.26 20.0 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.58 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 p -64.75 -23.3 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.725 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -51.62 -36.76 47.22 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.972 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.463 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 14.1 t70 -58.79 113.24 6.32 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.702 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 19.7 Cg_endo -58.31 -28.14 83.56 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.435 2.757 . . . . 0.0 113.994 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.551 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 5.9 mmt-85 -76.85 -46.24 25.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.095 0.474 . . . . 0.0 110.124 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.069 HG21 HG13 ' A' ' 12' ' ' ILE . 69.8 t -59.51 -42.44 87.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.493 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -71.57 -37.78 71.03 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.597 ' CD ' HD11 ' A' ' 86' ' ' LEU . 8.0 pt-20 -77.18 -37.25 54.05 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.021 0.439 . . . . 0.0 111.191 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.755 HG12 HD12 ' A' ' 86' ' ' LEU . 27.2 mt -75.11 -31.52 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.016 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -70.6 -52.68 19.85 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.042 0.448 . . . . 0.0 109.962 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.4 pt-20 -55.27 -41.78 72.69 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.718 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 28.4 t80 -59.65 -38.01 80.27 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.905 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.28 -43.53 88.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.113 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 37' ' ' LEU . 3.6 tp -69.31 -48.06 62.65 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.376 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 25' ' ' PHE . 1.5 pttm -67.73 -25.4 65.63 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.611 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 5.0 tp60 -74.99 -27.91 60.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.513 ' ND1' HD21 ' A' ' 35' ' ' LEU . 10.0 t-160 -65.03 -95.53 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.94 32.1 12.05 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -93.52 -38.02 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.937 0.399 . . . . 0.0 109.957 178.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.535 HE21 HD22 ' A' ' 35' ' ' LEU . 2.9 pt20 -113.79 -5.16 13.29 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.152 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.8 t30 67.51 91.94 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.953 0.501 . . . . 0.0 111.374 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.535 HD22 HE21 ' A' ' 33' ' ' GLN . 0.4 OUTLIER -133.58 160.14 38.36 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.436 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.33 124.6 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.116 HD12 ' HB2' ' A' ' 62' ' ' ALA . 6.2 tp -92.17 113.94 26.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.385 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.18 72.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.324 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.88 163.28 23.65 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.204 -1.474 . . . . 0.0 114.808 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.725 HG22 HD23 ' A' ' 60' ' ' LEU . 2.2 t -75.47 125.6 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.196 -0.502 . . . . 0.0 109.918 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.02 -62.63 1.41 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.57 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.75 171.68 16.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.025 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.596 ' HA3' ' CG ' ' A' ' 58' ' ' LEU . . . -171.1 -174.41 38.88 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.427 -1.368 . . . . 0.0 114.883 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 57' ' ' ASN . 28.3 mt-30 -146.82 168.79 20.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.451 -0.875 . . . . 0.0 111.172 -178.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.651 HD13 HG21 ' A' ' 12' ' ' ILE . 4.7 mp -142.86 132.49 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.419 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.6 mm -107.44 116.87 51.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.134 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.07 162.75 32.04 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.816 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -149.42 -70.78 0.01 OUTLIER Glycine 0 C--N 1.33 0.23 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -120.61 108.8 36.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -87.65 117.47 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 N-CA-C 116.395 1.652 . . . . 0.0 116.395 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.438 ' NE2' ' HB2' ' A' ' 53' ' ' ASP . 32.1 p-80 -121.7 23.47 10.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.605 -1.634 . . . . 0.0 107.446 175.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.744 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 73.7 33.4 1.04 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.028 -178.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.594 ' OD1' HD11 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -122.24 28.1 7.64 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.832 177.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.461 ' ND2' ' CG2' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -57.83 143.72 41.29 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.6 ' CE1' HD13 ' A' ' 78' ' ' LEU . 1.3 m-30 -95.06 138.62 32.54 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.591 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -119.56 135.61 54.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 112.036 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 44' ' ' GLN . 64.1 t-20 -133.52 114.24 13.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.15 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 19' ' ' VAL . 4.6 mp -144.35 168.68 19.5 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.1 mm -125.85 131.88 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.272 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.841 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -134.37 168.89 18.08 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.402 ' O ' ' HG ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -99.61 129.7 45.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.046 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 1.116 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -144.62 141.76 29.63 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.066 0.46 . . . . 0.0 112.194 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -142.06 165.4 27.54 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.507 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -94.74 -13.8 25.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.94 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -153.82 150.98 24.0 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-O 121.213 0.53 . . . . 0.0 112.109 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 65' ' ' SER . 19.3 Cg_exo -63.65 -37.7 45.28 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.554 2.836 . . . . 0.0 113.026 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -80.85 9.05 6.91 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -124.1 167.45 14.2 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.228 0.537 . . . . 0.0 111.728 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.521 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.7 m-85 -68.79 166.18 18.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.368 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 m -119.84 131.86 55.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.951 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 1.5 mmmp? -110.51 155.0 22.89 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.47 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.559 ' O ' ' HB2' ' A' ' 94' ' ' LEU . 20.8 m-85 -85.23 138.04 32.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.19 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 1.009 ' CE2' ' HB3' ' A' ' 62' ' ' ALA . 5.9 m-30 -125.71 140.37 52.76 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.949 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.482 ' HB2' HD12 ' A' ' 59' ' ' ILE . 3.6 t-20 -111.95 119.2 37.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 110.424 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 91' ' ' PHE . 34.3 m -128.78 158.91 41.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.496 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.08 127.36 73.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.724 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.674 HG21 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -124.53 145.41 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.047 0.451 . . . . 0.0 111.751 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.6 HD13 ' CE1' ' A' ' 55' ' ' TYR . 9.4 tp -114.32 127.0 55.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.784 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -91.91 127.97 37.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.558 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.01 139.99 52.97 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 52' ' ' TRP . . . -93.72 -30.34 14.94 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.791 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 m -54.23 -39.3 66.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.241 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.98 -3.86 27.04 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.457 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 54.56 53.77 10.23 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 120.996 0.427 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 t -171.49 -173.95 1.32 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.755 HD12 HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -101.45 165.97 10.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.798 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -147.91 128.69 14.3 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.026 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.611 ' CB ' ' HG2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -82.63 121.9 27.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.454 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 77' ' ' VAL . 2.5 t -83.57 -55.02 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.45 156.18 34.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.353 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.937 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.4 t80 -124.72 123.05 39.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.517 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 7.1 t -131.78 142.97 47.16 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.911 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.517 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.4 Cg_endo -86.99 138.6 5.03 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.008 2.472 . . . . 0.0 112.176 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -105.63 20.5 18.8 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 47.8 p90 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.068 -0.968 . . . . 0.0 111.469 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.204 0 N-CA-C 112.283 -0.327 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.728 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -96.78 147.97 5.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 117.212 0.506 . . . . 0.0 111.218 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 t -79.24 151.38 31.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.694 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -63.53 -21.83 29.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -53.01 -35.77 59.76 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.601 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 15.1 t0 -57.25 111.12 3.0 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.258 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.2 Cg_endo -59.89 -27.67 85.45 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.429 2.753 . . . . 0.0 113.801 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.485 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -77.64 -44.38 28.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.149 0.5 . . . . 0.0 110.068 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.728 HG21 HG13 ' A' ' 12' ' ' ILE . 54.0 t -61.53 -47.56 92.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.191 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -40.24 96.73 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 14.0 pt-20 -75.0 -42.95 56.46 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.901 0.381 . . . . 0.0 110.99 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 56' ' ' TYR . 50.2 mt -65.0 -34.65 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.339 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -62.68 -48.17 80.48 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -49.75 -51.28 40.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.364 178.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.667 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 32.0 t80 -56.55 -37.36 70.43 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.316 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.554 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -57.22 -48.1 79.65 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.97 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.6 tp -67.52 -43.08 81.69 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.624 ' HE2' ' CD2' ' A' ' 25' ' ' PHE . 3.7 pttm -75.03 -18.15 60.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.56 -39.0 32.82 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.967 0.349 . . . . 0.0 110.922 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -103.97 122.27 44.86 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.358 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -168.63 43.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.552 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -37.66 71.89 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.3 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.83 1.21 36.84 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.861 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 63.73 99.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.499 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -141.31 158.41 43.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 178.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.433 HD12 ' HE3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -116.36 125.22 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -177.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.037 HD11 ' HB2' ' A' ' 60' ' ' LEU . 3.4 tp -87.0 120.77 28.62 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.865 0.364 . . . . 0.0 110.749 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.417 ' H ' ' HA ' ' A' ' 62' ' ' ALA . . . -65.96 -34.51 78.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.895 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.85 162.57 11.32 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.186 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.62 HG22 ' CD2' ' A' ' 60' ' ' LEU . 54.2 t -67.8 136.03 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.86 0.464 . . . . 0.0 110.753 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.02 -65.76 1.14 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.619 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.13 146.66 25.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.389 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.584 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -146.95 -170.93 15.68 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 119.793 -1.194 . . . . 0.0 114.812 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' ASN . 17.3 mm-40 -142.16 150.74 41.46 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.558 -0.821 . . . . 0.0 111.295 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.517 HG22 ' CD ' ' A' ' 47' ' ' LYS . 63.0 mt -128.33 129.4 69.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.79 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 55' ' ' TYR . 4.7 mt -106.87 115.27 48.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.452 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.517 ' CD ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -136.01 162.75 32.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.662 0.744 . . . . 0.0 112.829 -178.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.89 -66.92 0.01 OUTLIER Glycine 0 C--N 1.329 0.193 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -120.26 109.27 37.13 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 175.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -87.02 117.04 1.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 N-CA-C 116.226 1.587 . . . . 0.0 116.226 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.99 24.02 10.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.426 -1.716 . . . . 0.0 107.03 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TRP . . . . . 0.764 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 62.88 35.51 13.48 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.44 -177.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.504 ' OD2' HD11 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -122.84 28.29 7.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.389 177.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.649 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 1.1 t-20 -47.64 146.03 2.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.447 ' HB3' HD12 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -98.05 116.52 30.44 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.73 178.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.649 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 38.8 m-85 -104.87 143.0 33.74 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.206 0.527 . . . . 0.0 111.844 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 44' ' ' GLN . 15.9 t-20 -144.39 110.63 5.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.715 HD21 HG13 ' A' ' 19' ' ' VAL . 4.0 mp -136.74 167.35 21.6 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 2.7 mm -122.04 121.62 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.042 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.037 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -125.08 168.21 13.69 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.771 0.319 . . . . 0.0 111.26 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 50.2 m -98.97 146.04 26.43 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.881 ' HB3' ' CE1' ' A' ' 73' ' ' TYR . . . -155.28 147.02 23.24 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -149.16 165.36 32.05 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.338 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -103.86 -5.82 21.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.042 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 68' ' ' GLU . 2.2 p -146.39 143.41 18.96 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-O 121.136 0.493 . . . . 0.0 112.046 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.42 -27.63 54.64 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.476 2.784 . . . . 0.0 113.365 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -95.23 14.19 23.05 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.423 ' HB2' ' OG ' ' A' ' 65' ' ' SER . 7.8 mt-10 -126.78 167.23 16.05 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.46 0.648 . . . . 0.0 112.48 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.496 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 5.3 m-85 -64.69 167.65 7.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.273 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 m -124.29 135.74 53.6 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.889 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HG3' ' CD2' ' A' ' 95' ' ' PHE . 27.9 mmmt -110.37 169.98 8.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.677 0.275 . . . . 0.0 111.067 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.477 ' C ' ' HB2' ' A' ' 94' ' ' LEU . 20.4 m-85 -89.85 151.17 21.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.52 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.881 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 9.2 m-85 -141.65 141.07 33.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.34 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.436 ' CB ' HD13 ' A' ' 59' ' ' ILE . 65.2 t30 -113.72 126.39 55.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.495 0.188 . . . . 0.0 110.89 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.961 HG12 ' HA ' ' A' ' 91' ' ' PHE . 6.4 m -132.37 140.21 48.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.161 0.505 . . . . 0.0 112.238 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.432 HG13 HD22 ' A' ' 57' ' ' ASN . 0.6 OUTLIER -102.99 110.42 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 26' ' ' ALA . 6.2 t -113.25 136.86 48.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.568 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 79' ' ' GLU . 7.3 tp -112.51 131.74 55.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.018 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.649 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -91.39 129.43 37.38 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.0 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HD3' ' HB3' ' A' ' 82' ' ' SER . 1.7 ttmp? -125.4 143.79 50.82 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.37 -29.91 11.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.572 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.449 ' HB3' ' HD3' ' A' ' 80' ' ' LYS . 6.8 t -53.81 -43.49 69.4 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.12 9.12 36.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.325 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.57 58.88 3.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.068 0.461 . . . . 0.0 111.375 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.6 p -173.8 -174.3 0.94 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.806 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.667 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -101.15 166.9 10.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.01 179.2 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.402 ' NZ ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -147.39 121.65 9.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.016 0.436 . . . . 0.0 111.717 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -81.01 110.17 16.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.902 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.98 -50.04 21.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.596 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.8 146.82 26.62 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.961 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.9 t80 -125.88 119.24 27.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.421 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.553 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 5.8 t -132.34 142.78 46.2 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.553 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.6 Cg_endo -80.34 139.04 12.83 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.925 2.417 . . . . 0.0 111.701 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.477 ' HB2' ' C ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -112.66 47.47 1.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CD2' ' HG3' ' A' ' 71' ' ' LYS . 3.2 p90 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.855 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 CA-C-O 120.186 -0.23 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.55 165.47 30.63 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.163 2.576 . . . . 0.0 112.755 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.81 70.04 0.05 OUTLIER Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.651 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.22 160.37 15.28 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.891 2.394 . . . . 0.0 112.94 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.14 26.09 2.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.091 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.6 mt -138.54 -49.33 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.302 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -143.68 151.24 23.16 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.788 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -146.02 133.89 21.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.739 0.304 . . . . 0.0 111.414 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.8 t -109.61 143.65 19.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.356 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.3 pt -117.78 162.08 16.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 43' ' ' GLY . . . -91.61 -158.09 34.28 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.093 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.074 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -101.31 159.39 4.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 117.71 0.755 . . . . 0.0 111.68 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -79.31 153.32 29.93 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.054 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.5 p -67.06 -23.38 30.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.686 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -53.21 -32.55 48.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.341 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.412 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 12.4 t70 -57.43 112.83 5.18 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.658 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.417 ' HA ' ' CG ' ' A' ' 20' ' ' LYS . 18.6 Cg_endo -59.58 -26.57 82.51 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.453 2.769 . . . . 0.0 113.934 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.498 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.7 OUTLIER -78.62 -44.15 24.63 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.275 0.56 . . . . 0.0 110.384 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.074 HG21 HG13 ' A' ' 12' ' ' ILE . 72.9 t -65.18 -39.65 86.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.65 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.417 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -69.41 -37.88 77.66 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 13.0 pt-20 -75.28 -37.24 61.01 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.214 0.531 . . . . 0.0 110.562 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.738 HG12 HD12 ' A' ' 86' ' ' LEU . 77.1 mt -74.62 -35.04 36.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.059 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -66.63 -54.89 18.48 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.242 0.544 . . . . 0.0 110.217 178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 11.3 pt-20 -53.66 -44.28 69.51 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.078 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.657 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 26.9 t80 -60.11 -35.39 75.12 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.435 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 23' ' ' ALA . . . -58.61 -47.11 85.46 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.903 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.841 HD22 ' HB3' ' A' ' 37' ' ' LEU . 2.4 tp -66.92 -43.79 82.41 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.702 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.585 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -70.93 -18.14 62.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.763 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 0.3 OUTLIER -87.08 -38.95 16.03 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.131 0.423 . . . . 0.0 111.205 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -102.42 125.42 49.13 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.911 0.386 . . . . 0.0 110.573 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -167.5 45.43 0.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.195 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.544 ' HG2' ' HG2' ' A' ' 33' ' ' GLN . 0.2 OUTLIER -64.36 -37.54 87.86 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.079 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.544 ' HG2' ' HG2' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -107.34 13.3 27.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.882 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 50.93 83.07 0.05 Allowed 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.528 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -118.68 165.11 14.38 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.403 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.86 124.25 68.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.036 HD12 ' HB2' ' A' ' 62' ' ' ALA . 7.1 tp -90.26 115.75 27.71 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.546 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.94 -28.96 69.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.456 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 163.26 174.29 32.96 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.577 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.664 HG22 HD23 ' A' ' 60' ' ' LEU . 2.0 t -81.37 132.74 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.568 0.347 . . . . 0.0 110.694 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.1 -63.33 1.27 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.334 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.43 163.73 29.81 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.845 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.788 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -152.33 163.32 30.21 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 119.954 -1.117 . . . . 0.0 114.436 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.41 ' H ' ' HG ' ' A' ' 58' ' ' LEU . 68.1 mt-30 -150.27 148.69 29.17 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.127 0.571 . . . . 0.0 110.054 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.59 ' CD1' HG21 ' A' ' 12' ' ' ILE . 4.6 mp -133.46 129.19 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.73 0.3 . . . . 0.0 111.281 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.6 mt -107.54 114.92 47.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.195 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.83 155.49 48.94 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.7 -70.4 0.08 OUTLIER Glycine 0 C--N 1.332 0.354 0 N-CA-C 108.744 -1.742 . . . . 0.0 108.744 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -120.83 108.99 36.28 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 175.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -85.83 119.18 1.85 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.733 1.622 . . . . 0.0 115.908 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -120.88 23.21 10.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.258 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.753 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 74.44 29.47 1.2 Allowed 'General case' 0 C--N 1.344 0.335 0 CA-C-N 114.554 -1.203 . . . . 0.0 111.711 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -122.31 27.32 7.99 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.591 177.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.402 ' HB3' ' HE1' ' A' ' 56' ' ' TYR . 2.3 t-20 -50.66 149.04 3.49 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.48 ' CE1' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -98.31 132.72 43.56 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.945 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.675 ' CB ' HG23 ' A' ' 77' ' ' VAL . 21.1 m-85 -117.63 144.18 45.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.299 0.571 . . . . 0.0 112.081 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -143.94 116.98 8.87 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.666 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.788 HD23 ' HA3' ' A' ' 43' ' ' GLY . 4.5 mp -143.18 164.06 31.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.1 mm -119.44 131.4 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.865 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.001 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.47 169.1 18.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.931 0.396 . . . . 0.0 111.619 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.0 m -98.81 135.09 40.76 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.988 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 1.036 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -153.59 143.23 21.8 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -140.58 164.61 29.69 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.457 178.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -98.92 -7.17 27.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.095 -0.502 . . . . 0.0 112.238 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.02 148.32 18.4 Favored Pre-proline 0 N--CA 1.465 0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.776 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -66.14 -27.96 48.84 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.951 2.434 . . . . 0.0 112.342 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -89.31 14.29 11.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.741 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -128.43 167.22 17.33 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-O 121.453 0.644 . . . . 0.0 112.484 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.513 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 8.3 m-85 -69.5 160.95 30.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.324 -178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -109.6 130.99 55.47 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.411 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.526 ' HE2' ' HB2' ' A' ' 95' ' ' PHE . 25.5 mmmt -112.94 170.08 8.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.02 0.438 . . . . 0.0 111.74 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -89.73 145.66 25.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.733 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.61 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 36.1 m-85 -140.94 136.88 32.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.1 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.79 ' HB2' HD23 ' A' ' 94' ' ' LEU . 0.2 OUTLIER -109.11 115.49 30.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.299 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.993 HG12 ' HA ' ' A' ' 91' ' ' PHE . 2.2 m -121.99 144.38 31.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.726 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 23.7 t -104.34 127.25 58.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.351 -0.841 . . . . 0.0 108.875 178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.675 HG23 ' CB ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -126.25 146.78 31.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.491 HD12 ' N ' ' A' ' 79' ' ' GLU . 11.8 tp -120.42 129.54 53.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.436 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.544 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -93.94 134.94 35.8 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 179.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.47 131.6 51.63 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.95 0.405 . . . . 0.0 111.91 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' A' ' 52' ' ' TRP . . . -89.23 -36.44 15.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.378 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.6 m -57.57 -41.74 81.68 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.148 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -11.23 50.75 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.05 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 60.53 45.51 10.56 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-O 120.824 0.345 . . . . 0.0 110.944 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.1 p -165.99 -169.06 1.39 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 111.263 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.738 HD12 HG12 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -105.86 170.81 7.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.475 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.68 142.7 27.01 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.916 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.763 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 1.5 tm? -101.11 115.79 31.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.381 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.446 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 3.6 t -74.52 -52.29 20.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -164.45 156.45 16.26 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.848 0.356 . . . . 0.0 111.95 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.993 ' HA ' HG12 ' A' ' 75' ' ' VAL . 4.6 t80 -120.74 124.77 45.95 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.618 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.41 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 2.9 t -132.63 137.69 30.38 Favored Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.01 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 96.6 Cg_endo -80.13 138.31 12.71 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.733 2.289 . . . . 0.0 112.332 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.79 HD23 ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -108.85 39.99 1.9 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.638 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.526 ' HB2' ' HE2' ' A' ' 71' ' ' LYS . 16.6 p90 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.641 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.097 0 CA-C-O 120.166 -0.241 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.97 154.96 71.83 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.964 2.443 . . . . 0.0 112.582 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' A' ' 4' ' ' PRO . . . -104.58 112.51 4.11 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.54 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' A' ' 3' ' ' GLY . 7.3 Cg_endo -86.49 153.14 9.09 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.266 2.644 . . . . 0.0 112.556 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.23 19.45 9.85 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.769 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.21 -49.43 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 116.844 -0.162 . . . . 0.0 111.073 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.83 119.89 1.26 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.953 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.418 ' CG ' ' HG2' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -125.42 167.11 15.43 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.549 0.214 . . . . 0.0 110.659 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 t -120.0 112.14 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.858 0.361 . . . . 0.0 111.485 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.1 pp -143.56 159.03 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.007 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . 118.42 -178.95 16.93 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.863 -0.684 . . . . 0.0 113.305 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.908 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -97.2 167.14 1.79 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-O 120.9 0.381 . . . . 0.0 111.267 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.2 m -91.92 150.34 21.08 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.092 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.97 -20.42 27.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.227 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -55.42 -35.91 65.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.547 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.435 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 13.6 t70 -57.49 115.96 12.44 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.904 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.0 Cg_endo -59.54 -28.09 86.59 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.502 2.801 . . . . 0.0 114.133 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.488 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -79.54 -43.47 22.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.034 0.445 . . . . 0.0 110.564 -179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.908 HG21 HG13 ' A' ' 12' ' ' ILE . 48.4 t -62.01 -41.46 91.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.834 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -72.44 -36.12 68.48 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 12.1 pt-20 -76.87 -37.0 56.35 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.089 0.471 . . . . 0.0 110.982 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.827 HG12 HD12 ' A' ' 86' ' ' LEU . 75.4 mt -76.28 -32.24 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.723 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.482 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -68.27 -50.9 50.62 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.199 0.523 . . . . 0.0 110.239 177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.5 pt-20 -58.57 -43.33 89.35 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.065 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.653 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 20.0 t80 -56.93 -37.45 71.5 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.713 ' HB1' HG11 ' A' ' 75' ' ' VAL . . . -58.91 -48.71 80.49 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.056 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.899 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.2 tp -64.58 -47.84 77.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.23 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.548 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -67.88 -17.07 64.37 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.569 ' HB3' HD12 ' A' ' 88' ' ' LEU . 19.5 tp60 -86.65 -38.17 17.32 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.33 0.11 . . . . 0.0 111.24 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.606 ' HB2' HD11 ' A' ' 88' ' ' LEU . 1.4 t60 -104.13 127.09 51.7 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.781 0.325 . . . . 0.0 110.708 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -171.57 44.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.093 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.65 -37.36 70.82 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.911 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.52 7.66 35.31 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 61.29 96.89 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.58 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -141.06 160.03 40.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.161 178.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.57 124.39 69.43 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.991 HD11 ' HB2' ' A' ' 60' ' ' LEU . 6.5 tp -87.89 116.21 25.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.182 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.27 -30.75 71.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 163.83 166.27 22.41 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 119.505 -1.331 . . . . 0.0 114.246 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.812 HG22 HD23 ' A' ' 60' ' ' LEU . 35.0 t -72.38 123.57 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.881 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.535 ' HB2' ' HA ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -92.4 -65.74 0.98 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.805 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -160.78 165.31 30.54 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.105 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.508 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -165.75 -174.06 34.89 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 119.665 -1.255 . . . . 0.0 114.306 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.453 ' N ' ' O ' ' A' ' 57' ' ' ASN . 49.4 mt-30 -140.13 167.92 21.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.744 -0.728 . . . . 0.0 110.957 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.509 HG22 ' HD3' ' A' ' 47' ' ' LYS . 77.0 mt -144.62 140.1 23.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.66 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 55' ' ' TYR . 28.1 mt -106.44 114.61 46.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.509 ' HD3' HG22 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -135.73 163.34 30.41 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.346 -0.843 . . . . 0.0 113.201 -177.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.37 -71.8 0.02 OUTLIER Glycine 0 C--N 1.332 0.338 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.585 ' O ' HG23 ' A' ' 49' ' ' ILE . 9.7 tt -120.48 109.23 36.74 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -81.1 115.22 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 N-CA-C 115.983 1.494 . . . . 0.0 115.983 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -122.24 11.42 10.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.349 -1.75 . . . . 0.0 108.338 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.777 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 76.51 31.97 0.57 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 124.43 1.092 . . . . 0.0 111.876 -178.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.82 26.32 8.73 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.069 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.06 149.88 43.97 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.434 ' CE1' HD13 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -101.59 124.16 46.79 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.629 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.672 ' HB2' HG23 ' A' ' 77' ' ' VAL . 13.9 m-85 -104.61 125.19 50.5 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.175 0.512 . . . . 0.0 112.058 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 44' ' ' GLN . 38.3 t-20 -124.32 111.47 15.85 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.654 HD21 HG13 ' A' ' 19' ' ' VAL . 4.2 mp -138.58 167.64 21.5 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.4 mm -129.05 128.29 66.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.756 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.991 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -133.04 169.35 16.97 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.779 0.324 . . . . 0.0 111.498 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 1.1 m -98.84 136.17 39.24 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.611 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.93 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -148.46 144.31 27.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.144 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -145.54 165.9 27.27 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.917 179.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -96.98 -9.09 28.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.796 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 68' ' ' GLU . 3.8 p -153.2 144.02 15.91 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-O 120.891 0.376 . . . . 0.0 111.582 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.87 -30.05 58.18 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.123 2.548 . . . . 0.0 112.851 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -87.8 12.72 12.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.421 ' HB2' ' OG ' ' A' ' 65' ' ' SER . 15.3 mt-10 -125.89 167.67 14.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.247 0.546 . . . . 0.0 111.741 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 8.4 m-85 -66.89 158.91 29.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.904 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 m -115.27 130.18 56.83 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.816 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 22.6 mmmt -107.95 169.33 8.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.767 0.318 . . . . 0.0 111.213 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -91.51 152.34 20.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.173 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.681 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 32.9 m-85 -144.16 139.67 28.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.499 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -109.95 127.09 54.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 110.139 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.713 HG11 ' HB1' ' A' ' 26' ' ' ALA . 42.3 t -126.96 151.04 33.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.539 0.685 . . . . 0.0 112.028 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 29.1 t -111.01 112.4 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.59 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.672 HG23 ' HB2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -118.89 142.53 33.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.037 0.446 . . . . 0.0 111.62 -178.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.528 HD12 ' N ' ' A' ' 79' ' ' GLU . 12.6 tp -118.95 128.35 54.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.614 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.528 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.8 tt0 -87.81 120.82 29.51 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.346 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HE3' ' CD2' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -113.01 131.22 55.86 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.136 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -93.14 -35.16 13.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.266 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.6 m -61.04 -42.38 98.36 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.553 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.34 -9.93 59.28 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.936 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 61.25 42.15 12.4 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.168 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.2 t -172.51 178.84 2.63 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.352 0.596 . . . . 0.0 111.321 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.827 HD12 HG12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -86.41 167.89 14.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.102 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -146.25 141.24 27.16 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.966 0.412 . . . . 0.0 111.041 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.606 HD11 ' HB2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -99.91 122.53 42.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.555 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.83 -52.73 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.929 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -157.66 155.69 30.46 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.492 ' HA ' HG22 ' A' ' 75' ' ' VAL . 2.3 t80 -123.94 125.1 44.02 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.971 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.569 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 3.2 t -132.64 143.75 50.05 Favored Pre-proline 0 N--CA 1.469 0.493 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.569 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 68.4 Cg_endo -84.7 139.0 7.41 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.865 2.376 . . . . 0.0 112.679 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.414 ' HA ' HD22 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -113.58 48.88 1.02 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.913 0.387 . . . . 0.0 110.92 179.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 30.3 p90 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.656 -0.688 . . . . 0.0 111.755 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.09 0 N-CA-C 112.364 -0.295 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.65 146.78 74.47 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.803 2.335 . . . . 0.0 112.728 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.486 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 179.1 -105.91 0.2 Allowed Glycine 0 C--N 1.332 0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.273 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.486 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 4.0 Cg_exo -79.82 163.94 23.22 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.035 2.49 . . . . 0.0 112.454 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.99 29.88 4.35 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.232 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.4 mt -127.22 -55.18 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.444 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.04 -178.25 30.93 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.616 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -90.34 137.37 32.41 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.599 0.238 . . . . 0.0 110.874 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.1 142.67 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.449 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.5 pt -141.13 165.89 18.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.838 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.02 -166.66 22.2 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.145 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.798 HD12 HD11 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -100.33 163.55 2.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.941 0.4 . . . . 0.0 111.261 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.0 m -92.16 150.38 20.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.353 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.23 -22.85 31.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -53.1 -34.82 58.33 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.459 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.424 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 10.1 t70 -57.79 115.13 10.03 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.434 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HA ' ' CG ' ' A' ' 20' ' ' LYS . 20.6 Cg_endo -61.18 -29.32 86.66 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.297 2.664 . . . . 0.0 114.009 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 1.8 mpt_? -77.76 -43.29 31.26 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.185 0.517 . . . . 0.0 110.488 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.722 HG11 HG13 ' A' ' 12' ' ' ILE . 55.1 t -61.58 -43.46 97.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.831 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -70.7 -36.28 73.19 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.532 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 12.3 pt-20 -76.78 -37.9 55.01 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.27 0.557 . . . . 0.0 110.848 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.703 HG12 HD12 ' A' ' 86' ' ' LEU . 58.3 mt -74.15 -33.74 36.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.523 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -69.82 -47.74 61.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.753 0.311 . . . . 0.0 110.852 178.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 9.8 pt-20 -57.51 -44.79 85.33 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.046 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.714 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 32.2 t80 -57.93 -37.38 73.98 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.826 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -54.64 -47.52 73.41 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.739 179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.074 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.1 tp -67.26 -45.72 75.82 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.51 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.529 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -69.43 -17.92 63.69 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.561 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 6.0 tp60 -83.4 -37.94 22.61 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.469 0.176 . . . . 0.0 111.161 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.485 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 2.6 t60 -97.7 128.6 44.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.273 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -174.63 36.48 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.27 -38.38 30.99 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.97 0.414 . . . . 0.0 110.191 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.458 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 8.9 mt-30 -84.51 -19.85 32.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.146 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.458 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 27.7 t-20 74.79 91.65 0.08 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.295 0.638 . . . . 0.0 112.537 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.525 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.4 OUTLIER -141.17 167.07 23.07 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.068 178.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.451 ' HB ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -124.83 124.76 68.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.074 ' HB3' HD22 ' A' ' 27' ' ' LEU . 9.9 tp -90.6 113.24 25.22 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.443 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.87 -27.54 68.3 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.666 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.37 177.29 35.27 Favored Glycine 0 C--N 1.338 0.662 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.011 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.672 HG22 HD23 ' A' ' 60' ' ' LEU . 3.1 t -84.81 138.59 18.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.006 0.522 . . . . 0.0 110.987 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.68 -66.5 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.433 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.26 169.66 17.27 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.81 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.58 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -159.33 174.22 36.21 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 119.761 -1.209 . . . . 0.0 114.916 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.581 ' O ' HD13 ' A' ' 45' ' ' ILE . 2.1 mm100 -153.75 139.23 17.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.139 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.864 HD12 ' CD2' ' A' ' 56' ' ' TYR . 5.9 mm -124.36 133.7 68.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.855 0.359 . . . . 0.0 111.373 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.6 mt -114.45 115.91 50.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.77 160.45 39.22 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.905 -178.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.33 -75.77 0.07 OUTLIER Glycine 0 C--N 1.332 0.357 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.565 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.6 tt -113.39 108.99 51.7 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -87.34 117.57 1.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 116.628 1.741 . . . . 0.0 116.628 -175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.6 22.35 10.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.541 -1.663 . . . . 0.0 107.622 175.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.779 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 76.69 31.49 0.56 Allowed 'General case' 0 C--N 1.345 0.391 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.92 -178.856 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -122.03 26.97 8.29 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.637 177.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.669 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 1.0 OUTLIER -53.14 147.5 9.69 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.527 -178.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.91 118.15 32.68 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.919 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.864 ' CD2' HD12 ' A' ' 45' ' ' ILE . 44.6 m-85 -106.05 134.07 49.76 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 121.311 0.577 . . . . 0.0 112.397 -178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -130.92 126.53 36.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.51 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.589 HD21 HG13 ' A' ' 19' ' ' VAL . 1.6 mp -149.65 154.55 38.79 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.619 HD13 ' HB2' ' A' ' 74' ' ' ASN . 1.3 mm -112.46 127.9 69.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.97 178.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.986 HD22 HD21 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -130.46 169.23 15.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.954 0.407 . . . . 0.0 111.872 -178.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.9 m -100.45 133.76 44.39 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.328 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.996 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -147.34 138.11 23.53 Favored 'General case' 0 C--O 1.231 0.119 0 O-C-N 123.547 0.529 . . . . 0.0 112.101 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.569 ' HB3' ' HA ' ' A' ' 70' ' ' SER . 0.4 OUTLIER -135.22 164.34 27.92 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.586 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -88.78 -18.21 28.2 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.31 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.4 p -150.55 146.44 19.71 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 111.266 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.19 -26.01 49.93 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.224 2.616 . . . . 0.0 113.292 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -86.73 2.99 46.75 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -129.19 167.13 18.06 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.519 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.7 m-85 -54.72 159.24 2.29 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.569 ' HA ' ' HB3' ' A' ' 63' ' ' LYS . 11.9 m -117.61 143.44 46.13 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.067 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.485 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 2.8 mmmt -116.01 166.01 12.48 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.852 0.358 . . . . 0.0 111.094 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -91.86 146.99 23.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.32 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.691 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 22.0 m-85 -141.23 139.91 33.85 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.984 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.619 ' HB2' HD13 ' A' ' 59' ' ' ILE . 6.2 t-20 -110.24 125.76 53.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.845 0.355 . . . . 0.0 110.51 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.918 HG12 ' HA ' ' A' ' 91' ' ' PHE . 6.0 m -128.71 153.69 38.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.424 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.22 110.37 31.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.881 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.826 HG21 ' HB2' ' A' ' 26' ' ' ALA . 1.7 t -115.51 128.17 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.039 0.447 . . . . 0.0 111.504 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.425 HD12 ' N ' ' A' ' 79' ' ' GLU . 12.1 tp -102.16 131.53 48.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.046 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -90.94 129.79 36.93 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.207 179.485 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -125.7 134.18 51.9 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.083 0.468 . . . . 0.0 111.896 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -92.31 -30.63 15.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.966 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 12.2 m -59.58 -34.88 73.28 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.542 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -104.46 4.85 33.65 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.414 0.153 . . . . 0.0 111.414 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 46.89 57.32 5.74 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 111.466 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 72.4 p -176.0 176.12 1.83 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.313 0.578 . . . . 0.0 111.307 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.714 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -92.72 170.95 9.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.723 178.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.55 119.92 8.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.782 0.325 . . . . 0.0 111.235 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.561 ' HB3' ' HG2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -83.15 106.01 14.59 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.39 -51.4 25.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.395 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.67 147.69 27.68 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.9 0.381 . . . . 0.0 111.992 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.918 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.2 t80 -124.73 121.7 35.39 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.903 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.487 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 11.2 t -131.85 141.85 43.05 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.404 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.487 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 84.2 Cg_endo -83.74 138.33 8.18 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.742 2.295 . . . . 0.0 111.61 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 94' ' ' LEU . 0.3 OUTLIER -109.65 40.87 1.79 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.648 0.261 . . . . 0.0 111.568 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 13.8 p90 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.047 -0.978 . . . . 0.0 111.411 179.778 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 CA-C-O 120.13 -0.261 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.24 132.9 31.0 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.834 2.356 . . . . 0.0 112.34 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.93 121.8 1.01 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.726 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -84.77 -176.52 2.5 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.959 2.439 . . . . 0.0 112.622 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.53 -60.31 0.99 Allowed 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.771 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.6 mt -121.72 2.06 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.821 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -106.33 149.07 16.57 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.627 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -136.09 124.62 23.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.772 0.32 . . . . 0.0 111.035 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.13 143.29 39.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.223 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.61 153.73 31.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.467 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.47 -173.48 14.97 Favored Glycine 0 C--N 1.331 0.29 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.319 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.918 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -96.95 156.8 3.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 117.201 0.501 . . . . 0.0 111.428 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.0 m -88.5 154.62 20.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.211 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.9 -20.66 27.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.146 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -54.92 -35.62 64.36 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.523 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.423 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 12.8 t70 -59.0 114.98 10.3 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.501 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.3 Cg_endo -59.27 -27.52 85.23 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.365 2.71 . . . . 0.0 114.216 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.563 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 7.9 mmp_? -78.42 -47.73 16.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.323 0.582 . . . . 0.0 110.157 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.918 HG21 HG13 ' A' ' 12' ' ' ILE . 55.3 t -58.31 -40.45 77.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.392 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.401 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -73.57 -36.07 65.55 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.3 pt-20 -76.21 -36.22 58.71 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.223 0.535 . . . . 0.0 110.71 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.698 HG12 HD12 ' A' ' 86' ' ' LEU . 22.5 mt -74.59 -36.94 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.056 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -66.28 -52.73 44.49 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.118 0.485 . . . . 0.0 110.334 178.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.0 pt-20 -55.16 -43.95 74.73 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.024 178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 30.8 t80 -58.32 -35.32 71.7 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.934 178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -60.37 -47.33 86.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.839 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.4 tp -65.56 -44.04 88.0 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.116 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -72.33 -18.48 61.76 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.594 ' HB3' HD12 ' A' ' 88' ' ' LEU . 4.3 tp60 -83.58 -37.7 22.59 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.454 0.169 . . . . 0.0 111.039 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.501 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 0.5 OUTLIER -105.03 126.54 52.17 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.61 -0.268 . . . . 0.0 110.535 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -172.67 43.47 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.86 0.362 . . . . 0.0 111.659 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.45 -37.52 83.09 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.817 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.67 4.82 26.22 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 65.64 97.13 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.415 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.1 OUTLIER -134.6 153.94 51.72 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.7 178.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.14 124.47 73.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.946 HD11 ' HB2' ' A' ' 60' ' ' LEU . 9.1 tp -90.0 117.32 28.71 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.409 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.45 ' HB2' ' HE2' ' A' ' 63' ' ' LYS . . . -65.79 -31.18 72.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.314 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 160.38 171.91 26.93 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.8 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.705 HG22 HD23 ' A' ' 60' ' ' LEU . 2.5 t -75.1 128.56 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 122.798 0.439 . . . . 0.0 110.976 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -100.76 -62.78 1.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.589 -179.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.51 167.41 27.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.538 ' HA3' ' CD2' ' A' ' 58' ' ' LEU . . . -156.51 169.4 33.89 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 119.988 -1.101 . . . . 0.0 114.279 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 57' ' ' ASN . 9.0 mt-30 -141.91 137.74 31.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.017 -0.591 . . . . 0.0 110.225 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.634 HG13 HD12 ' A' ' 12' ' ' ILE . 40.0 mt -122.66 124.64 71.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 111.472 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.3 mt -107.55 115.07 47.93 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.846 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.565 ' HG3' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -138.16 162.98 32.84 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.95 -178.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.2 -68.94 0.02 OUTLIER Glycine 0 C--N 1.331 0.253 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.567 ' O ' HG23 ' A' ' 49' ' ' ILE . 3.7 tt -120.53 109.11 36.75 Favored Pre-proline 0 C--O 1.233 0.201 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -88.93 116.8 0.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 N-CA-C 116.394 1.652 . . . . 0.0 116.394 -175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.3 23.76 10.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.681 -1.599 . . . . 0.0 107.611 175.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.803 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 75.14 33.02 0.74 Allowed 'General case' 0 C--N 1.344 0.334 0 CA-C-N 114.623 -1.172 . . . . 0.0 111.109 -178.181 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 7.9 p-10 -122.9 27.3 7.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.904 178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.505 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 0.9 OUTLIER -56.62 144.59 31.48 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -177.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.01 121.51 40.01 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.316 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.505 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 12.9 m-85 -107.32 139.85 41.15 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.256 0.551 . . . . 0.0 112.239 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 44' ' ' GLN . 48.3 t30 -137.12 111.05 8.23 Favored 'General case' 0 C--O 1.225 -0.207 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.705 HD21 HG13 ' A' ' 19' ' ' VAL . 4.9 mp -134.76 166.23 23.44 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.4 mm -127.73 126.94 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.448 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.946 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -130.66 169.38 15.72 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.95 0.405 . . . . 0.0 111.739 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.9 m -95.64 140.21 30.79 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.356 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.913 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -154.8 147.11 23.89 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -149.87 166.89 28.17 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.101 179.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -102.15 -5.26 24.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.06 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -150.35 148.2 23.62 Favored Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.42 -34.25 54.84 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.082 2.522 . . . . 0.0 112.51 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -90.59 14.28 13.65 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -113.12 167.15 10.77 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.241 0.544 . . . . 0.0 112.002 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.594 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.8 m-85 -64.56 179.13 0.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.08 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.55 119.83 25.57 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 71' ' ' LYS . 0.3 OUTLIER -107.44 165.79 11.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.03 0.443 . . . . 0.0 111.829 -178.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -90.87 146.68 23.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.848 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.839 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 16.2 m-85 -141.46 137.55 32.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.327 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.506 ' HB2' ' HG ' ' A' ' 94' ' ' LEU . 48.7 t-20 -110.38 130.19 55.6 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.776 0.322 . . . . 0.0 110.799 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 91' ' ' PHE . 30.5 m -129.07 146.28 34.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 112.256 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 89' ' ' VAL . 12.1 t -105.58 110.5 31.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 t -118.73 139.26 46.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.946 0.403 . . . . 0.0 111.491 -178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 79' ' ' GLU . 9.5 tp -114.94 127.15 55.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.973 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.51 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -90.61 126.58 36.0 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.783 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.88 135.14 51.58 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.501 ' HB2' ' HB3' ' A' ' 52' ' ' TRP . . . -90.22 -31.2 17.12 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.824 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.75 -39.46 71.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.003 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.19 -7.83 34.67 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.251 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.17 50.5 11.71 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-O 121.061 0.458 . . . . 0.0 111.008 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -172.27 -175.53 1.43 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.908 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.698 HD12 HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -97.27 165.87 11.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.284 179.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.86 122.91 10.77 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.949 0.404 . . . . 0.0 111.038 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -82.73 112.6 19.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.056 -179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.415 ' HB ' ' HB ' ' A' ' 76' ' ' VAL . 2.7 t -75.35 -49.27 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.712 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -161.79 155.53 21.56 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.587 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.3 t80 -123.21 124.07 42.21 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.392 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.566 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 4.9 t -132.25 142.61 45.65 Favored Pre-proline 0 N--CA 1.468 0.462 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 83.8 Cg_endo -78.3 138.52 15.92 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.668 2.246 . . . . 0.0 111.885 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.506 ' HG ' ' HB2' ' A' ' 74' ' ' ASN . 0.3 OUTLIER -115.64 39.49 2.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.698 0.285 . . . . 0.0 111.458 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.8 p90 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.534 -0.746 . . . . 0.0 111.237 179.626 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 CA-C-O 120.147 -0.252 . . . . 0.0 112.693 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.32 148.85 34.6 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.928 2.419 . . . . 0.0 112.575 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.21 -159.71 9.42 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.818 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.14 -175.0 2.32 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.341 2.694 . . . . 0.0 112.272 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -92.82 -66.02 0.96 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.779 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -147.08 57.39 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.531 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.69 -47.05 0.5 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.359 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -117.82 140.23 49.98 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 120.953 0.406 . . . . 0.0 112.018 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.8 t -124.38 136.21 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.409 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.7 pt -138.76 165.9 23.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.03 -176.48 22.06 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.679 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.097 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -112.87 156.98 13.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 117.803 0.801 . . . . 0.0 112.632 -179.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.7 t -76.55 152.16 36.08 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.097 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.9 p -62.56 -27.63 43.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.655 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -47.1 -38.42 11.34 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.336 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 12.6 t70 -57.13 114.03 7.31 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.352 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.48 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 12.1 Cg_endo -55.75 -31.58 80.91 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.613 2.876 . . . . 0.0 114.328 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.535 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 0.1 OUTLIER -74.95 -44.74 46.77 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.196 0.522 . . . . 0.0 110.251 179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.097 HG21 HG13 ' A' ' 12' ' ' ILE . 54.3 t -60.94 -42.6 93.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.653 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -72.72 -37.06 67.9 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.922 -179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 11.4 pt-20 -78.57 -39.37 37.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.803 0.335 . . . . 0.0 111.398 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.423 HD12 ' CE2' ' A' ' 56' ' ' TYR . 43.0 mt -73.22 -32.13 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.769 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.616 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -69.5 -48.18 61.43 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.45 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -50.59 -49.7 55.75 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.764 178.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.626 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 41.7 t80 -58.32 -37.92 76.06 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.279 178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 23' ' ' ALA . . . -55.64 -39.28 70.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.028 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.894 HD22 ' HB3' ' A' ' 37' ' ' LEU . 2.0 tp -74.45 -47.86 30.97 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.608 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.626 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -67.14 -18.3 65.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -178.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.53 ' CD ' ' HB3' ' A' ' 88' ' ' LEU . 0.9 OUTLIER -77.79 -31.01 51.59 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.568 0.223 . . . . 0.0 111.002 179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -75.03 -118.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.101 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 65.76 34.0 7.79 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.36 -38.49 41.83 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.864 0.364 . . . . 0.0 110.213 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 0.6 OUTLIER -117.7 10.14 13.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.116 179.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 14.5 t-20 69.47 95.98 0.07 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.028 0.531 . . . . 0.0 111.986 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.49 ' HA ' ' CD2' ' A' ' 64' ' ' HIS . 0.1 OUTLIER -138.46 146.85 42.58 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.563 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.29 124.72 72.84 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.978 HD11 ' HB2' ' A' ' 60' ' ' LEU . 8.5 tp -90.04 115.86 27.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.153 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.77 -28.29 68.91 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.408 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.8 173.92 32.08 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 119.56 -1.305 . . . . 0.0 114.12 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.629 HG22 HD23 ' A' ' 60' ' ' LEU . 2.3 t -79.32 137.79 21.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 115.228 -0.486 . . . . 0.0 110.532 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.54 -63.93 1.33 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.485 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.02 163.8 33.11 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.484 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.757 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -161.32 175.37 37.93 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.546 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' ASN . 50.7 mm-40 -149.43 155.53 40.57 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.707 -0.746 . . . . 0.0 110.384 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.651 ' CD1' HG21 ' A' ' 12' ' ' ILE . 4.2 mp -137.2 122.83 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.735 0.302 . . . . 0.0 110.956 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.0 mt -108.08 118.4 55.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.987 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.457 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -137.32 163.08 31.85 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.897 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -139.56 -69.26 0.04 OUTLIER Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 49' ' ' ILE . 7.4 tp -120.28 111.89 34.87 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -87.53 114.81 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 N-CA-C 116.357 1.637 . . . . 0.0 116.357 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -121.85 22.98 10.27 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.404 -1.726 . . . . 0.0 107.209 175.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.752 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.75 33.89 1.25 Allowed 'General case' 0 C--N 1.344 0.345 0 CA-C-N 114.618 -1.174 . . . . 0.0 111.283 -177.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 15.5 m-20 -121.32 26.81 8.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.423 177.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.457 ' OD1' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -58.56 143.98 44.26 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.322 -178.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.434 ' HE1' HD22 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -96.2 125.74 40.93 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.316 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.423 ' CE2' HD12 ' A' ' 22' ' ' ILE . 15.8 m-85 -109.46 129.84 55.53 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.908 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.434 ' O ' ' N ' ' A' ' 44' ' ' GLN . 12.6 t-20 -126.5 114.19 17.8 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.763 HD21 HG13 ' A' ' 19' ' ' VAL . 4.1 mp -142.07 161.1 38.85 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.734 HD13 ' HA ' ' A' ' 74' ' ' ASN . 3.5 mm -119.9 131.49 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 114.429 -1.26 . . . . 0.0 109.404 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.978 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -135.21 165.89 24.36 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.955 0.407 . . . . 0.0 112.083 -179.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.3 m -96.38 136.34 37.0 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.95 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.936 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -148.06 142.59 26.47 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -144.05 166.07 26.02 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.708 179.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.49 ' CD2' ' HA ' ' A' ' 35' ' ' LEU . 47.6 m80 -104.84 -3.15 23.84 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.121 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.41 145.96 20.16 Favored Pre-proline 0 N--CA 1.465 0.317 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.13 -29.65 47.59 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.284 2.656 . . . . 0.0 112.598 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -98.82 14.55 28.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.843 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -120.9 167.15 12.86 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.13 0.49 . . . . 0.0 111.604 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 6.7 m-85 -69.45 160.57 31.15 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.0 m -116.6 135.76 53.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.127 177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 95' ' ' PHE . 3.5 mmmm -112.04 165.35 12.2 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.753 0.311 . . . . 0.0 110.709 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -89.13 153.15 21.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.742 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.85 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 14.7 m-85 -139.39 142.17 37.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.778 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.734 ' HA ' HD13 ' A' ' 59' ' ' ILE . 53.9 t-20 -111.83 118.76 36.44 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.909 HG12 ' HA ' ' A' ' 91' ' ' PHE . 29.7 m -130.71 151.0 35.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.96 118.61 57.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.731 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.419 HG21 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -117.3 144.48 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 121.111 0.482 . . . . 0.0 111.819 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 79' ' ' GLU . 5.9 tp -120.33 125.65 48.57 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.943 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.9 tt0 -90.05 120.1 30.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.539 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -125.85 133.91 51.8 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -88.58 -37.22 15.84 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.196 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -37.83 87.27 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.464 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.88 -15.78 58.76 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.761 178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 72.46 31.33 1.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.56 -165.15 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.286 0.565 . . . . 0.0 111.88 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.733 HD22 ' H ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -94.3 169.12 10.46 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.022 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.501 ' NZ ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -148.72 138.03 21.78 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.93 0.395 . . . . 0.0 111.952 179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.542 HD22 ' N ' ' A' ' 89' ' ' VAL . 0.2 OUTLIER -97.44 109.31 22.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.862 179.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.542 ' N ' HD22 ' A' ' 88' ' ' LEU . 1.9 t -74.54 -54.35 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.449 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -145.14 145.73 31.5 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.909 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.2 t80 -125.22 117.61 24.22 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.877 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.622 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.6 t -132.7 144.44 52.95 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.969 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.622 ' HD2' HG12 ' A' ' 92' ' ' VAL . 89.3 Cg_endo -87.43 138.5 4.65 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.974 2.449 . . . . 0.0 112.322 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.479 ' CD2' ' HB2' ' A' ' 74' ' ' ASN . 0.4 OUTLIER -98.85 32.52 2.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.321 179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.423 ' HB3' ' HE2' ' A' ' 71' ' ' LYS . 10.4 p90 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.593 -0.718 . . . . 0.0 111.129 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 CA-C-O 120.219 -0.212 . . . . 0.0 112.682 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.21 164.5 35.17 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.801 2.334 . . . . 0.0 112.641 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 139.85 90.53 0.19 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.754 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.65 -174.06 2.12 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.161 2.574 . . . . 0.0 112.198 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.95 -68.24 0.94 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.099 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -143.85 56.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.996 0.427 . . . . 0.0 111.19 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -146.62 132.8 4.57 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.633 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -142.19 124.38 15.49 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.837 0.351 . . . . 0.0 111.251 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.15 144.07 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.958 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.4 pt -111.03 158.14 11.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.964 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.52 -163.88 14.56 Favored Glycine 0 C--N 1.335 0.488 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.219 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.901 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -101.49 167.39 2.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 117.493 0.647 . . . . 0.0 111.237 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -101.51 157.73 16.59 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.075 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.81 -22.43 30.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -53.98 -35.88 62.3 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.479 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.455 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 16.3 t70 -59.64 113.5 7.27 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.633 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.455 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 19.1 Cg_endo -58.16 -27.83 81.66 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.304 2.669 . . . . 0.0 114.06 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.517 ' O ' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -77.07 -48.67 17.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.159 0.504 . . . . 0.0 110.27 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.901 HG21 HG13 ' A' ' 12' ' ' ILE . 52.0 t -57.67 -41.56 79.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.93 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.02 -40.66 78.51 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 18' ' ' ARG . 12.9 pt-20 -72.93 -40.02 65.79 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.995 0.426 . . . . 0.0 110.676 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 18' ' ' ARG . 18.2 mt -65.77 -40.03 86.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.564 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.048 0.452 . . . . 0.0 110.248 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.48 ' CG ' ' N ' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -51.94 -52.78 47.86 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.74 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 25.3 t80 -56.86 -35.38 68.83 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.725 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.29 -48.34 80.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.372 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.833 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.7 tp -68.63 -46.9 67.99 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.586 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.555 ' CG ' ' HA ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -68.89 -18.2 64.09 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.44 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 5.8 tp60 -84.87 -37.3 20.8 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -71.56 -103.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.415 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 56.4 36.16 27.08 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -37.74 88.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.804 0.335 . . . . 0.0 110.934 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.436 ' H ' ' HG3' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -123.7 13.23 9.29 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.482 179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 68.15 86.89 0.13 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.877 0.471 . . . . 0.0 111.771 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.505 HD21 ' CZ ' ' A' ' 91' ' ' PHE . 0.2 OUTLIER -125.91 158.19 35.8 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.835 178.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.542 ' HB ' ' HE3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -118.39 125.13 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 -177.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.977 HD12 ' HB2' ' A' ' 62' ' ' ALA . 9.9 tp -90.4 113.5 25.43 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.966 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.17 -27.06 68.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.735 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 161.38 166.77 20.77 Favored Glycine 0 C--N 1.337 0.633 0 C-N-CA 119.712 -1.232 . . . . 0.0 114.09 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.806 HG22 HD23 ' A' ' 60' ' ' LEU . 10.1 t -77.23 137.07 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.588 0.355 . . . . 0.0 110.646 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -106.1 -67.9 0.91 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.154 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -163.09 173.53 13.4 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.558 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.52 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -170.14 -163.69 24.61 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 119.807 -1.187 . . . . 0.0 114.255 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 57' ' ' ASN . 41.0 mt-30 -153.94 137.71 16.15 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.075 -0.562 . . . . 0.0 111.136 -178.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.695 HG22 ' ND2' ' A' ' 54' ' ' ASN . 7.5 mt -114.97 126.16 72.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.112 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 65.3 mt -109.64 117.62 54.99 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.606 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.01 162.19 33.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.935 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -135.29 -71.99 0.07 OUTLIER Glycine 0 C--N 1.334 0.431 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 49' ' ' ILE . 12.6 tt -120.11 112.27 34.85 Favored Pre-proline 0 C--O 1.233 0.225 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.98 114.54 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 N-CA-C 115.891 1.458 . . . . 0.0 115.891 -175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.97 20.37 10.78 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.227 -1.806 . . . . 0.0 107.3 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.765 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 71.87 32.93 1.79 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.215 -178.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 5.0 p-10 -122.16 26.98 8.23 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.542 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.695 ' ND2' HG22 ' A' ' 45' ' ' ILE . 0.3 OUTLIER -57.34 148.03 24.15 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.44 ' CE1' HD13 ' A' ' 78' ' ' LEU . 0.1 OUTLIER -98.95 132.79 44.01 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.981 179.049 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.815 ' HB2' HG23 ' A' ' 77' ' ' VAL . 32.3 m-85 -119.22 135.46 54.67 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.23 0.538 . . . . 0.0 112.022 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.462 ' O ' ' N ' ' A' ' 44' ' ' GLN . 49.0 t30 -130.73 111.85 12.54 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.845 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.624 HD21 HD11 ' A' ' 12' ' ' ILE . 3.9 mp -141.7 163.81 31.91 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 -177.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.523 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.3 mm -122.72 138.18 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 114.036 -1.438 . . . . 0.0 109.345 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.962 HD22 HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -141.61 168.93 18.6 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.779 0.323 . . . . 0.0 111.84 -179.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.8 m -92.1 138.5 31.48 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.224 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.977 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -156.38 146.61 21.4 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -149.67 164.49 35.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.675 178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.424 ' CE1' ' HB2' ' A' ' 35' ' ' LEU . 60.5 m80 -102.17 -2.76 28.62 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.93 144.54 19.18 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-O 121.031 0.443 . . . . 0.0 112.132 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.23 -33.01 50.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.121 2.547 . . . . 0.0 112.108 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -90.45 14.63 12.48 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.671 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -117.87 167.09 11.73 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.2 0.524 . . . . 0.0 111.725 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.562 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 6.7 m-85 -64.77 -176.4 0.25 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.402 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.421 ' C ' ' HD3' ' A' ' 71' ' ' LYS . 0.8 OUTLIER -130.61 122.62 27.8 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.231 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HD3' ' C ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -111.06 169.71 8.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.936 0.398 . . . . 0.0 111.643 -178.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.436 ' C ' ' HB2' ' A' ' 94' ' ' LEU . 10.6 m-85 -92.75 149.57 21.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.578 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.791 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 24.8 m-85 -144.0 137.87 28.0 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.767 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.51 ' HB2' HD11 ' A' ' 94' ' ' LEU . 51.4 t30 -109.4 126.48 53.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.793 0.33 . . . . 0.0 110.412 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.769 HG12 ' HA ' ' A' ' 91' ' ' PHE . 0.1 OUTLIER -127.73 146.17 33.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.483 -178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.24 117.61 48.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.185 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.738 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -119.1 135.24 60.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.066 0.46 . . . . 0.0 112.146 -178.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 79' ' ' GLU . 5.4 tp -117.35 124.45 48.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.333 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.45 124.36 34.41 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.831 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.55 149.72 49.24 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -100.2 -27.39 13.54 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.968 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 m -54.53 -43.39 71.88 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.61 0.243 . . . . 0.0 110.932 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.14 -6.93 43.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.061 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 61.03 50.33 5.12 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 120.769 0.318 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -174.47 -163.19 0.14 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.112 0.482 . . . . 0.0 111.266 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.72 HD22 ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -104.11 170.31 7.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.076 179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.564 ' HE3' HD23 ' A' ' 78' ' ' LEU . 2.2 tmmm? -148.27 117.98 7.08 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.817 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -79.04 106.74 11.29 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.563 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.61 -54.38 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.713 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.47 151.32 40.18 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.09 0.471 . . . . 0.0 112.232 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.769 ' HA ' HG12 ' A' ' 75' ' ' VAL . 3.2 t80 -127.04 120.33 28.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.692 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.41 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 12.2 t -132.32 138.99 33.47 Favored Pre-proline 0 CA--C 1.529 0.138 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.471 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 94.6 Cg_endo -82.88 135.61 7.77 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.847 2.365 . . . . 0.0 111.838 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 74' ' ' ASN . 1.4 mt -109.68 44.78 1.15 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.765 0.317 . . . . 0.0 111.297 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.471 ' CE1' ' HB2' ' A' ' 93' ' ' PRO . 43.8 p90 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.092 -0.956 . . . . 0.0 111.132 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 CA-C-O 120.165 -0.241 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.94 165.34 30.32 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.95 2.434 . . . . 0.0 112.733 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 124.12 -102.53 0.72 Allowed Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.661 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.617 ' HG3' ' HB3' ' A' ' 8' ' ' GLU . 85.7 Cg_endo -84.74 174.26 7.71 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.007 2.471 . . . . 0.0 112.627 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.73 -28.73 6.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.655 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.9 mm -111.42 -55.48 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 116.726 -0.216 . . . . 0.0 111.012 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.62 169.13 35.61 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.172 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.617 ' HB3' ' HG3' ' A' ' 4' ' ' PRO . 2.7 pt-20 -146.96 167.89 22.85 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.834 0.35 . . . . 0.0 111.127 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.41 110.75 29.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.689 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -144.21 147.84 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.242 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 43' ' ' GLY . . . 108.91 -171.47 15.49 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.466 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.857 HG13 HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -96.64 161.0 2.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 121.05 0.452 . . . . 0.0 111.596 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.75 153.83 20.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.981 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.39 -21.66 29.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.961 0.41 . . . . 0.0 109.974 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.55 -36.34 61.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.646 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.442 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 10.7 t70 -59.72 114.82 10.51 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.489 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.2 Cg_endo -59.4 -30.08 91.77 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.542 2.828 . . . . 0.0 114.193 -178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 4.6 mpt_? -76.5 -43.67 38.51 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.257 0.551 . . . . 0.0 110.535 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.857 HG21 HG13 ' A' ' 12' ' ' ILE . 47.2 t -62.19 -42.32 94.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.329 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -71.3 -36.03 71.51 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.449 ' HG3' HG13 ' A' ' 22' ' ' ILE . 12.2 pt-20 -76.29 -38.25 56.4 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.228 0.537 . . . . 0.0 110.679 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.804 HG12 HD12 ' A' ' 86' ' ' LEU . 85.6 mt -75.46 -32.64 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.325 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.526 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -69.77 -51.1 36.92 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.382 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 11.3 pt-20 -56.16 -43.39 78.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.703 178.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.659 ' HA ' ' HG2' ' A' ' 28' ' ' LYS . 23.7 t80 -57.31 -38.27 73.76 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.731 178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.477 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -57.05 -46.18 82.64 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.107 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.924 HD22 ' HB3' ' A' ' 37' ' ' LEU . 3.1 tp -69.18 -45.03 70.98 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.635 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.659 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -71.12 -17.78 62.55 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.68 ' HB3' HD12 ' A' ' 88' ' ' LEU . 3.9 tp-100 -84.41 -38.59 20.05 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.401 ' HB2' HD11 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -97.66 124.98 42.18 Favored 'General case' 0 N--CA 1.461 0.111 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -162.71 40.81 0.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.756 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -37.87 34.53 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.279 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 16.0 mt-30 -95.34 -16.7 22.18 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.955 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 33' ' ' GLN . 16.6 t30 72.62 91.58 0.09 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.045 0.45 . . . . 0.0 111.903 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.445 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -140.75 162.64 34.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.11 178.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.77 124.74 73.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -177.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.975 HD11 ' HB2' ' A' ' 60' ' ' LEU . 12.0 tp -83.58 118.91 24.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.206 178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.415 ' H ' ' HA ' ' A' ' 62' ' ' ALA . . . -65.31 -30.69 71.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.831 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.9 166.29 15.09 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 119.983 -1.103 . . . . 0.0 113.843 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.765 HG22 HD23 ' A' ' 60' ' ' LEU . 18.2 t -68.5 130.14 33.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 115.516 -0.342 . . . . 0.0 110.325 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.95 -56.91 2.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.505 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -148.81 154.59 39.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.411 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.59 ' HA3' HD23 ' A' ' 58' ' ' LEU . . . -152.73 173.3 31.75 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 119.849 -1.167 . . . . 0.0 114.325 -179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' ASN . 18.1 mt-30 -146.97 159.54 43.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.798 -0.701 . . . . 0.0 109.98 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 19' ' ' VAL . 14.7 mt -144.0 131.14 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.714 0.293 . . . . 0.0 111.473 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.5 mt -107.63 115.56 49.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.323 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 162.66 32.52 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.65 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.43 -87.46 0.08 OUTLIER Glycine 0 C--N 1.331 0.281 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 49' ' ' ILE . 1.5 mt -104.3 108.52 60.57 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 176.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.96 115.91 3.35 Favored 'Trans proline' 0 C--N 1.347 0.453 0 N-CA-C 116.491 1.689 . . . . 0.0 116.491 -175.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.35 19.91 11.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.446 -1.706 . . . . 0.0 107.325 175.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.763 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.08 38.28 0.91 Allowed 'General case' 0 C--N 1.345 0.408 0 CA-C-N 114.488 -1.233 . . . . 0.0 111.631 -178.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.36 26.33 8.47 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.597 -1.183 . . . . 0.0 109.603 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -49.1 136.55 14.66 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.394 0.678 . . . . 0.0 112.609 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.635 ' CE1' HD13 ' A' ' 78' ' ' LEU . 3.8 m-85 -99.86 126.34 45.96 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.73 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.659 ' HB2' HG23 ' A' ' 77' ' ' VAL . 6.0 m-85 -109.38 144.83 37.05 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -177.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 44' ' ' GLN . 9.0 t-20 -144.14 112.26 6.33 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.124 -0.944 . . . . 0.0 108.808 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.708 HD21 HG13 ' A' ' 19' ' ' VAL . 5.0 mp -138.16 168.78 19.01 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 2.7 mm -126.85 120.61 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-N 114.198 -1.364 . . . . 0.0 109.565 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.975 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -127.03 164.1 22.27 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.94 0.4 . . . . 0.0 111.279 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.8 m -94.39 141.65 28.33 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.738 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.895 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -152.05 148.09 27.27 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.511 0.507 . . . . 0.0 112.23 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -150.54 164.57 35.65 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.726 179.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -93.96 -11.64 30.47 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.844 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.2 p -149.7 143.1 16.41 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 111.935 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.88 -22.81 48.32 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.507 2.805 . . . . 0.0 113.539 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -89.6 3.32 52.94 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -128.04 166.95 17.43 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-O 121.377 0.608 . . . . 0.0 112.526 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 5.6 m-85 -53.46 167.46 0.21 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.834 -1.076 . . . . 0.0 113.749 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -125.69 134.1 51.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.519 -1.219 . . . . 0.0 108.825 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.454 ' HA ' ' HD2' ' A' ' 71' ' ' LYS . 23.9 mmmt -107.76 167.98 9.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.067 0.461 . . . . 0.0 111.819 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . 95.7 m-85 -88.37 151.31 22.68 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.621 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.873 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 14.0 m-85 -142.42 138.19 30.91 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.865 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.524 ' HB2' ' CD1' ' A' ' 59' ' ' ILE . 8.1 t-20 -110.82 119.68 39.9 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.623 ' CG1' HD21 ' A' ' 88' ' ' LEU . 41.4 t -130.94 149.59 33.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-O 121.049 0.452 . . . . 0.0 111.671 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.413 HG22 ' ND2' ' A' ' 57' ' ' ASN . 33.6 t -109.24 129.79 63.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.273 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -128.85 146.89 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.016 0.436 . . . . 0.0 111.97 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.635 HD13 ' CE1' ' A' ' 55' ' ' TYR . 12.0 tp -118.58 126.25 51.57 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.442 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -88.77 128.04 35.62 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.901 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -125.03 130.14 51.72 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 52' ' ' TRP . . . -89.45 -35.79 15.79 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.324 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 32.2 m -61.88 -35.48 78.46 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.823 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.55 -7.3 53.23 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.973 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 m120 55.71 47.43 20.52 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 122.646 0.379 . . . . 0.0 111.411 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.4 t -174.04 -169.0 0.44 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.268 0.556 . . . . 0.0 111.167 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.804 HD12 HG12 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -105.14 168.15 9.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.925 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -147.05 132.67 18.8 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.973 0.416 . . . . 0.0 111.449 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.68 HD12 ' HB3' ' A' ' 29' ' ' GLN . 0.1 OUTLIER -85.96 121.57 28.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.822 179.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.566 HG23 ' HA ' ' A' ' 77' ' ' VAL . 2.4 t -85.02 -54.95 7.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.847 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.485 ' O ' HG13 ' A' ' 75' ' ' VAL . . . -160.82 134.14 6.62 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.251 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 75' ' ' VAL . 1.4 t80 -106.49 126.82 52.74 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.787 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.703 HG12 ' HD2' ' A' ' 93' ' ' PRO . 2.1 t -132.47 147.41 65.54 Favored Pre-proline 0 N--CA 1.466 0.329 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.45 -178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.703 ' HD2' HG12 ' A' ' 92' ' ' VAL . 61.5 Cg_endo -92.44 138.37 1.77 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.17 2.58 . . . . 0.0 112.826 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.451 HD23 ' CB ' ' A' ' 74' ' ' ASN . 0.4 OUTLIER -99.61 27.47 5.32 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.275 179.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.44 ' CB ' ' HE3' ' A' ' 71' ' ' LYS . 6.5 p90 . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.534 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 CA-C-O 120.1 -0.278 . . . . 0.0 112.652 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.15 132.84 28.96 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.836 2.357 . . . . 0.0 112.668 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.54 130.74 1.18 Allowed Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.794 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -84.45 176.26 6.55 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.877 2.385 . . . . 0.0 112.791 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.93 -45.34 0.86 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.461 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.76 -38.58 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.287 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.52 -133.37 3.32 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.778 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -128.7 136.94 51.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.729 0.3 . . . . 0.0 111.198 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -124.69 143.58 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.415 HD13 ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -114.45 160.59 13.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.76 -179.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -110.45 -157.29 15.67 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.51 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.102 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -96.45 167.3 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 117.185 0.492 . . . . 0.0 111.482 -179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.5 m -91.27 149.76 21.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.7 p -65.15 -19.04 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.506 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -57.43 -37.94 73.58 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.008 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 20' ' ' LYS . 18.4 t70 -57.99 113.63 6.87 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.031 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HA ' ' CD ' ' A' ' 20' ' ' LYS . 13.9 Cg_endo -56.17 -27.45 65.76 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.57 2.846 . . . . 0.0 114.321 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' HA ' ' HG2' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -79.73 -38.99 32.13 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.903 0.383 . . . . 0.0 110.873 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.102 HG21 HG13 ' A' ' 12' ' ' ILE . 45.1 t -67.31 -41.17 86.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.906 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.473 ' CD ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -73.86 -34.16 64.38 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.519 ' HG2' ' HA ' ' A' ' 18' ' ' ARG . 10.8 pt-20 -77.52 -37.77 50.27 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.064 0.459 . . . . 0.0 110.935 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.854 HG12 HD12 ' A' ' 86' ' ' LEU . 93.8 mt -75.92 -31.15 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.734 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -69.09 -51.82 34.76 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.041 0.448 . . . . 0.0 110.271 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 8.3 pt-20 -55.71 -47.34 77.01 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.203 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.64 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 27.0 t80 -55.57 -37.96 68.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.818 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.535 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.15 -51.16 68.98 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.234 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.915 HD22 ' HB3' ' A' ' 37' ' ' LEU . 2.7 tp -62.21 -44.98 95.36 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -72.59 -17.41 61.7 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.615 ' HB3' HD12 ' A' ' 88' ' ' LEU . 3.5 tp-100 -82.12 -38.55 24.6 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.617 ' HB2' ' CD1' ' A' ' 88' ' ' LEU . 2.9 t60 -108.23 129.18 55.21 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.814 0.34 . . . . 0.0 110.353 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -170.28 41.18 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.543 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -37.13 86.55 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.85 9.18 42.66 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.524 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 42.2 t30 52.78 88.14 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.592 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -127.99 157.63 40.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.515 179.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -117.59 124.15 72.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.915 ' HB3' HD22 ' A' ' 27' ' ' LEU . 1.5 tt -90.99 113.99 26.39 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.866 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.17 -28.01 69.11 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.825 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 60' ' ' LEU . . . 162.93 168.73 25.3 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 119.313 -1.422 . . . . 0.0 114.345 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.519 ' CG2' HD23 ' A' ' 60' ' ' LEU . 1.6 t -76.14 136.42 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 115.106 -0.547 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -103.61 -65.32 1.02 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.714 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -156.58 171.3 20.56 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.155 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.505 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -166.39 -174.39 35.7 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.651 -1.261 . . . . 0.0 114.558 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.413 ' N ' ' O ' ' A' ' 57' ' ' ASN . 25.7 mt-30 -151.24 143.17 23.89 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.864 -0.668 . . . . 0.0 111.128 -178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.703 HD12 HD12 ' A' ' 12' ' ' ILE . 2.9 mp -122.17 125.52 73.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.234 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.0 mt -107.41 118.89 56.04 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.77 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.412 ' HB3' ' OD1' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -136.47 163.16 31.15 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.975 -178.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -148.19 -66.72 0.01 OUTLIER Glycine 0 C--N 1.33 0.224 0 N-CA-C 108.534 -1.827 . . . . 0.0 108.534 177.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.601 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -120.46 108.27 37.88 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 175.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -90.53 117.51 0.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 116.212 1.582 . . . . 0.0 116.212 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 23.36 10.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.463 175.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.757 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 72.97 31.85 1.44 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.314 -178.122 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 20.9 m-20 -121.91 27.18 8.23 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.556 177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.412 ' OD1' ' HB3' ' A' ' 47' ' ' LYS . 0.2 OUTLIER -56.02 153.61 8.66 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.116 -178.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.15 122.44 45.34 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.983 -0.287 . . . . 0.0 111.437 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.584 ' CB ' HG23 ' A' ' 77' ' ' VAL . 17.7 m-85 -102.13 133.35 47.12 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.037 0.446 . . . . 0.0 111.953 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.413 ' O ' ' N ' ' A' ' 44' ' ' GLN . 39.8 t30 -132.91 111.68 11.25 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.067 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.642 HD21 HD11 ' A' ' 12' ' ' ILE . 4.0 mp -140.34 166.27 25.14 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.598 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.8 mm -124.12 129.44 74.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 114.295 -1.32 . . . . 0.0 109.439 178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.897 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -131.63 168.84 17.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.722 0.296 . . . . 0.0 111.504 -179.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.3 m -100.65 133.95 44.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.362 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.592 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -145.1 141.03 28.46 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 123.486 0.491 . . . . 0.0 112.186 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -139.74 166.55 24.31 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.751 179.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -93.2 -16.48 24.79 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.652 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.75 153.05 35.82 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-O 120.688 0.28 . . . . 0.0 111.659 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.21 -31.62 74.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.76 2.307 . . . . 0.0 112.111 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -96.16 14.38 24.18 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.463 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -115.37 167.32 10.97 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-O 121.105 0.478 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.514 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 9.3 m-85 -71.72 152.16 43.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.852 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.6 m -115.08 133.79 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.377 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 22.7 mmmt -113.99 165.08 12.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.801 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.41 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . 1.1 m-85 -87.69 148.45 24.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.532 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 59' ' ' ILE . 46.6 m-85 -138.62 140.75 39.04 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.881 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.683 ' HB2' HD23 ' A' ' 94' ' ' LEU . 31.4 t-20 -108.79 116.49 32.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 0.0 109.956 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.747 HG12 HD21 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -119.33 142.67 33.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.941 -178.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 t -107.52 120.16 58.37 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-N 115.405 -0.816 . . . . 0.0 108.959 178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.592 HG21 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -123.37 146.37 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 79' ' ' GLU . 9.3 tp -119.81 125.39 48.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.341 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.501 ' N ' HD12 ' A' ' 78' ' ' LEU . 1.7 tt0 -87.73 124.2 33.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.686 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -122.7 137.82 54.8 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.404 0.621 . . . . 0.0 112.545 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -96.43 -27.16 15.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.688 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.5 t -59.58 -41.35 90.02 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.323 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.34 9.1 43.98 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.509 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.81 57.51 5.93 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.498 0.319 . . . . 0.0 111.557 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 177.96 -177.99 0.23 Allowed 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.455 0.645 . . . . 0.0 111.613 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.854 HD12 HG12 ' A' ' 22' ' ' ILE . 0.4 OUTLIER -93.31 166.83 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.905 179.329 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.96 126.93 13.62 Favored 'General case' 0 CA--C 1.526 0.052 0 CA-C-O 120.797 0.332 . . . . 0.0 111.258 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.747 HD21 HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -86.7 114.77 23.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.197 179.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.73 -54.11 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.319 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -159.33 144.28 15.62 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.86 0.362 . . . . 0.0 111.856 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.638 ' HA ' HG13 ' A' ' 75' ' ' VAL . 6.0 t80 -112.77 127.32 56.12 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.82 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.456 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 5.2 t -132.46 139.78 35.84 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.456 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.2 Cg_endo -81.99 138.59 10.37 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.903 2.402 . . . . 0.0 112.217 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.683 HD23 ' HB2' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -107.6 25.44 11.49 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.64 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.586 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 30.4 p90 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.629 -0.7 . . . . 0.0 111.586 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.166 0 CA-C-O 120.074 -0.292 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -79.18 135.11 11.95 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.903 2.402 . . . . 0.0 112.629 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.49 150.3 17.14 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.629 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -90.38 164.75 4.47 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.178 2.585 . . . . 0.0 112.636 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.24 -46.84 3.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.911 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pt -125.73 32.53 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.098 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.15 -124.66 3.72 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.762 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -134.2 143.97 48.17 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.861 0.363 . . . . 0.0 111.604 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.1 t -100.92 143.33 14.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.87 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.3 150.86 33.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.091 0.472 . . . . 0.0 112.108 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.25 -160.95 9.13 Favored Glycine 0 C--N 1.333 0.408 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.486 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 1.069 HG13 HG21 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -98.0 166.84 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 117.706 0.753 . . . . 0.0 112.144 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 t -89.9 154.26 20.0 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.58 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.2 p -64.75 -23.3 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.725 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -51.62 -36.76 47.22 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.972 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.463 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 14.1 t70 -58.79 113.24 6.32 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.702 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 19.7 Cg_endo -58.31 -28.14 83.56 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.435 2.757 . . . . 0.0 113.994 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.551 ' HD2' ' CZ2' ' A' ' 52' ' ' TRP . 5.9 mmt-85 -76.85 -46.24 25.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.095 0.474 . . . . 0.0 110.124 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.069 HG21 HG13 ' A' ' 12' ' ' ILE . 69.8 t -59.51 -42.44 87.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.493 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -71.57 -37.78 71.03 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.597 ' CD ' HD11 ' A' ' 86' ' ' LEU . 8.0 pt-20 -77.18 -37.25 54.05 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.021 0.439 . . . . 0.0 111.191 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.755 HG12 HD12 ' A' ' 86' ' ' LEU . 27.2 mt -75.11 -31.52 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.016 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -70.6 -52.68 19.85 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.042 0.448 . . . . 0.0 109.962 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 21' ' ' GLU . 12.4 pt-20 -55.27 -41.78 72.69 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.718 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 28.4 t80 -59.65 -38.01 80.27 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.905 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.28 -43.53 88.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.113 179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 37' ' ' LEU . 3.6 tp -69.31 -48.06 62.65 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.376 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 25' ' ' PHE . 1.5 pttm -67.73 -25.4 65.63 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.611 ' HG2' ' CB ' ' A' ' 88' ' ' LEU . 5.0 tp60 -74.99 -27.91 60.34 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.513 ' ND1' HD21 ' A' ' 35' ' ' LEU . 10.0 t-160 -65.03 -95.53 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . 52.94 32.1 12.05 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 30' ' ' HIS . 0.0 OUTLIER -93.52 -38.02 11.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.937 0.399 . . . . 0.0 109.957 178.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.535 HE21 HD22 ' A' ' 35' ' ' LEU . 2.9 pt20 -113.79 -5.16 13.29 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.152 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.8 t30 67.51 91.94 0.08 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.953 0.501 . . . . 0.0 111.374 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.535 HD22 HE21 ' A' ' 33' ' ' GLN . 0.4 OUTLIER -133.58 160.14 38.36 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.436 179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.33 124.6 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.246 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.116 HD12 ' HB2' ' A' ' 62' ' ' ALA . 6.2 tp -92.17 113.94 26.35 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.385 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.18 72.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.324 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 169.88 163.28 23.65 Favored Glycine 0 C--N 1.34 0.777 0 C-N-CA 119.204 -1.474 . . . . 0.0 114.808 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.725 HG22 HD23 ' A' ' 60' ' ' LEU . 2.2 t -75.47 125.6 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.196 -0.502 . . . . 0.0 109.918 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -91.02 -62.63 1.41 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.57 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -162.75 171.68 16.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.025 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.596 ' HA3' ' CG ' ' A' ' 58' ' ' LEU . . . -171.1 -174.41 38.88 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 119.427 -1.368 . . . . 0.0 114.883 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 57' ' ' ASN . 28.3 mt-30 -146.82 168.79 20.54 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.451 -0.875 . . . . 0.0 111.172 -178.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.651 HD13 HG21 ' A' ' 12' ' ' ILE . 4.7 mp -142.86 132.49 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.419 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.6 mm -107.44 116.87 51.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.134 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.07 162.75 32.04 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.816 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -149.42 -70.78 0.01 OUTLIER Glycine 0 C--N 1.33 0.23 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -120.61 108.8 36.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 175.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -87.65 117.47 1.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 N-CA-C 116.395 1.652 . . . . 0.0 116.395 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.438 ' NE2' ' HB2' ' A' ' 53' ' ' ASP . 32.1 p-80 -121.7 23.47 10.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.605 -1.634 . . . . 0.0 107.446 175.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.744 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 73.7 33.4 1.04 Allowed 'General case' 0 C--N 1.346 0.425 0 CA-C-N 114.368 -1.287 . . . . 0.0 112.028 -178.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.594 ' OD1' HD11 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -122.24 28.1 7.64 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.832 177.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.461 ' ND2' ' CG2' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -57.83 143.72 41.29 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.6 ' CE1' HD13 ' A' ' 78' ' ' LEU . 1.3 m-30 -95.06 138.62 32.54 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.591 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -119.56 135.61 54.71 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 112.036 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 44' ' ' GLN . 64.1 t-20 -133.52 114.24 13.37 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.15 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.681 HD21 HG13 ' A' ' 19' ' ' VAL . 4.6 mp -144.35 168.68 19.5 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 1.1 mm -125.85 131.88 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.272 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.841 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -134.37 168.89 18.08 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.402 ' O ' ' HG ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -99.61 129.7 45.78 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.046 179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 1.116 ' HB2' HD12 ' A' ' 37' ' ' LEU . . . -144.62 141.76 29.63 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.066 0.46 . . . . 0.0 112.194 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -142.06 165.4 27.54 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.507 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -94.74 -13.8 25.36 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.94 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 0.1 OUTLIER -153.82 150.98 24.0 Favored Pre-proline 0 N--CA 1.465 0.313 0 CA-C-O 121.213 0.53 . . . . 0.0 112.109 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 65' ' ' SER . 19.3 Cg_exo -63.65 -37.7 45.28 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.554 2.836 . . . . 0.0 113.026 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -80.85 9.05 6.91 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -124.1 167.45 14.2 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.228 0.537 . . . . 0.0 111.728 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.521 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 4.7 m-85 -68.79 166.18 18.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.368 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 m -119.84 131.86 55.41 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.951 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 95' ' ' PHE . 1.5 mmmp? -110.51 155.0 22.89 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.041 -0.264 . . . . 0.0 110.47 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.559 ' O ' ' HB2' ' A' ' 94' ' ' LEU . 20.8 m-85 -85.23 138.04 32.6 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.19 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 1.009 ' CE2' ' HB3' ' A' ' 62' ' ' ALA . 5.9 m-30 -125.71 140.37 52.76 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.949 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.482 ' HB2' HD12 ' A' ' 59' ' ' ILE . 3.6 t-20 -111.95 119.2 37.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.782 0.325 . . . . 0.0 110.424 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 91' ' ' PHE . 34.3 m -128.78 158.91 41.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.496 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.08 127.36 73.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.724 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.674 HG21 HG22 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -124.53 145.41 31.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.047 0.451 . . . . 0.0 111.751 -179.388 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.6 HD13 ' CE1' ' A' ' 55' ' ' TYR . 9.4 tp -114.32 127.0 55.65 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.784 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 53' ' ' ASP . 0.9 OUTLIER -91.91 127.97 37.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.558 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.01 139.99 52.97 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.688 ' HB2' ' HB3' ' A' ' 52' ' ' TRP . . . -93.72 -30.34 14.94 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.791 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.0 m -54.23 -39.3 66.64 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.241 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -101.98 -3.86 27.04 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.457 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 54.56 53.77 10.23 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-O 120.996 0.427 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.2 t -171.49 -173.95 1.32 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.755 HD12 HG12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -101.45 165.97 10.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.798 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -147.91 128.69 14.3 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.026 179.738 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.611 ' CB ' ' HG2' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -82.63 121.9 27.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.454 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 77' ' ' VAL . 2.5 t -83.57 -55.02 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -155.45 156.18 34.84 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.353 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.937 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.4 t80 -124.72 123.05 39.17 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.507 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.517 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 7.1 t -131.78 142.97 47.16 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.911 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.517 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.4 Cg_endo -86.99 138.6 5.03 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.008 2.472 . . . . 0.0 112.176 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -105.63 20.5 18.8 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' HB3' ' HB3' ' A' ' 71' ' ' LYS . 47.8 p90 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.068 -0.968 . . . . 0.0 111.469 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 CA-C-O 120.081 -0.288 . . . . 0.0 112.592 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.74 148.6 52.95 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.651 2.234 . . . . 0.0 112.556 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.56 -72.06 0.95 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.635 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.572 ' HD2' ' HA2' ' A' ' 7' ' ' GLY . 1.1 Cg_endo -82.99 -172.7 1.46 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.279 2.653 . . . . 0.0 112.398 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.14 -38.49 69.2 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.027 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.5 mp -86.7 -46.87 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.572 ' HA2' ' HD2' ' A' ' 4' ' ' PRO . . . 105.53 -138.05 14.06 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.829 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -132.7 162.13 32.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.681 0.276 . . . . 0.0 110.824 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 t -99.16 112.68 31.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.878 0.37 . . . . 0.0 111.384 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 22.8 pt -140.16 138.91 37.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.277 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.39 -170.97 24.48 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.268 -0.491 . . . . 0.0 112.283 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.728 HG13 HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -96.78 147.97 5.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 117.212 0.506 . . . . 0.0 111.218 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 t -79.24 151.38 31.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.694 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 p -63.53 -21.83 29.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -53.01 -35.77 59.76 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.601 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 15.1 t0 -57.25 111.12 3.0 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.258 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 16' ' ' ASP . 18.2 Cg_endo -59.89 -27.67 85.45 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.429 2.753 . . . . 0.0 113.801 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.485 ' HG2' ' CH2' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -77.64 -44.38 28.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.149 0.5 . . . . 0.0 110.068 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.728 HG21 HG13 ' A' ' 12' ' ' ILE . 54.0 t -61.53 -47.56 92.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.191 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -40.24 96.73 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 24' ' ' GLU . 14.0 pt-20 -75.0 -42.95 56.46 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 120.901 0.381 . . . . 0.0 110.99 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 56' ' ' TYR . 50.2 mt -65.0 -34.65 72.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.339 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -62.68 -48.17 80.48 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.476 ' HG2' ' N ' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -49.75 -51.28 40.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.364 178.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.667 ' CG ' ' HB2' ' A' ' 86' ' ' LEU . 32.0 t80 -56.55 -37.36 70.43 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.316 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.554 ' HB2' HG21 ' A' ' 77' ' ' VAL . . . -57.22 -48.1 79.65 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.97 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.942 HD22 ' HB3' ' A' ' 37' ' ' LEU . 1.6 tp -67.52 -43.08 81.69 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.624 ' HE2' ' CD2' ' A' ' 25' ' ' PHE . 3.7 pttm -75.03 -18.15 60.39 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.56 -39.0 32.82 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.967 0.349 . . . . 0.0 110.922 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -103.97 122.27 44.86 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.358 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -168.63 43.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.552 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -37.66 71.89 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.3 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.83 1.21 36.84 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.861 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 63.73 99.54 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.499 HD12 ' HB1' ' A' ' 62' ' ' ALA . 0.2 OUTLIER -141.31 158.41 43.92 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.354 178.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.433 HD12 ' HE3' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -116.36 125.22 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -177.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.037 HD11 ' HB2' ' A' ' 60' ' ' LEU . 3.4 tp -87.0 120.77 28.62 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.865 0.364 . . . . 0.0 110.749 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.417 ' H ' ' HA ' ' A' ' 62' ' ' ALA . . . -65.96 -34.51 78.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.895 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.85 162.57 11.32 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 119.897 -1.144 . . . . 0.0 114.186 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.62 HG22 ' CD2' ' A' ' 60' ' ' LEU . 54.2 t -67.8 136.03 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.86 0.464 . . . . 0.0 110.753 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.02 -65.76 1.14 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.619 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -153.13 146.66 25.01 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.389 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.584 ' HA3' ' HG ' ' A' ' 58' ' ' LEU . . . -146.95 -170.93 15.68 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 119.793 -1.194 . . . . 0.0 114.812 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' ASN . 17.3 mm-40 -142.16 150.74 41.46 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.558 -0.821 . . . . 0.0 111.295 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.517 HG22 ' CD ' ' A' ' 47' ' ' LYS . 63.0 mt -128.33 129.4 69.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.79 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 55' ' ' TYR . 4.7 mt -106.87 115.27 48.03 Favored 'Isoleucine or valine' 0 C--O 1.241 0.618 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.452 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.517 ' CD ' HG22 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -136.01 162.75 32.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.662 0.744 . . . . 0.0 112.829 -178.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.89 -66.92 0.01 OUTLIER Glycine 0 C--N 1.329 0.193 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.564 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -120.26 109.27 37.13 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 175.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -87.02 117.04 1.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 N-CA-C 116.226 1.587 . . . . 0.0 116.226 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.99 24.02 10.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 113.426 -1.716 . . . . 0.0 107.03 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.764 ' HA ' ' CE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER 62.88 35.51 13.48 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.44 -177.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.504 ' OD2' HD11 ' A' ' 78' ' ' LEU . 1.0 OUTLIER -122.84 28.29 7.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.389 177.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.649 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 1.1 t-20 -47.64 146.03 2.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.447 ' HB3' HD12 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -98.05 116.52 30.44 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.73 178.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.649 ' CE1' ' HB3' ' A' ' 54' ' ' ASN . 38.8 m-85 -104.87 143.0 33.74 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.206 0.527 . . . . 0.0 111.844 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 44' ' ' GLN . 15.9 t-20 -144.39 110.63 5.5 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.715 HD21 HG13 ' A' ' 19' ' ' VAL . 4.0 mp -136.74 167.35 21.6 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 73' ' ' TYR . 2.7 mm -122.04 121.62 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.042 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.037 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -125.08 168.21 13.69 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.771 0.319 . . . . 0.0 111.26 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 50.2 m -98.97 146.04 26.43 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.47 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.881 ' HB3' ' CE1' ' A' ' 73' ' ' TYR . . . -155.28 147.02 23.24 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 69' ' ' PHE . 0.0 OUTLIER -149.16 165.36 32.05 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.338 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -103.86 -5.82 21.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.29 -0.414 . . . . 0.0 112.042 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.423 ' OG ' ' HB2' ' A' ' 68' ' ' GLU . 2.2 p -146.39 143.41 18.96 Favored Pre-proline 0 N--CA 1.466 0.366 0 CA-C-O 121.136 0.493 . . . . 0.0 112.046 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.42 -27.63 54.64 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.476 2.784 . . . . 0.0 113.365 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -95.23 14.19 23.05 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.423 ' HB2' ' OG ' ' A' ' 65' ' ' SER . 7.8 mt-10 -126.78 167.23 16.05 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.46 0.648 . . . . 0.0 112.48 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.496 ' O ' ' HB3' ' A' ' 63' ' ' LYS . 5.3 m-85 -64.69 167.65 7.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.65 -1.159 . . . . 0.0 113.273 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.6 m -124.29 135.74 53.6 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.889 178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HG3' ' CD2' ' A' ' 95' ' ' PHE . 27.9 mmmt -110.37 169.98 8.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.677 0.275 . . . . 0.0 111.067 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.477 ' C ' ' HB2' ' A' ' 94' ' ' LEU . 20.4 m-85 -89.85 151.17 21.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.52 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.881 ' CE1' ' HB3' ' A' ' 62' ' ' ALA . 9.2 m-85 -141.65 141.07 33.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.34 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.436 ' CB ' HD13 ' A' ' 59' ' ' ILE . 65.2 t30 -113.72 126.39 55.19 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.495 0.188 . . . . 0.0 110.89 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.961 HG12 ' HA ' ' A' ' 91' ' ' PHE . 6.4 m -132.37 140.21 48.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-O 121.161 0.505 . . . . 0.0 112.238 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.432 HG13 HD22 ' A' ' 57' ' ' ASN . 0.6 OUTLIER -102.99 110.42 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 26' ' ' ALA . 6.2 t -113.25 136.86 48.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.568 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.649 HD12 ' N ' ' A' ' 79' ' ' GLU . 7.3 tp -112.51 131.74 55.44 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.018 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.649 ' N ' HD12 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -91.39 129.43 37.38 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.0 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' HD3' ' HB3' ' A' ' 82' ' ' SER . 1.7 ttmp? -125.4 143.79 50.82 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -101.37 -29.91 11.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.572 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.449 ' HB3' ' HD3' ' A' ' 80' ' ' LYS . 6.8 t -53.81 -43.49 69.4 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.82 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.12 9.12 36.43 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.325 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.57 58.88 3.61 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.068 0.461 . . . . 0.0 111.375 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.6 p -173.8 -174.3 0.94 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.806 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.667 ' HB2' ' CG ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -101.15 166.9 10.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.01 179.2 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.402 ' NZ ' HD23 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -147.39 121.65 9.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.016 0.436 . . . . 0.0 111.717 -179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 91' ' ' PHE . 0.0 OUTLIER -81.01 110.17 16.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.902 178.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.5 t -76.98 -50.04 21.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.596 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -150.8 146.82 26.62 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.961 ' HA ' HG12 ' A' ' 75' ' ' VAL . 1.9 t80 -125.88 119.24 27.3 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.421 178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.553 ' CG1' ' HD2' ' A' ' 93' ' ' PRO . 5.8 t -132.34 142.78 46.2 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.553 ' HD2' ' CG1' ' A' ' 92' ' ' VAL . 86.6 Cg_endo -80.34 139.04 12.83 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.925 2.417 . . . . 0.0 111.701 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.477 ' HB2' ' C ' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -112.66 47.47 1.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.242 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.481 ' CD2' ' HG3' ' A' ' 71' ' ' LYS . 3.2 p90 . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.104 -0.951 . . . . 0.0 111.855 179.406 . . . . . . . . 1 1 . 1 stop_ save_